CREMA TRATTAMENTO PSORIASI OFFERTA -50% !

Home Blog Page 98

Psorilax:Salva |crema pastosa x psoriasi

0

Psorilax: prezzo, funziona, recensioni, opinioni, dove si compra

Sfondo dell'invenzione

(0001) La psoriasi è la malattia immunologica comune dell'umanità stessa di invasione e attacco della pelle. La psoriasi può essere utilizzata come microlesione sulla zona del corpo, forse può anche attaccare la maggior parte delle superfici della pelle, delle articolazioni e degli occhi. Il danno discontinuo sulla pelle è comunemente indicato come la macchiolina della psoriasi. La vera causa psoriasica della malattia non è nota, ma è generalmente riconosciuto che questa malattia ha basi ereditarie e ambientali. La percentuale di rinnovamento della pelle non psoriasica della pelle della psoriasi nota è molto più elevata, e la quest'ultima è stata effettuata una volta ogni 28 giorni circa e la prima ha luogo una volta a 4 giorni con pochi. Sebbene il trattamento della terapia multipla psoriasica sia commerciale, la maggior parte dei trattamenti deve continuare a essere somministrata e soggetta a zone di invasione e attacco e sono organizzati effetti collaterali significativi.

(0002) la serotonina (chiamata anche 5-idrossi-triptamina o 5-HT) è il neurotrasmettitore che partecipa da vicino alla fisiopatologia neuropsicopatica di molti tipi e trattamenti. La serotonina svolge un ruolo nella diversa famiglia di molecole di recettori della serotonina (questo documento è chiamato ” Recettore 5-HT “o” 5-HTR “). Il terreno classico, sulla farmacologia, cioè, secondo l'effetto di vari antagonisti della serotonina, il recettore della famiglia della serotonina del sistema nervoso centrale (CNS) è diviso in sette (7) sottoclasse individuale.Pertanto, sebbene tutti i recettori 5-HT si combinino con la specificità della serotonina, sono diversi sulla farmacologia e dividendo altri codici genici. Finora, sono identificati dieci quattro (14) tipi di recettori della serotonina del SNC vengono controllati in modo più specifico. In particolare, questi 14 tipi indipendentemente dal recettore 5-HT possono essere suddivisi in sette (7) sottoclassi di farmacologia individuale, chiamati 5-HT1,5-HT2,5-HT3,5-HT4,5-HT5,5 -HT6 e 5-HT7. Molte trapunte in questi sottocla ss si divide ulteriormente, come questo recettore sulla farmacologia, seguendo la classificazione: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT1F, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3A , 5-HT3B, 5-HT4,5-HT5A, 5-HT6,5-HT7. Tuttavia, quando l'acido nucleico che confronta la sequenza di recettori e aminoacidi, percentuale di omogeneità e farmacologia tra la sottoclasse si divide in gruppi non correlati.

(0003) si attivano in base alle caratteristiche architettoniche, al secondo sistema di messaggistica e all'affinità di una parte o simili, 14 tipi di recettori della serotonina indipendentemente identificati che comprendono sette sottoclassi. La clonazione molecolare mostra che il recettore 5-HT appartiene almeno a due superfamiglie di proteine: il recettore collegato alla proteina GG, e ha sette domini che si estendono su membrana di inferenza (TMD) (5-HT1A, 1B, 1D, 1E, 5-HT2); Con il recettore dei canali ionici parzialmente recintato, ha quattro TMD che inferiscono (5-HT3). La sottofamiglia 5-HT2 è ulteriormente suddivisa in 3 tipi: 5-HT2A, 5-HT2B e 5-HT2C. È utile nella depressione del trattamento, ansia, psicosi e disturbo alimentare a cui sono considerati gli antagonisti del recettore 5-HT2A e 5-HT2C. Omogeneità amminoacidica totale del recettore 5-HT2A e 5-HT2C totale circa il 51% e circa l'80% dell'omogeneità del dominio che attraversa la membrana. Il recettore 5-HT2A di riorganizzazione della linea cellulare dei mammiferi, gli studi dimostrano che il recettore ha due tipi di stati affini, uno stato affine prontamente alto e uno stato affine basso.

(0004) recenti studi dimostrano che la serotonina può svolgere un ruolo nel sistema immunitario, poiché nella prova digitale esiste un recettore della serotonina che può immunizzare ogni cellula. Il problema “spirito / corpo” ha attirato persone di diversi soggetti per contare il secolo Le persone pensano sempre, hanno una relazione tra grave emozione o pressione e sistema immunitario. La serotonina è il neurotrasmettitore di ampia dispersione e noto che svolge un ruolo importante nel disturbo emotivo e nella depressione. Tuttavia il suo effetto nel regolare la risposta immunitaria non è noto, e capisce ancora meno.

(0005) documento ha riferito che la fonte esterna aggiunge l'effetto immunoregolatorio della serotonina alla cultura dei linfociti. In alcuni casi, ha dimostrato che la serotonina stimola le cellule T (Foon et al., 1976, J.Immunol.117: 1545-1552; Kut et al., 1992, Immunopharmacol.Immunotoxicol.14: 783-796; Young et al., 1993, Immunology80: 395-400), e la maggior parte dei rapporti di laboratorio aggiunge l'alta concentrazione di serotonina e sopprime la propagazione (Slauson et al., 1984, Cell.Immunol.84: 240-252; Khan et al., 1986, Int.Arch.Allergy Appl.Immunol.81: 378-380; Mossner ﹠ amp; Lesch, 1998, Brain, Behavior, and Immunity 12: 249- 271). Pertanto, se al massimo per la serotonina nella regolazione della risposta immunitaria, può avere effetto — avere questo effetto, l'arte nota non è chiara.

(0006) sulla funzione di controllo della risposta immunitaria, (1975, J.Exp.Med.142: 732-738) ipotesi nei topi, ha bisogno di serotonina per regolare la reazione super rapida (DTH) mediata da cellule di T a Gershon et al..yy l'autore di questa ricerca è con la dipendenza del carattere vasoattivo della serotonina coppia reazione DTH a causa di questa ammina biogenica.

(0007) dal Miles Research Center di West Haven, una serie di studi CT mostra che l'esistenza e la partecipazione (Aune et al., 1990, J.Immunol.145: 1826-1831 del recettore 5-HT 1a nelle persone e Mus T cell; Aune et al., 1993, J.Immunol.151: 1175-1183; Aune et al., 1994, J.Immunol.153: 1826-1831). Queste ricerche sono state stabilite, la cellula T umana che IL-2 stimola le razze che si incontrano con il triptofano idrossilasi — prontamente, partecipa al primo enzima che il triptofano trasforma in serotonina — il blocco-sopprimere e l'inibizione descritta può — cioè sopprimere il metabolita dell'enzima– -e viene invertito dall'acido dell'aggiunta di 5-idrossi triptamina e, usando l'antagonista recettoriale specifico 5-HT 1a, possono bloccare la moltiplicazione in vitro delle cellule T umane. Nel modello murino, hanno dimostrato, l'antagonista del recettore 1a piuttosto di 2 antagonismi del recettore possono sopprimere la reazione di proprietà tactiosensible nel corpo all'oxazalone, piuttosto che la risposta anticorpale.

(0008) utilizza antagonismi di tipo 1a e 2 di recettori, Laberge et al. (1996, J.Immunol.156: 310-315), la serotonina può indurre il fattore chemiotattico IL-16 dalla cellula T CD8 + e questa attività può essere soppressa dalla specificità aggiungendo 2 inibitori del recettore anziché 1a antagonista del recettore. Pertanto, il lavoro nel sistema immunitario sebbene l'arte nota mostri la serotonina, quale effetto descritto poco chiaro è, e non illustra che il sistema immunitario può essere regolato usando l'antagonista del recettore.

(0009) esiste un elenco di minoranze di riferimenti che dimostrano che la serotonina può funzionare nel sistema immunitario. Nel 1989, Askenase e il suo collega hanno dimostrato che l'antagonista 5-HTR2 può nei topi, sopprimere la reazione super rapida (DTH) della proprietà tardiva (Amiesen et al ., 1989, J.Immunol.142: 3171-3179) .Detrazioni come Amiese, “Tardy effect DTH effector possibilità T cellula funzione espressiva 5-HT2R e questi recettori potrebbero aver bisogno di attivazione nel corpo, quindi il fattore linfatico infiammatorio locale dipendenza DTH situazione che produce DTH di cellule T “. Questi dati sono successivamente fuori nel freddo e i mastociti della gente comune non contengono serotonina perché il mastocita dei roditori contiene serotonina, quindi questo risultato non è adatto per l'immunità umana. Successivamente, Aune et al. (1994, J.Immunol.153: 489-498) prova, l'antagonista 5-HTR1a può sopprimere il DTH interno del corpo di Mus e rispondere, e mostrare, l'inibizione incontro soppressore propagazione delle cellule T del triptofano idrossilasi (partecipando al primo enzima che il triptofano si trasforma in serotonina). Inoltre, questi autori forniscono una serie di informazioni importanti, ma non riescono a riconoscere il ruolo maggiore della serotonina nella regolazione della dipendenza delle cellule T.

(0010) il macrofago e il recettore dei linfociti di espressione possono alla serotonina producono le prime prove della risposta proposta nel 1984 (Roszman et al., 1984, Soc.Neurosci.10: 726). Nel tempo, mostrano che nei diversi recettori della serotonina di 14 tipi di farmacologi noti, il linfocita di tranquillizzazione è espresso ed è simile al recettore 5-HT2A, 2B, 2C, 6 e 7 (Ameisen et al., 1989, J.Immunol.142: 3171-3179; Stefulj et al., 2000, Cervello, comportamento e immunità 14: 219-224) e aumento del recettore 5-HT1A e 5-HT3 (Aune et al., 1993, J.Immunol.151: 1175-1183 quando attivazione; Meynielet al., 1997, Immunol.Lett.55: 151-160; Stefulj et al., 2000, Cervello, comportamento e immunità 14: 219-224).

(0011) sebbene non sia mai stato illustrato da chiaro se il recettore della serotonina — ha questi effetti — per i linfociti e la funzione nell'immunomodulante, ma generalmente si sa che, tranne come recettori del recettore 3 della serotonina del canale cationico, tutto questo (riassunto si riferisce a Barnes e Sharp per il recettore accoppiato alle proteine ​​g che comprende 7 domini di estensione della membrana, 1999, NeuroPharm.38: 1083-1152). Più specificamente, 1 recettore agisce sull'adenil ciclasi, provoca la modulazione verso il basso del cAMP (De Vivo ﹠ amp; Maayani, 1986, J.Pharmacol.Exp.Ther.238: 248-252).

(0012) rispetto al recettore 5-HT1A, quindi il 5-HT6 presente sulla cellula T di tranquillizzazione e il recettore 5-HT7 aumentano il lavoro del cAMP (Ruat et al., 1993, Biochem.Biophys.Res.Commun.193: 268-276 in risposta alla serotonina; Ruat et al., 1993, Proc.Natl.Acad.Sci.USA 90: 8547-8551). Nell'evidente situazione controintuitiva, 5-HT6 che esiste sulla cellula a riposo e recettore 5-HT7 dovrebbe funzionare la risposta delle cellule t che rallenta e il recettore 1a dovrebbe essere compensato dal segnale che invia dal recettore 5-HT6 e 5-HT7. L'accoppiamento positivo del recettore 5-HT2A e 5-HT2C e la fosfolipasi C e causare Ca nel cellula pura e delicata di fosfatidil-4
2+Aumento dell'accumulo, aprendo così la reazione in cascata della trasduzione del segnale della protein chinasi C (il sommario si riferisce a Boess e Martin, 1994, Neuropharmacology 33: 275-317).

(0013) prima della supposizione, nei topi la serotonina causa l'ipersensibilità ritardata mediata dalle cellule di T (DTH) (Gershon et al., 1975, J.Exp.Med.142: 732-738). La conclusione che ottiene è che la dipendenza della serotonina della coppia di reazione DTH è dovuta al carattere vasoattivo di questa ammina biogenica. Mescola l'effetto immunoregolatorio di aver riportato serotonina in letteratura. In alcuni casi, la fonte esterna 5-HT ha dimostrato di stimolare le cellule T attivate (Foon et al ., 1976, J.Immunol.117: 1545-1552; Kut et al., 1992, Immunopharmacol.Immunotoxicol.14: 783-796; Young et al., 1993, Immunology 80: 395-400), e la maggior parte del laboratorio rapporto, il 5-HT esogeno di alta concentrazione sopprime la proliferazione attiva delle cellule T (Slauson et al., 1984, Cell.Immunol.84: 240-252; Khan et al., 1986, Int.Arch.Allergy Appl.Immunol.81 : 378-380; Mossner ﹠ amp; Lesch, 1998, Cervello, Comportamento e Immunità 12: 249-271). Pertanto, potrebbe non avere alcun effetto sul sistema immunitario se si conosce la serotonina — c'è questo ef ragione, perché la spiegazione della ricerca è in proporzione armoniosa su questo neurotrasmettitore e riduce la risposta immunitaria.

(0014) esiste una domanda secolare nella terapia psoriasica del trattamento di sfruttamento, in cui detto trattamento a) non comprende e fa sì che il paziente continui la somministrazione del farmaco; B) ha un effetto collaterale minimo; E c) fornisce per molto tempo sx. La presente invenzione ha soddisfatto questa richiesta.

Il sommario dell'invenzione

(0015) la presente invenzione include il metodo di trattamento della psoriasi umana, in cui detto metodo comprende che la zona di danno utilizza la regione di lesione della psoriasi di (somministrazione intralesionale) di fenotiazina sulla pelle del paziente.

(0016) la presente invenzione comprende anche il metodo di trattamento psoriasico umano e in cui detto metodo comprende che la zona di danno utilizza la perfenazina o suoi derivati, la regione di lesione della psoriasi sulla pelle del paziente.

(0017) da un lato, la difenazina è la difenazina HCl e, dall'altro, la difenazina è la difenazina caprate (estere).

(0018) in una forma di realizzazione, la perfenazina danneggia il dosaggio di circa 2,5 μ g tra circa 50 μ g con ciascuno e gli usi. In un'altra forma di realizzazione, la perfenazina danneggia il dosaggio di circa 5 μ g tra circa 20 μ g con ciascuno e gli usi. un'altra forma di realizzazione, la perfenazina danneggia il dosaggio di circa 7,5 μ g tra circa 15 μ g con ciascuna e usi.In un'altra forma di realizzazione, la difenazina danneggia il dosaggio di circa 5 μ g tra circa 10 μ g con ciascuna e usi.In forma di realizzazione preferita, la difenazina viene utilizzato con ogni dosaggio che danneggia circa 10 μ g.

(0019) in un'altra forma di realizzazione, la perfenazina viene utilizzata con un volume di circa 0,1 ml tra circa 2 ml. In un'altra forma di realizzazione, la perfenazina viene utilizzata con un volume di circa 0,5 ml tra circa 1 ml. In un'altra forma di realizzazione, la perfenazina viene utilizzata con il volume di circa 0,75 ml tra circa 1 ml.

(0020) in un altro aspetto della presente invenzione, la perfenazina viene iniettata direttamente nella regione della lesione. Secondo il presente aspetto facoltativo della presente invenzione, la perfenazina viene somministrata nella regione della lesione mediante terapia di ionoforesi (ionoforesi).

Descrizione dettagliata dell'invenzione

(0021) la presente invenzione si riferisce al trattamento della psoriasi della malattia autoimmune nei pazienti umani. Lo schema terapeutico comprende o usa direttamente o indirettamente l'antagonista interazionale della serotonina per il paziente che ha descritto la serotonina e il recettore della serotonina interagire. Da un lato, l'applicazione può o direttamente o sopprimere indirettamente i composti interattivi della fenotiazina della serotonina e del recettore della serotonina. I composti preferiti della fenotiazina che vengono utilizzati per lo schema terapeutico della presente invenzione sono la perfenazina o suoi derivati. La via di somministrazione preferita del composto chimico perfenazina è che il composto chimico viene somministrato direttamente nella regione di lesione della psoriasi, cioè la zona di danno porta composto chimico al paziente.

(0022) le composizioni e il metodo per la descrizione della serotonina e l'inibizione interazionale del recettore della serotonina sono descritti nella pubblicazione della domanda di brevetto USA n. 2003 / 0100570. Inoltre, l'applicazione della perfenazina e dei suoi derivati ​​che regolano la risposta immunitaria è descritta nel numero di domanda PCT PCT /US03/19595. Ogni corpo integrale di questi elenchi di riferimenti è incorporato in questo documento come riferimento.Inoltre, la psoriasi curativa dell'uso di composti di fenotiazina è indicata nella pubblicazione della domanda di brevetto USA n. US2004 / 0029860 che autorizza Gil-Ad et al. e US2005 / 0013853. Tuttavia, non vengono introdotti nella zona di danno aperta del composto di queste domande di brevetto. Al contrario, la divulgazione di questi elenchi di riferimenti illustra chiaramente che l'applicazione ai composti psoriasici del trattamento con fenotiazina dovrebbe essere generalmente con cerotto, gel o unguento formano un'applicazione esterna nel paziente e in cui la pelle del paziente non fora mai in nessuna forma. In alternativa, questi elenchi di riferimenti descrivono i parenterali e trasportano composti di fenotiazina da utilizzare per il trattamento della psoriasi al paziente.

(0023) nella presente invenzione, è stato scoperto che il trasporto di composti di fenotiazina all'approccio di ottimizzazione psoriasico è che il distretto di lesione del colpo trasporta un composto chimico (consegna intralesionale) nella regione di lesione della psoriasi, in modo da fornire rapidamente un effetto benefico al paziente perché al paziente può essere somministrata una dose locale più accurata.Inoltre, quando i composti di fenotiazina esterni dell'applicazione, il paziente presenta il rischio di utilizzare un dosaggio superiore alla dose raccomandata, può causare potenzialmente effetti collaterali indesiderati. Si utilizza crema o unguento ed è particolarmente importante quando viene utilizzato dal paziente piuttosto che dal professionista che si sottopone alla formazione. Analogamente, i composti di fenotiazina di trasporto simili, endovenosi o intramuscolari alla psoriasi del trattamento del paziente forniscono potenzialmente e sono stati superiori al dosaggio del paziente al dosaggio richiesto di composto chimico, quindi causa l'aumento del rischio di effetti collaterali. La zona del danno è u il vantaggio che ha il personale sanitario professionale di conseguenza, e quindi garantisce che il dosaggio richiesto accurato sia direttamente somministrato e sottoposto all'invasione e al tessuto di attacco.

Definizione

(0024) come usato nel presente documento, seguendo ogni termine ha un significato relativo in questa parte.

(0025) l'articolo “(a)” e “uno (an)” sono usati per questo documento, e questo articolo che si intende (cioè almeno uno) più di uno o è oggetto fraseologico. Ad esempio, “a tipo di elemento chiave (un elemento) “indica un tipo di elemento chiave o più di un elemento chiave.

(0026) come qui utilizzato, “alleviare (alleviare)” la malattia indica l'ordine di gravità che riduce uno o più sintomi descritti della malattia.

(0027) termine dispositivo di somministrazione (applicatore) “; come qui usato termine; essere inteso per essere usato per usare qualsiasi dispositivo che la serotonina e l'inibitore interattivo della serotonina del recettore della serotonina ricevono da psoriatico, includendo ma non limitandosi a tale iniezione sottocutanea siringa, pipetta, apparato di ionoforesi o simili.

(0028) termine “dose efficace”, come usato nel presente documento, la quantità che significa inibitore è sufficiente per mediare la riduzione rilevabile della trasduzione del segnale della serotonina che trasmette dal recettore della serotonina sulla cellula. Utilizzare un metodo standard ben noto nella tecnica, può stimare la trasmissione del segnale della serotonina, come ma non essere limitato al metodo secondo cui è descritto un altro posto di questo documento, comprendono ad esempio che è piatto e / o stimare il livello di attivazione cellulare per stimare l'acqua legata di serotonina e recettore.

(0029) il personale tecnico comprenderà che, tale importo può cambiare e può essere in base a molti fattori facilmente determinabili dalla malattia da trattare o dalla malattia, dalle persone che hanno trattato l'età e la salute e la salute, l'ordine di gravità di malattia, il particolare composto dell'uso ecc.

(0030) “omogeneità” è usata per questo documento, si intende due somiglianze di sequenza di subunità tra la molecola di polimero, per esempio, e tra due molecole di acido nucleico, ad esempio, tra due molecole di DNA o due molecole di RNA, o tra due peptidi molecole Quando il sito della subunità di due molecole era occupato da una subunità monomerica identica, ad esempio, se quando la posizione in ciascuna delle due molecole di DNA è occupata dall'adenina, allora avevano l'omologia in questa posizione. L'omologia tra due sequenze è la diretta funzione di accoppiamento o numero di sito omologa, ad esempio, se metà nel sito in due sequenze di composti chimici (ad esempio, in lunghezza è 5 siti nel polimero di 10 subunità) hanno omologia, quindi queste due sequenze hanno il 50% di omologia, se Il 90% nel sito, ad esempio, in 10 siti 9 sono accoppiati o omologhi, quindi queste due sequenze hanno l'omologia del 90%. Ad esempio, la sequenza di DNA 3 'ATTGCC5' e 3 'TATGGC hanno l'omologia del 50%. quest'area, termine “omogeneità” e sinonimo di “omologia”.

(0031) Il termine “risposta immunitaria” viene utilizzato in questo articolo, si intende il processo che provoca l'attivazione della funzione effettrice nella cellula T, cellula B, cellula NK (NK) e / o cellula presentante l'antigene e / o inattivazione. Pertanto, come esperto nella tecnica per comprendere, la risposta immunitaria include, ma non si limita a, l'attivazione dell'anafilassi quella specificità antigenica a cui qualsiasi cellula T di supporto rilevabile o cellula T citotossica viene risposta o allos attiva, produce anticorpo, T è mediata da cellule ecc.

(0032) il termine “immunocita” intende partecipare a causare immunoreattivo qualsiasi cellula usata qui. Questa cellula include ma non si limita a, cellula T, cellula B, cellula NK, cellula presentante l'antigene ecc.

(0033) il termine “inibitore interazionale della serotonina e del recettore della serotonina” viene utilizzato per questo documento, si intende qualsiasi composto chimico o molecola in grado di sopprimere la trasduzione del segnale intrapresa dai recettori del tipo serotonina con il rilevamento. Questo composto chimico comprende il recettore della serotonina antagonista, agonista inverso ecc.

(0034) “materiale espositivo (materiale didattico)”, come usando questo termine nel presente documento, comprende la pubblicazione, la registrazione, la carta o può essere usato per trasmettere il composto chimico della presente invenzione nel kit di test in qualsiasi altro mezzo di espressione per realizzare alleviando o trattare la funzionalità della psoriasi. Il materiale espositivo del kit di test può, ad esempio, investire nel contenitore che contiene il composto chimico della presente invenzione, magari trasportare con il contenitore che contiene il composto chimico descritto. In alternativa, il materiale espositivo può separare il trasporto con contenitore, e intenzione è, materiale per istruzioni di collaborazione per il ricevitore e il composto chimico.

(0035) “trasporto della zona di danno” come utilizzato per questo documento, si intende che il composto chimico viene consegnato direttamente alla regione della lesione della psoriasi sulla pelle. Questo termine comprende il composto chimico dell'iniezione diretta nella regione della lesione, comprende anche il trasporto della regione della lesione della psoriasi di composto chimico sulla pelle, in cui la pelle non si rompe durante il trasporto (ad esempio, metodo di trasporto ionoforetico ecc.) Tuttavia l'applicazione della crema, unguento, cerotto e il gel che vengono applicati direttamente sulla pelle si è chiaramente liberata in questo termine .

(0036) “recettore della serotonina” comprende il polipeptide con il legame specifico della serotonina.

(0037) il termine “legame specifico” è come usato qui, si riferisce all'identificazione e (prontamente in combinazione con l'albume della famiglia serotonina che esiste nel campione, l'albume dopaminergico, l'albume adrenergico, l'istamina, la melatonina e la serotonina), ma non riconoscimento o congiuntamente fondamentalmente con il recettore di altre molecole nel campione.

(0038) il termine “trattamento” è come qui usato, si riferisce a ridurre la frequenza della malattia o della malattia, quindi la frequenza del sintomo in uno o più sintomi della malattia di riduzione dell'esperienza o della malattia degli animali.

Descrivere

(0039) la presente invenzione si riferisce al trattamento del metodo psoriasico delle persone, in cui detto metodo comprende il distretto di lesioni del colpo di stato dei suoi pazienti porta composto chimico. Come menzionato sopra, il composto chimico è la fenotiazina preferibilmente, più preferibilmente la perfenazina o suoi derivati. Tuttavia, ciò che è necessario evidenziare è, sebbene la divulgazione fornita nel presente documento sia descritta come la difenazina come composto preferito, solo la perfenazina è inclusa nel presente documento che trasporta un composto chimico per trattare un esempio di composto chimico psoriasico per il paziente come utilizzato dalla zona di danno. l'invenzione deve essere interpretata come, e comprende il derivato della perfenazina e altre fenotiazine, sebbene il composto chimico esemplare in effetti della presente invenzione sia una perfenazina. La presente invenzione dovrebbe anche essere interpretata come e comprende qualsiasi altro inibitore della serotonina e la sua interazione con l'accettore, e in cui detto inibitore è trasportato dalla zona di danno ed è arrivato al paziente.

(0040) applicabile a quella perenazina di grado farmaceutico HCl della presente invenzione che può derivare da più fonti, comprende American Pharmaceutical Partners (Schaumburg, IL). Nel contesto dell'invenzione, l'intenzione di perfenazina HCl comprende perfenazina HCl e derivato di perfenazina HCl, analogo , il metabolita e il suo profarmaco di stricti jurise. In particolare, la difenazina caprato (estere) deve essere interpretata come comprendente in particolare la presente invenzione. L'effetto della perfenazina caprato (estere) è identico all'effetto della perfenazina HCl. Tuttavia, il caprate della perfenazina ( derivato estere) provoca la durata della recitazione che si prolunga dal rilascio lento del sito di iniezione. La lattina di perfenazina caprate (estere) di grado farmaceutico (Bedford OH) si ottiene da Bedford Lab. Questo documento sottolinea anche, e noto anche nel nome d'arte della perfenazina si chiama Prolixin
TME permesso
TM

(0041) sebbene la forma di perfenazina applicata come, la difenazina viene applicata direttamente nel danno psoriasi sulla pelle psoriasica. Questo per rendersi conto che mediante iniezione di uso di spilli e siringhe o una serie di spilli e qualche tipo o dispositivo di iniezione in cui in realtà la pelle forare o rompere. In alternativa, la perfenazina viene applicata ai danni mediante ionoforesi, utilizza la tecnologia di ionoforesi comune ben nota agli esperti del settore. Vengono definite la ionoforesi o la gestione della trasmissione elettrica (ElectroMotive Drug Administration) e (EMDA) e utilizzano corrente unidirezionale con la pelle esterna dell'introduzione della medicina ionizzata. La ionoforesi è molto efficace per trasportare la medicina al metodo per essere attaccato la posizione. Essere diversi dalla medicina viene consegnato direttamente alle aree di infiammazione, la ionoforesi della medicina viene inviata la medicina di alta concentrazione organizzando in media. Esistono diverse apparecchiature e metodi, utilizzati per la pelle della medicina ionica tric osmose per le persone. Ad esempio, ProMed Products, RA FischerCompany e altri accordi di fornitura sono utilizzati per produrre medicinali per il progresso della ionoforesi cutanea.Inoltre, il metodo e l'apparato di ionoforesi più recenti sono descritti nel brevetto statunitense numero RE38.341, RE38, 000, RE37.796 e RE36.626 e domanda n. 2004/0039328 in, tutti autorizzano Henley e incorporano questo documento come riferimento con un corpo integrale.

(0042) il dosaggio di perfenazina che viene applicato a ciascun danno del paziente è considerato come la perfenazina da circa 0,1 μ g a circa 100 μ g. Preferibilmente, l'ambito della quantità di perfenazina è che ciascuno danneggia circa 1 μ g a circa 100 μ g di perfenazine. Più preferibilmente, la quantità di perfenazina di applicazione di ciascun danno è estremamente circa 100 μ g di circa 2,5 μ g, ancor più preferibilmente, è che circa 5,0 μ g sono circa 100 μ g; Ancora più preferibilmente, sia che circa 7,5 μ g sono circa 75 μ g; Più preferibilmente, sia da circa 10 μ g a circa 60 μ g; Ancora più preferibilmente, sia che circa 10 μ g sono circa 50 μ g; Ancora più preferibilmente, essere da circa 10 a circa 40 μ g; Più preferibilmente, sia da circa 10 μ g a circa 30 μ g; Ancora più preferibilmente, sia che da circa 10 μ g siano a circa 20 μ g; Più preferibilmente, sia che ciascuno danneggi circa 10 μ g di perfenazine approssimativamente. Si dovrebbe apprezzare che anche la quantità di perfenazina è contenuta nella presente invenzione rispetto a un aumento minore descritto nel presente documento, purché rientri nell'ambito aperto.

(0043) la perfenazina preferita viene applicata a che il volume del danno è inferiore a circa 3 ml, preferibilmente circa 2,5 ml, più preferibilmente da circa 2,0 ml ancora più preferibilmente da circa 1,5 ml ancora più preferibilmente da circa 1,0 ml, e anche il volume è inferiore al 1 ml, includere ma non limitato a circa 750 μ l, 500 μ l, 250 μ l, 100 μ l, 75 μ l, 50 μ l, 25 μ l, 10 μ l, 5 μl e anche essere da basso a moderato circa 1 μ l. Inoltre, comprende nella presente invenzione meno dell'aumento di volume come qui descritto, purché rientri nell'ambito come qui descritto.

(0044) il personale tecnico è generalmente medico addestrato, conoscerà e userà la perfenazina per danni arbitrari con l'uso dell'intera frequenza del paziente.Ad esempio, la frequenza di somministrazione cambierà in base al numero di gravità della malattia, danno da trattare e dimensioni, guarigione della ferita velocità, età e sesso del paziente, salute generale del paziente e altri fattori evidenti del personale tecnico.

(0045) la preparazione di perfenazina concreta applicata cambierà il fattore che dipenderà anche dal cospicuo numero arbitrario di personale tecnico.Il vettore farmaceuticamente accettabile include ma non è limitato a glicerolo, acqua, soluzione salina, etanolo e altre soluzioni saline farmaceuticamente accettabili come il fosfato e sale di acido organico. L'esempio di questi e altri trasportatori farmaceuticamente accettabili è descritto nella Remington's Pharmaceutical Sciences (1991, Mack Publication Co., NewJersey), la cui divulgazione è incorporata in questo documento come riferimento, è descritta in questo documento come il suo corpo integrale. Inoltre, i preparati farmaceutici concreti di perfenazina e loro derivati ​​e altre fenotiazine sono divulgati nella domanda di brevetto degli Stati Uniti di presentazione simultanea, domanda di esercizio è che il suo intero corpo integrale di divulgazione è incorporato in questo documento come riferimento in ” Nuove formulazioni per le fenotiazine; compresa la fenofenazina e la sua D erivativi “.

(0046) la composizione farmaceutica può preparare, sigillare o vendere sotto forma di acqua iniettabile sterile o sospensioni o soluzioni oleose. Questa sospensione o soluzione può essere preparata secondo la tecnologia nota e può comprendere un altro disperdente di composizione come descritto nel presente documento, agente bagnante o sospensione agente eccetto quel componente attivo.Questi preparati sterili possono essere utilizzati possono accettare preparati diluenti o solventi al di fuori dell'intestino non tossico, come, ad esempio, acqua o 1,3 butilenglicole.Altri possono accettare diluenti e solventi che includono ma non sono limitati alla soluzione di Ringer, soluzione isotonica di cloruro di sodio ed espressa oi, come monogliceride sintetico o digliceride.

(0047) la composizione farmaceutica che viene utilizzata per il metodo dell'invenzione può essere usata, preparata, sigillata e / o venduta per essere adatta alla dannosa preparazione interna del trasporto.La preparazione di altre considerazioni comprende la proiezione di nanoparticelle (nanoparticelle proiettate), liposomiale formulazione, contiene l'eritrocito di nuovo sigillante del componente attivo e basato sulla preparazione immunologica. Le composizioni possono comprendere un trasportatore farmaceuticamente accettabile e un aumento noto e aiutare altre composizioni della somministrazione del medicamento.Preparare che altri sono possibili come nano-particella, liposoma, l'eritrocita di sigillatura di nuovo e può anche essere utilizzato per il composto chimico viene trasmesso al paziente in base al sistema immunologico.

(0048) come qui usato, il termine “trasportatore farmaceuticamente accettabile” significa tale composizione chimica che: il componente attivo può mescolarsi con esso e, dopo la miscelazione, può essere usato per il componente attivo descritto viene somministrato all'oggetto.

(0049) come qui usato, il termine estere o sale “fisiologicamente accettabile” indica l'estere o la forma salina del componente attivo, e qualsiasi altra compatibilità di componente di se stesso e composizione farmaceutica è innocua per l'oggetto dell'uso delle composizioni.

(0050) la preparazione di una combinazione di farmaci come qui descritta può essere effettuata con qualsiasi metodo noto o con il metodo dopo che questo si è sviluppato nella preparazione del campo farmaceutico. In una parola, questi metodi di preparazione comprendono un componente attivo e un trasportatore o uno o più altri elementi ausiliari sono associati, se desiderato o necessario, e successivamente con la modellatura o il sigillo del prodotto e richiesta unità monodose o dose multipla.

(0051) la composizione farmaceutica della presente invenzione può essere con dose unitaria singola o grandi quantità di preparati di una pluralità di dose unitaria singola, imballaggio o vendita. Come usando in questo documento, “dose unitaria (dose unitaria)” è il discreto quantità di composizione farmaceutica che contiene il componente attivo del volume programmato.La quantità di componente attivo è generalmente uguale e verrà applicata al dosaggio del componente attivo dell'oggetto o della parte adatta di questa dose di classe, ad esempio, e come 1 / 2o o 1/3 di questo dosaggio di classe.

(0052) relative quantity of active component in the pharmaceutical composition of the present invention, pharmaceutically acceptable carrier and any other composition is with variable, and this depends on identity, stature and the situation of institute's treatment target, and further depends on the approach of using compositions.As example, compositions can comprise the active component between 0.1% to 100% (w/w).Controlled or the extended release preparation of pharmaceutical composition of the present invention can be used the routine techniques preparation.

(0053) the present invention includes and relate to damage zone and carry phenothiazine compounds such as perphenazine to give psoriatic's all ingredients box.This test kit comprises the chemical compound of effective dose and further comprises applicator and use their expository material.Though exemplary test kit is included in herein, in view of disclosure of the present invention, the content of other useful test kit will be conspicuous to the technical staff.In these test kits each comprises in the present invention.

(0054) the present invention further considers that damage zone uses the perphenazine or derivatives thereof and give the patient, and its steroid is co-administered.Steroid does not need to use simultaneously with the perphenazine chemical compound.But steroid can be before using perphenazine, afterwards or during be administered to the patient, and in these schemes each should be interpreted as being included in the term ” associating ” that this paper uses.Steroid can external application in patient's injury region, steroid damage zone is as described herein used, perhaps steroid can per os, carry any alternate manner of steroid to use in parenteral or this area.The non-limitative example that is used for steroid of the present invention comprises dexamethasone, tazarotene (tazarotene) and methotrexate.Also consider to use non-steroidal compound, include but not limited to be used for the treatment of psoriasic etrentinate and Accutane (isotretinoin) and perphenazine associating, as disclosed herein.

(0055) each and the disclosure of each patent, patent application and publication quoted of this paper all is incorporated herein by reference.

(0056) although the present invention discloses with reference to the specific embodiment, clearly, others skilled in the art can design other embodiment of the present invention and variation, and do not deviate from true spirit of the present invention and scope.The claims intention is interpreted into and comprises all these class embodiment and equivalent variations.

Psorilax:Prezzo elevato |crema per assottigliare la pelle da psoriasi

0

Psorilax: prezzo, funziona, recensioni, opinioni, originale


1-8
UN
B
C
D
E
F
sol
H
io
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z



p-Acetamidophenol vedere
acetaminofene
p-Aminohippurate vedere
Acido p-aminoinoppurico

Browser meshAcido p-aminoinoppurico

QU 62
p-diidrossibenzeni vedere
idrochinoni
p-Hydroxyacetanilide vedere
acetaminofene
p-idrossifenil-orciprenalina vedere
fenoterolo
p-Hydroxyphenylorciprenaline vedere
fenoterolo
p, p'-DDE vedere
Dichlorodiphenyl Dichloroethylene
p', p'-DDT vedere
DDT
p, p-diclorodifenildicloroetilene vedere
Dichlorodiphenyl Dichloroethylene
P1 Purinoceptor vedere
Recettori, purinergici P1
Purinoceptor P1 vedere
Recettori, purinergici P1
P2 Purinoceptor vedere
Recettori, purinergici P2
P2 Purinoceptors vedere
Recettori, purinergici P2
P2 Wave vedere
Potenziali evocati
P200 potenziali evocati vedere
Potenziali evocati
p25 Presequenza peptide-citocromo ossidasi vedere
Complesso di trasporto di elettroni IV
P50 potenziali evocati vedere
Potenziali evocati
P50 Wave vedere
Potenziali evocati
P600 potenziali evocati vedere
Potenziali evocati
Test additivo seriale uditivo vedere
Test neuropsicologici

Browser meshPacemaker, artificiale

WG 26
Guarda anche
Stimolazione cardiaca, artificiale
Pacemaker, biologico vedere
Orologi biologici
Pacemaker, biologici vedere
Orologi biologici
Pacemaker, biologici vedere
Orologi biologici
Pachymeninges vedere
Dura madre
pachimeningite vedere
Meningite
Pachymeninx vedere
Dura madre
Americani delle isole del Pacifico vedere
Oceanic Ancestry Group
Americani delle isole del Pacifico vedere
Oceanic Ancestry Group
Delfini bianchi del Pacifico vedere
delfini
Stimolazione, cardiaca, artificiale vedere
Stimolazione cardiaca, artificiale
Inserti del pacchetto vedere
Etichettatura del prodotto
Inserti del pacchetto, farmaco vedere
Etichettatura dei farmaci
Imballaggio, droga vedere
Imballaggio farmaceutico
Imballaggio, alimenti vedere
Imballaggi alimentari
Volume di globuli rossi compresso vedere
ematocrito

Browser meshpaclitaxel

QV 269
Paclitaxel, (4 alfa) -Isomero vedere
paclitaxel
PACS (Radiologia) vedere
Sistemi di informazione radiologica
Paddock marca 1 di carbone attivo vedere
Carbone
Paddock Brand 2 di carbone attivo vedere
Carbone
Padutin vedere
callicreine
PAF-Acether vedere
Fattore di attivazione piastrinica
Malattia Di Paget, Osso vedere
Osteite Deformante
Malattia di Paget dell'osso vedere
Osteite Deformante
La malattia ossea di Paget vedere
Osteite Deformante
PAH vedere
Acido p-aminoinoppurico
Carenza di PAH vedere
Phenylketonurias

Browser meshDolore
Generale
WL 704
Diagnosi
WB 176
Infermieristica (generale)
WY 160.5
Prevenzione e controllo
WL 704.6
Terapia vedere
Gestione del dolore
Terapia farmacologica
WL 704.6
Localizzato, per sito
Guarda anche
Analgesia
Guarda anche
analgesici
Guarda anche
Cure palliative
Valutazione del dolore vedere
Misurazione del dolore
Dolore, bruciore vedere
Dolore
Centri del dolore vedere
Cliniche del dolore
Dolore, cronico vedere
Dolore cronico

Browser meshCliniche del dolore

WL 27-28
Dolore, schiacciamento vedere
Dolore
Disturbo del dolore vedere
Disturbi Somatoformi
Dolore, facciale vedere
Dolore facciale

Browser meshDolore, intrattabile
Generale
WL 704
Diagnosi
WB 176
Infermieristica (generale)
WY 160.5
Prevenzione e controllo
WL 704.6
Terapia vedere
Gestione del dolore
Terapia farmacologica
WL 704.6
Localizzato, per sito

Browser meshGestione del dolore
Generale
WL 704.6
Infermieristica (generale)
WY 160.5
Di malattie specifiche, con assistenza infermieristica della malattia o con il campo speciale dell'assistenza infermieristica, ad es.
Infermieristica oncologica
WY 156
Localizzato, per sito
Guarda anche
Malattia cronica

Browser meshMisurazione del dolore
Generale
WB 176
In malattie specifiche, con la malattia
Guarda anche
Soglie sensoriali
Dolore, mestruale vedere
dismenorrea
Dolore, migratorio vedere
Dolore

Browser meshPercezione del dolore

WL 704

Browser meshDolore, postoperatorio

WO 184
Dolore, radiante vedere
Dolore
Recettori del dolore vedere
nocicettori
Unità antidolorifiche vedere
Cliniche del dolore
Sensazione del dolore diminuita vedere
Disturbi somatosensoriali
Servizio del dolore, acuto vedere
Cliniche del dolore
Dolore, spaccatura vedere
Dolore
Sindrome da dolore di tipo I, complesso regionale vedere
Distrofia simpatica riflessa
Sindrome del dolore di tipo I, regionale, complessa vedere
Distrofia simpatica riflessa
Sindromi dolorose, complesso regionale vedere
Sindromi dolorose regionali complesse

Browser meshDipingere
Avvelenamento da piombo
QV 292
Rischi per la salute sul lavoro, ecc.
WA 400-495

Browser meshDipinti
Relativo alla medicina
WZ 331
Relativo alla psichiatria
WM 49

Browser meshApprendimento associato associato
LB 1064
Paladin Marchio di Alprostadil vedere
alprostadil
Paladin Brand of Testosterone vedere
Testosterone

Browser meshNeoplasie Palatali
Generale
WV 410
Lavora per il dentista
WU 280

Browser meshOtturatori palatali

WV 440

Browser meshPalato

WV 410
Guarda anche
Palatoschisi
Guarda anche
Neoplasie Palatali

Browser meshPalato, duro

WV 410
Osso palatino vedere
Palato, duro

Browser meshTonsil Palatina

WV 430
Guarda anche
Tonsillectomia
Incompetenza palato-faringea vedere
Insufficienza Velofaringea
paleocortex vedere
Corteccia cerebrale

Browser meshPaleodontology
GN 209
Guarda anche
Dente

Browser meshPaleografia
Z 105-115.5

Browser meshPaleontologia
Come professione QE 714.7
Guarda anche
Fossili
Guarda anche
mummie

Browser meshpaleopatologia

QZ 11.5
In medicina veterinaria SF 758
Paleostriatum vedere
Globus Pallidus
I palestinesi vedere
arabi
Palicourea vedere
Rubiaceae
Palitrex vedere
Cephalexin

Browser meshPalladio
Chimica dentale e metallurgia
WU 180
Chimica inorganica QD 181.P4
Farmacologia
QV 290

Browser meshCure palliative
Generale
WB 310
Neonato o bambino
WS 220
Vedi infermieristica
Infermieristica ospedaliera e cure palliative
Guarda anche
Infermieristica ospedaliera e cure palliative
Guarda anche
Dolore
Guarda anche
Medicina Palliativa
Medicina delle cure palliative vedere
Medicina Palliativa
Cure infermieristiche vedere
Infermieristica ospedaliera e cure palliative

Browser meshMedicina Palliativa

WB 310
Guarda anche
Infermieristica ospedaliera e cure palliative
Guarda anche
Cure palliative
Infermieristica Palliativa vedere
Infermieristica ospedaliera e cure palliative
Cure palliative di supporto vedere
Cure palliative
Chirurgia Palliativa vedere
Cure palliative
Terapia Palliativa vedere
Cure palliative
Trattamento palliativo vedere
Cure palliative
pallidum vedere
Globus Pallidus
Reazione a foglia di palma vedere
Muco cervicale
Palmo della mano vedere
Mano
Palm Pilot vedere
Computer, palmare
Riflesso palmo-mentale vedere
Riflesso, Anormale
Cheratoderma palmoplantare vedere
Cheratoderma, Palmoplantar
Pustolosi di Palmoplantaris vedere
Psoriasi

Browser meshPalpazione

WB 275
Congiuntiva palpebrale vedere
Congiuntiva
Palpitin vedere
Disopyramide
Palpitine vedere
Disopyramide
Paralisi vedere
Paralisi
Paralisi, sopranucleare progressiva vedere
Paralisi sopranucleare, progressiva
paludism vedere
Malaria

Browser meshopuscoli
collezioni
W6
Funziona su Z 691
Altri, per argomento

Browser meshPan Paniscus
Generale QL 737.P94
Come animali da laboratorio
QY 60.P7
Guarda anche
Malattie delle scimmie

Browser meshPan troglodytes
Generale QL 737.P94
Come vettori di malattia
QX 720
Come animali da laboratorio
QY 60.P7
Guarda anche
Malattie delle scimmie
Enfisema Panacinar vedere
Enfisema polmonare
Panacrine vedere
Danazol
Panadol vedere
acetaminofene
Panafcort vedere
prednisone
Panasol vedere
prednisone
Panavir vedere
probucolo

Browser meshPanax
Come pianta medicinale
QV 766.5.P2
Distribuzione geografica
QV 770
Panax ginseng vedere
Panax
Sindrome di Panayiotopoulos vedere
Epilessie parziali

Browser meshSindrome Di Pancoast

WF 658
Tumore di Pancoast vedere
Sindrome Di Pancoast
Sindrome di Pancoast vedere
Sindrome Di Pancoast

Browser meshPancreas

WI 800-830
Chirurgia generale
WI 830
Neonato o bambino
WS 310
Guarda anche
Fibrosi cistica
Guarda anche
Isole di Langerhans
Guarda anche
pancreatectomia

Browser meshPancreas, Artificiale

WI 830
Pancreas, endocrino artificiale vedere
Sistemi di infusione di insulina
Cancro al pancreas vedere
Neoplasie Pancreatiche
Pancreas, Endocrino vedere
Isole di Langerhans

Browser meshPancreas, Esocrino

WI 800-830
Neoplasie Di Pancreas vedere
Neoplasie Pancreatiche

Browser meshTrapianto Di Pancreas

WI 830

Browser meshpancreatectomia

WI 830
Cancro del pancreas vedere
Neoplasie Pancreatiche

Browser meshCisti Pancreatica

WI 803
Fibrosi cistica pancreatica vedere
Fibrosi cistica

Browser meshMalattie Pancreatiche
Generale
WI 803
Neonato o bambino
WS 311
Chirurgia
WI 830
Per una malattia specifica, con malattia
Guarda anche
iperinsulinismo

Browser meshCondotte pancreatiche

WI 802

Browser meshFistola Pancreatica

WI 803

Browser meshTest di funzionalità pancreatica

QY 140

Browser meshOrmoni pancreatici

WK 802
Isole Pancreatiche vedere
Isole di Langerhans
Trapianto di isole pancreatiche vedere
Trapianto delle isole di Langerhans

Browser meshSucco pancreatico

WI 802
Guarda anche
tripsina

Browser meshNeoplasie Pancreatiche

WI 810

Browser meshPseudocisti Pancreatica

WI 803

Browser meshpancreaticoduodenectomia

WI 980

Browser meshPancreatite

WI 805

Browser meshPancreatite, necrotizzante acuta

WI 805

Browser meshPancreatite Cronica

WI 805
pancreatoduodenectomia vedere
pancreaticoduodenectomia
pancreozimina vedere
cholecystokinin
Recettori del pancreozymin vedere
Recettori, colecistochinina
Panda, Gigante vedere
Ursidae
Panda, maggiore vedere
Ursidae

Browser meshpandemie
Generale
WA 105
Malattie specifiche per malattia
Pangen vedere
collagene
Panhematin vedere
Hemin
panipopituitarismo vedere
ipopituitarismo

Browser meshPanico

WM 172
Attacchi di panico vedere
Malattia da panico

Browser meshMalattia da panico

WM 172
Enfisema panlobulare vedere
Enfisema polmonare

Browser meshPanniculite Nonsulare Non Suppurativa

WR 140

Browser meshpanoftalmite

WW 140
Radiografia panoramica vedere
Radiografia, panoramica
Panotitis vedere
Otite
Panpharma Marca di strepomicina solfato vedere
Streptomicina
Pantomography vedere
Radiografia, panoramica
Pantopon vedere
Oppio

Browser meshAcido pantotenico

QU 187
Pap test vedere
Test di Papanicolaou
Pap test vedere
Test di Papanicolaou

Browser meshpapaina

QU 136
Papanicolaou Smear vedere
Test di Papanicolaou

Browser meshTest di Papanicolaou
Generale
QY 95
Macchie vaginali
WP 141

Browser meshpapaver

QV 766-770
Guarda anche
Oppio
Papaver somniferum vedere
papaver
papaveretum vedere
Oppio

Browser meshCarta
Rifiuti industriali
WA 778
Stampa Z 237, ecc.
Cromatografia su carta vedere
Cromatografia, carta
Papilla, interdentale vedere
gengiva
Carcinoma papillare della tiroide vedere
Cancro alla tiroide, papillare
Meningioma papillare vedere
meningioma

Browser meshMuscoli Papillari

WG 201-202
Carcinoma a cellule renali papillari vedere
Carcinoma, cellule renali
Carcinoma papillare della tiroide vedere
Cancro alla tiroide, papillare

Browser meshpapilledema

WW 280
Guarda anche
Oftalmoscopia
Papilledema associato a riduzione della pressione intraoculare vedere
papilledema
Papilledema associato ad aumento della pressione intracranica vedere
papilledema
papillite vedere
papilledema
Papillite, ottica vedere
papilledema

Browser meshpapilloma

QZ 365
Localizzato, per sito
Papilloma, Shope vedere
Infezioni da virus tumorali
Papilloma, cellula squamosa vedere
papilloma
papillomatosi vedere
papilloma

Browser meshPapillomaviridae

QW 166

Browser meshInfezioni Da Papillomavirus

QZ 204

Browser meshVaccini del papillomavirus
Generale
QZ 204
Per la prevenzione delle neoplasie cervicali uterine
WP 480
Guarda anche
Vaccini contro il cancro

Browser meshPapio
QL 737.P93
Generale QL 737.P93
Come animali da laboratorio
QY 60.P7
Guarda anche
Malattie delle scimmie
PAPP-D vedere
Lactogen placentare
Febbre Pappataci vedere
Febbre Di Flebotomo
Acrodermatite Papulare dell'Infanzia vedere
acrodermatite
Rosacea papulopustolare vedere
rosacea
Sindrome Acrolocata Papulovesicolare vedere
acrodermatite
acido para-aminoinoppurico vedere
Acido p-aminoinoppurico
Para-atletica vedere
Sport per persone con disabilità
para-diidrossibenzeni vedere
idrochinoni
Para-Influenza Virus Tipo 1 vedere
Parainfluenza Virus 1, Umano
para-tirosina vedere
tirosina
Parabasalia vedere
Parabasalidea

Browser meshParabasalidea

QW 250
Parabasalids vedere
Parabasalidea

Browser meshparacentesi

WB 373-377
Guarda anche
punture
WB 373-377, ecc.
Blocco paracervicale vedere
Anestesia, ostetrica
Paracetamolo vedere
acetaminofene
Parachlamydiaceae vedere
Chlamydiales
Paracadutismo vedere
aviazione
Granuloma paracoccidioidale vedere
paracoccidioidomicosi
Infezione da Paracoccidioides brasiliensis vedere
paracoccidioidomicosi

Browser meshparacoccidioidomicosi

WC 460
Paracolobactrum vedere
Enterobacteriaceae
Paracousis vedere
Disturbi dell'udito
Fattori del peptide paracrino vedere
Peptidi e proteine ​​di segnalazione intercellulare
Fattori proteici paracrini vedere
Peptidi e proteine ​​di segnalazione intercellulare
Paracusis vedere
Disturbi dell'udito
Paradentium vedere
parodonto
Embolia paradossale vedere
Embolia, paradossale
Sonno paradossale vedere
Dormi, REM
Ernia iatale paraesofagea vedere
Ernia iatale

Browser meshParaganglia, Chromaffin

WK 102
In altri organi, con l'organo

Browser meshparaganglioma

QZ 380
Localizzato, per sito
Paraganglioma, corpo carotideo vedere
Tumore del corpo carotideo

Browser meshParaganglioma, extra-surrenale

QZ 380
Localizzato, per sito
Paraganglioma, gangliocitico vedere
paraganglioma
Paraganglioma, non cromaffina vedere
Paraganglioma, extra-surrenale
Paraganglioma, Noncromaffina vedere
Paraganglioma, extra-surrenale
Paragangliomas 1 vedere
paraganglioma
Paragangliomas, Familial, 1 vedere
paraganglioma
Paragangliomas, Nonchromaffin familiare, 1 vedere
Paraganglioma, extra-surrenale
Paragangliomata vedere
paraganglioma

Browser meshParagonimiasi

WC 805

Browser meshParagonimus

QX 353
Infezione da Paragonimus vedere
Paragonimiasi
Infezione da Paragonimus westermani vedere
Paragonimiasi
Paragreen A vedere
paraquat
Paraimmunoglobulinemias vedere
paraproteinemia
parainfluenza vedere
Infezioni da Paramyxoviridae

Browser meshVaccini contro la parainfluenza

WC 518

Browser meshParainfluenza Virus 1, Umano

QW 168.5.P2
Infezioni da virus della parainfluenza vedere
Infezioni da Paramyxoviridae
Virus della parainfluenza di tipo 1 vedere
Parainfluenza Virus 1, Umano
Parakeratosi Variegata vedere
parapsoriasi
Paralysants vedere
Agenti di guerra chimica

Browser meshParalizza, periodico familiare

WD 205.5.P2
Paralysins vedere
agglutinine

Browser meshParalisi
Generale
WL 346
Gli agitani vedono
Morbo di Parkinson
WL 359
Divers'
WD 712
Viso facciale
Paralisi facciale
WL 330
Vedi infantile
Poliomielite
WC 555, ecc.
I muscoli oculari vedono
oftalmoplegia
WW 410
Vedi respiratorio
Paralisi respiratoria
WF 140
Corda vocale vedere
Paralisi delle corde vocali
WV 535
Guarda anche
Emiplegia
Guarda anche
Paraplegia
Guarda anche
tetraplegia
Paralisi Agitane vedere
Morbo di Parkinson
Paralisi, Bulbar vedere
Paralisi bulbare, progressiva
Paralisi, Generale vedere
neurosyphilis
Paralisi, gambe vedere
Paraplegia
Paralisi, estremità inferiori vedere
Paraplegia
Paralisi, arti inferiori vedere
Paraplegia

Browser meshParalisi Ostetrica

WS 405
Paralisi Ostetrica vedere
Paralisi Ostetrica
Paralisi, Pseudobulbar vedere
Paralisi pseudobulbare
Paralisi, muscolo respiratorio vedere
Paralisi respiratoria
Paralisi, Spastica vedere
Spasticità muscolare
Paralisi, Spinale, Quadriplegico vedere
tetraplegia
Paralisi, unilaterale, cavo vocale vedere
Paralisi delle corde vocali
Paralisi, cavo vocale, unilaterale vedere
Paralisi delle corde vocali
Avvelenamento da crostacei paralitici vedere
Avvelenamento da crostacei
Risonanza paramagnetica vedere
Spettroscopia di risonanza di spin elettronico

Browser meshParamecium

QW 220
Paramedico vedere
Personale sanitario alleato
Personale paramedico vedere
Personale sanitario alleato
I paramedici vedere
Personale sanitario alleato
Paramedici, emergenza vedere
Tecnici medici di emergenza

Browser meshParametrite

WP 275
parametrio vedere
Peritoneo
Paramyoclonus Multiplex vedere
mioclono
Paramyosin vedere
tropomyosin

Browser meshParamyxoviridae

QW 168.5.P2

Browser meshInfezioni da Paramyxoviridae

WC 518
paramyxovirus vedere
Respirovirus
Paramyxovirus 1, aviario vedere
Virus della malattia di Newcastle
Infezioni da paramyxovirus vedere
Infezioni da Respirovirus
Cancro al seno paranasale vedere
Neoplasie del seno paranasale

Browser meshNeoplasie del seno paranasale

WV 340

Browser meshSeni paranasali

WV 340-358
Guarda anche
Seno etmoide
WV 355
Guarda anche
Seno frontale
WV 350
Guarda anche
Seno mascellare
WV 345
Guarda anche
Seno sfenoidale
WV 358

Browser meshSindromi endocrine paraneoplastiche

WK 145
Guarda anche
Ormoni, ectopici
Paranoia vedere
Disturbi paranoici

Browser meshComportamento paranoico

WM 205
Disturbo paranoico, condiviso vedere
Disturbo paranoico condiviso

Browser meshDisturbi paranoici

WM 205
Personalità paranoica vedere
Disturbo della personalità paranoica

Browser meshDisturbo della personalità paranoica

WM 190.5.P2
Psicosi paranoiche vedere
Disturbi paranoici
Schizofrenia paranoica vedere
Schizofrenia, paranoica
Paraosmia vedere
Disturbi dell'olfatto

Browser meshDisturbi Parafilici

WM 610
Guarda anche
Reati sessuali
parafilie vedere
Disturbi Parafilici

Browser meshparafimosi

WJ 790
Parafrenia, involontaria vedere
Disturbo depressivo, maggiore

Browser meshParaplegia

WL 346
Paraplegia, atassico vedere
Paraplegia
Paraplegia, cerebrale vedere
Paraplegia
Paraplegia, flaccida vedere
Paraplegia
Paraplegia, Spastic vedere
Paraplegia
Paraplegia, spastica, ereditaria vedere
Paraplegia spastica ereditaria
Paraplegia, Spinale vedere
Paraplegia
Parapodium vedere
Dispositivi ortotici

Browser meshparaproteinemia

WH 400
Guarda anche
amiloidosi
WD 205.5.A6
Guarda anche
Mieloma multiplo
WH 540

Browser meshparaproteine

QW 601
Guarda anche
Proteine ​​del mieloma

Browser meshparapsoriasi

WR 204
Parapsoriasi in placche vedere
parapsoriasi

Browser meshParapsicologia
BF 1009-1389
Scienze occulte BF 1404-1999
Guarda anche
Terapie spirituali
Guarda anche
Telepatia

Browser meshparaquat
Aspetti di salute pubblica
WA 240
Meningioma parassagittale vedere
meningioma
Parascaris vedere
Ascaridoidea
Controllo parassiti vedere
Controllo delle malattie trasmissibili
Interazioni parassita-host vedere
Interazioni host-parassiti
Relazioni parassita-ospite vedere
Interazioni host-parassiti
Infezioni da parassiti vedere
Malattie Parassitarie

Browser meshparassiti
Generale
QX 4
Parassiti animali
Zoologia QL 757
Controllo delle malattie trasmissibili
WA 240
Guarda anche
Antielmintici
Guarda anche
Agenti anti-infettivi
Guarda anche
Agenti antiprotozoari
Guarda anche
Parassitologia Alimentare
Guarda anche
Interazioni host-parassiti
Guarda anche
Malattie Parassitarie

Browser meshMalattie Parassitarie

WC 695-900
Assistenza infermieristica
WY 153
Veterinaria vedi
Malattie parassitarie, animali SF 810.A3

Browser meshMalattie parassitarie, animali
SF 810.A3
Infezioni oculari parassitarie vedere
Infezioni oculari, parassitarie
Infezioni parassitarie vedere
Malattie Parassitarie
Infezioni parassitarie, animali vedere
Malattie parassitarie, animali
Infezioni parassitarie del polmone vedere
Malattie polmonari, parassitarie
Malattie intestinali parassitarie vedere
Malattie intestinali, parassitarie
Malattie epatiche parassitarie vedere
Malattie del fegato, parassitarie
Malattie polmonari parassitarie vedere
Malattie polmonari, parassitarie
Malattie della pelle parassitarie vedere
Malattie della pelle, parassitarie
Vermi parassiti vedere
elminti
antiparassitari vedere
Agenti antiparassitari

Browser meshParassitologia
Come professione
QX 21
Biografia
Collettivo
WZ 112.5.P15
Individuale
WZ 100
Guarda anche
parassiti
Guarda anche
Malattie Parassitarie
Parassitologia, Cibo vedere
Parassitologia Alimentare
parasuicidio vedere
Suicidio, tentato
Agenti bloccanti parasimpatici vedere
parasimpaticolitici
Gangli parasimpatici vedere
Gangli, parasimpatici

Browser meshSistema nervoso parasimpatico

WL 610
Guarda anche
parasimpaticolitici
Guarda anche
parasimpaticomimetici
Malattie del sistema nervoso parasimpatico vedere
Malattie del sistema nervoso autonomo
Agenti parasimpatico vedere
parasimpaticolitici
Farmaci parasimpatico vedere
parasimpaticolitici
Effetto parasimpatico vedere
parasimpaticolitici
Effetti parasimpatico vedere
parasimpaticolitici

Browser meshparasimpaticolitici

QV 132
Guarda anche
Agenti antiulcera
Guarda anche
Agenti Antiparkinson
Guarda anche
Antagonisti del Muscarin
Guarda anche
Rilassanti muscolari, centrale
Agenti parasimpaticomimetici vedere
parasimpaticomimetici
Farmaci parasimpaticomimetici vedere
parasimpaticomimetici
Effetto parasimpaticomimetico vedere
parasimpaticomimetici
Effetti parasimpaticomimetici vedere
parasimpaticomimetici

Browser meshparasimpaticomimetici

QV 122
Guarda anche
Inibitori della colinesterasi
Corpo paraterminale vedere
Setto di cervello

Browser meshparathion
Salute pubblica
WA 240
Parathletics vedere
Sport per persone con disabilità
paratormone vedere
Ormone paratiroideo
paratirina vedere
Ormone paratiroideo
Adenoma paratiroideo vedere
Neoplasie paratiroidi
Cancro alla paratiroide vedere
Neoplasie paratiroidi
Carcinoma paratiroideo vedere
Neoplasie paratiroidi

Browser meshMalattie paratiroidi

WK 300
Disturbi paratiroidi vedere
Malattie paratiroidi

Browser meshGhiandole paratiroidi

WK 300

Browser meshOrmone paratiroideo

WK 300
Guarda anche
ipoparatiroidismo
Ormone paratiroideo (1-34) vedere
Ormone paratiroideo
Ormone paratiroideo (1-84) vedere
Ormone paratiroideo
Peptide dell'ormone paratiroideo (1-34) vedere
Ormone paratiroideo

Browser meshNeoplasie paratiroidi

WK 300
paratopes vedere
Siti leganti, anticorpo
Paratropomyosin vedere
tropomyosin
Cisti paratubale vedere
Cisti parovariana

Browser meshparatuberculosis
Generale SF 809.P375
Nei bovini SF 967.P33

Browser meshFebbre paratifo

WC 266
Veterinario SF 809.S24
Vaccino paratifo vedere
Vaccini tifo-paratifo
Mesoderma parassiale vedere
mesoderma
Parcillin vedere
Penicillina G
Parencephalon vedere
Cervelletto

Browser meshRapporti genitore-figlio
Generale
WS 105.5.F2
Adolescente
WS 462.5.F2
Relazione genitore-figlio vedere
Rapporti genitore-figlio
Relazione figlio-genitore vedere
Rapporti genitore-figlio
Genitore, single vedere
Genitore single
Età dei genitori vedere
genitori
Imprinting parentale vedere
Imprinting genomico

Browser meshCongedo parentale
Opere generali HD 6065-6065.5
Alimentazione parenterale vedere
Nutrizione parenterale
Iperalimentazione parenterale vedere
Parenteral Nutrition, Total
Infusioni parenterali vedere
Infusioni, parenterali

Browser meshNutrizione parenterale

WB 410
Guarda anche
Emulsioni grasse, endovenose

Browser meshParenteral Nutrition, Total
Generale
WB 410
Guarda anche
Idrolizzati proteici
QU 55
Epatite non-A, non-B trasmessa per via parenterale vedere
Epatite C
Stato di genitorialità vedere
genitori

Browser meshParenting

WS 105.5.C3
Guarda anche
Educazione dei figli

Browser meshgenitori
HQ 755,7-759,92
E illegittimità HQ 998-999
Argomenti speciali, per argomento
Guarda anche
Figlio di genitori con handicap
Guarda anche
Genitore single

Browser meshParesi

WL 346
Veterinaria vedi
Paresis parente SF 967.M5

Browser meshparestesia

WR 280
Parestesia distale vedere
parestesia
Parestesia, Dolorosa vedere
parestesia
Neurosifilide paretica vedere
neurosyphilis

Browser meshCellule parietali, gastriche
Citologia
WI 301
Fisiologia
WI 302
Guarda anche
Acido gastrico
Guarda anche
Fattore intrinseco
Corteccia parietale vedere
Lobo parietale

Browser meshLobo parietale

WL 307
Lobule parietale vedere
Lobo parietale
Pericardio parietale vedere
Pericardio
Peritoneo parietale vedere
Peritoneo
Pleura parietale vedere
pleura
Regione parietale vedere
Lobo parietale
Trauma della regione parietale vedere
Trauma craniocerebrale
Sindrome Di Parinaud vedere
Disturbi della motilità oculare
Sindrome di Parinaud vedere
Disturbi della motilità oculare

Browser meshInfermieristica parrocchiale

WY 86.5
Guarda anche
Religione e medicina
Registri parrocchiali vedere
Registri
Park Davis marchio di fenitoina vedere
fenitoina
Park Davis Brand of Thrombin vedere
trombina
Parke Davis Marchio di Aciclovir vedere
aciclovir
Marchio Parke Davis di acido mefenamico vedere
Acido mefenamico
Marchio di Vasopressin (USP) di Parke-Davis vedere
vasopressins
Parke Davis Marchio di Vidarabine vedere
Vidarabine
Parkemed vedere
Acido mefenamico

Browser meshMorbo di Parkinson

WL 359
Farmaci per vedere
Agenti Antiparkinson
QV 80
Morbo di Parkinson 2 vedere
Disturbi Parkinsoniani
Malattia di Parkinson 2, Autosomica recessiva giovanile vedere
Disturbi Parkinsoniani
Malattia di Parkinson, autosomica dominante. Giovanile vedere
Disturbi Parkinsoniani
Malattia di Parkinson autosomica recessiva, esordio precoce vedere
Disturbi Parkinsoniani
Morbo di Parkinson, sperimentale vedere
Disturbi Parkinsoniani
Malattia di Parkinson, familiare, autosomica recessiva vedere
Disturbi Parkinsoniani
Malattia di Parkinson, idiopatica vedere
Morbo di Parkinson
Malattia di Parkinson, giovanile vedere
Disturbi Parkinsoniani
Malattia di Parkinson, giovanile, autosomica dominante vedere
Disturbi Parkinsoniani
Malattia di Parkinson, giovanile, autosomica recessiva vedere
Disturbi Parkinsoniani

Browser meshMalattia di Parkinson, secondaria

WL 359
Morbo di Parkinson, vascolare secondario vedere
Malattia di Parkinson, secondaria
Malattia di Parkinson, sintomatica vedere
Malattia di Parkinson, secondaria
Malattie di Parkinson vedere
Disturbi Parkinsoniani

Browser meshDisturbi Parkinsoniani

WL 359
Sindrome Parkinsoniana vedere
Disturbi Parkinsoniani
Sindromi parkinsoniane vedere
Disturbi Parkinsoniani
parkinsonismo vedere
Disturbi Parkinsoniani
Parkinsonismo, esordio precoce, con fluttuazione diurna vedere
Disturbi Parkinsoniani
Parkinsonismo a esordio precoce con fluttuazione diurna vedere
Disturbi Parkinsoniani
Parkinsonismo, sperimentale vedere
Disturbi Parkinsoniani
Parkinsonismo giovanile vedere
Disturbi Parkinsoniani
Parkinsonismo, giovanile, autosomica dominante vedere
Disturbi Parkinsoniani
Parkinsonismo, giovanile, autosomico recessivo vedere
Disturbi Parkinsoniani
Parkinsonismo, secondario vedere
Malattia di Parkinson, secondaria
Parkinsonismo Sintomatico vedere
Malattia di Parkinson, secondaria
Morbo di Parkinson vedere
Morbo di Parkinson
Morbo di Parkinson, idiopatico vedere
Morbo di Parkinson
Morbo di Parkinson, Lewy Body vedere
Morbo di Parkinson
Parlodel vedere
bromocriptina
Marchio Parmed di Penicillina G Potassio vedere
Penicillina G
parodontite vedere
parodontite
parodonto vedere
parodonto
parodontosi vedere
Malattie Parodontali
Paronal vedere
asparaginasi

Browser meshparonichia

WR 475
Cancro parotideo vedere
Neoplasie parotidee
Calcoli del dotto parotideo vedere
Calcoli del condotto salivare

Browser meshGhiandola parotide

WI 230

Browser meshNeoplasie parotidee

WI 230

Browser meshRegione parotide

WE 705
Guarda anche
Ghiandola parotide
Parotiditis vedere
parotite

Browser meshparotite

WI 230
Guarda anche
Parotite
WC 520
Parotite, Epidemia vedere
Parotite

Browser meshCisti parovariana

WP 275
Fibrillazione atriale parossistica vedere
Fibrillazione atriale
Emoglobinuria parossistica fredda vedere
Emoglobinuria, parossistica
Discinesia parossistica vedere
Corea
Dispnea parossistica vedere
Dispnea, parossistica
Emoglobinuria parossistica vedere
Emoglobinuria, parossistica
Emoglobinuria parossistica, fredda vedere
Emoglobinuria, parossistica
Emoglobinuria parossistica, notturna vedere
Emoglobinuria, parossistica
Dolore ai nervi parossistici vedere
Nevralgia
Emoglobinuria notturna parossistica vedere
Emoglobinuria, parossistica
Discinesia oculare parossistica vedere
Disturbi della motilità oculare
Tachicardia reciproca parossistica vedere
Tachicardia, parossistica
Sonno parossistico vedere
narcolessia
Tachicardia parossistica vedere
Tachicardia, parossistica
Parrot Fever vedere
Psittacosi
Pars Distalis of Pituitary vedere
Ghiandola pituitaria, anteriore
Pars Nervosa dell'ipofisi vedere
Ghiandola pituitaria, posteriore
Sindrome di Parsonage-Aldren-Turner vedere
Neurite del plesso brachiale
Sindrome di Parsonage-Turner vedere
Neurite del plesso brachiale

Browser meshPartenogenesi
Generale QH 487
Ricerca sull'uomo
WQ 208
Anencefalia parziale vedere
anencefalia
Ankyloglossia parziale vedere
anchiloglossia
Protesi parziale vedere
Protesi parziale
Epilessia parziale vedere
Epilessie parziali
Sindrome alcolica fetale parziale vedere
Disturbi fetali dello spettro alcolico
Artroplastica parziale del ginocchio vedere
Artroplastica, sostituzione, ginocchio
Sostituzione parziale del ginocchio vedere
Artroplastica, sostituzione, ginocchio
Ventilazione liquida parziale vedere
Ventilazione liquida
Monosomia parziale vedere
Cancellazione del cromosoma
Agonisti degli oppiacei parziali vedere
Analgesici, oppioidi
Corde vocali per paralisi parziale (paresi) vedere
Paralisi delle corde vocali
Pneumonectomia parziale vedere
pneumonectomia
Disturbo convulsivo parziale vedere
Epilessie parziali
Convulsioni parziali vedere
Convulsioni
Convulsioni parziali, semplici, coscienza conservata vedere
Epilessie parziali
Trisomia parziale vedere
Trisomia
Sindrome di Down parziale trisomia 21 vedere
Sindrome di Down

Browser meshAcceleratori di particelle
QC generale 787.P3
In radioterapia
WN 250
Guarda anche
Radiochirurgia
Spettrometria di emissione di raggi X indotta da particelle vedere
Spettrometria, emissione di raggi X.
Spettrometria di emissione di raggi X indotta da particelle vedere
Spettrometria, emissione di raggi X.

Browser meshDimensione delle particelle
Inquinanti dell'aria
WA 754, ecc.
Guarda anche
La materia particellare

Browser meshLa materia particellare
Esposizione ambientale
WA 754
Esposizione occupazionale
WA 450
Abuso del partner vedere
Abuso del coniuge
Comunicazione del partner vedere
Relazioni interpersonali
Notifica del partner vedere
Traccia dei contatti

Browser meshPratica di partenariato

W 92
Legislazione
W 33

Browser meshPratica di partenariato, dentale

WU 79
Pratiche di partenariato, dentale vedere
Pratica di partenariato, dentale

Browser meshParesi parziale
SF 967.M5

Browser meshParto

WQ 300
Partusisten vedere
fenoterolo

Browser meshParvoviridae

QW 165.5.P3

Browser meshInfezioni da Parvoviridae

WC 500

Browser meshparvovirus

QW 165.5.P3
Infezioni da parvovirus vedere
Infezioni da Parvoviridae
Parvovirus, Raccoon vedere
parvovirus
Paryphostomum vedere
Trematoda
Pasadena Brand of Estrogens, Conjugated (USP) vedere
Estrogeni, coniugati (USP)
Pasadena marca di testosterone vedere
Testosterone
Pasivirus vedere
Picornaviridae
Passauer Marchio di caffeina vedere
Caffeina

Browser meshPasseriformi
QL 696.P2-.P298
Dipendenza passiva, neonatale vedere
Sindrome da astinenza neonatale
Personalità passiva-aggressiva vedere
Disturbo della personalità passivo-aggressivo

Browser meshDisturbo della personalità passivo-aggressivo

WM 190.5.P3
Disturbi passivi della personalità aggressiva vedere
Disturbo della personalità passivo-aggressivo
Trasferimento passivo di anticorpi vedere
Immunizzazione, passiva
Eutanasia passiva vedere
Eutanasia, passiva
Iperemia passiva vedere
iperemia
Immunoterapia passiva vedere
Immunizzazione, passiva
Gamma passiva di movimento vedere
Gamma di movimento, articolare
Fumo passivo vedere
Inquinamento del fumo di tabacco
Stretching passivo vedere
Esercizi di stretching muscolare
Trasferimento passivo dell'immunità vedere
Immunizzazione, passiva
Tremore passivo vedere
Tremore
Personalità dipendente dalla passiva vedere
Disturbo della personalità dipendente
Tendenze passate vedere
Crescita demografica
paste vedere
pomate

Browser meshPasteurella

QW 140

Browser meshInfezioni Pasteurella
Generale
WC 200
Veterinario SF 809.P38
pasteurellosi vedere
Infezioni Pasteurella

Browser meshPastorizzazione
Generale
WA 695-722
Per latte e prodotti lattiero-caseari
WA 719
Guarda anche
Sterilizzazione

Browser meshPastorale

WM 61
Guarda anche
Servizio di cappellania, ospedale
Guarda anche
Religione e medicina
Guarda anche
Religione e psicologia
Psicologia Pastorale vedere
Pastorale
Pastori vedere
Clero
Tecniche Patch-Clamp vedere
Tecniche Patch-Clamp

Browser meshTecniche Patch-Clamp

QY 95

Browser meshTest di patch

QY 260

Browser meshpatella
Generale
WE 870
lesioni
WE 872

Browser meshLussazione rotulea

WE 872

Browser meshSindrome del dolore patellofemorale

WE 870
Sindrome Patellofemorale vedere
Sindrome del dolore patellofemorale
Brevetto del dotto arterioso vedere
Dotto arterioso, brevetto
Pervietà del dotto arterioso vedere
Dotto arterioso, brevetto
Brevetto Ductus Arteriosus Familial vedere
Dotto arterioso, brevetto
Brevetto Forame Ovale vedere
Forame Ovale, brevetto
Medicinali brevettati vedere
Farmaci senza ricetta
Forame ovale in vernice vedere
Forame Ovale, brevetto

Browser meshBrevetti come argomento
Generale (medico)
W 32-33
Prodotti chimici TP 210
farmaci
QV 736
Argomenti speciali per argomento (modulo numero 32-33 nel programma NLM ove applicabile)
Strumenti medici (modulo numero 26 in qualsiasi programma NLM ove applicabile)

Browser meshComportamento paterno
Generale
WS 105.5.F2
Adolescente
WS 462.5.F2

Browser meshPrivazione paterna
Adolescente
WS 462.5.D3
Neonato o bambino
WS 105.5.D3
Stato educativo paterno vedere
Stato educativo

Browser meshPaternità
Aspetti forensi
W 791
See also
DNA Fingerprinting
Paternity Benefits see
Salaries and Fringe Benefits
Paternity Leave see
Parental Leave
Patey Mastectomy see
Mastectomy, Modified Radical
Pathogen-Host Interactions see
Host-Pathogen Interactions
Pathogen Transmission see
Disease Transmission, Infectious
Pathogen Transmission, Horizontal see
Disease Transmission, Infectious
Pathogen Transmission, Patient-Professional see
Infectious Disease Transmission, Patient-to-Professional
Pathogen Transmission, Professional-to-Patient see
Infectious Disease Transmission, Professional-to-Patient
Pathogenesis of Disease see
Disease
Pathogenic Fungi see
Fungi
Pathogenicity see
Virulence
Pathogenicity Factors see
Virulence Factors
Pathogens, Blood-Borne see
Blood-Borne Pathogens
Pathologic Calcification see
Calcinosis
Pathologic Constriction see
Constriction, Pathologic
Pathologic Dilatation see
Dilatation, Pathologic
Pathologic Dilatations see
Dilatation, Pathologic
Pathologic Ossification see
Ossification, Heterotopic

Mesh BrowserPathologic Processes
Generale
QZ 140
In conjunction with the specialty 
QZ 4
Pathological Fracture see
Fractures, Spontaneous
Pathological Fractures see
Fractures, Spontaneous
Pathological Gambling see
Gambling
Pathological Processes see
Pathologic Processes
Pathological Waste see
Medical Waste
Pathological Waste Disposal see
Medical Waste Disposal

Mesh BrowserPathologists
Generale
QZ 21
Biografia
Collective
WZ 112.5.P2
Individuale
WZ 100

Mesh BrowserPathology
Generale
QZ 21
In conjunction with pathologic processes 
QZ 4
See also
Pathologic Processes
See also
Pathologists
See also
Pathology, Clinical

Mesh BrowserPathology, Clinical
Generale
QY 4
As a profession 
QY 21

Mesh BrowserPathology Department, Hospital

WX 207
Pathology Departments, Hospital see
Pathology Department, Hospital
Pathology, Forensic see
Forensic Pathology
Pathology, Language see
Speech-Language Pathology
Pathology, Maxillofacial see
Pathology, Oral

Mesh BrowserPathology, Molecular

QZ 50

Mesh BrowserPathology, Oral

WU 140
Mouth pathology 
WU 140
Tooth pathology 
WU 140
Pathology, Speech see
Speech-Language Pathology
Pathology, Speech-Language see
Speech-Language Pathology

Mesh BrowserPathology, Surgical

WO 142

Mesh BrowserPathology, Veterinary
SF 769-769.44
Pathomycin see
Sisomicin

Mesh BrowserPatient Acceptance of Health Care

W 85
In the hospital 
WX 158.5
Special areas of health care, by area
Patient Acceptance of Healthcare see
Patient Acceptance of Health Care
Patient Activation see
Patient Participation
Patient Adherence see
Patient Compliance

Mesh BrowserPatient Admission

WX 158
See also
Patient Readmission

Mesh BrowserPatient Advocacy

W 85.4
Special topics, by subject
See also
Patient Rights
Patient Appointments see
Appointments and Schedules

Mesh BrowserPatient Care

W 84-84.8
Of hospital patients 
WX 162-162.5
See also names of specific types of care, e.g.,
Nursing Care 
WY 100, etc.

Mesh BrowserPatient Care Management

W 84.7
In nursing 
WY 100
Of hospital patients 
WX 162-162.5
Special topics, by subject

Mesh BrowserPatient Care Planning
Generale
W 84.7
In nursing 
WY 100
Of hospital patients 
WX 162-162.5
See also
Aftercare
See also
Community Participation

Mesh BrowserPatient Care Team

W 84.8
Hospital team 
WX 162.5
See also
Nursing, Team 
WY 125

Mesh BrowserPatient-Centered Care

W 84.7
In hospitals and health facilities 
WX 162
Patient-Centered Nursing see
Patient-Centered Care

Mesh BrowserPatient Compliance

W 85
In hospitals 
WX 158.5
In mental hospitals 
WM 29.5
Special areas of compliance, by subject
See also
Treatment Refusal
Patient Cooperation see
Patient Compliance
Patient Credit see
Patient Credit and Collection

Mesh BrowserPatient Credit and Collection
Dental administration 
WU 77
Hospital administration 
WX 157
In other specific fields, by subject
Medical administration 
W 80
Patient Data Privacy see
Confidentiality

Mesh BrowserPatient Discharge

WX 158
Patient Dumping see
Patient Transfer

Mesh BrowserPatient Education as Topic
Generale
WA 590
For specific conditions, with the condition
Patient Elopement see
Treatment Refusal
Patient Empowerment see
Patient Participation
Patient Engagement see
Patient Participation
Patient-Family Lodging see
Housing
Patient-Focused Care see
Patient-Centered Care
Patient Generated Clinical Data see
Patient Generated Health Data
Patient Generated Data see
Patient Generated Health Data

Mesh BrowserPatient Generated Health Data

WB 291
Patient Handling see
Moving and Lifting Patients
Patient Involvement see
Patient Participation

Mesh BrowserPatient Isolation

WX 167

Mesh BrowserPatient Isolators

WX 147
Patient Lifting see
Moving and Lifting Patients
Patient Monitoring see
Monitoring, Physiologic
Patient Moving see
Moving and Lifting Patients
Patient Moving and Lifting see
Moving and Lifting Patients
Patient Non-Adherence see
Patient Compliance
Patient Non-Compliance see
Patient Compliance
Patient Nonadherence see
Patient Compliance
Patient Noncompliance see
Patient Compliance
Patient Ombudsman see
Patient Advocacy
Patient Ombudsmen see
Patient Advocacy

Mesh BrowserPatient Participation
Generale
W 85
Hospital patients 
WX 158.5
See also
Health Literacy
See also
Patient Education as Topic
Patient Participation Rates see
Patient Participation

Mesh BrowserPatient Readmission

WX 158
Patient Records, Computerized see
Health Records, Personal
Patient Recruitment see
Patient Selection
Patient Refusal of Treatment see
Treatment Refusal
Patient Repositioning see
Moving and Lifting Patients
Patient Representatives see
Patient Advocacy

Mesh BrowserPatient Rights

W 85.4
Special topics, by subject
See also
Bioethical Issues 
WB 60
See also
Patient Advocacy

Mesh BrowserPatient Safety
Generale
WX 185
In specific types of health facilities, class with type of facility in the number for administration if number for safety or accident prevention is unavailable

Mesh BrowserPatient Satisfaction
With health services, medical treatment, etc. 
W 85.2
With hospitals 
WX 158.5
With mental hospitals
WM 29.5
With special hospitals, by type, e.g., Hospitals, Maternity
WQ 27-28
With other services or products, by subject
See also
Patient Acceptance of Health Care 
W 85
Patient Schedules see
Appointments and Schedules

Mesh BrowserPatient Selection
Ricerca
W 20.5
Ethics
W 20.55.H9
Specific topics, by topic
See also
Health Care Rationing
Patient-to-Professional Disease Transmission see
Infectious Disease Transmission, Patient-to-Professional
Patient-to-Professional Transmission see
Infectious Disease Transmission, Patient-to-Professional

Mesh BrowserPatient Transfer

WX 158
Patient Transition see
Patient Transfer
Patient Turfing see
Patient Transfer

Mesh BrowserPatients

W 85
In hospitals 
WX 158.5
In mental institutions 
WM 29.5
With specific disabilities, with the disability
See also
Inpatients
See also
Outpatients
Patients' Libraries see
Libraries, Hospital
Patients' Rights see
Patient Rights
Patient's Rights see
Patient Rights
Patriarchy see
Family Characteristics
Pattern Baldness see
Alopecia
Pattern, Clinical Practice see
Practice Patterns, Physicians'
Pattern, Dental Practice see
Practice Patterns, Dentists'
Pattern Recognition, Auditory see
Pattern Recognition, Physiological

Mesh BrowserPattern Recognition, Physiological
Generale
WL 705
Auditory 
WV 272
Pattern Recognition, Tactile see
Pattern Recognition, Physiological

Mesh BrowserPattern Recognition, Visual

WW 105
Patterns, Clinical Practice see
Practice Patterns, Physicians'
Patterns, Dental Practice see
Practice Patterns, Dentists'
Patterson-Brown-Kelly Syndrome see
Plummer-Vinson Syndrome
Patterson-Kelly Syndrome see
Plummer-Vinson Syndrome
Patterson's Syndrome see
Plummer-Vinson Syndrome
Paxene see
Paclitaxel
Pay Equity see
Salaries and Fringe Benefits
Pay for Performance see
Reimbursement, Incentive
PCP see
Phencyclidine
PCP Abuse see
Phencyclidine Abuse
PCP-GABA see
Baclofen
PCR see
Polymerase Chain Reaction
PCR 4099 see
Clopidogrel
PCR-4099 see
Clopidogrel
PD-107779 see
Enoxacin
PDA Computer see
Computers, Handheld
Pea Family see
Fabaceae

Mesh BrowserPeak Expiratory Flow Rate

WF 102
Physical examination 
WB 284
As a diagnostic test 
WF 141
Arachidi see
Arachis

Mesh BrowserPiselli
Dietary use in health and disease 
WB 430
Peat see
Soil
Peat Coal see
Coal
Peat Therapy see
Mud Therapy
Peccary see
Artiodactyla
Pecten Oculi see
Retinal Vessels
Pectin see
Pectins
Pectinic Acid see
Pectins

Mesh BrowserPectins

QV 71
Pectoral Muscle see
Pectoralis Muscles
Pectoral Nerves see
Thoracic Nerves

Mesh BrowserPectoralis Muscles

WE 715
Pectus Excavatum see
Funnel Chest
Pedagogy see
Teaching
Pedameth see
Methionine
Pederasty see
Paraphilic Disorders

Mesh BrowserPediatric Dentistry

WU 480
See also age groups under
Oral Hygiene
See also
Dental Care for Children 
WU 480

Mesh BrowserPediatric Emergency Medicine

WS 205
Pediatric Hospitals see
Hospitals, Pediatric
Pediatric Intensive Care Units see
Intensive Care Units, Pediatric

Mesh BrowserPediatric Nurse Practitioners

WY 128

Mesh BrowserPediatric Nursing

WY 159
See also
Maternal-Child Nursing
See also
Nurses, Pediatric

Mesh BrowserPediatric Obesity
Generale
WS 115
Adolescent 
WS 132
Child 
WS 130
Infant 
WS 120
Pediatric Psychology see
Psychology, Child

Mesh BrowserPediatricians
Generale
WS 21
Biografia
Collective
WZ 112.5.P3
Individuale
WZ 100

Mesh BrowserPediatria
General works 
WS 100
As a profession 
WS 21
Diseases (General) 
WS 200
Popular works 
WS 80
Therapeutics (General) 
WS 366
See also
Pediatric Dentistry
See also
Pediatric Nursing
See also
Pediatricians
Pedicled Flap see
Surgical Flaps
Pediculi see
Pediculus
Pediculosis see
Lice Infestations

Mesh BrowserPediculus
General QL 570-570.3
As parasites or insect vectors 
QX 502
Pedodontics see
Pediatric Dentistry

Mesh BrowserPedophilia

WM 610
PEEP see
Positive-Pressure Respiration

Mesh BrowserPeer Group
Adolescent 
WS 462.5.I5
Child 
WS 105.5.I5
Persons with particular diseases under the diseases, e.g.,
Diabetes Mellitus
See also names of particular groups, e.g.,
Physicians

Mesh BrowserPeer Review
Anesthesia 
WO 221
Embryology 
QS 621
Histology 
QS 521
Nursing 
WY 16
(Form number 21 in any NLM schedule where applicable)
See also
Ethical Review
Peer Review, Grants see
Peer Review, Research

Mesh BrowserPeer Review, Health Care
Nursing 
WY 16
(Form number 21 in any NLM schedule where applicable)
Peer Review Organizations see
Professional Review Organizations
Peer Review, Publishing see
Peer Review, Research

Mesh BrowserPeer Review, Research
Nursing 
WY 16
(Form number 21 in any NLM schedule where applicable)
PEFR see
Peak Expiratory Flow Rate
Peg, Dental see
Dental Pins
Pegs, Dental see
Dental Pins
Pekamin see
Penicillin G

Mesh BrowserPellagra

WD 126
Pellethane see
Polyurethanes
Pellets, Drug see
Drug Implants
Peloid Therapy see
Mud Therapy
Pelotherapy see
Mud Therapy

Mesh BrowserPelvic Bones

WE 760
Pelvic Cancer see
Pelvic Neoplasms
Pelvic Diaphragm see
Pelvic Floor
Pelvic Disease, Inflammatory see
Pelvic Inflammatory Disease
Pelvic Exam see
Gynecological Examination
Pelvic Examination see
Gynecological Examination

Mesh BrowserPelvic Exenteration

WE 760

Mesh BrowserPelvic Floor
General (including both male and female) 
WE 760
Femmina
WP 155
Male 
WE 760
Pelvic Floor Diseases see
Pelvic Floor Disorders

Mesh BrowserPelvic Floor Disorders
General (including both male and female) 
WJ 140
Femmina
WP 155
Male 
WJ 140

Mesh BrowserPelvic Infection

WP 155

Mesh BrowserPelvic Inflammatory Disease

WP 155

Mesh BrowserPelvic Neoplasms
Generale
WE 760
Nursing 
WY 156

Mesh BrowserPelvic Organ Prolapse

WP 155

Mesh BrowserPelvic Pain

WP 155
Pelvic Plexus see
Hypogastric Plexus
Pelvic Pouches see
Colonic Pouches
Pelvic Region see
Pelvis

Mesh BrowserPelvimetry
Generale
WE 760
In obstetrics 
WQ 320
See also
Pelvis

Mesh BrowserPelvis
Generale
WE 760
Gynecology 
WP 155
Obstetrics 
WQ 320
See also
Pelvic Exenteration
See also
Pelvic Infection
See also
Pelvic Inflammatory Disease
See also
Pelvimetry
Pelvis Cancer see
Pelvic Neoplasms
Pelvis Neoplasms see
Pelvic Neoplasms

Mesh BrowserPemphigus

WR 200
Neonatorum see
Impetigo 
WR 225
Pemphigus Foliaceus see
Pemphigus
Pemphigus Vulgaris see
Pemphigus
Penamox see
Amoxicillin
Pendular Nystagmus see
Nystagmus, Pathologic
Penetrating Eye Injuries see
Eye Injuries, Penetrating
Penetrating Missile Injuries, Head see
Head Injuries, Penetrating
Penetrex see
Enoxacin
Pengesod see
Penicillin G
Penibiot see
Penicillin G
Penicilina G Llorente see
Penicillin G

Mesh BrowserPenicillamine

QV 354

Mesh BrowserPenicillanic Acid

QV 354
Penicillanic Acid Sulfone see
Sulbactam
Penicillin see
Penicillins
Penicillin, Aminobenzyl see
Ampicillin

Mesh BrowserPenicillin G

QV 354
Penicillin G Jenapharm see
Penicillin G
Penicillin G Potassium see
Penicillin G
Penicillin G Sodium see
Penicillin G
Penicillin Grünenthal see
Penicillin G

Mesh BrowserPenicillin Resistance
Generale
QV 354
Drug therapy 
WB 330

Mesh BrowserPenicillinase

QU 136

Mesh BrowserPenicillins

QV 354

Mesh BrowserPenicillium

QW 180.5.D38
Penile Cancer see
Penile Neoplasms

Mesh BrowserPenile Erection

WJ 790

Mesh BrowserPenile Implantation

WJ 790
For the treatment of impotence 
WJ 709

Mesh BrowserPenile Neoplasms

WJ 790
Penile Prosthesis Implantation see
Penile Implantation
Penile Tumescence see
Penile Erection
Penilevel see
Penicillin G
Peniroger see
Penicillin G

Mesh BrowserPenis

WJ 790
Penis Cancer see
Penile Neoplasms
Penis Neoplasms see
Penile Neoplasms
Penn Brand of Activated Charcoal see
Charcoal
Pensa Brand of Aciclovir see
Acyclovir
Pensa Brand of Aciclovir Sodium Salt see
Acyclovir

Mesh BrowserPensions
HD 7088-7252
For particular groups of people, by group, e.g.,
Nurses 
WY 77

Mesh BrowserPentachlorophenol
Public health aspects 
WA 240
Toxicology 
QV 627
Pentafraction see
Hydroxyethyl Starch Derivatives
Pentanisia see
Rubiaceae
Pentas see
Rubiaceae
Pentaspan see
Hydroxyethyl Starch Derivatives
Pentastarch see
Hydroxyethyl Starch Derivatives

Mesh BrowserPentazocine

QV 89
Pentazocine Hydrochloride see
Pentazocine
Pentazocine Lactate see
Pentazocine
Pentenes see
Alkenes
Penthiobarbital see
Thiopental
Penthrane see
Methoxyflurane
Pentose-Phosphate Pathway see
Pentose Phosphate Pathway

Mesh BrowserPentose Phosphate Pathway

QU 75
Pentose Phosphate Shunt see
Pentose Phosphate Pathway
Pentose Shunt see
Pentose Phosphate Pathway
Pentosephosphate Pathway see
Pentose Phosphate Pathway
Pentosephosphate Shunt see
Pentose Phosphate Pathway

Mesh BrowserPentoses

QU 81
Pentothal see
Thiopental
Pentothal Sodico see
Thiopental

Mesh BrowserPentoxifylline

QV 107
Pentoxil see
Pentoxifylline
Pentrane see
Methoxyflurane
Pentrexyl see
Ampicillin
People with Disabilities see
Disabled Persons
Peponocephala electra see
Dolphins
Pepsin see
Pepsin A
Pepsin 1 see
Pepsin A
Pepsin 3 see
Pepsin A

Mesh BrowserPepsin A

QV 66
Pepsinogen B see
Pepsinogens

Mesh BrowserPepsinogens
Enzymology 
QU 142
Gastric physiology 
WI 302
See also
Gastric Juice

Mesh BrowserPeptic Ulcer

WI 350-370
See also
Anti-Ulcer Agents
See also
Gastrectomy
See also
Peptic Ulcer Hemorrhage
See also
Zollinger-Ellison Syndrome

Mesh BrowserPeptic Ulcer Hemorrhage

WI 350
See also
Peptic Ulcer

Mesh BrowserPeptic Ulcer Perforation

WI 350
Peptidase Inhibitors see
Protease Inhibitors
Peptidases see
Peptide Hydrolases

Mesh BrowserPeptide Biosynthesis

QU 68
See also
Protein Biosynthesis
Peptide Biosynthesis, Ribosomal see
Protein Biosynthesis

Mesh BrowserPeptide Hormones

WK 185
See also
Intercellular Signaling Peptides and Proteins
Peptide Hydrolase Inhibitors see
Protease Inhibitors

Mesh BrowserPeptide Hydrolases

QU 136
Peptide Leader Sequences see
Protein Sorting Signals
Peptide Peptidohydrolase Inhibitors see
Protease Inhibitors
Peptide Peptidohydrolases see
Endopeptidases
Peptide Sequence Analysis see
Sequence Analysis, Protein
Peptide Sequence Determination see
Sequence Analysis, Protein
Peptide Signal Sequences see
Protein Sorting Signals

Mesh BrowserPeptides

QU 68
See also
Amino Acid Sequence 
QU 60
See also
Oxytocin 
QV 173

Mesh BrowserPeptococcus

QW 142.5.C6

Mesh BrowserPerception
Infant or child 
WS 105.5.D2
Neurophysiology 
WL 705
Psychology BF 292
See also specific types of perception
See also
Kinesthesis
See also
Self Concept
See also
Sensation
Perception, Social see
Social Perception
Perceptrons see
Neural Networks, Computer

Mesh BrowserPerceptual Defense

WM 193.5.P3

Mesh BrowserPerceptual Disorders
Generale
WM 204
Neurologic manifestations 
WL 340
Specific sensory disorder, with the organ involved
Perceptual Disorders, Auditory see
Auditory Perceptual Disorders

Mesh BrowserPerceptual Distortion

WL 705
See also
Perceptual Disorders
Perceptual Motor Performance see
Psychomotor Performance
Perchlorethylene see
Tetrachloroethylene
Perchloroethylene see
Tetrachloroethylene
Percoffedrinol N see
Caffeine

Mesh BrowserPercussion

WB 278
Percussion Myotonia see
Myotonia
Percutaféine see
Caffeine
Percutaneous Absorption see
Skin Absorption
Percutaneous Administration see
Administration, Cutaneous
Percutaneous Atherectomy see
Atherectomy
Percutaneous Electric Nerve Stimulation see
Transcutaneous Electric Nerve Stimulation
Percutaneous Electrical Nerve Stimulation see
Transcutaneous Electric Nerve Stimulation
Percutaneous Electrical Neuromodulation see
Transcutaneous Electric Nerve Stimulation
Percutaneous Nephrolithotomy see
Nephrolithotomy, Percutaneous
Percutaneous Nephrostomy see
Nephrostomy, Percutaneous
Percutaneous Neuromodulation Therapy see
Transcutaneous Electric Nerve Stimulation
Percutaneous Transluminal Angioplasty see
Angioplasty
Percutaneous Transluminal Atherectomy see
Atherectomy
Percutaneous Transluminal Coronary Angioplasty see
Angioplasty, Balloon, Coronary
Percutaneous Ultrasonic Lithotripsy see
Lithotripsy
Perdipine see
Nicardipine
Peremin see
Histamine

Mesh BrowserPerfectionism
BF 698.35.P47
Perfluorocarbons see
Fluorocarbons
Perforated Appendicitis see
Appendicitis
Performance Appraisal, Employee see
Employee Performance Appraisal
Performance-Enhancing Drugs see
Performance-Enhancing Substances
Performance-Enhancing Effect see
Performance-Enhancing Substances
Performance-Enhancing Effects see
Performance-Enhancing Substances

Mesh BrowserPerformance-Enhancing Substances
Generale
QV 55
Specific substance, with substance
See also
Doping in Sports

Mesh BrowserPerfume

WA 744

Mesh BrowserPerfusion
Organ preservation 
WO 665
Specific organs, with the organ
Perfusion Cancer Chemotherapy, Regional see
Chemotherapy, Cancer, Regional Perfusion

Mesh BrowserPerfusion Imaging

WN 203
Perfusion Magnetic Resonance Imaging see
Magnetic Resonance Angiography
Perfusion, Pulsatile see
Pulsatile Flow
Perfusion Pumps see
Infusion Pumps
Perfusion Pumps, Implantable see
Infusion Pumps, Implantable
Perfusion Scintigraphy see
Perfusion Imaging
Perfusion Weighted MRI see
Magnetic Resonance Angiography
Pergonal see
Menotropins
Pergonal-500 see
Menotropins
Perhepar see
Liver Extracts
Perhexilene see
Perhexiline

Mesh BrowserPerhexiline

QV 150
Perhydrol see
Hydrogen Peroxide
Peri-implant Endosseous Healing see
Osseointegration
Periactin see
Cyproheptadine
Periallocortex see
Cerebral Cortex
Perianesthesia Nursing see
Perioperative Nursing
Perianeurysmal Fibrosis, Inflammatory see
Retroperitoneal Fibrosis
Perianeurysmal Inflammatory Fibrosis see
Retroperitoneal Fibrosis
Periaortitis, Chronic see
Retroperitoneal Fibrosis

Mesh BrowserPeriapical Abscess

WU 230
Periapical Cyst see
Radicular Cyst

Mesh BrowserPeriapical Diseases

WU 230
See also
Dental Pulp Diseases
Periapical Fibrous Dysplasia see
Cementoma

Mesh BrowserPeriapical Granuloma

WU 240
Periapical Periodontitis, Chronic Nonsuppurative see
Periapical Granuloma
Periapical Periodontitis, Suppurative see
Periapical Abscess

Mesh BrowserPeriaqueductal Gray

WL 310
Periaqueductal Gray Matter see
Periaqueductal Gray
Periarteritis Nodosa see
Polyarteritis Nodosa

Mesh BrowserPeriarthritis

WE 344
Pericardial Cavity see
Pericardium
Pericardial Cyst see
Mediastinal Cyst

Mesh BrowserPericardial Effusion
Generale
WG 275
Clinical examination 
QY 210
See also
Cardiac Tamponade
Pericardial Space see
Pericardium
Pericardial Tamponade see
Cardiac Tamponade

Mesh BrowserPericarditis

WG 275

Mesh BrowserPericarditis, Constrictive

WG 275

Mesh BrowserPericarditis, Tuberculous

WG 275

Mesh BrowserPericardium

WG 275
Pericementitis see
Periodontitis
Peridinium see
Dinoflagellida

Mesh BrowserPerilymph

WV 250
Perilymphatic Duct see
Cochlear Aqueduct
Perimenopausal Bone Loss see
Osteoporosis, Postmenopausal

Mesh BrowserPerimenopause

WP 580
Perimetry see
Visual Field Tests

Mesh BrowserPerinatal Care

WQ 210
Nursing see
Neonatal Nursing 
WY 157.3

Mesh BrowserPerinatal Death

WQ 225
See also
Fetal Death
See also
Infant Death
See also
Perinatal Mortality
Perinatal Medicine see
Perinatology

Mesh BrowserPerinatal Mortality

WA 900
See also
Infant Death
See also
Infant Mortality
See also
Perinatal Death
Perinatal Nursing see
Neonatal Nursing
Perinatal Subarachnoid Hemorrhage see
Subarachnoid Hemorrhage

Mesh BrowserPerinatology

WQ 210-211
See also
Fetal Diseases
See also
Infant, Newborn, Diseases
See also
Maternal-Child Nursing
See also
Neonatology
See also
Perinatal Care
See also
Pregnancy Complications

Mesh BrowserPerineum
Generale
WE 760
In the female 
WP 170
Perineurium see
Peripheral Nerves
Period Analysis see
Demography
Periodic Abstinence see
Natural Family Planning Methods
Periodic Alternating Nystagmus see
Nystagmus, Pathologic
Periodic Disease see
Familial Mediterranean Fever
Periodic Disease, Wolff's see
Familial Mediterranean Fever
Periodic Paralysis, Familial see
Paralyses, Familial Periodic
Periodic Peritonitis see
Familial Mediterranean Fever

Mesh BrowserPeriodical

W1
Bibliography of medical and medically related ZW 1
Government administrative reports and statistics 
W2
Hospital administrative reports and statistics 
WX 2
Periodicals see
Periodical

Mesh BrowserPeriodicals as Topic
General PN 4699-5650
Medico
WZ 345
Specific topics, with the topic

Mesh BrowserPeriodicity
Animal behavior QL 753-755.5
Animal physiology QP 84.6
Biology (General) QH 527
Human physiology 
QT 167
Plants QK 761
See also
Biological Clocks
See also
Circadian Rhythm
See also
Menstrual Cycle
Periodontal Bone Loss see
Alveolar Bone Loss

Mesh BrowserPeriodontal Cyst

WU 240
Periodontal Cyst, Apical see
Radicular Cyst

Mesh BrowserPeriodontal Diseases

WU 240-242
Periodontoclasia 
WU 242
Periodontosis 
WU 242
Pyorrhea alveolaris 
WU 242
Periodontal Guided Tissue Regeneration see
Guided Tissue Regeneration, Periodontal

Mesh BrowserPeriodontal Index

WU 240
Periodontal Indexes see
Periodontal Index

Mesh BrowserPeriodontal Ligament

WU 240
Periodontal Medicine see
Periodontics

Mesh BrowserPeriodontal Pocket

WU 242

Mesh BrowserPeriodontal Prosthesis

WU 240
Periodontal Resorption see
Alveolar Bone Loss

Mesh BrowserPeriodontal Splints

WU 240

Mesh BrowserPeriodontics

WU 240-242
Periodontists see
Dentists

Mesh BrowserPeriodontitis

WU 242
Periodontitis, Apical, Chronic Nonsuppurative see
Periapical Granuloma
Periodontitis, Apical, Suppurative see
Periapical Abscess

Mesh BrowserPeriodontium

WU 240-242

Mesh BrowserPerioperative Care
Generale
WO 178
Aged 
WO 950
Child 
WO 925
See also
Perioperative Nursing

Mesh BrowserPerioperative Medicine

WO 21

Mesh BrowserPerioperative Nursing

WY 161-162
Formazione scolastica
WY 18-18.5
Perioperative Care 
WO 178
See also
Operating Room Nursing 
WY 162
See also
Postanesthesia Nursing 
WY 154

Mesh BrowserPerioperative Period

WO 178
Periorbital Headache see
Headache

Mesh BrowserPeriostitis

WE 251
Peripersonal Space see
Personal Space
Peripheral Angiopathies see
Peripheral Vascular Diseases
Peripheral Arterial Catheterization see
Catheterization, Peripheral

Mesh BrowserPeripheral Arterial Disease

WG 550
Peripheral Arterial Diseases see
Peripheral Arterial Disease
Peripheral Artery Disease see
Peripheral Arterial Disease
Peripheral Autoimmune Demyelinating Disease see
Polyradiculoneuropathy
Peripheral Autonomic Nervous System Diseases see
Autonomic Nervous System Diseases

Mesh BrowserPeripheral Blood Stem Cell Transplantation

WH 380
Peripheral Catheterization see
Catheterization, Peripheral
Peripheral Giant Cell Granuloma see
Granuloma, Giant Cell
Peripheral Nerve Diseases see
Peripheral Nervous System Diseases

Mesh BrowserPeripheral Nerve Injuries

WL 530
Peripheral Nerve Injury see
Peripheral Nerve Injuries
Peripheral Nerve Neoplasms see
Peripheral Nervous System Neoplasms
Peripheral Nerve Neoplasms, Benign see
Peripheral Nervous System Neoplasms
Peripheral Nerve Neoplasms, Malignant see
Peripheral Nervous System Neoplasms
Peripheral Nerve Neoplastic Infiltration see
Peripheral Nervous System Neoplasms
Peripheral Nerve Tumors see
Peripheral Nervous System Neoplasms

Mesh BrowserPeripheral Nerves

WL 500-544
See also
Cranial Nerves 
WL 330
See also
Nerve Fibers
See also
Spinal Nerves 
WL 400

Mesh BrowserPeripheral Nervous System

WL 500-544
Infant or child 
WS 340
See also
Neural Pathways

Mesh BrowserPeripheral Nervous System Agents

QV 76.5
Peripheral Nervous System Benign Neoplasms see
Peripheral Nervous System Neoplasms
Peripheral Nervous System Disease see
Peripheral Nervous System Diseases

Mesh BrowserPeripheral Nervous System Diseases

WL 520-544
Infant or child 
WS 340.5
Veterinary SF 895
Localized, by site
Peripheral Nervous System Disorders see
Peripheral Nervous System Diseases
Peripheral Nervous System Drugs see
Peripheral Nervous System Agents
Peripheral Nervous System Effect see
Peripheral Nervous System Agents
Peripheral Nervous System Effects see
Peripheral Nervous System Agents
Peripheral Nervous System Malignant Neoplasms see
Peripheral Nervous System Neoplasms

Mesh BrowserPeripheral Nervous System Neoplasms

WL 520
Localized, by site
Peripheral Neuropathies see
Peripheral Nervous System Diseases
Peripheral Neuropathy, Alcohol-Induced see
Alcoholic Neuropathy
Peripheral Resistance see
Vascular Resistance
Peripheral Stem Cell Transplantation see
Peripheral Blood Stem Cell Transplantation

Mesh BrowserPeripheral Vascular Diseases
General works 
WG 505
Veterinary SF 811
Peripheral Venous Catheterization see
Catheterization, Peripheral
Peripherally Inserted Central Catheter Line Insertion see
Catheterization, Peripheral
Periphlebitis see
Phlebitis

Mesh BrowserPerissodactyla
QL 737.U6-737.U64

Mesh BrowserPeristalsis

WI 102
Intestinal 
WI 402
Peristaltic Pumps, Implantable see
Infusion Pumps, Implantable
Periston see
Povidone
Peritol see
Cyproheptadine
Peritoneal Carcinomatosis see
Peritoneal Neoplasms

Mesh BrowserPeritoneal Cavity

WI 575
See also
Ascitic Fluid
See also
Laparoscopy

Mesh BrowserPeritoneal Dialysis

WJ 378
As treatment for diseases other than those of the kidney, by site or disease
See also
Kidneys, Artificial

Mesh BrowserPeritoneal Dialysis, Continuous Ambulatory

WJ 378

Mesh BrowserPeritoneal Diseases

WI 575
Peritoneal Effusion see
Ascitic Fluid
Peritoneal Fluid see
Ascitic Fluid
Peritoneal Infusions see
Infusions, Parenteral

Mesh BrowserPeritoneal Neoplasms

WI 575
Peritoneal Surface Malignancy see
Peritoneal Neoplasms
Peritoneoscopy see
Laparoscopy

Mesh BrowserPeritoneum

WI 575
See also
Ascitic Fluid
See also
Laparoscopy
Peritoneum, Parietal see
Peritoneum
Peritoneum, Visceral see
Peritoneum

Mesh BrowserPeritonitis

WI 575
Perlinganit see
Nitroglycerin
Permanent Dental Filling see
Dental Restoration, Permanent
Permanent Dental Fillings see
Dental Restoration, Permanent
Permanent Dental Restoration see
Dental Restoration, Permanent
Permanent Dental Restorations see
Dental Restoration, Permanent
Permanent Filling, Dental see
Dental Restoration, Permanent
Permanent Fillings, Dental see
Dental Restoration, Permanent
Permanent Nystagmus see
Nystagmus, Pathologic
Permanent Vegetative State see
Persistent Vegetative State

Mesh BrowserPermeability
Capillary see
Capillary Permeability 
WG 700
Cells see
Cell Membrane Permeability 
QU 375
Magnetic induction QC 754.2.P4
Other special topics, by subject
Permeability, Capillary see
Capillary Permeability
Permeability, Cell Membrane see
Cell Membrane Permeability
Permeability, Microvascular see
Capillary Permeability
Permeases see
Membrane Transport Proteins
Permits see
Licensure
Pernicious Anemia see
Anemia, Pernicious
Pernicious Vomiting of Pregnancy see
Hyperemesis Gravidarum
Pernio see
Chilblains
Perniosis see
Chilblains
Perodicticus potto see
Lorisidae
Peroneal Muscular Atrophy see
Charcot-Marie-Tooth Disease
Peroneal Muscular Atrophy with Pyramidal Features, Autosomal Dominant see
Spastic Paraplegia, Hereditary
Peroperative Care see
Intraoperative Care
Peroperative Complications see
Intraoperative Complications
Peroperative Period see
Intraoperative Period
Peroxidase-Antiperoxidase Complex Technic see
Immunoenzyme Techniques
Peroxidase-Antiperoxidase Complex Technique see
Immunoenzyme Techniques
Peroxidase-Labeled Antibody Technic see
Immunoenzyme Techniques
Peroxidase-Labeled Antibody Technique see
Immunoenzyme Techniques

Mesh BrowserPeroxidases

QU 140
Peroxide, Hydrogen see
Hydrogen Peroxide

Mesh BrowserPeroxides
Inorganic chemistry QD 181.O1
See also
Lipid Peroxides
See also
Reactive Oxygen Species

Mesh BrowserPeroxisomal Disorders

WD 205.5.L5
Peroxisomal Dysfunction, General see
Peroxisomal Disorders
Peroxisomal Dysfunction, Multiple see
Peroxisomal Disorders
Peroxisomal Dysfunction, Single see
Peroxisomal Disorders

Mesh BrowserPeroxisomes

QU 350
See also
Peroxisomal Disorders
Persantin see
Dipyridamole
Persantine see
Dipyridamole

Mesh BrowserPersian Gulf Syndrome

WD 600
Persian Gulf War see
Iraq War, 2003-2011
Persian Gulf War, 1991 see
Gulf War
Persistent Atrial Fibrillation see
Atrial Fibrillation
Persistent Cerebral Embryonic Artery see
Central Nervous System Vascular Malformations
Persistent Common Atrioventricular Canal see
Endocardial Cushion Defects
Persistent Fetal Circulation see
Persistent Fetal Circulation Syndrome

Mesh BrowserPersistent Fetal Circulation Syndrome

WS 410-421
See also
Ductus Arteriosus, Patent
Persistent Ostium Primum see
Heart Septal Defects, Atrial
Persistent Pulmonary Hypertension of Newborn see
Persistent Fetal Circulation Syndrome
Persistent Tremor see
Tremor
Persistent Unawareness State see
Persistent Vegetative State

Mesh BrowserPersistent Vegetative State

WB 182
See also
Akinetic Mutism
See also
Coma

Mesh BrowserPerson-Centered Psychotherapy

WM 420.5.N8
Person-Centered Therapy see
Person-Centered Psychotherapy
Personal Communication see
Communication

Mesh BrowserPersonal Construct Theory
General BF 698.9.P47
In psychotherapy 
WM 420.5.P3
Personal Digital Assistant see
Computers, Handheld
Personal Expenditures see
Financing, Personal
Personal Genetic Information see
Genetic Privacy
Personal Health Information see
Health Records, Personal
Personal Health Records see
Health Records, Personal

Mesh BrowserPersonal Health Services

W 84
Personal Hygiene see
Hygiene
Personal Identification Systems see
Records
Personal Liability see
Liability, Legal
Personal Medical Records see
Health Records, Personal

Mesh BrowserPersonal Narrative
Special topics, by subject
See also
Autobiography
See also
Personal Narratives as Topic
Personal Narratives see
Personal Narrative

Mesh BrowserPersonal Narratives as Topic
As a literary form CT 25
In psychotherapy 
WM 450.5.W9
See also
Autobiographies as Topic
See also
Personal Narrative

Mesh BrowserPersonal Protective Equipment
Generale
WA 260
Sports and leisure activities 
QT 250-261
See also specific devices

Mesh BrowserPersonal Satisfaction
Job satisfaction HF 5549.5.J63
Special topics, by subject
Success (General) BJ 1611-1618

Mesh BrowserPersonal Space
Social psychology HM 1171

Mesh BrowserPersonality
BF 698-698.9
Dependency BF 575.D34
In psychoanalysis 
WM 460.5.P3

Mesh BrowserPersonality Assessment
Psychiatric interview 
WM 143
Psychiatric testing 
WM 145
Psychological BF 698.4-698.8

Mesh BrowserPersonality Development
General BF 698
Adolescent 
WS 462.5.P3
Infant or child 
WS 105.5.P3
Psychoanalysis 
WM 460.5.P3
See also
Socialization
Personality Disorder, Antisocial see
Antisocial Personality Disorder
Personality Disorder, Borderline see
Borderline Personality Disorder
Personality Disorder, Compulsive see
Compulsive Personality Disorder
Personality Disorder, Dependent see
Dependent Personality Disorder
Personality Disorder, Histrionic see
Histrionic Personality Disorder
Personality Disorder, Paranoid see
Paranoid Personality Disorder
Personality Disorder, Passive-Aggressive see
Passive-Aggressive Personality Disorder
Personality Disorder, Schizoid see
Schizoid Personality Disorder
Personality Disorder, Schizotypal see
Schizotypal Personality Disorder

Mesh BrowserPersonality Disorders
Generale
WM 190
Adolescent 
WS 470.P3
Infant or child 
WS 350.8.P3
Personality Disorders, Passive Aggressive see
Passive-Aggressive Personality Disorder
Personality, Hysterical see
Histrionic Personality Disorder

Mesh BrowserPersonality Inventory
Psychiatry 
WM 145.5.M6
Psychology BF 698.5-698.8

Mesh BrowserPersonality Tests
Psychiatry 
WM 145
Psychology BF 698.5-698.8
Personality Type A see
Type A Personality
Personalized Medicine see
Precision Medicine

Mesh BrowserPersonnel Administration, Hospital

WX 159-159.8
In psychiatric hospitals 
WM 30.2
In special hospitals, with the hospital
Personnel Discipline see
Employee Discipline

Mesh BrowserPersonnel Downsizing
HF 5549.5.D55
Hospitals 
WX 159
In special areas, by subject
Nursing 
WY 30

Mesh BrowserPersonnel, Hospital

WX 159-159.8
See also names of specific types of personnel, e.g.,
Operating Room Technicians
Personnel, Hospital, Organization and Administration see
Personnel Administration, Hospital

Mesh BrowserPersonnel Management
General HF 5549-5549.5
Health Personnel (General) 
W 80
In medical practice 
W 80
In psychiatry 
WM 30.2
Nursing 
WY 30
Special fields, by subject, e.g.,
Nursing, Supervisory
See also
Personnel Administration, Hospital
Personnel Management, Hospital see
Personnel Administration, Hospital
Personnel, Nursing see
Nurses
Personnel Recruitment see
Personnel Selection

Mesh BrowserPersonnel Selection
General HF 5549.5.S38
In medicine 
W 21
Special fields, by subject
Personnel Staffing see
Personnel Staffing and Scheduling

Mesh BrowserPersonnel Staffing and Scheduling
Hospitals 
WX 159
Nursing 
WY 30
Psychiatry 
WM 30.2

Mesh BrowserPersonnel Turnover
Hospitals 
WX 159
Nursing 
WY 30
Psychiatry 
WM 30.2
Specific profession, by subject
Personnel Work see
Personnel Management
Persons with Disabilities see
Disabled Persons

Mesh BrowserPersons With Hearing Impairments
HV 2367-2395
Special topics, by subject
See also
Correction of Hearing Impairment
See also
Deaf-Blind Disorders
See also
Deafness
See also
Education of Hearing Disabled
See also
Hearing Disorders
Perspiration see
Sweat
Perspiratory Glands see
Sweat Glands
Persuasion see
Persuasive Communication

Mesh BrowserPersuasive Communication
BF 637.P4
See also
Behavior Control
See also
Propaganda
See also
Psychological Warfare
See also
Suggestion
Perthes Disease see
Legg-Calve-Perthes Disease
Pertofran see
Desipramine
Pertofrane see
Desipramine
Pertrofran see
Desipramine
Pertussigen see
Pertussis Toxin
Pertussis see
Whooping Cough
Pertussis Agglutinins see
Virulence Factors, Bordetella

Mesh BrowserPertussis Toxin

WC 340

Mesh BrowserPertussis Vaccine

WC 340
See also
Whooping Cough
Peruvian Bark see
Cinchona
Pervasive Child Development Disorders see
Child Development Disorders, Pervasive
Pervasive Development Disorders see
Child Development Disorders, Pervasive
Perversion, Sex see
Paraphilic Disorders
Pes Planus see
Flatfoot
Pes Valgus, Congenital Convex see
Flatfoot

Mesh BrowserPessaries

WP 26

Mesh BrowserPest Control

WA 240
Agriculture SB 950-990.5
See also
Insect Control 
QX 600
Pest Control, Biologic see
Pest Control, Biological

Mesh BrowserPest Control, Biological
Agriculture SB 975-978
Arthropods 
QX 600
Public Health (General) 
WA 240
See also names of other specific types of pest control
See also
Chemosterilants
Pest Management see
Pest Control

Mesh BrowserPesticide Residues
Salute pubblica
WA 240
See also
Food Contamination

Mesh BrowserPesticides
Agriculture SB 951-970.4
Industrial poisoning
WA 465
Salute pubblica
WA 240
Toxicology 
WA 240
Pestis galli Myxovirus see
Influenza A virus
Pet Facilitated Therapy see
Animal Assisted Therapy
PET Scan see
Positron-Emission Tomography
Pet Therapy see
Animal Assisted Therapy
Pet-Human Bonding see
Bonding, Human-Pet
Petechiae see
Purpura
Pethidine see
Meperidine
Petit Mal Convulsion see
Seizures
Petit Mal Epilepsy see
Epilepsy, Absence
Petrogale see
Macropodidae
Petrolatum, Liquid see
Mineral Oil

Mesh BrowserPetroleum
Toxicology 
QV 633.5.F6
Petromyzontidae see
Lampreys
Petromyzontiformes see
Lampreys

Mesh BrowserPetrous Bone

WV 230
Petrous Pyramid see
Petrous Bone
Petrous Sinus Thrombophlebitis see
Sinus Thrombosis, Intracranial
Petrous Sinus Thrombosis see
Sinus Thrombosis, Intracranial

Mesh BrowserAnimali
General SF 411-416.6
Anatomy and physiology SF 761-768.2
Diseases SF 981
See also specific pets
See also
Bonding, Human-Pet
Petylyl see
Desipramine
Peyote see
Mescaline
PF-1593 see
Bumetanide
Pfaundler-Hurler Syndrome see
Mucopolysaccharidosis I
Pfeiffer Syndrome see
Acrocephalosyndactylia
Pfizer Brand of Amoxicillin Sodium Salt see
Amoxicillin
Pfizer Brand of Doxorubicin Hydrochloride see
Doxorubicin
Pfizer Brand of Flurbiprofen see
Flurbiprofen
Pfizer Brand of Human Growth Hormone see
Human Growth Hormone
Pfizer Brand of Mefenamic Acid see
Mefenamic Acid
Pfizer Brand of Minoxidil see
Minoxidil
Pfizer Brand of Netilimicin see
Netilmicin
Pfizer Brand of Nifedipine see
Nifedipine
Pfizer Brand of Penicillin G Potassium see
Penicillin G
Pfizer Brand of Phenytoin see
Phenytoin
Pfizer Brand of Prazosin Hydrochloride see
Prazosin
Pfizer Brand of Ribavirin see
Ribavirin
Pfizer Brand of Roxithromycin see
Roxithromycin
Pfizer Brand of Sorbitol see
Sorbitol
Pfizer Brand of Spironolactone see
Spironolactone
Pfizer Brand of Sulbactam Sodium see
Sulbactam
Pfizer Brand of Thrombin see
Thrombin
Pfizer Brand of Tinidazole see
Tinidazole
Pfizer Brand of Tiotixene see
Thiothixene
Pfizer Brand of Tiotixene Dihydrochloride see
Thiothixene
Pfizer Brand of Tolbutamide see
Tolbutamide
Pfizerpen see
Penicillin G
PGA see
Prostaglandins A
PGE see
Prostaglandins E
PGE1 see
Alprostadil
PGE1alpha see
Alprostadil
PGF see
Prostaglandins F
PGF2 see
Dinoprost
PGF2 alpha see
Dinoprost
PGF2alpha see
Dinoprost
PGH Synthase see
Prostaglandin-Endoperoxide Synthases
PGH2 Synthetase see
Prostaglandin-Endoperoxide Synthases
PGI2 see
Epoprostenol
PGX see
Epoprostenol
pH see
Hydrogen-Ion Concentration
Phacochoerus see
Swine

Mesh BrowserPhacoemulsification

WW 260
Phacomatoses see
Neurocutaneous Syndromes
Phacomatosis see
Neurocutaneous Syndromes
Phacomatosis, Bourneville see
Tuberous Sclerosis
Phaeomelanins see
Melanins
Phage lambda see
Bacteriophage lambda
Phage Receptors see
Receptors, Virus
Phagedenic Gingivitis see
Gingivitis, Necrotizing Ulcerative
Phages see
Bacteriophages
Phagnalon see
Asteraceae
Phagocyte see
Phagocytes

Mesh BrowserPhagocyte Bactericidal Dysfunction

QW 740

Mesh BrowserPhagocytes

QW 690
See also
Histiocytes 
WH 650, etc.
See also
Macrophages 
WH 650, etc.
See also
Monocytes 
WH 200, etc.
See also
Neutrophils 
WH 200, etc.
Phagocytic Cell see
Phagocytes
Phagocytic Cells see
Phagocytes

Mesh BrowserPhagocytosis

QW 690
See also
Macrophages
Phakectomy see
Cataract Extraction
Phakomatoses see
Neurocutaneous Syndromes
Phakomatosis see
Neurocutaneous Syndromes
Phakomatosis, Bourneville see
Tuberous Sclerosis
Phalanges of Fingers see
Finger Phalanges
Phalanges of Toes see
Toe Phalanges
Phallic Stage see
Psychosexual Development

Mesh BrowserPhantom Limb

WE 170
Phantom Limb Pain see
Phantom Limb
Phantom Pain see
Phantom Limb
Phantom, Radiographic see
Phantoms, Imaging
Phantom, Radiologic see
Phantoms, Imaging
Phantom Sensation see
Phantom Limb

Mesh BrowserPhantoms, Imaging

WN 150
Phantoms, Radiographic see
Phantoms, Imaging
Phantoms, Radiologic see
Phantoms, Imaging
Pharm-Allergan Brand of Flurbiprofen Sodium see
Flurbiprofen
Pharma Investi Brand of Aciclovir see
Acyclovir
Pharma Investi Brand of Amiodarone Hydrochloride see
Amiodarone
Pharma Tek Brand of Bacitracin see
Bacitracin
Pharmaceutic Adjuvant see
Adjuvants, Pharmaceutic
Pharmaceutic Adjuvants see
Adjuvants, Pharmaceutic

Mesh BrowserPharmaceutic Aids

QV 800
Pharmaceutic Aids (Preservatives) see
Preservatives, Pharmaceutical
Pharmaceutic Chemistry see
Chemistry, Pharmaceutical
Pharmaceutic Education, Continuing see
Education, Pharmacy, Continuing
Pharmaceutic Education, Graduate see
Education, Pharmacy, Graduate
Pharmaceutic Ethics see
Ethics, Pharmacy
Pharmaceutic Policy see
Drug and Narcotic Control
Pharmaceutic Preparations see
Pharmaceutical Preparations
Pharmaceutic Preservative see
Preservatives, Pharmaceutical
Pharmaceutic Preservatives see
Preservatives, Pharmaceutical
Pharmaceutic Service, Hospital see
Pharmacy Service, Hospital
Pharmaceutic Services see
Pharmaceutical Services
Pharmaceutic Services, Community see
Community Pharmacy Services
Pharmaceutic Services Insurance see
Insurance, Pharmaceutical Services
Pharmaceutic Societies see
Societies, Pharmaceutical
Pharmaceutic Society see
Societies, Pharmaceutical
Pharmaceutic Solutions see
Pharmaceutical Solutions
Pharmaceutic Technology see
Technology, Pharmaceutical
Pharmaceutical Adjuvant see
Adjuvants, Pharmaceutic
Pharmaceutical Adjuvants see
Adjuvants, Pharmaceutic
Pharmaceutical Aids see
Pharmaceutic Aids
Pharmaceutical Arithmetic see
Drug Dosage Calculations
Pharmaceutical Calculations see
Drug Dosage Calculations
Pharmaceutical Care see
Pharmaceutical Services
Pharmaceutical Chemistry see
Chemistry, Pharmaceutical
Pharmaceutical Development see
Drug Development
Pharmaceutical Economics see
Economics, Pharmaceutical
Pharmaceutical Education, Continuing see
Education, Pharmacy, Continuing
Pharmaceutical Education, Graduate see
Education, Pharmacy, Graduate
Pharmaceutical Epidemiology see
Pharmacoepidemiology
Pharmaceutical Ethics see
Ethics, Pharmacy
Pharmaceutical Fees see
Fees, Pharmaceutical
Pharmaceutical Formulation see
Drug Compounding
Pharmaceutical Industry see
Drug Industry
Pharmaceutical Plants see
Plants, Medicinal
Pharmaceutical Policy see
Drug and Narcotic Control

Mesh BrowserPharmaceutical Preparations
Generale
QV 55
Administration & dosage 
QV 748
Administrative methods 
WB 340-356
See also specific methods, e.g.,
Administration, Intranasal
Adverse effects 
QV 56
See also
Iatrogenic Disease
Analysis 
QV 25
Metabolism 
QV 38
Mucopolysaccharidosis IV 
WD 205.5.C2
Preservation 
QV 754
Public health aspects
WA 730
Proprietary 
QV 772
Public health aspects 
WA 730
Standards 
QV 771
Supply & distribution 
QV 736
See also
Autonomic Agents
See also
Drug Packaging
See also
Legislation, Drug
See also
Nonprescription Drugs
See also
Nostrums
See also
Pharmacology
See also
Plants, Medicinal
See also names of specific drugs and types of drugs
See also
Receptors, Drug

Mesh BrowserPharmaceutical Preparations, Dental

QV 50
Pharmaceutical Preservative see
Preservatives, Pharmaceutical
Pharmaceutical Preservatives see
Preservatives, Pharmaceutical
Pharmaceutical Products see
Pharmaceutical Preparations

Mesh BrowserPharmaceutical Research

QV 20.5
Pharmaceutical Service, Community see
Community Pharmacy Services
Pharmaceutical Service, Hospital see
Pharmacy Service, Hospital

Mesh BrowserPharmaceutical Services

QV 737
Hospital see
Pharmacy Service, Hospital 
WX 179
Insurance see
Insurance, Pharmaceutical Services 
W 265, etc.
Militare
General UH 420-425
Navy VG 270-275
Pharmaceutical Services, Community see
Community Pharmacy Services
Pharmaceutical Services Insurance see
Insurance, Pharmaceutical Services
Pharmaceutical Societies see
Societies, Pharmaceutical
Pharmaceutical Society see
Societies, Pharmaceutical

Mesh BrowserPharmaceutical Solutions
Generale
QV 786.5.S6
See also specific solution terms, e.g.,
Contact Lens Solutions
Used for specific purposes, by subject
See also
Solutions
Pharmaceutical Technology see
Technology, Pharmaceutical

Mesh BrowserPharmaceutical Vehicles

QV 800
Pharmaceuticals see
Pharmaceutical Preparations
Pharmaceuticals, Dental see
Pharmaceutical Preparations, Dental
Pharmaceuticals, Veterinary see
Veterinary Drugs
Pharmaceutics see
Biopharmaceutics
Pharmachemie Brand of Etoposide see
Etoposide
Pharmachemie Brand of Fluorouracil Monosodium Salt see
Fluorouracil
Pharmacia Brand 1 of Alprostadil see
Alprostadil
Pharmacia Brand 2 of Alprostadil see
Alprostadil
Pharmacia Brand of Antithrombin see
Antithrombin III
Pharmacia Brand of Estrogens, Conjugated (USP) see
Estrogens, Conjugated (USP)
Pharmacia Brand of Prednisone see
Prednisone
Pharmacia Brand of Sulpiride see
Sulpiride
Pharmacia Brand of Thioctic Acid see
Thioctic Acid

Mesh BrowserPharmacies

QV 737
Directories 
QV 722
Public health aspects 
WA 730
See also
Pharmacy Service, Hospital 
WX 179
Pharmacist-Patient Relations see
Professional-Patient Relations

Mesh BrowserPharmacists
Generale
QV 21
Biografia
Collective
WZ 112.5.P4
Individuale
WZ 100
Directories 
QV 22
Registrazione
QV 29
Pharmacists' Aides see
Pharmacy Technicians
Pharmacoacupuncture Therapy see
Acupuncture Therapy
Pharmacoacupuncture Treatment see
Acupuncture Therapy
Pharmacoeconomics see
Economics, Pharmaceutical

Mesh BrowserPharmacoepidemiology

QV 771

Mesh BrowserPharmacogenetics

QV 38.5
See also
Drug Resistance
See also
Precision Medicine
See also
Toxicology
Pharmacogenomics see
Pharmacogenetics

Mesh BrowserPharmacognosy

QV 752
See also
Ethnopharmacology
See also
Medicine, Traditional
See also
Phytotherapy
See also
Plants, Medicinal

Mesh BrowserPharmacokinetics

QV 38
Pharmacologic Phenomena see
Pharmacological Phenomena
Pharmacologic Phenomenon see
Pharmacological Phenomena
Pharmacologic Process see
Pharmacological Phenomena
Pharmacologic Processes see
Pharmacological Phenomena
Pharmacological Concepts see
Pharmacological Phenomena

Mesh BrowserPharmacological Phenomena
Generale
QV 37
Dentale
QV 50
Veterinary SF 915
In conjunction with pharmaceutical preparations 
QV 4
See also
Pharmaceutical Preparations
Pharmacological Phenomenon see
Pharmacological Phenomena
Pharmacological Processes see
Pharmacological Phenomena

Mesh BrowserPharmacology

QV 21
See also
Pharmaceutical Preparations
See also
Pharmacological Phenomena

Mesh BrowserPharmacology, Clinical
As a profession 
QV 21
See also
Drug Therapy
See also
Pharmacological Phenomena

Mesh BrowserPharmacopoeia

QV 738

Mesh BrowserPharmacopoeia, Homeopathic

WB 930
Pharmacopoeias see
Pharmacopoeia

Mesh BrowserPharmacopoeias as Topic

QV 738
Pharmacopuncture see
Acupuncture
farmacoterapia see
Drug Therapy

Mesh BrowserPharmacovigilance

QV 771
See also
Drug Monitoring

Mesh BrowserPharmacy

QV 701-737
Generale
QV 704
As a profession 
QV 21
Instrumentation 
QV 26
Military UH 420-425
Naval VG 270-275
Veterinary SF 915
See also
Community Pharmacy Services
See also
Drug Prescriptions
See also
Education, Pharmacy
See also
History of Pharmacy
See also
Legislation, Pharmacy
See also
Pharmacists
See also
Pharmacy Service, Hospital
See also
Technology, Pharmaceutical

Mesh BrowserPharmacy Administration

QV 737
Veterinary medicine SF 915
See also
Fees, Pharmaceutical
See also
Insurance, Pharmaceutical Services
See also
Pharmacy Service, Hospital 
WX 179
Pharmacy Administrations see
Pharmacy Administration
Pharmacy Audit see
Quality of Health Care
Pharmacy Distribution see
Pharmacies
Pharmacy Economics see
Economics, Pharmaceutical
Pharmacy Education see
Education, Pharmacy
Pharmacy Education, Continuing see
Education, Pharmacy, Continuing
Pharmacy Education, Graduate see
Education, Pharmacy, Graduate
Pharmacy Ethics see
Ethics, Pharmacy
Pharmacy Faculty see
Faculty, Pharmacy
Pharmacy Fee see
Fees, Pharmaceutical
Pharmacy, History see
History of Pharmacy
Pharmacy Law see
Legislation, Pharmacy
Pharmacy Legislation see
Legislation, Pharmacy
Pharmacy Library see
Libraries, Special
Pharmacy Licensure see
Licensure, Pharmacy
Pharmacy Philosophy see
Philosophy
Pharmacy Practice Patterns see
Pharmacy
Pharmacy School see
Schools, Pharmacy
Pharmacy Schools see
Schools, Pharmacy
Pharmacy Service, Clinical see
Pharmacy Service, Hospital

Mesh BrowserPharmacy Service, Hospital

WX 179
Pharmacy Services see
Pharmaceutical Services
Pharmacy Services, Community see
Community Pharmacy Services
Pharmacy Services Insurance see
Insurance, Pharmaceutical Services
Pharmacy Societies see
Societies, Pharmaceutical
Pharmacy Society see
Societies, Pharmaceutical

Mesh BrowserPharmacy Technicians

QV 21.5
Pharmacy Technology see
Technology, Pharmaceutical
Pharmadine see
Povidone-Iodine
Pharmafrid Brand of Spironolactone see
Spironolactone
Pharmakon Brand of Procaine Hydrochloride see
Procaine
Pharmascience Brand of Activated Charcoal see
Charcoal
Pharmascience Brand of Bacitracin see
Bacitracin
Pharmascience Brand of Baclofen see
Baclofen
Pharmascience Brand of Buspirone Hydrochloride see
Buspirone
Pharmascience Brand of Desipramine Hydrochloride see
Desipramine
Pharmascience Brand of Lindane see
Hexachlorocyclohexane
Pharmascience Brand of Mefenamic Acid see
Mefenamic Acid
Pharmascience Brand of Methadone Hydrochloride see
Methadone
Pharmascience Brand of Trazodone Hydrochloride see
Trazodone
Pharmascience Brand of Tryptophan see
Tryptophan
Pharmaxolon see
Carbenoxolone
Pharmazam Brand of Naltrexone Hydrochloride see
Naltrexone
Pharmtech Brand of Thiopental Sodium see
Thiopental
Pharmygiène Brand of Activated Charcoal see
Charcoal
Pharnyx Cancer see
Pharyngeal Neoplasms
Pharyngeal Arch see
Branchial Region
Pharyngeal Arches see
Branchial Region
Pharyngeal Cancer see
Pharyngeal Neoplasms
Pharyngeal Clefts see
Branchial Region

Mesh BrowserPharyngeal Diseases

WV 400-440
General works 
WV 400
Infant or child 
WV 400-440
Nursing 
WY 158.5
Pharyngeal Grooves see
Branchial Region

Mesh BrowserPharyngeal Neoplasms

WV 410
Pharyngeal Pouch Syndrome see
DiGeorge Syndrome
Pharyngeal Tonsil see
Adenoids
Pharyngeal Tonsils see
Adenoids

Mesh BrowserFaringite

WV 410
Pharyngotympanic Tube see
Eustachian Tube

Mesh BrowserPharynx
Generale
WV 410
In digestion 
WI 190
In respiration 
WF 490
Infant or child 
WS 280
See also
Deglutition
Pharynx Diseases see
Pharyngeal Diseases
Pharynx Neoplasms see
Pharyngeal Neoplasms
Phase-Contrast Microscopy see
Microscopy, Phase-Contrast
Phasmidia see
Nematoda
PHD Ib see
Pseudohypoparathyroidism
PHD1b see
Pseudohypoparathyroidism
Phenacaine see
Anesthetics, Local

Mesh BrowserPhenacetin

QV 95
Phenadone see
Methadone

Mesh BrowserPhenanthrenes

QV 138.C1
Organic chemistry QD 395

Mesh BrowserPhenanthridines
As antineoplastic agents 
QV 269
Organic chemistry QD 401

Mesh BrowserPhencyclidine

QV 77.7
See also
Phencyclidine Abuse

Mesh BrowserPhencyclidine Abuse

WM 270
Phencyclidine Hydrobromide see
Phencyclidine
Phencyclidine Hydrochloride see
Phencyclidine
Phencyclidine-Related Disorders see
Phencyclidine Abuse
Phenemal see
Phenobarbital

Mesh BrowserPhenethylamines

QU 61
Organic chemistry QD 341.A8

Mesh BrowserPhenformin

WK 825

Mesh BrowserPhenobarbital

QV 88
Phenobarbital, Monosodium Salt see
Phenobarbital
Phenobarbital Sodium see
Phenobarbital
Phenobarbitone see
Phenobarbital

Mesh BrowserPhenols

QV 223
Phenomena, Biochemical see
Biochemical Phenomena
Phenomena, Biological see
Biological Phenomena
Phenomena, Microbiologic see
Microbiological Phenomena
Phenomenography see
Learning
Phenoterol see
Fenoterol

Mesh BrowserPhenothiazines
As antithelmintics 
QV 253
Organic chemistry QD 401
See also
Antipsychotic Agents

Mesh BrowserPhenotype

QU 500
See also
Somatotypes
Phenotypic Plasticity see
Adaptation, Physiological

Mesh BrowserPhenoxybenzamine

QV 132
Phenoxybenzamine Hydrochloride see
Phenoxybenzamine
Phentanyl see
Fentanyl

Mesh BrowserPhenyl Ethers
Organic chemistry QD 341.E7
Used for special purposes, by subject

Mesh BrowserPhenylacetates

QU 98
Organic chemistry QD 341.A2
Phenylacetic Acids see
Phenylacetates

Mesh BrowserPhenylalanine

QU 60
Phenylalanine Hydroxylase Deficiency see
Phenylketonurias
Phenylalanine Hydroxylase Deficiency Disease see
Phenylketonurias
Phenylalanine Hydroxylase Deficiency Disease, Severe see
Phenylketonurias
Phenylalanine, L-Isomer see
Phenylalanine
Phenylamines see
Aniline Compounds
Phenylbarbital see
Phenobarbital

Mesh BrowserPhenylbutazone

QV 95

Mesh BrowserPhenylenediamines
Biochemistry 
QU 61
Toxicity 
QV 632
Phenylethylamines see
Phenethylamines
Phenylethylbarbituric Acid see
Phenobarbital
Phenylethylbiguanide see
Phenformin
Phenylglycolic Acid see
Mandelic Acids
Phenylketonuria see
Phenylketonurias
Phenylketonuria, Atypical see
Phenylketonurias
Phenylketonuria, Classical see
Phenylketonurias
Phenylketonuria I see
Phenylketonurias
Phenylketonuria II see
Phenylketonurias
Phenylketonuria Type 2 see
Phenylketonurias

Mesh BrowserPhenylketonurias

WD 205.5.A5

Mesh BrowserPhenytoin

QV 85
Phenytoin Sodium see
Phenytoin

Mesh BrowserPheochromocytoma

QZ 380
Localized, by site
Pheochromocytoma, Extra-Adrenal see
Pheochromocytoma
Pheresis see
Blood Component Removal

Mesh BrowserPheromones
Communication QL 776
Secretion QP 190
Pheromones, Sexual see
Sex Attractants
Philanthropic Funds see
Fund Raising

Mesh BrowserPhilately
HE 6187-6228
Medico
WZ 340
Philippine Hemorrhagic Fever see
Severe Dengue

Mesh BrowserPhilology
P 1-1091
See also “phrase books” under specialty headings, e.g.,
Medicine
See also names of language groups under specific Philology headings, e.g.,
Philology, Classical
Special topics, by subject
Specific languages in appropriate LC PA-PM schedules

Mesh BrowserPhilology, Classical
PA 1-199
Grammars for physicians and pharmacists PA 2092
See also specific language subheadings under
Philology

Mesh BrowserPhilology, Oriental
PJ 70-95

Mesh BrowserPhilology, Romance
PC 1-41
Philosophical Overview see
Philosophy

Mesh BrowserPhilosophy
B 69-99
Of science Q 174-175.3
See also names of specific philosophies, e.g.,
Existentialism

Mesh BrowserPhilosophy, Medical

W 61

Mesh BrowserPhilosophy, Nursing

WY 86
Philtrum see
Lip

Mesh BrowserPhimosis

WJ 790
Phizer Brand of Phenytoin see
Phenytoin

Mesh BrowserPhlebitis
Generale
WG 600
Pyelophlebitis 
WJ 351
Specific localities, by site

Mesh BrowserPhlebography

WG 600
Localized, by site or disease
Phlebothrombosis see
Venous Thrombosis

Mesh BrowserPhlebotomus Fever

WC 526

Mesh BrowserPhlebotomy

WB 381
See also
Bloodletting
See also
Infusions, Intravenous
See also
Injections, Intravenous
See also
Leeching
Phlegmasia Alba Dolens see
Thrombophlebitis
Phlegmon see
Cellulitis
Phobia, Dental see
Dental Anxiety
Phobia, School see
Phobic Disorders

Mesh BrowserPhobia, Social

WM 178
See also
Ansia
Phobias see
Phobic Disorders

Mesh BrowserPhobic Disorders

WM 178
Phobic Neuroses see
Phobic Disorders
Phocoenidae see
Porpoises
Phocoenoides dalli see
Porpoises

Mesh BrowserPhonation

WV 501
See also
Speech
See also
Voice
See also
Voice Quality

Mesh BrowserPhonetics
P 215-240
General P 221
Physiological aspects 
WV 501

Mesh BrowserPhonocardiography

WG 141.5.P4
Phonological Impairments see
Articulation Disorders
Phonology Impairment see
Articulation Disorders
Phorbol Diesters see
Phorbol Esters

Mesh BrowserPhorbol Esters
Toxicology 
QV 633
Phorias see
Strabismus

Mesh BrowserPhosgene

QV 664
Phosophatidylcholine-Sterol Acyltransferase see
Phosphatidylcholine-Sterol O-Acyltransferase
Phosphatases see
Phosphoric Monoester Hydrolases
Phosphate see
Phosphates

Mesh BrowserPhosphates

QV 285
See also
Phosphorous Acids
See also
Phosphorus
Phosphates, Inorganic see
Phosphates

Mesh BrowserPhosphatidate Phosphatase

QU 136
Phosphatidate Phosphohydrolase see
Phosphatidate Phosphatase
Phosphatides see
Phospholipids
Phosphatidic Acid Phosphatase see
Phosphatidate Phosphatase
Phosphatidic Acid Phosphohydrolase see
Phosphatidate Phosphatase
Phosphatidyl Choline see
Phosphatidylcholines
Phosphatidyl Cholines see
Phosphatidylcholines
Phosphatidyl Inositol see
Phosphatidylinositols
Phosphatidylcholine see
Phosphatidylcholines

Mesh BrowserPhosphatidylcholine-Sterol O-Acyltransferase

QU 141

Mesh BrowserPhosphatidylcholines

QU 93

Mesh BrowserPhosphatidylethanolamines

QU 93
Phosphatidylinositol see
Phosphatidylinositols

Mesh BrowserPhosphatidylinositols

QU 93

Mesh BrowserPhosphines
As pesticides 
WA 240
Inorganic chemistry QD 181.P1

Mesh BrowserPhosphocreatine

QU 61
Phosphocreatine, Disodium Salt see
Phosphocreatine
Phosphodiesterase Activating Factor see
Calmodulin
Phosphodiesterase Activator Protein see
Calmodulin
Phosphodiesterase Protein Activator see
Calmodulin
Phosphodiesterases see
Phosphoric Diester Hydrolases
Phosphohistone Phosphatase see
Phosphoprotein Phosphatases
Phosphohydrolases see
Phosphoric Monoester Hydrolases
Phosphoinositides see
Phosphatidylinositols
Phospholipase see
Phospholipases

Mesh BrowserPhospholipases

QU 136

Mesh BrowserPhospholipases A

QU 136

Mesh BrowserPhospholipids

QU 93
Phosphomonoesterases see
Phosphoric Monoester Hydrolases
Phosphomycin see
Fosfomycin
Phosphonates see
Organophosphonates
Phosphonic Acid Esters see
Organophosphonates
Phosphonic Acids see
Phosphorous Acids
Phosphonomycin see
Fosfomycin

Mesh BrowserPhosphopeptides

QU 68
Phosphoprotein Phosphatase see
Phosphoprotein Phosphatases
Phosphoprotein Phosphatase-2C see
Phosphoprotein Phosphatases

Mesh BrowserPhosphoprotein Phosphatases

QU 136
Phosphoprotein Phosphohydrolase see
Phosphoprotein Phosphatases

Mesh BrowserPhosphoproteins

QU 55.2
Phosphorescence Measurements see
Luminescent Measurements
Phosphorescent Assays see
Luminescent Measurements
Phosphorescent Measurements see
Luminescent Measurements

Mesh BrowserPhosphoric Acids
QD 181.P1
Pharmacology 
QV 138.P4

Mesh BrowserPhosphoric Diester Hydrolases

QU 136

Mesh BrowserPhosphoric Monoester Hydrolases

QU 136

Mesh BrowserPhosphorous Acids

QV 138.P4
See also
Phosphates
See also
Phosphorus

Mesh BrowserPhosphorus
Biochemistry 
QU 130
Inorganic chemistry QD 181.P1
Of bone 
WE 200
Pharmacology 
QV 138.P4
Toxicology 
QV 627
See also
Organophosphorus Compounds
See also
Organothiophosphorus Compounds
See also
Phosphates
See also
Phosphorous Acids
See also
Phosphorus Isotopes
Phosphorus-31 see
Phosphorus

Mesh BrowserPhosphorus Isotopes
Inorganic chemistry QD 181.P1
Pharmacology 
QV 138.P4

Mesh BrowserPhosphorus Metabolism Disorders

WD 200.5.P4

Mesh BrowserPhosphorylases

QU 141

Mesh BrowserPhosphorylation
QD 281.P46
Phosphorylation, Oxidative see
Oxidative Phosphorylation
Phosphorylcholine, Acetyl Glyceryl Ether see
Platelet Activating Factor
Phosphorylcreatine see
Phosphocreatine
Phosphoseryl-Protein Phosphatase see
Phosphoprotein Phosphatases
Phosphostigmine see
Parathion

Mesh BrowserPhosphotransferases

QU 141
Phosphotransferases, ATP see
Phosphotransferases
Phosvel see
Leptophos
Photoaging of Skin see
Skin Aging

Mesh BrowserPhotobiology
General QH 515
See also
Luce
See also
Photochemistry QD 701-731
See also
Photosynthesis QK 882

Mesh BrowserPhotochemical Processes
General QD 701-731
Other special topics, by subject

Mesh BrowserPhotochemistry
General QD 701-731
As a profession QD 39.5
Other special topics, by subject
See also
Photochemical Processes

Mesh BrowserPhotochemotherapy
Generale
WB 480
For neoplasms 
QZ 270
Photochemotherapy, Extracorporeal see
Photopheresis
Photochemotherapy, Hematoporphyrin see
Hematoporphyrin Photoradiation
Photocoagulation see
Light Coagulation
Photocopying see
Copying Processes
Photodensitometry, X-Ray see
Absorptiometry, Photon
Photodermatitis see
Photosensitivity Disorders
Photodynamic Therapy see
Photochemotherapy

Mesh BrowserPhotogrammetry
TR 708
Photographic Memory see
Eidetic Imagery

Mesh BrowserPhotography
TR 144-145
In psychotherapy 
WM 450.5.P5
Medical TR 708
Used for specific subjects, by subject
See also
Microfilming
See also
Motion Pictures
See also
Photography, Dental

Mesh BrowserPhotography, Dental
General TR 708
In orthodontics 
WU 400
Special purposes by topic
Photography, Fundus Fluorescence see
Fluorescein Angiography
Photography, Intraoral see
Photography, Dental
Photography, Orthodontic see
Photography, Dental
Photokeratectomy see
Corneal Surgery, Laser
Photokymography see
Electrokymography

Mesh BrowserPhotometry
Analytical chemistry (General) QD 79.P46
Optics and Photonics QC 391
Quantitative analysis QD 117.P5
Used for diagnosis of particular disorders, with the disorder or system

Mesh BrowserPhotomicrography
QH 251
Photon Absorptiometry see
Absorptiometry, Photon
Photonics see
Optics and Photonics

Mesh BrowserPhotons
Physics QC 793.5.P42-793.5.P429
Radiation effects of 
WN 600-630
Special topics, by subject

Mesh BrowserPhotopheresis

WB 480
Photopic Vision see
Color Vision
Photoproteins see
Luminescent Proteins
Photoradiation see
Luce
Photoradiation, Hematoporphyrin see
Hematoporphyrin Photoradiation
Photoradiation Therapy see
Phototherapy

Mesh BrowserPhotoreceptor Cells

WL 102.9
See also
Retinal Pigments

Mesh BrowserPhotoreceptor Cells, Invertebrate
QL 364

Mesh BrowserPhotoreceptor Cells, Vertebrate

WW 270
Photoreceptors, Invertebrate see
Photoreceptor Cells, Invertebrate
Photoreceptors, Retinal see
Photoreceptor Cells, Vertebrate
Photoreceptors, Vertebrate see
Photoreceptor Cells, Vertebrate

Mesh BrowserPhotorefractive Keratectomy
Generale
WW 340
Used for specific disorder, with the disorder

Mesh BrowserPhotosensitivity Disorders

WR 160
Photosensitization see
Photosensitivity Disorders
Photosensitizers see
Photosensitizing Agents

Mesh BrowserPhotosensitizing Agents

QV 60
See also
Hematoporphyrin Photoradiation
See also
Photochemotherapy
See also
PUVA Therapy
Photosensitizing Effect see
Photosensitizing Agents
Photosensitizing Effects see
Photosensitizing Agents

Mesh BrowserPhotosynthesis
QK 882

Mesh BrowserPhototherapy

WB 480
PHP Ia see
Pseudohypoparathyroidism
Phrase see
Phrases

Mesh BrowserPhrases
Anesthesia 
WO 215
Embryology 
QS 615
Forensic medicine and dentistry 
W 615
Histology 
QS 515
Immunology 
QW 515
Pharmacy and pharmaceutics 
QV 715
Special topics, by subject
Medical (Form number 15 in any NLM schedule where applicable)

Mesh BrowserPhrenic Nerve

WL 400

Mesh BrowserPhrenology
BF 866-885

Mesh BrowserPhthalic Acids

QU 98
Organic chemistry QD 341.A2
Toxicology 
QV 612

Mesh BrowserPhthalic Anhydrides

QU 98
Toxicology 
QV 612
Phthalidyl Ampicillin see
Talampicillin

Mesh BrowserPhthiraptera
General QL 461-599.82
As parasites or insect vectors 
QX 501-502
See also
afidi
See also
Insect Control
See also
Lice Infestations
See also
Pediculus
Phthiriasis see
Lice Infestations
Phthisis see
Tuberculosis, Pulmonary
Phthivazid see
Isoniazid
Phthivazide see
Isoniazid

Mesh BrowserPhycomyces

QW 180.5.P4

Mesh BrowserPhyllodes Tumor

WP 870
Phylogenomics see
Phylogeny

Mesh BrowserPhylogeny

QU 500
See also
Classificazione
Phymatous Rosacea see
Rosacea
Phymet see
Methadone

Mesh BrowserPhysarum

QW 230
Physeptone see
Methadone
Physiatrics see
Physical and Rehabilitation Medicine

Mesh BrowserPhysiatrists

W 21
Physiatry see
Physical and Rehabilitation Medicine
Physical Activity see
Exercise

Mesh BrowserPhysical and Rehabilitation Medicine

WB 460-545
See also
Biomechanical Phenomena
See also
Physiatrists
Physical Anthropology see
Anthropology, Physical
Physical Barriers see
Architectural Accessibility
Physical Chemistry see
Chemistry, Physical
Physical Chemistry Concepts see
Chemical Phenomena
Physical Chemistry Phenomena see
Chemical Phenomena
Physical Chemistry Process see
Chemical Phenomena
Physical Chemistry Processes see
Chemical Phenomena
Physical Concepts see
Physical Phenomena
Physical Containment see
Containment of Biohazards
Physical Education see
Physical Education and Training

Mesh BrowserPhysical Education and Training

QT 255
Physical Education, Training see
Physical Education and Training
Physical Effort see
Physical Exertion

Mesh BrowserPhysical Endurance

QT 256
Special topics, by subject
See also
Endurance Training
Physical Ergonomics see
Ergonomics
Physical Exam see
Physical Examination

Mesh BrowserPhysical Examination
Generale
WB 200-288
Aged 
WT 141
Infant or child 
WS 141
Veterinary SF 772.5
See also
Gynecological Examination
Physical Examination, Preadmission see
Diagnostic Tests, Routine
Physical Examinations and Diagnoses see
Physical Examination

Mesh BrowserPhysical Exertion

QT 256
See also
Exercise
See also
Fatigue
See also
Gli sport
See also
Work

Mesh BrowserPhysical Fitness
Generale
QT 256
In aviation medicine 
WD 705
For automobile driving 
WA 275
See also
Exercise
See also
Exercise Test
See also
Exercise Therapy
See also
Physical Endurance
Physical Fitness Testing see
Exercise Test
Physical Medicine see
Physical and Rehabilitation Medicine
Physical Medicine and Rehabilitation see
Physical and Rehabilitation Medicine

Mesh BrowserPhysical Phenomena
General works QC 21-21.3
See also
Biophysical Phenomena
Physical Phenomenon see
Physical Phenomena
Physical Process see
Physical Phenomena
Physical Processes see
Physical Phenomena
Physical Restraint see
Restraint, Physical
Physical Sciences see
Natural Science Disciplines
Physical Stamina see
Physical Endurance

Mesh BrowserPhysical Therapist Assistants

WB 460
See also
Physical Therapy Modalities
See also
Physical Therapy Specialty

Mesh BrowserPhysical Therapists

WB 460
See also
Physical Therapy Modalities
See also
Physical Therapy Specialty
Physical Therapy Assistants see
Physical Therapist Assistants

Mesh BrowserPhysical Therapy Department, Hospital

WX 223
Physical Therapy Departments, Hospital see
Physical Therapy Department, Hospital

Mesh BrowserPhysical Therapy Modalities

WB 460-545
Generale
WB 460
Hospital departments see
Physical Therapy Department, Hospital 
WX 223
In psychiatry 
WM 405-412
Veterinary SF 925
See also
Exercise Movement Techniques
See also
Musculoskeletal Manipulations
See also
Physical Therapists
See also
Physical Therapy Specialty
See also
Postoperative Care

Mesh BrowserPhysical Therapy Specialty

WB 460
See also
Physical Therapists
See also
Physical Therapy Modalities
Physical Therapy Techniques see
Physical Therapy Modalities
Physically Challenged see
Disabled Persons
Physically Disabled see
Disabled Persons
Physically Handicapped see
Disabled Persons
Physician Anesthetists see
Anesthesiologists
Physician Assignment Acceptance see
Medicare Assignment

Mesh BrowserPhysician Assistants

W 21.5
Physician-Assisted Suicide see
Suicide, Assisted

Mesh BrowserPhysician Executives
Generale
W 88
Hospital and health facilities 
WX 155
Physician-Hospital Organizations see
Hospital-Physician Joint Ventures
Physician-Hospital Relations see
Hospital-Physician Relations

Mesh BrowserPhysician Impairment
Medicine 
W 21
For general impairment of physicians in various specialties, class in the number for the profession where applicable

Mesh BrowserPhysician-Nurse Relations
From the nurse's perspective 
WY 88
From the physician's perspective 
W 62
Physician Nurse Relationship see
Physician-Nurse Relations

Mesh BrowserPhysician-Patient Relations
Generale
W 62
Adolescent 
WS 462.5.I5
In psychiatry 
WM 62
In surgery 
WO 62
Infant or child 
WS 105.5.I5
Intelectually disabled
WS 107.5.R4
See also
Truth Disclosure
Physician Patient Relations see
Physician-Patient Relations
Physician Patient Relationship see
Physician-Patient Relations
Physician-Patient Transmission see
Infectious Disease Transmission, Professional-to-Patient
Physician Practice Management Company see
Practice Management
Physician Services, Insurance see
Insurance, Physician Services
Physician Shortage Area see
Medically Underserved Area
Physician, Woman see
Physicians, Women

Mesh BrowserPhysicians
Biografia
Collective
WZ 112-150
Individuale
WZ 100
Directories 
W 22
Storia
WZ 51-80.5
See also names of specific ethnic groups, e.g.,
African Americans
WZ 80.5.B5
Interpersonal Relations 
W 62
See also
Interprofessional Relations
See also
Physician-Nurse Relations
See also
Physician-Patient Relations
Liability 
W 44
See also
Insurance, Liability
W 44, etc.
Literary & artistic works 
WZ 350
Militare
WZ 112.5.M4
Women see
Physicians, Women
Special topics by subject
Physicians' Assistants see
Physician Assistants
Physicians' Extenders see
Physician Assistants

Mesh BrowserPhysicians, Family

W 89
See also
Family Practice
Physicians, General Practice see
General Practitioners
Physicians, Junior see
Medical Staff, Hospital
Physician's Office see
Physicians' Offices

Mesh BrowserPhysicians' Offices
Architectural planning and construction 
WX 140
Gestione
W 80

Mesh BrowserPractice Patterns, Physicians'

W 87
Physician's Practice Patterns see
Practice Patterns, Physicians'

Mesh BrowserPhysicians, Primary Care

W 89
Physicians' Role see
Physician's Role

Mesh BrowserPhysician's Role

W 62

Mesh BrowserPhysicians, Women

W 21
Biografia
Collective
WZ 150
Individuale
WZ 100
Storia
WZ 80.5.W5
See also special topics under
Physicians
Physicochemical Concepts see
Chemical Phenomena
Physicochemical Phenomena see
Chemical Phenomena
Physicochemical Phenomenon see
Chemical Phenomena
Physicochemical Process see
Chemical Phenomena
Physicochemical Processes see
Chemical Phenomena

Mesh BrowserPhysics
QC 21-21.3
As a profession QC 29
See also
Physical Phenomena
Physics, Radiologic see
Health Physics

Mesh BrowserPhysiognomy
BF 840-861
See also
Facial Expression 
WB 275, etc.
Physiologic Angiogenesis see
Neovascularization, Physiologic
Physiologic Availability see
Biological Availability
Physiologic Calcification see
Calcification, Physiologic
Physiologic Monitoring see
Monitoring, Physiologic
Physiologic Neovascularization see
Neovascularization, Physiologic
Physiologic Nystagmus see
Nystagmus, Physiologic
Physiologic Ossification see
Osteogenesis
Physiologic Psychology see
Psychophysiology
Physiological Adaptation see
Adaptation, Physiological
Physiological Chemistry see
Biochemistry
Physiological Concepts see
Physiological Phenomena
Physiological Neonatal Jaundice see
Jaundice, Neonatal

Mesh BrowserPhysiological Phenomena
Generale
QT 4
Human (General) 
QT 104
School texts 
QT 210-215
Special topics, by subject
See also
Adaptation, Physiological
See also
Physiology
Physiological Phenomenon see
Physiological Phenomena
Physiological Process see
Physiological Phenomena
Physiological Processes see
Physiological Phenomena
Physiological Psychology see
Psychophysiology
Physiological Stress see
Stress, Physiological
Physiological Stress Reaction see
Stress, Physiological
Physiological Stress Reactivity see
Stress, Physiological
Physiological Stress Response see
Stress, Physiological
Physiologists see
Physiology

Mesh BrowserPhysiology
As a profession 
QT 21
Biografia
Collective
WZ 112.5.P5
Individuale
WZ 100
See also
Physiological Phenomena
Physiology, Bacterial see
Bacterial Physiological Phenomena
Physiology, Blood see
Blood Physiological Phenomena
Physiology, Cardiovascular see
Cardiovascular Physiological Phenomena
Physiology, Cell see
Cell Physiological Phenomena

Mesh BrowserPhysiology, Comparative
Generale
QT 4
Domestic animals only SF 768
Wild animals only QP 33
Physiology, Dental see
Dental Physiological Phenomena
Physiology, Digestive see
Digestive System Physiological Phenomena
Physiology, Musculoskeletal see
Musculoskeletal Physiological Phenomena
Physiology, Nervous System see
Nervous System Physiological Phenomena
Physiology, Ocular see
Ocular Physiological Phenomena
Physiology of the Eye see
Ocular Physiological Phenomena
Physiology, Plant see
Plant Physiological Phenomena
Physiology, Respiratory see
Respiratory Physiological Phenomena
Physiology, Skin see
Skin Physiological Phenomena
Physiology, Urinary Tract see
Urinary Tract Physiological Phenomena
Physiology, Viral see
Virus Physiological Phenomena
Physiotherapists see
Physical Therapists
Physiotherapy Specialty see
Physical Therapy Specialty
Physiotherapy (Specialty) see
Physical Therapy Specialty
Physiotherapy (Techniques) see
Physical Therapy Modalities

Mesh BrowserPhysostigmine

QV 124
Phytate see
Phytic Acid

Mesh BrowserPhytic Acid

QU 84
Phytin see
Phytic Acid
Phyto-Estrogen see
Phytoestrogens
Phytochemical see
Phytochemicals

Mesh BrowserPhytochemicals
General QK 861-899
Medicinal and nutritional aspects 
QV 766-770
Specific chemical, with the chemical

Mesh BrowserPhytochrome
QK 898.P67
Phytoestrogen see
Phytoestrogens

Mesh BrowserPhytoestrogens
Dietary use in health and disease 
WB 430
Phytohormones see
Plant Growth Regulators
Phytomitogens see
Mitogens
Phytonutrient see
Phytochemicals
Phytonutrients see
Phytochemicals
Phytopathology see
Plant Pathology
Phytophagineae see
Plant Viruses
Phytoremediation see
Biodegradation, Environmental
Phytoreovirus see
Reoviridae

Mesh BrowserPhytotherapy

WB 925
As therapy of a particular disease or system, with the disease or system
See also
Drugs, Chinese Herbal
See also
Ethnobotany
See also
Ethnopharmacology
See also
Herbal Medicine
See also
Pharmacognosy
See also
Plant Extracts
See also
Plants
See also
Plants, Medicinal
Phytourease see
Urease

Mesh BrowserPia Mater

WL 200
Pial Vein see
Cerebral Veins

Mesh BrowserPica

WM 175
PICC Line Catheterization see
Catheterization, Peripheral
PICC Line Placement see
Catheterization, Peripheral
PICC Placement see
Catheterization, Peripheral

Mesh BrowserPicibanil
As an antineoplastic agent 
QV 269
Picibanyl see
Picibanil
Pick Disease of Heart see
Pericarditis, Constrictive
Pick's Disease of Heart see
Pericarditis, Constrictive

Mesh BrowserPicloram
Salute pubblica
WA 240
Picodnaviruses see
Parvoviridae

Mesh BrowserPicornaviridae

QW 168.5.P4

Mesh BrowserPicornaviridae Infections

WC 501
Picornavirus Infections see
Picornaviridae Infections
Picornaviruses see
Picornaviridae

Mesh BrowserPicrates

QV 223
Picric Acid see
Picrates

Mesh BrowserPictorial Work
Embryology 
QS 617
Forensic medicine and dentistry 
W 617
General Surgery 
WO 517
Histology 
QS 517
Immunology 
QW 517
Operative dentistry 
WU 317
Oral surgery 
WU 600.7
Orthodontics 
WU 417
Pharmacy and pharmaceutics 
QV 717
Prosthodontics 
WU 507
(Form number 17 in any NLM schedule where applicable)
See also
Caricature
Pictorial Works see
Pictorial Work
Picture Archiving and Communication Systems see
Radiology Information Systems
Picture Archiving, Radiologic see
Radiology Information Systems
Picture Frustration Study see
Projective Techniques
Pie Torcido see
Clubfoot
Piebald Dolphins see
Dolphins
Pierre Fabre Brand of Caffeine see
Caffeine
Pierre Fabre Brand of Enoxacin Sesquihydrate see
Enoxacin
Pierre Fabre Brand of Etoposide see
Etoposide
Pierre Fabre Brand of Tinidazole see
Tinidazole
Pig Skin Dressings see
Biological Dressings
Pigeon Breeder's Lung see
Bird Fancier's Lung
Pigeons see
Columbidae

Mesh BrowserPigment Epithelium of Eye

WW 103
Of particular parts of the eye, with the part, e.g.,
Retina 
WW 270
Pigmentary Cirrhosis see
Hemochromatosis
Pigmentary Retinopathy see
Retinitis Pigmentosa

Mesh BrowserPigmentation
Anthropology GN 197
Manifestations of disease 
WR 143
Physiology 
WR 102
See also
Skin Pigmentation

Mesh BrowserPigmentation Disorders

WR 265-267
Manifestations of disease 
WR 143
Pigmented Moles see
Nevus, Pigmented

Mesh BrowserPigments, Biological
Generale
QU 110
Plants
Biochemistry QD 441
Botany QK 898.P7
See also names of specific pigments
See also
Pigmentation
See also
Porphyrins
Pigments, Inorganic see
Coloring Agents
Pigmy Killer Whale see
Dolphins
Pigs see
Swine
Pikas see
Lagomorpha
Pilar Cyst see
Epidermal Cyst
Pilates-Based Exercises see
Exercise Movement Techniques
Pilates Training see
Exercise Movement Techniques
Piles see
Hemorrhoids
Pill Rolling Tremor see
Tremor
pillole see
Tablets

Mesh BrowserPilocarpine

QV 122
Pilocarpine Hydrochloride see
Pilocarpine
Pilocarpine, Monohydrochloride, (3S-cis)-Isomer see
Pilocarpine
Pilocarpine Mononitrate, (3S-cis)-Isomer see
Pilocarpine
Pilocarpine Nitrate see
Pilocarpine
Pilocytic Astrocytoma see
Astrocytoma
Pilonidal Cyst see
Pilonidal Sinus

Mesh BrowserPilonidal Sinus

WE 750
Pilot see
Pilots

Mesh BrowserPilots
In aviation medicine 
WD 700-745
In naval medicine 
WD 800
In space medicine 
WD 750-758
Pin, Dental see
Dental Pins
Pinacolyl Methylphosphonofluoridate see
Soman
Pinadone see
Methadone
Pinalgesic see
Mefenamic Acid
Pineal Body see
Pineal Gland

Mesh BrowserPineal Gland

WK 350
Pineal Gland Tumor see
Pinealoma
Pineal Neoplasms see
Pinealoma
Pineal Parenchymal Tumors see
Pinealoma
Pineal Tumors see
Pinealoma
Pinealocytoma see
Pinealoma

Mesh BrowserPinealoma

WK 350
Pineoblastoma see
Pinealoma
Pineocytoma see
Pinealoma
Pinewood Brand of Mefenamic Acid see
Mefenamic Acid
Pinewood Brand of Methadone Hydrochloride see
Methadone
Pink Disease see
Acrodynia
Pinnipedia see
Caniformia
Pinnipeds see
Caniformia
Pinprick Sensation Diminished see
Somatosensory Disorders
Pins, Dental see
Dental Pins

Mesh BrowserPinta

WC 422
Pintoform see
Propafenone
Pipcil see
Piperacillin

Mesh BrowserPipe Smoking
Generale
WM 295
Specific substances, by topic
Pipe Tobacco see
Tobacco Products
Pipera-Hameln see
Piperacillin

Mesh BrowserPiperacillin

QV 354
Piperacillin Curasan see
Piperacillin
Piperacillin Fresenius see
Piperacillin
Piperacillin Hexal see
Piperacillin
Piperacillin Monosodium Salt see
Piperacillin
Piperacillin-Ratiopharm see
Piperacillin
Piperacillin Sodium see
Piperacillin
Pipercillin see
Piperacillin
Pipracil see
Piperacillin
Pipril see
Piperacillin
Piren-Basan see
Pirenzepine
Pirenzepin see
Pirenzepine
Pirenzepin-Ratiopharm see
Pirenzepine
Pirenzepin Von Ct see
Pirenzepine

Mesh BrowserPirenzepine
As an anti-ulcer agent 
QV 69
As an antipsychotic agent 
QV 77.9
Pirenzepine Dihydrochloride see
Pirenzepine
Piriton see
Chlorpheniramine
Piroplasmosis see
Babesiosis

Mesh BrowserPiroxicam

QV 95
Pisa Brand of Aciclovir see
Acyclovir
Pisa Brand of Atracurium Besilate see
Atracurium
Pisa Brand of Bupivacaine Hydrochloride see
Bupivacaine
Pisa Brand of Cefotaxime Sodium see
Cefotaxime
Pisa Brand of Ceftriaxone Sodium see
Ceftriaxone
Pisa Brand of Dobutamine Hydrochloride see
Dobutamine
Pisa Brand of Enflurane see
Enflurane
Pisa Brand of Human Growth Hormone see
Human Growth Hormone
Pisa Brand of Thiopental Sodium see
Thiopental
Pisum see
Piselli
Pisum sativum see
Piselli

Mesh BrowserPit and Fissure Sealants

WU 190
Pit Fissure Sealants see
Pit and Fissure Sealants
Pit Viper Venom see
Crotalid Venoms
Pit Viper Venoms see
Crotalid Venoms

Mesh BrowserPitch Discrimination

WV 272

Mesh BrowserPitch Perception

WV 272
Pithecellobium see
Fabaceae
Pithecolobium see
Fabaceae
Pitocin see
Oxytocin
Pitressin see
Vasopressins
Pittosporaceae see
Rosales
Pittosporum see
Rosales
Pituitary Adenoma see
Pituitary Neoplasms
Pituitary Adenoma, Prolactin-Secreting see
Prolactinoma

Mesh BrowserPituitary-Adrenal Function Tests

WK 510

Mesh BrowserPituitary-Adrenal System

WK 510
Pituitary Cancer see
Pituitary Neoplasms
Pituitary Carcinoma see
Pituitary Neoplasms
Pituitary Diencephalic Syndrome see
Hypothalamic Diseases

Mesh BrowserPituitary Diseases

WK 550-590
Generale
WK 550
Surgery 
WK 590
Of specific diseases, with disease
Pituitary Disorders see
Pituitary Diseases
Pituitary Dwarf see
Dwarfism, Pituitary
Pituitary Dwarfism see
Dwarfism, Pituitary
Pituitary Dwarfism II see
Laron Syndrome
Pituitary FSH Hypersecretion see
Hyperpituitarism

Mesh BrowserPituitary Function Tests

WK 502
See also
Pituitary-Adrenal Function Tests 
WK 510
Pituitary Gigantism see
Gigantism

Mesh BrowserPituitary Gland

WK 500-590
See also
Hypophysectomy

Mesh BrowserPituitary Gland, Anterior

WK 510
Pituitary Gland Diseases see
Pituitary Diseases
Pituitary Gland Function Tests see
Pituitary Function Tests

Mesh BrowserPituitary Gland, Posterior

WK 520
Pituitary Growth Hormone see
Growth Hormone
Pituitary Growth Hormones, Recombinant see
Growth Hormone
Pituitary Hormone-Release Inhibiting Hormones see
Pituitary Hormone Release Inhibiting Hormones

Mesh BrowserPituitary Hormone Release Inhibiting Hormones

WK 515

Mesh BrowserPituitary Hormone-Releasing Hormones

WK 515

Mesh BrowserPituitary Hormones

WK 502
See also
Hypopituitarism

Mesh BrowserPituitary Hormones, Anterior

WK 515

Mesh BrowserPituitary Hormones, Posterior
Generale
WK 520
See also
Neurophysins 
QU 55.2
Pituitary Insufficiency see
Hypopituitarism
Pituitary LH Hypersecretion see
Hyperpituitarism

Mesh BrowserPituitary Neoplasms

WK 585
See also
Adenoma, Acidophil
See also
Adenoma, Chromophobe
Pituitary Stalk see
Pituitary Gland
Pituitary TSH Hypersecretion see
Hyperpituitarism
Pituitary Tumors see
Pituitary Neoplasms
Pituitrin see
Pituitary Hormones, Posterior

Mesh BrowserPityriasis

WR 204
Pivamiser see
Pivampicillin

Mesh BrowserPivampicillin

QV 354
Pivampicillin Hydrochloride see
Pivampicillin
Pivampicillin Monohydrochloride see
Pivampicillin
PIXE see
Spectrometry, X-Ray Emission
PKU, Atypical see
Phenylketonurias
PL 108-173 see
Medicare Part D
PL 93-579 see
vita privata
PL93-579 see
vita privata
PL93-641 see
Health Planning
Place of Birth see
Residence Characteristics

Mesh BrowserPlacebos

WB 330
Placement Agencies, Nursing see
Employment

Mesh BrowserPlacenta

WQ 212
Growth and Development see
Placentation
See also
Maternal-Fetal Exchange
See also
Placental Circulation

Mesh BrowserPlacenta Diseases

WQ 212
Placenta Disorders see
Placenta Diseases
Placental Abruption see
Abruptio Placentae
Placental Blood Stem Cell Transplantation see
Cord Blood Stem Cell Transplantation

Mesh BrowserPlacental Circulation

WQ 212
See also
Maternal-Fetal Exchange
Placental Development see
Placentation
Placental Diseases see
Placenta Diseases

Mesh BrowserPlacental Extracts
Pharmacology 
QV 370
Therapeutic use (General) 
WB 391
Used for treatment of particular disorders, with the disorder or system

Mesh BrowserPlacental Function Tests

WQ 212

Mesh BrowserPlacental Hormones

WK 920

Mesh BrowserPlacental Insufficiency

WQ 212
Placental Labyrinth Layer see
Chorionic Villi

Mesh BrowserPlacental Lactogen

WK 920
See also
Receptors, Somatotropin
Placental Luteotropin see
Placental Lactogen
Placental Proteins see
Pregnancy Proteins
Placental Villi see
Chorionic Villi

Mesh BrowserPlacentation

QS 645
Placentoma, Normal see
Placenta
Placentome see
Placenta
Plagiocephaly, Craniosynostosis see
Craniosynostoses
Plagiocephaly, Synostotic see
Craniosynostoses

Mesh BrowserPlague

WC 350-355
Generale
WC 350
Cattle see
Rinderpest SF 966
Epidemic 
WC 355
Fowl Plague see
Influenza in Birds SF 995.6.I6

Mesh BrowserPlague Vaccine

WC 350
Plan, Dental Care see
Insurance, Dental
Planigraphy, X-Ray see
Tomography, X-Ray
Planista gangetica see
Dolphins

Mesh BrowserPlankton
Aquatic biology (General) QH 90.8.P5
Freshwater biology QH 96.8.P5
Marine biology QH 91.8.P5
Plant ecology QK 933-935
Zoology
Freshwater QL 143
Ocean QL 123
Planned Parenthood see
Family Planning Services
Planned Pregnancy see
Family Planning Services
Planning, Computer-Assisted Radiotherapy see
Radiotherapy Planning, Computer-Assisted
Planning, Health and Welfare see
Health Planning
Planning, Health Facility see
Health Facility Planning
Planning, Hospital see
Hospital Planning
Planning Methodology see
Planning Techniques
Planning Organizations, Health see
Health Planning Organizations
Planning Technic see
Planning Techniques

Mesh BrowserPlanning Techniques
Health administration 
WA 525-546
Health services 
W 84-84.8
Hospital administration 
WX 150
Hospital and health facilities 
WX 140
In other particular areas, by subject
See also
Health Planning
See also
Social Planning
Planning Theories see
Planning Techniques
Plannings, Hospital see
Hospital Planning
Plans, Dental Care see
Insurance, Dental
Plans, Nursing Care see
Patient Care Planning
Plant Alkaloids see
Alkaloids
Plant Antigens see
Antigens, Plant
Plant Aril see
Fruit
Plant Bacteriology see
Plant Pathology
Plant Bioactive Compounds see
Phytochemicals
Plant Biologically Active Compounds see
Phytochemicals

Mesh BrowserPlant Breeding
SB 123-123.5
Of individual plants, with the plant
Plant Capsule see
Fruit

Mesh BrowserPlant Cells
QK 725
Plant-Derived Chemicals see
Phytochemicals
Plant-Derived Compounds see
Phytochemicals

Mesh BrowserPlant Diseases
SB 599-990.5
General works SB 731
Biological control SB 975-978
Trees SB 761-767
Plant DNA see
DNA, Plant
Plant-Drug Interactions see
Herb-Drug Interactions
Plant Embryos see
Seeds
Plant Estrogen see
Phytoestrogens
Plant Estrogens see
Phytoestrogens

Mesh BrowserPlant Extracts

QV 766-770
See also
Phytotherapy
Plant Extracts, Chinese see
Drugs, Chinese Herbal
Plant Galls see
Plant Tumors
Plant Gene Expression Regulation see
Gene Expression Regulation, Plant
Plant Genome see
Genome, Plant

Mesh BrowserPlant Growth Regulators
QK 745
Plant Hormones see
Plant Growth Regulators
Plant Lice see
afidi
Plant Louse see
afidi
Plant Microspores see
Pollen
Plant Mycology see
Plant Pathology

Mesh BrowserPlant Oils
Biochemistry 
QU 86
Dietary use in health or disease 
WB 425
Public health aspects 
WA 722

Mesh BrowserPlant Pathology
SB 621-795
Plant Physiologic Phenomena see
Plant Physiological Phenomena
Plant Physiologic Phenomenon see
Plant Physiological Phenomena

Mesh BrowserPlant Physiological Phenomena
QK 710-899
Plant Physiological Phenomenon see
Plant Physiological Phenomena
Plant Physiological Process see
Plant Physiological Phenomena
Plant Physiological Processes see
Plant Physiological Phenomena
Plant Physiology see
Plant Physiological Phenomena

Mesh BrowserPlant Poisoning
Generale
WA 700
Veterinary SF 757.5
See also
Plants, Toxic
Plant Preparation see
Plant Preparations

Mesh BrowserPlant Preparations

QV 766-770
Atlases 
QV 717
For specific disease with the disease
Specific drug or chemical with the drug or chemical
Specific plants, with the plant
See also
Phytotherapy

Mesh BrowserPlant Proteins
QK 898.P8
See also
Plant Proteins, Dietary
See also
Plants

Mesh BrowserPlant Proteins, Dietary
Generale
QU 55.4
cucinando
WB 430
Dietary use in health or disease 
WB 430
Plant RNA see
RNA, Plant
Plant Rubber see
Rubber

Mesh BrowserPlant Tumors
SB 741.5
Of specific plants with the plant, e.g., tree galls SB 767
Plant Virology see
Plant Pathology

Mesh BrowserPlant Viruses

QW 163
Plant Zygotes see
Seeds
Plantar Prints see
Dermatoglyphics
Plantar Ulcer see
Foot Ulcer
Plantaris Muscle see
Muscle, Skeletal
Plantes et Médecines Brand of Glycyrrhetinic Acid see
Glycyrrhetinic Acid

Mesh BrowserPlants
QK 41-45.2
Anatomy and histology QK 641-673
Biotechnology TP 248.27.P55
Chemistry QK 861-899
Cytology QK 725
Genetics QK 981-981.7
Microbiology 
QW 60
Mycology 
QW 180
Virology 
QW 163
See also
Ethnobotany
See also
Ethnopharmacology
See also
Herbicides
See also
Pharmacognosy
See also
Phytotherapy
See also
Plant Pathology
See also
Plant Physiological Phenomena
See also
Plant Proteins
See also
Plants, Medicinal
See also
Plants, Toxic
See also
Pollen
See also
Seeds

Mesh BrowserPlants, Edible
QK 98.5
Dietary use in health and disease 
WB 430-432

Mesh BrowserPlants, Genetically Modified
General SB 123.57
Public health aspects as food 
WA 695-722
For specific plant, with the plant
See also
Food, Genetically Modified
See also
Genetic Engineering

Mesh BrowserPlants, Medicinal

QV 766-770
Atlases 
QV 717
Culture SB 293-295
See also
Ethnobotany
See also
Ethnopharmacology
See also
Medicine, Traditional
See also
Pharmacognosy
See also
Phytotherapy
See also
Plant Extracts
Plants, Poisonous see
Plants, Toxic

Mesh BrowserPlants, Toxic
Generale
QV 762
Botany QK 100.A1
See also
Plant Poisoning
See also
Plants, Medicinal
Plants, Transgenic see
Plants, Genetically Modified
Planum Polare see
Temporal Lobe
Plaque, Dental see
Dental Plaque
Plaque Therapy, Radioisotope see
Brachytherapy
Plaque, Ulcerating, Carotid Artery see
Carotid Stenosis
Plasdone see
Povidone

Mesh BrowserPlasma

WH 400
Blood transfusion 
WB 356
See also
Serum
Plasma Albumin see
Serum Albumin
Plasma Cell Dyscrasias see
Paraproteinemias
Plasma Cell Myeloma see
Multiple Myeloma
Plasma Cell Neoplasms see
Neoplasms, Plasma Cell
Plasma Cell Tumor see
Plasmacytoma

Mesh BrowserPlasma Cells

WH 400

Mesh BrowserPlasma Exchange

WB 356
Plasma Expanders see
Plasma Substitutes
Plasma Factor VIII Complex see
von Willebrand Factor
Plasma Membrane see
Cell Membrane
Plasma Protein Binding Capacity see
Protein Binding
Plasma Proteins see
Blood Proteins

Mesh BrowserPlasma Substitutes

WH 450
See also
Blood Substitutes
Plasma Thromboplastin Component Deficiency see
Hemophilia B

Mesh BrowserPlasma Volume

WG 106
Plasma Volume Expanders see
Plasma Substitutes
Plasmacytes see
Plasma Cells
Plasmacytoid Dendritic Cells see
Dendritic Cells

Mesh BrowserPlasmacytoma

WH 540

Mesh BrowserPlasmapheresis

WH 460
Plasmasteril see
Hydroxyethyl Starch Derivatives
Plasmid see
Plasmids

Mesh BrowserPlasmids
Generale
QU 470
In Bacteria 
QW 51
See also
Extrachromosomal Inheritance
See also
Genetic Vectors
See also
R Factors
Plasmin Inhibitor see
Antifibrinolytic Agents
Plasmin Inhibitors see
Antifibrinolytic Agents

Mesh BrowserPlasminogen
Blood coagulation 
WH 310
Enzymology 
QU 142
Plasminogen Activator see
Plasminogen Activators
Plasminogen Activator, Tissue-Type see
Tissue Plasminogen Activator

Mesh BrowserPlasminogen Activators
Biochemistry 
QU 136
Blood coagulation 
WH 310
Plasmocytoma see
Plasmacytoma

Mesh BrowserPlasmodium

QW 214
See also
Antimalarials
Plasmodium Infections see
Malaria
Plasmosome see
Cell Nucleolus
Plast Apyr Levulosa Mein see
Fructose
Plaster, Adhesive see
Bandages
Plaster Casts see
Casts, Surgical
Plaster of Paris see
Calcium Sulfate
Plastic Casts see
Casts, Surgical
Plastic Surgery see
Surgery, Plastic
Plastic Surgery, Neck see
Cervicoplasty
Plasticity, Neuronal see
Neuronal Plasticity

Mesh BrowserPlastics
Toxicology 
QV 633
Used as biomedical materials 
QT 37.5.P7
Special uses by topic
Used in medical equipment (Form number 26 in any NLM schedule where applicable
Platanista see
Dolphins

Mesh BrowserPlatelet Activating Factor

QU 93
In blood coagulation 
WH 310
Platelet-Activating Substance see
Platelet Activating Factor

Mesh BrowserPlatelet Adhesiveness

WH 310
Platelet Aggregating Factor see
Platelet Activating Factor

Mesh BrowserPlatelet Aggregation

WH 310
Platelet Aggregation Enhancing Factor see
Platelet Activating Factor

Mesh BrowserPlatelet Aggregation Inhibitors

QV 180
Platelet Antagonists see
Platelet Aggregation Inhibitors
Platelet Antiaggregants see
Platelet Aggregation Inhibitors
Platelet Derived Growth Factor see
Platelet-Derived Growth Factor

Mesh BrowserPlatelet Function Tests

QY 410
Platelet Glycoproteins see
Platelet Membrane Glycoproteins
Platelet Inhibitors see
Platelet Aggregation Inhibitors

Mesh BrowserPlatelet Membrane Glycoproteins

QU 55.7
Platelet Transforming Growth Factor see
Transforming Growth Factor beta

Mesh BrowserPlatelet Transfusion

WB 356

Mesh BrowserPlatelet-Derived Growth Factor

WH 300

Mesh BrowserPlateletpheresis

WH 460
Platelets see
Blood Platelets
Platelets, Blood see
Blood Platelets
Platidiam see
Cisplatin
Platino see
Cisplatin
Platinol see
Cisplatin

Mesh BrowserPlatinum
Inorganic chemistry QD 181.P8
Pharmacology 
QV 290
See also
Organoplatinum Compounds
Platinum Black see
Platinum
Platinum Diamminodichloride see
Cisplatin
Platyfish see
Cyprinodontiformes

Mesh BrowserPlatyhelminths

QX 350-422
Platyrrhina see
Cebidae
Platysmaplasty see
Rhytidoplasty
Platysmotomy see
Rhytidoplasty
Plavix see
Clopidogrel
Play see
Play and Playthings

Mesh BrowserPlay and Playthings
In childhood 
WS 105.5.P5
Projective techniques 
WM 145.5.P8
Psychology (General) BF 717
Recreation 
QT 250
See also
Play Therapy

Mesh BrowserPlay Therapy
Generale
WM 450.5.P7
With Children 
WS 350.4
Special topics, by subject
Playthings see
Play and Playthings

Mesh BrowserPleasure
Physiology 
WL 702
Psychology BF 515
See also
Pleasure-Pain Principle

Mesh BrowserPleasure-Pain Principle
Psychoanalysis 
WM 460.5.P5
Psychology BF 515
See also
Pleasure
Plegia see
Paralysis
Pleoconial Myopathies see
Mitochondrial Myopathies
Pleocytosis see
Leukocytosis
Pleomix-Alpha see
Thioctic Acid
Pleomix-Alpha N see
Thioctic Acid
Pleoptics see
Orthoptics

Mesh BrowserPlethysmography

WG 141.5.P7
Special topics, by subject, e.g.,
Venous Thrombosis 
WG 610

Mesh BrowserPlethysmography, Impedance

WG 141.5.P7
Used in diagnosis of specific conditions, by subject, e.g.,
Arteriosclerosis 
WG 550
Plethysmography, Impedance, Transthoracic see
Cardiography, Impedance
Plethysmography, Transthoracic Impedance see
Cardiography, Impedance

Mesh BrowserPlethysmography, Whole Body

WF 141.5.P7
Used in diagnosis of specific conditions, by subject, e.g.,
Tracheal Stenosis 
WF 490

Mesh BrowserPleura

WF 700-746
Secretion 
QY 210
Tuberculosis see
Tuberculosis, Pleural 
WF 390
See also
Pleurisy
See also
Pleuropneumonia 
WC 202
See also
Pneumonolysis 
WF 668
Pleural Aspiration see
Thoracentesis

Mesh BrowserPleural Cavity

WF 700

Mesh BrowserPleural Diseases
Generale
WF 700
Infant or child 
WS 285

Mesh BrowserPleural Effusion
Generale
WF 700
Clinical analysis 
QY 210
See also
Thoracentesis
Pleural Endoscopy see
Thoracoscopy

Mesh BrowserPleural Neoplasms

WF 700
Pleural Rub see
Respiratory Sounds

Mesh BrowserPleurisy

WF 744
See also
Pleura
Pleurisy, Tuberculous see
Tuberculosis, Pleural
Pleuritis see
Pleurisy
Pleurocentesis see
Thoracentesis

Mesh BrowserPleurodynia, Epidemic

WC 501
Pleurodynia Virus see
Enterovirus B, Human
Pleuropericarditis see
Pericarditis

Mesh BrowserPleuropneumonia

WC 202
In cattle see
Pleuropneumonia, Contagious SF 964

Mesh BrowserPleuropneumonia, Contagious
SF 964
Pleuropneumonia Like Organisms see
Mycoplasma
Pleuropneumonia-Like Organisms see
Mycoplasma
Pleuroscopes see
Thoracoscopes
Pleuroscopy see
Thoracoscopy
Plexus Choroideus see
Choroid Plexus

Mesh BrowserPlicamycin

QV 269
Plough Brand of Quinine Sulfate see
Quinine
Plug, Surgical see
Surgical Instruments
Plugs, Surgical see
Surgical Instruments
Plumbing see
Sanitary Engineering
Plumbism see
Lead Poisoning
Plumbism, Neurologic, Childhood see
Lead Poisoning, Nervous System, Childhood

Mesh BrowserPlummer-Vinson Syndrome

WI 258
Pluralism see
Cultural Diversity

Mesh BrowserPluripotent Stem Cells

QU 325
Pluserix see
Measles-Mumps-Rubella Vaccine

Mesh BrowserPlutonium
Adverse effects 
WN 610-615
Nuclear Physics QC 796.P9
PM-GPs see
Platelet Membrane Glycoproteins
PMS-Baclofen see
Baclofen
PMS-Buspirone see
Buspirone
PMS-Desipramine see
Desipramine
PMS-Lindane see
Hexachlorocyclohexane
PMS-Mefenamic Acid see
Mefenamic Acid
PMS-Trazodone see
Trazodone
PMS-Tryptophan see
Tryptophan

Mesh BrowserPneumatosis Cystoides Intestinalis

WI 418
Pneumococcal Diseases see
Pneumococcal Infections

Mesh BrowserPneumococcal Infections

WC 217
See also
Pneumonia, Pneumococcal 
WC 204
Pneumococcal Polysaccharide Vaccine see
Pneumococcal Vaccines

Mesh BrowserPneumococcal Vaccines

WC 217
Pneumococcus see
Streptococcus pneumoniae

Mesh BrowserPneumoconiosis

WF 654
Pneumocystis carinii Infections see
Pneumocystis Infections

Mesh BrowserPneumocystis Infections

WC 450
Pneumoencephalographic Cisternography see
Pneumoencephalography

Mesh BrowserPneumoencephalography

WL 141.5.P8
Pneumogastric Nerve see
Vagus Nerve
Pneumogastric Nerve Disorders see
Vagus Nerve Diseases
Pneumology see
Pulmonary Medicine
Pneumomediastinum see
Mediastinal Emphysema

Mesh BrowserPneumomediastinum, Diagnostic

WF 975

Mesh BrowserPneumonectomy

WF 668

Mesh BrowserPneumonia

WC 202-209

Mesh BrowserPneumonia, Aspiration

WC 209

Mesh BrowserPneumonia, Bacterial

WC 202
Pneumonia, Interstitial see
Lung Diseases, Interstitial

Mesh BrowserPneumonia, Lipid

WC 209
Pneumonia, Lobar see
Pneumonia

Mesh BrowserPneumonia, Mycoplasma

WC 202

Mesh BrowserPneumonia, Pneumococcal

WC 204
Pneumonia, Primary Atypical see
Pneumonia, Mycoplasma

Mesh BrowserPneumonia, Staphylococcal

WC 204

Mesh BrowserPneumonia, Viral

WC 207
Pneumonic Plague see
Plague
Pneumonitis see
Pneumonia
Pneumonitis, Avian Hypersensitivity see
Bird Fancier's Lung
Pneumonitis, Hypersensitivity see
Alveolitis, Extrinsic Allergic
Pneumonitis, Hypersensitivity, Avian see
Bird Fancier's Lung
Pneumonitis, Interstitial see
Lung Diseases, Interstitial
Pneumonology see
Pulmonary Medicine

Mesh BrowserPneumonolysis

WF 668

Mesh BrowserPneumoperitoneum

WI 575

Mesh BrowserPneumoperitoneum, Artificial

WI 141
Used for diagnosis of particular disorders, with the disorder or system
Pneumoretroperitoneum see
Retropneumoperitoneum

Mesh BrowserPneumothorax

WF 746
See also
Hemopneumothorax
See also
Thoracentesis

Mesh BrowserPneumothorax, Artificial

WF 768
Pneumovax see
Pneumococcal Vaccines
PNS Diseases see
Peripheral Nervous System Diseases
PNS (Peripheral Nervous System) Diseases see
Peripheral Nervous System Diseases
Pnu-Imune Vaccine see
Pneumococcal Vaccines
Po 12 see
Glycyrrhetinic Acid

Mesh BrowserPoaceae
General QK 495.G74
As medicinal plants 
QV 766-770
Cultivation SB 197-202
As allergens 
QW 910
See also
Pollen
Pocket PC see
Computers, Handheld
Pocket, Periodontal see
Periodontal Pocket

Mesh BrowserPodiatry

WE 890
See also
Foot Diseases
Podoconiosis see
Elephantiasis
POEM Procedure see
Pyloromyotomy

Mesh BrowserPoetry
About medicine 
WZ 330
By health personnel 
WZ 350
Light verse in medicine and related fields 
WZ 305

Mesh BrowserPoetry as Topic
About medicine 
WZ 330
In psychotherapy 
WM 450.5.W9
Point-of-Care see
Point-of-Care Systems

Mesh BrowserPoint-of-Care Systems
In hospitals (General) 
WX 162
Special topics, by subject
See also
Medical Order Entry Systems
Point of Care Technology see
Point-of-Care Systems

Mesh BrowserPoint-of-Care Testing
Generale
WX 162
In ambulatory care facilities 
WX 205
In hospitals 
WX 162
In physicians' offices 
W 80
Point of Care Testing see
Point-of-Care Testing

Mesh BrowserPoison Control Centers

QV 600
Directories 
QV 605
In hospitals 
WX 215
Poison Ivy see
Toxicodendron
Poison Ivy Dermatitis see
Dermatitis, Toxicodendron
Poison Oak see
Toxicodendron
Poison Sumac see
Toxicodendron

Mesh BrowserPoisoning

QV 600-667
Industrial 
WA 465
See also specific types of poisoning
See also
Antidotes
See also
Foodborne Diseases
See also
Toxicology
Poisoning, Arsenic, Nervous System see
Arsenic Poisoning
Poisoning, Blood see
Sepsis
Poisoning, Carbon Monoxide see
Carbon Monoxide Poisoning
Poisoning, Carbon Tetrachloride see
Carbon Tetrachloride Poisoning
Poisoning, CCl4 see
Carbon Tetrachloride Poisoning
Poisoning, Ergot see
Ergotism
Poisoning, Fluoride see
Fluoride Poisoning
Poisoning, Food see
Foodborne Diseases
Poisoning, Fungus see
Mycotoxicosis
Poisoning, Gas see
Gas Poisoning
Poisoning, Illuminating Gas see
Carbon Monoxide Poisoning
Poisoning, Lead see
Lead Poisoning
Poisoning, Lead, Nervous System, Childhood see
Lead Poisoning, Nervous System, Childhood
Poisoning, Lead, Neurologic, Childhood see
Lead Poisoning, Nervous System, Childhood
Poisoning, Mercury see
Mercury Poisoning
Poisoning, Mushroom see
Mushroom Poisoning
Poisoning, Nervous System see
Neurotoxicity Syndromes
Poisoning, Plant see
Plant Poisoning
Poisoning, Staphylococcal Food see
Staphylococcal Food Poisoning
Poisonous Animals see
Animals, Poisonous
Poisonous Fishes see
Fishes, Poisonous
Poisonous Gases see
Gases
Poisonous Plants see
Plants, Toxic

Mesh BrowserPoisons

QV 600-666
Detection 
QV 602
Industrial protection 
WA 465
Inorganic 
QV 610
Lists of 
QV 604
Organic 
QV 627-633
Public health aspects 
WA 730
See also names of specific poisons
Polar Bears see
Ursidae
Polar Regions see
Cold Climate
Polarcardiography see
Vectorcardiography
Polarization Microscopy see
Microscopy, Polarization

Mesh BrowserPolarography
Organic analysis QD 272.E4
Quantitative analysis QD 116.P64
Policies, Economic see
Economics
Policy Analysis see
Policy Making
Policy Development see
Policy Making
Policy, Economic see
Economics
Policy Makers see
Administrative Personnel

Mesh BrowserPolicy Making
General H 97
In special topics, by subject
See also
Health Policy
See also
Public Policy
Poliglusam see
Chitosan
Polio see
Poliomyelitis
Polio Encephalitis see
Poliomyelitis
Poliodystrophia Cerebri see
Diffuse Cerebral Sclerosis of Schilder

Mesh BrowserPoliomyelitis

WC 555
Prevention & control 
WC 556
See also
Postpoliomyelitis Syndrome
Poliomyelitis, Acute see
Poliomyelitis
Poliomyelitis Infection see
Poliomyelitis
Poliomyelitis, Nonpoliovirus see
Poliomyelitis
Poliomyelitis, Preparalytic see
Poliomyelitis
Poliosis see
Hair Color

Mesh BrowserPoliovirus

QW 168.5.P4
Poliovirus Type 1 see
Poliovirus
Poliovirus Type 2 see
Poliovirus
Poliovirus Type 3 see
Poliovirus

Mesh BrowserPoliovirus Vaccine, Inactivated

WC 556

Mesh BrowserPoliovirus Vaccine, Oral

WC 556

Mesh BrowserPoliovirus Vaccines

WC 556
Polioviruses see
Poliovirus
Polishes, Dental see
Dentifrices

Mesh BrowserPolitical Systems
General JC 11
In psychoanalysis, psychoanalytic therapy, or psychoanalytic interpretation 
WM 460.5.P7
Related to special topics, by subject
See also names of specific systems, e.g.,
Communism

Mesh BrowserPollen
General QK 658
As a food preparation 
WB 447
As an allergen 
QW 910
See also
Allergens
See also
Rhinitis, Allergic, Seasonal
Pollen Allergy see
Rhinitis, Allergic, Seasonal
Pollen Grains see
Pollen
Pollinosis see
Rhinitis, Allergic, Seasonal
Pollutants see
Environmental Pollutants
Pollutants, Environmental see
Environmental Pollutants
Pollution, Environmental see
Environmental Pollution

Mesh BrowserPolonium
Adverse effects 
WN 610-615
Nuclear Physics QC 796.P6
Polopirin see
Aspirin
Polopiryna see
Aspirin
Polstigmine see
Neostigmine
Polvidone see
Povidone
Poly(A)+ mRNA see
RNA, Messenger
Poly(A)+ RNA see
RNA, Messenger
Poly(A) RNA see
RNA, Messenger
Poly(A) Tail see
RNA, Messenger
Poly-Adenosine Diphosphate-Ribose see
Poly Adenosine Diphosphate Ribose

Mesh BrowserPoly Adenosine Diphosphate Ribose

QU 57
See also
Adenosine Diphosphate Ribose
Poly ADP Ribose see
Poly Adenosine Diphosphate Ribose
Poly(ADP-Ribose) see
Poly Adenosine Diphosphate Ribose
Poly-ADPR see
Poly Adenosine Diphosphate Ribose
poly(Mannuronic Acid), Sodium Salt see
Alginates
Polyacrylamide Gel Electrophoresis see
Electrophoresis, Polyacrylamide Gel
Polyacrylamide Gel Electrophoresis, 2-D see
Electrophoresis, Gel, Two-Dimensional
Polyacrylamide Gel Electrophoresis, 2D see
Electrophoresis, Gel, Two-Dimensional
Polyacrylamide Gel Electrophoresis, Two-Dimensional see
Electrophoresis, Gel, Two-Dimensional
Polyadenylated mRNA see
RNA, Messenger
Polyalkenoate Cements see
Glass Ionomer Cements

Mesh BrowserPolyamines

QU 61
Organic chemistry
Aliphatic QD 305.A8
Aromatic QD 341.A8
Polyangiaceae see
Myxococcales
Polyangium see
Myxococcales
Polyanhydroglucuronic Acid see
Cellulose

Mesh BrowserPolyarteritis Nodosa

WG 518
See also
Vasculitis, Central Nervous System
Polyarthritis see
Artrite
Polyarthritis, Juvenile, Rheumatoid Factor Negative see
Arthritis, Juvenile
Polyarthritis, Juvenile, Rheumatoid Factor Positive see
Arthritis, Juvenile
Polyarthritis Rheumatica see
Rheumatic Fever

Mesh BrowserPolybrominated Biphenyls
Toxicology 
QV 633.5.B4
Polybromobiphenyl Compounds see
Polybrominated Biphenyls
Polychemotherapy see
Drug Therapy, Combination
Polychlorocamphene see
Toxaphene
Polycillin see
Ampicillin
Polycose see
Glucans

Mesh BrowserPolycyclic Aromatic Hydrocarbons
Toxicology 
QV 633

Mesh BrowserPolycyclic Compounds
Organic chemistry QD 305-341
Toxicology 
QV 633
See also
Heterocyclic Compounds
Polycyclic Hydrocarbons, Aromatic see
Polycyclic Aromatic Hydrocarbons
Polycystic Kidney see
Polycystic Kidney Diseases
Polycystic Kidney Disease see
Polycystic Kidney Diseases

Mesh BrowserPolycystic Kidney Diseases

WJ 358
Polycystic Kidneys see
Polycystic Kidney Diseases
Polycystic Ovarian Syndrome see
Polycystic Ovary Syndrome

Mesh BrowserPolycystic Ovary Syndrome

WP 320
Polycystic Ovary Syndrome 1 see
Polycystic Ovary Syndrome
Polycystic Renal Disease see
Polycystic Kidney Diseases

Mesh BrowserPolycythemia

WH 180
Polycythemia Ruba Vera see
Polycythemia Vera
Polycythemia Rubra Vera see
Polycythemia Vera

Mesh BrowserPolycythemia Vera

WH 180

Mesh BrowserPolyelectrolytes

QV 270
Polyendocrine Autoimmune Syndrome, Type II see
Polyendocrinopathies, Autoimmune

Mesh BrowserPolyendocrinopathies, Autoimmune

WK 140
Polyendocrinopathy-Candidiasis-Ectodermal-Dystrophy, Autoimmune see
Polyendocrinopathies, Autoimmune
Polyfluorinated Telomer Alcohols see
Fluorocarbons
Polygamy see
Matrimonio
Polygenic Characters see
Multifactorial Inheritance
Polygenic Inheritance see
Multifactorial Inheritance
Polygenic Traits see
Multifactorial Inheritance
Polyglandular Autoimmune Syndrome, Type 1 see
Polyendocrinopathies, Autoimmune
Polyglandular Autoimmune Syndrome, Type 2 see
Polyendocrinopathies, Autoimmune
Polyglandular Autoimmune Syndrome, Type 3 see
Polyendocrinopathies, Autoimmune
Polyglandular Autoimmune Syndrome, Type I see
Polyendocrinopathies, Autoimmune
Polyglandular Deficiency Syndrome, Type 2 see
Polyendocrinopathies, Autoimmune
Polyglandular Type I Autoimmune Syndrome see
Polyendocrinopathies, Autoimmune
Polyglandular Type II Autoimmune Syndrome see
Polyendocrinopathies, Autoimmune
Polyglandular Type III Autoimmune Syndrome see
Polyendocrinopathies, Autoimmune
Polyglobin see
Immunoglobulin G
Polyglucin see
Dextrans
Polyglucoses see
Glucans

Mesh BrowserPolygonaceae
As a medicinal plant 
QV 766.5.P6
Geographic distribution
QV 770
Polygyny see
Matrimonio
Polyisocyanates see
Polyurethanes
Polymenorrhea see
Menstruation Disturbances

Mesh BrowserPolymerase Chain Reaction

QU 550.5.P6

Mesh BrowserPolymers
Organic chemistry QD 381-388
Toxicology 
QV 633
Used in dentistry 
WU 190
Used in medicine 
QT 37.5.P7
Classify by use where applicable
Polymorphic Crystals see
Crystallization
Polymorphic Reticulosis see
Granuloma, Lethal Midline
Polymorphism, Crystallization see
Crystallization

Mesh BrowserPolymorphism, Genetic

QU 477
Polymorphism (Genetics) see
Polymorphism, Genetic
Polymorphonuclear Leukocytes see
Neutrophils
Polymox see
Amoxicillin

Mesh BrowserPolymyalgia Rheumatica

WE 550
See also
Giant Cell Arteritis
Polymyoclonus see
Myoclonus
Polymyositis-Dermatomyositis see
Dermatomyositis
Polymyxin E see
Colistin
Polyneuritis see
Neuritis
Polyneuritis, Alcoholic see
Alcoholic Neuropathy
Polyneuritis Endemica see
Beriberi

Mesh BrowserPolyneuropathies

WL 520
Polyneuropathy, Acquired see
Polyneuropathies
Polyneuropathy, Acute Inflammatory see
Guillain-Barre Syndrome
Polyneuropathy, Alcoholic see
Alcoholic Neuropathy
Polyneuropathy, Arsenic-Induced see
Arsenic Poisoning
Polyneuropathy, Critical Illness see
Polyneuropathies
Polyneuropathy, Familial see
Polyneuropathies
Polyneuropathy, Inflammatory Demyelinating, Acute see
Guillain-Barre Syndrome
Polyneuropathy, Inherited see
Polyneuropathies
Polyneuropathy, Motor see
Polyneuropathies
Polynuclear Aromatic Hydrocarbons see
Polycyclic Aromatic Hydrocarbons
Polynucleosomes see
Nucleosomes
Polynucleotide Vaccines see
Vaccines, DNA

Mesh BrowserPolynucleotides

QU 57
Polyoma Virus see
Polyomavirus
Polyoma Viruses see
Polyomavirus

Mesh BrowserPolyomaviridae

QW 166

Mesh BrowserPolyomavirus

QW 166
Polyomavirus macacae see
Simian virus 40
Polyopsia see
Diplopia
Polypeptide Hormones see
Peptide Hormones
Polypeptides see
Peptides
Polyphagia see
Hyperphagia
Polyphagidae see
Cockroaches

Mesh BrowserPolyphosphates

QV 285
Polyplasdone XL see
Povidone
Polyplax see
Anoplura
Polyploid see
Polyploidy
Polyploid Cell see
Polyploidy

Mesh BrowserPolyploidy
Generale
QU 477
In humans 
QS 677
Polyposis, Adenomatous Intestinal see
Adenomatous Polyposis Coli
Polyposis Coli see
Adenomatous Polyposis Coli
Polyposis Coli, Familial see
Adenomatous Polyposis Coli
Polyposis, Skin Pigmentation, Alopecia, And Fingernail Changes see
Intestinal Polyposis
Polyposis Syndrome, Familial see
Adenomatous Polyposis Coli

Mesh BrowserPolyps
Generale
QZ 140
Neoplastic 
QZ 200
Localized, by site
See also
Colonic Polyps
See also
Intestinal Polyps
See also
Nasal Polyps
Polyradiculitis see
Polyradiculopathy
Polyradiculoneuritis see
Polyradiculoneuropathy

Mesh BrowserPolyradiculoneuropathy

WL 544
Polyradiculoneuropathy, Acute Inflammatory see
Guillain-Barre Syndrome
Polyradiculoneuropathy, Acute Inflammatory Demyelinating see
Guillain-Barre Syndrome

Mesh BrowserPolyradiculopathy

WL 400
Polyradiculopathy, Abdominal see
Polyradiculopathy

Mesh BrowserPolysaccharides

QU 83

Mesh BrowserPolysaccharides, Bacterial

QW 52
Polyserositis, Familial Paroxysmal see
Familial Mediterranean Fever
Polyserositis, Recurrent see
Familial Mediterranean Fever
Polysyndactyly see
Syndactyly
Polytrauma see
Multiple Trauma
Polyunsaturated Fatty Acids see
Fatty Acids, Unsaturated

Mesh BrowserPolyurethanes
Biomedical applications 
QT 37.5.P7
Tubing for tracheal prosthesis 
WF 490
Used for special purposes, by subject
Polyvidon see
Povidone
Polyvinylpyrrolidone see
Povidone
Polyvinylpyrrolidone Iodine see
Povidone-Iodine

Mesh BrowserPolyvinyls
Biomedical applications 
QT 37.5.P7
Chemical technology TP 1180.V48
Used for particular purposes, by subject, e.g., in blood bags
Pomelo Tree see
Citrus
Pomeroy Method see
Sterilization, Tubal
Pomeroy Sterilization see
Sterilization, Tubal
Pompholyx see
Eczema, Dyshidrotic
Ponalar see
Mefenamic Acid
Ponalgic see
Mefenamic Acid
Pondimin see
Fenfluramine
Pondocillin see
Pivampicillin
Pongidae see
Hominidae
Pongidae Diseases see
Ape Diseases

Mesh BrowserPongo pygmaeus
QL 737.P94
See also
Ape Diseases
Pongo pygmaeus pygmaeus see
Pongo pygmaeus
Ponmel see
Mefenamic Acid

Mesh BrowserPons

WL 310
Pons Varolii see
Pons
Ponstan see
Mefenamic Acid
Ponstan Forte see
Mefenamic Acid
Ponstel see
Mefenamic Acid
Ponsyl see
Mefenamic Acid
Pontal see
Mefenamic Acid
Ponte see
Pons
Pontiac Fever see
Legionnaires' Disease
Pontic see
Denture, Partial, Fixed
Ponticulus Posterior of the Atlas see
Cervical Atlas
Ponticulus Posticus see
Cervical Atlas
Pontine Capillary Telangiectasias see
Central Nervous System Vascular Malformations
Pontine Neoplasms see
Brain Stem Neoplasms
Pontine Tumors see
Brain Stem Neoplasms
Pontiride see
Sulpiride
Pontoporia blainvillei see
Dolphins

Mesh BrowserPopliteal Artery

WG 595.P6
Popliteal Space see
Knee

Mesh BrowserPopliteal Vein

WG 625.P6
See also blood supply under
Knee 
WE 870
Papavero see
Papaver

Mesh BrowserPopular Work
Acquired immunodeficiency syndrome 
WC 503.8
Cardiovascular system 
WG 113
Dentistry 
WU 80
Geriatrics 
WT 120
Gynecology 
WP 120
HIV Infections 
WC 503.8
Medicine (General) 
WB 120-130
Neoplasms 
QZ 201
Nutrition 
QU 240
Obesità
WD 212
Obstetrics 
WQ 150
Ophthalmology 
WW 80
Pediatria
WS 80
Psychiatry 
WM 75
Vitamins 
QU 240
Special topics, by subject
See also
Juvenile Literature

Mesh BrowserPopulation
HB 848-3697
Genetics see
Genetics, Population
Health problems of special population groups 
WA 300-395
Movement HB 1951-2577
See also
Demography HB 1951-2577
Population at Risk see
Fattori di rischio
Population-Based Planning see
Community Health Planning

Mesh BrowserPopulation Characteristics
General HB 848-3697
Health problems of special population groups 
WA 300-395

Mesh BrowserPopulation Control
General HQ 766
By country HQ 766.5.A-Z
See also
Abortion, Legal
See also
Contraception
See also
Family Planning Policy 
WA 550
See also
Family Planning Services 
WA 550
See also
Sterilization, Reproductive
Population Decrease see
Population Dynamics

Mesh BrowserPopulation Density
HB 1953
See also
Crowding
See also
Social Isolation
Population Distribution see
Demography

Mesh BrowserPopulation Dynamics
General HB 848-3697
In public health 
WA 950
Population biology QH 352
Special topics, by subject
See also
Genetics, Population
Population Explosion see
Population Growth
Population Genetics see
Genetics, Population

Mesh BrowserPopulation Growth
HB 848-3697
Population Growth and Natural Resources see
Population Growth

Mesh BrowserPopulation Health

WA 300
Population Health Support see
Population Health
Population Heterogeneity see
Population Characteristics
Population Law see
Legislation as Topic
Population Policy see
Public Policy
Population Pressure see
Population Dynamics
Population Program Specialists see
Allied Health Personnel
Population Programs see
Population Control
Population Programs, Goals see
Population Control
Population Register see
Registries
Population Replacement see
Population Dynamics
Population Size see
Population Density
Population Size and Growth see
Population Growth
Population Spatial Distribution see
Demography
Population Statistics see
Population Characteristics

Mesh BrowserPopulation Surveillance
Epidemiological studies 
WA 950
See also names of specific types of surveys, e.g.,
Health Surveys 
WA 900, etc.
Population Theory see
Population Dynamics
Populations at Risk see
Fattori di rischio
Poradenitis Nostras see
Lymphogranuloma Venereum
Porcelain see
Dental Porcelain
Porcelain, Dental see
Dental Porcelain
Porcine Xenograft Bioprosthesis see
Bioprosthesis
Porcine Xenograft Dressings see
Biological Dressings

Mesh BrowserPorifera
QL 370.7-374.2
Pornography see
Erotica
PORP see
Ossicular Prosthesis
Porphyria see
Porphyrias

Mesh BrowserPorphyrias

WD 205.5.P6
Special types, by system in which produced
Porphyrin Disorder see
Porphyrias

Mesh BrowserPorphyrins
Generale
QU 110
Special types, by system in which produced, e.g.,
Hemoglobins 
WH 190

Mesh BrowserPorpoises
QL 737.C434
Portacaval Anastomosis see
Portacaval Shunt, Surgical
Portacaval Shunt see
Portacaval Shunt, Surgical

Mesh BrowserPortacaval Shunt, Surgical

WI 720
Portal Hypertension see
Hypertension, Portal

Mesh BrowserPortal System

WI 720
See also
Liver Circulation
See also
Portography
Portal-Systemic Encephalopathy see
Hepatic Encephalopathy

Mesh BrowserPortal Vein

WI 720
See also
Portography
Portasystemic Shunt see
Portasystemic Shunt, Surgical

Mesh BrowserPortasystemic Shunt, Surgical

WI 720

Mesh BrowserPortasystemic Shunt, Transjugular Intrahepatic

WI 720

Mesh BrowserPortography

WI 720
Portosystemic Encephalopathy see
Hepatic Encephalopathy
Portosystemic Shunt see
Portasystemic Shunt, Surgical
Portosystemic Shunt, Surgical see
Portasystemic Shunt, Surgical
Portosystemic Shunt, Transjugular Intrahepatic see
Portasystemic Shunt, Transjugular Intrahepatic

Mesh BrowserPortraits as Topic
N 7575
Posiject see
Dobutamine
Position Agnosia see
Agnosia
Position Description see
Job Description
Position Sense see
Proprioception
Position Sense Disorders see
Somatosensory Disorders
Positional Vertigo see
Vertigo
Positioning, Radiography see
Technology, Radiologic
Positive End-Expiratory Pressure see
Positive-Pressure Respiration
Positive Eugenics see
Eugenics
Positive Feedback, Biochemical see
Feedback, Physiological

Mesh BrowserPositive-Pressure Respiration

WF 145
In first aid 
WA 292
Positive-Pressure Ventilation see
Positive-Pressure Respiration
Positive Psychology see
Psychology, Positive
Positive Reinforcement see
Reinforcement, Psychology

Mesh BrowserPositron-Emission Tomography

WN 206
Positrons see
Electrons
Post-acute Care see
Subacute Care
Post and Core Technic see
Post and Core Technique

Mesh BrowserPost and Core Technique

WU 515
Post-Anesthesia Nursing see
Postanesthesia Nursing
Post-Basic Nursing Education see
Education, Nursing, Continuing
Post Central Gyrus see
Somatosensory Cortex
Post-Cholecystectomy Syndrome see
Postcholecystectomy Syndrome
Post-Choledochoduodenostomy Syndrome see
Postcholecystectomy Syndrome
Post-Choledochojejunostomy Syndrome see
Postcholecystectomy Syndrome
Post-Choledochostomy Syndrome see
Postcholecystectomy Syndrome
Post-Comatose Unawareness State see
Persistent Vegetative State
Post-Concussive Encephalopathy see
Chronic Traumatic Encephalopathy
Post-Core Technic see
Post and Core Technique
Post-Heparin Lipase see
Lipoprotein Lipase
Post-implantation Embryo Development see
Embryonic Development
Post-Infectious Arthritis see
Arthritis, Reactive
Post-menopausal Period see
Postmenopause
Post-Menopause see
Postmenopause
Post-Mortem Examination see
Autopsy
Post-Natal Depression see
Depression, Postpartum
Post-Partum Depression see
Depression, Postpartum
Post-partum Thyroiditis see
Postpartum Thyroiditis
Post-Polio Syndrome see
Postpoliomyelitis Syndrome
Post-Poliomyelitis Muscular Atrophy see
Postpoliomyelitis Syndrome
Post-Poliomyelitis Syndrome see
Postpoliomyelitis Syndrome
Post-Registration Nursing Education see
Education, Nursing, Continuing
Post-Surgical Nursing see
Postanesthesia Nursing
Post Technic see
Post and Core Technique
Post Technique see
Post and Core Technique
Post-Transcriptional Gene Silencing see
RNA Interference
Post-Transcriptional RNA Modification see
RNA Processing, Post-Transcriptional
Post-Transcriptional RNA Processing see
RNA Processing, Post-Transcriptional
Post-Transfusion Purpura see
Transfusion Reaction
Post-Translational Amino Acid Modification see
Protein Processing, Post-Translational
Post-Translational Modifications see
Protein Processing, Post-Translational
Post-Translational Protein Modification see
Protein Processing, Post-Translational
Post-Translational Protein Processing see
Protein Processing, Post-Translational
Post-Traumatic Encephalopathy see
Chronic Traumatic Encephalopathy
Post-Traumatic Hydrocephalus see
Hydrocephalus
Post-Traumatic Myelopathy see
Spinal Cord Injuries
Post-Traumatic Seizure Disorder see
Epilepsy, Post-Traumatic
Post-Traumatic Stress Disorders see
Stress Disorders, Post-Traumatic
Post-Traumatic Tic Disorder see
Tic Disorders
Post-Traumatic Unawareness State see
Persistent Vegetative State
Post-Traumatic Vegetative State see
Persistent Vegetative State
Post-Vaccinal Encephalitis see
Encephalomyelitis, Acute Disseminated
Post-Vaccinal Encephalomyelitis see
Encephalomyelitis, Acute Disseminated
Postabortal Programs see
Aftercare
Postabortion see
Aftercare
Postabsorptive Hypoglycemia see
Hypoglycemia
Postacton see
Lypressin
Postacute Care see
Subacute Care
Postage Stamps see
Philately

Mesh BrowserPostanesthesia Nursing

WY 161
Postcentral Gyrus see
Somatosensory Cortex
Postcesarean Section see
Cesarean Section

Mesh BrowserPostcholecystectomy Syndrome

WI 770
See also
Cholecystectomy
Postcholedochoduodenostomy Syndrome see
Postcholecystectomy Syndrome
Postcholedochojejunostomy Syndrome see
Postcholecystectomy Syndrome
Postcholedochostomy Syndrome see
Postcholecystectomy Syndrome
Postcoital Contraceptives see
Contraceptives, Postcoital
Postcomatose Unawareness State see
Persistent Vegetative State

Mesh BrowserPoster
Embryology 
QS 617
Forensic medicine and dentistry 
W 617
General Surgery 
WO 517
Histology 
QS 517
Immunology 
QW 517
Operative dentistry 
WU 317
Oral surgery 
WU 600.7
Orthodontics 
WU 417
Pharmacy and pharmaceutics 
QV 717
Prosthodontics 
WU 507
(Form number 17 in any NLM schedule where applicable)
See also
Pictorial Work
Posterior Cerebral Artery Aneurysm see
Intracranial Aneurysm
Posterior Cervical Pain see
Neck Pain
Posterior Chamber see
Eye
Posterior Choroidal Artery Infarction see
Cerebral Infarction
Posterior Circulation Brain Infarction see
Brain Infarction
Posterior Circulation Infarction, Brain see
Brain Infarction
Posterior Circulation Transient Ischemic Attack see
Ischemic Attack, Transient
Posterior Commissure, Laryngeal see
Larynx
Posterior Commissure, Larynx see
Larynx
Posterior Communicating Artery Aneurysm see
Intracranial Aneurysm

Mesh BrowserPosterior Cruciate Ligament

WE 870
See also
Anterior Cruciate Ligament
Posterior Fascicle see
Bundle of His
Posterior Fascicular Block see
Bundle-Branch Block
Posterior Fossa Hemorrhage see
Intracranial Hemorrhages
Posterior Fossa Meningioma see
Meningioma
Posterior Interosseous Nerve Syndrome see
Radial Neuropathy
Posterior Ischemic Optic Neuropathy see
Optic Neuropathy, Ischemic
Posterior Lobe of Pituitary see
Pituitary Gland, Posterior
Posterior Longitudinal Ligament Calcification see
Ossification of Posterior Longitudinal Ligament
Posterior Longitudinal Ligament Ossification see
Ossification of Posterior Longitudinal Ligament
Posterior Neck Pain see
Neck Pain
Posterior Optic Neuritis see
Optic Neuritis
Posterior Paracentral Lobule see
Parietal Lobe
Posterior Parietal Cortex see
Parietal Lobe
Posterior Pituitary Diseases see
Pituitary Diseases
Posterior Spinal Artery Syndrome see
Spinal Cord Vascular Diseases
Posterior Urethral Stricture see
Urethral Stricture
Posterior Vitreous Detachment see
Vitreous Detachment
Posterosuperior Glenoid Impingement see
Shoulder Impingement Syndrome
Postexanthem Encephalomyelitis see
Encephalomyelitis, Acute Disseminated

Mesh BrowserPostgastrectomy Syndromes

WI 380
Postgraduate Education see
Education, Graduate
Postgraduate Nursing Education see
Education, Nursing, Graduate
Postheparin Lipase see
Lipoprotein Lipase
Postheparin Lipoprotein Lipase see
Lipoprotein Lipase
Postherpetic Neuralgia see
Neuralgia, Postherpetic
Postimplantation Embryo Development see
Embryonic Development
Postinfectious Arthritis see
Arthritis, Reactive
Postinfectious Encephalomyelitis see
Encephalomyelitis, Acute Disseminated
Postinor see
Norgestrel
Postintubation Croup see
Croup
Postmarketing Product Surveillance see
Product Surveillance, Postmarketing
Postmenopausal Bone Loss see
Osteoporosis, Postmenopausal
Postmenopausal Hormone Replacement Therapy see
Estrogen Replacement Therapy
Postmenopausal Osteoporosis see
Osteoporosis, Postmenopausal
Postmenopausal Period see
Postmenopause

Mesh BrowserPostmenopause

WP 580

Mesh BrowserPostmortem Changes
Generale
QZ 35
Forensic aspects 
W 825
Postmortem Diagnosis see
Diagnosi
Postmortem Examination see
Autopsy

Mesh BrowserPostnatal Care

WQ 500
See also
Maternal-Child Nursing 
WY 157.3
See also
Neonatal Nursing 
WY 157.3
Postnatal Depression see
Depression, Postpartum
Postneonatal Mortality see
Infant Mortality
Postnidation Embryo Development see
Embryonic Development
Postnidation Embryo Development, Animal see
Embryonic Development

Mesh BrowserPostoperative Care
Generale
WO 183
Aged 
WO 950
Child 
WO 925
See also
Perioperative Nursing
See also
Physical Therapy Modalities

Mesh BrowserPostoperative Complications

WO 184-185
Specific complications, by site

Mesh BrowserPostoperative Hemorrhage

WO 184
Postoperative Hemorrhages see
Postoperative Hemorrhage
Postoperative Pain see
Pain, Postoperative

Mesh BrowserPostoperative Period

WO 183
Postoperative Procedures see
Postoperative Care
Postoperative Pulmonary Atelectasis see
Pulmonary Atelectasis
Postoperative Wound Infection see
Surgical Wound Infection
Postpartum see
Postpartum Period
Postpartum Abstinence see
Sexual Abstinence
Postpartum Amenorrhea see
Amenorrhea
Postpartum Care see
Postnatal Care
Postpartum Depression see
Depression, Postpartum

Mesh BrowserPostpartum Hemorrhage

WQ 330
Postpartum Hypopituitarism see
Hypopituitarism
Postpartum Panhypopituitarism see
Hypopituitarism

Mesh BrowserPostpartum Period

WQ 500-505
Postpartum Pituitary Insufficiency see
Hypopituitarism
Postpartum Programs see
Postnatal Care
Postpartum Sepsis see
Puerperal Infection

Mesh BrowserPostpartum Thyroiditis

WQ 500
Postpartum Weight Retention see
Gestational Weight Gain
Postpartum Women see
Postpartum Period
Postphlebitic Disease see
Postphlebitic Syndrome

Mesh BrowserPostphlebitic Syndrome

WG 610
Postphlebitic Ulcer see
Postphlebitic Syndrome
Postpoliomyelitis Muscular Atrophy see
Postpoliomyelitis Syndrome

Mesh BrowserPostpoliomyelitis Syndrome

WC 555
See also
Poliomyelitis
Postprandial Hyperglycemia see
Hyperglycemia
Postprandial Hypoglycemia see
Hypoglycemia

Mesh BrowserPostthrombotic Syndrome

WG 610
See also
Varicose Ulcer
Posttranscriptional Gene Silencing see
RNA Interference
Posttranscriptional RNA Processing see
RNA Processing, Post-Transcriptional
Posttransfusion Purpura see
Transfusion Reaction
Posttranslational Amino Acid Modification see
Protein Processing, Post-Translational
Posttranslational Modifications see
Protein Processing, Post-Translational
Posttranslational Protein Processing see
Protein Processing, Post-Translational
Posttraumatic Stress Disorders see
Stress Disorders, Post-Traumatic
Posttraumatic Unawareness State see
Persistent Vegetative State

Mesh BrowserPostural Balance

WE 104
Postural Equilibrium see
Postural Balance
Postural Low Back Pain see
Low Back Pain

Mesh BrowserPosture

WE 104
See also
Hypotension, Orthostatic
See also
Kinesics
Postvaccinal Encephalitis see
Encephalomyelitis, Acute Disseminated
Postviral Fatigue Syndrome see
Fatigue Syndrome, Chronic
Postzoster Arteritis see
Vasculitis, Central Nervous System
Potable Water see
Drinking Water

Mesh BrowserPotassium
Biochemistry 
QU 130.2
Inorganic chemistry QD 181.K1
Pharmacology 
QV 277
Toxicology 
QV 277
See also
Hypokalemia
See also
Potassium Isotopes
Potassium Alginate see
Alginates
Potassium Aspartate see
Aspartic Acid
Potassium Channel see
Potassium Channels

Mesh BrowserPotassium Channels
Generale
QU 55.7
See also
Sodium-Potassium-Exchanging ATPase

Mesh BrowserPotassium Chloride
Inorganic chemistry QD 181.K1
Pharmacology 
QV 277
Potassium Cyclamate see
Cyclamates

Mesh BrowserPotassium Deficiency

WD 105
See also
Hypokalemia
Potassium EDTA see
Edetic Acid
Potassium Ion Channels see
Potassium Channels

Mesh BrowserPotassium Isotopes
Inorganic chemistry QD 181.K1
Pharmacology 
QV 277
Potassium Orotate see
Orotic Acid

Mesh BrowserPotassium Permanganate

QV 229
Potassium Pump see
Sodium-Potassium-Exchanging ATPase
Potassium Urate see
Uric Acid
Potentials, Event-Related see
Evoked Potentials
Pott Disease see
Tuberculosis, Spinal
Pottos see
Lorisidae
Pott's Disease see
Tuberculosis, Spinal
Pott's Paraplegia see
Tuberculosis, Spinal

Mesh BrowserPoultry
General SF 481-507
As meat
Dietary use in health and disease
WB 426
Microbiology
QW 85
Public health aspects
WA 707
Physiology SF 768.2.P6
See also
Poultry Products

Mesh BrowserPoultry Diseases
SF 995-995.6

Mesh BrowserPoultry Products
Dietary use in health and disease 
WB 426
Microbiology 
QW 85
Public health aspects 
WA 707
See also
Eggs

Mesh BrowserPoverty
Economic conditions HC 79.P6
By country HC 94-1085
Health problems (General) 
WA 31
Psychological aspects
Adolescent
WS 462.5.D3
Child
WS 105.5.D3
Welfare HV 697-3024
See also
Cultural Deprivation

Mesh BrowserPoverty Areas
Health problems (General) 
WA 30
Special topics, by subject

Mesh BrowserPovidone

WH 450
Povidone, Unspecified see
Povidone

Mesh BrowserPovidone-Iodine
As a local anti-infective agent 
QV 231
Powassan Encephalitis see
Encephalitis, Tick-Borne
Powassan virus see
Encephalitis Viruses, Tick-Borne
Powassan Virus Disease see
Encephalitis, Tick-Borne

Mesh BrowserPowders
In pharmaceutical preparations (General) 
QV 786.5.P7
Power see
Power, Psychological
Power, Personal see
Power, Psychological

Mesh BrowserPower Plants
General TJ 164
Prevention and control of accidents and diseases 
WA 440-485
Power, Professional see
Power, Psychological

Mesh BrowserPower, Psychological
As an expression of will BF 608-618, etc.
Manipulation or control by others BF 632.5
Other aspects, by subject
See also
Social Control, Informal
Power (Psychology) see
Power, Psychological
Power, Social see
Power, Psychological
Power Sources, Bioelectric see
Bioelectric Energy Sources

Mesh BrowserPoxviridae

QW 165.5.P6

Mesh BrowserPoxviridae Infections

WC 584-590
Poxvirus Infections see
Poxviridae Infections
Poxvirus officinale see
Vaccinia virus
Poxvirus variolae see
Variola virus
Poxviruses see
Poxviridae
PPD see
Tuberculin
PPD-B see
Tuberculin
PPD-CG see
Tuberculin
PPD-F see
Tuberculin
PPD-L see
Tuberculin
PPD-S see
Tuberculin
PPLO see
Mycoplasma
Practical Nurses see
Nursing, Practical
Practical Nursing see
Nursing, Practical
Practice Association, Independent see
Independent Practice Associations
Practice Association, Individual see
Independent Practice Associations
Practice, Dental Associateship see
Partnership Practice, Dental
Practice, Dental General see
General Practice, Dental
Practice, Dental Group see
Group Practice, Dental
Practice, Dental Partnership see
Partnership Practice, Dental

Mesh BrowserPractice Guideline
On specific topics, by subject

Mesh BrowserPractice Guidelines as Topic
Generale
W 84.4
Special topics, by subject

Mesh BrowserPractice Management
Generale
W 80
Specific profession, with the profession
See also
Practice Management, Dental
See also
Practice Management, Medical
See also
Practice Management, Veterinary

Mesh BrowserPractice Management, Dental

WU 77-79

Mesh BrowserPractice Management, Medical

W 80
For specific profession, with the profession
Practice Management Services see
Practice Management
Practice Management Services, Dental see
Practice Management, Dental
Practice Management Services, Medical see
Practice Management, Medical
Practice Management Services, Veterinary see
Practice Management, Veterinary

Mesh BrowserPractice Management, Veterinary
SF 756.4
See also
Hospitals, Animal
Practice Pattern, Clinical see
Practice Patterns, Physicians'
Practice Pattern, Dental see
Practice Patterns, Dentists'
Practice Patterns, Clinical see
Practice Patterns, Physicians'
Practice Patterns, Dental see
Practice Patterns, Dentists'

Mesh BrowserPractice Patterns, Nurses'

WY 128
Practice Patterns, Physician's see
Practice Patterns, Physicians'
Practice Patterns, Professional see
Practice Patterns, Physicians'

Mesh BrowserPractice Patterns, Dentists'

WU 29
Practices, Dental Associateship see
Partnership Practice, Dental
Practices, Dental General see
General Practice, Dental
Practices, Dental Group see
Group Practice, Dental
Practices, Dental Partnership see
Partnership Practice, Dental

Mesh BrowserPractolol
Generale
QV 132
As an anti-arrhythmia agent 
QV 150
Practon see
Spironolactone
Prader-Labhart-Willi Syndrome see
Prader-Willi Syndrome
Prader Labhart Willi Syndrome see
Prader-Willi Syndrome

Mesh BrowserPrader-Willi Syndrome

QS 675
See also
Intellectual Disability
Praecuneus see
Parietal Lobe
Prairie Dogs see
Sciuridae
Pralifan see
Mitoxantrone
Prandase see
Acarbose
Prasfarma Brand of Doxorubicin Hydrochloride see
Doxorubicin
Prasfarma Brand of Etoposide see
Etoposide
Prasfarma Brand of Tegafur see
Tegafur
Prasiquantel see
Praziquantel
Pratsiol see
Prazosin
Praxel see
Paclitaxel
Prayer see
Religione
Prayer Healing see
Faith Healing

Mesh BrowserPraziquantel

QV 253
Praziquantel, (+-)-Isomer see
Praziquantel
Praziquantel, (R)-Isomer see
Praziquantel
Praziquantel, (S)-Isomer see
Praziquantel

Mesh BrowserPrazosin

QV 151
Prazosin HCL see
Prazosin
Prazosin Hydrochloride see
Prazosin
Pre-CTOX p25 see
Electron Transport Complex IV

Mesh BrowserPre-Eclampsia

WQ 215
See also
Toxemia

Mesh BrowserPre-Excitation Syndromes

WG 330.5.P7
Pre-implantation Embryo Development see
Embryonic Development
Pre-Par see
Ritodrine
Pre-Post Tests see
Evaluation Studies as Topic
Pre-Prorenin see
Renin
Preadmission Physical Examination see
Diagnostic Tests, Routine

Mesh BrowserPreanesthetic Medication

WO 234
Prebet see
Gallopamil

Mesh BrowserPrebiotics

QU 145.5
See also
Probiotici

Mesh BrowserPrecancerous Conditions

QZ 204
Precarious Employment see
Employment
Precautions, Universal see
Universal Precautions
Precentral Gyrus see
Frontal Lobe
Precentral Motor Area see
Motor Cortex
Precentral Motor Cortex see
Motor Cortex

Mesh BrowserPreceptorship
Dentistry 
WU 20
In other fields, by subject
Medicine 
W 20
Nursing 
WY 18.5
Pharmacy 
QV 20
Veterinary medicine SF 756.3-756.37

Mesh BrowserPrecipitin Tests

QY 265
Precision Attachment, Denture see
Denture Precision Attachment

Mesh BrowserPrecision Medicine
Generale
WB 102.7
Genetic techniques 
QU 550
See also
Pharmacogenetics
Preclinical Drug Evaluation see
Drug Evaluation, Preclinical
Preclinical Drug Evaluations see
Drug Evaluation, Preclinical
Precocious Puberty see
Puberty, Precocious
Precocious Puberty, Central see
Puberty, Precocious
Precocious Puberty, Male Limited see
Puberty, Precocious
Precocious Puberty, Male-Limited see
Puberty, Precocious
Precolicin E1 see
Colicins
Precordial Catch see
Chest Pain
Precordial Catch Syndrome see
Chest Pain
Precose see
Acarbose
Precuneus see
Parietal Lobe
Precuneus Cortex see
Parietal Lobe

Mesh BrowserPrecursor Cell Lymphoblastic Leukemia-Lymphoma

WH 250
Precursor-Complement 3 see
Complement C3
Predate see
Prednisolone

Mesh BrowserPredatory Behavior
QL 758
Predental Education see
Education, Predental
Prediabetes see
Prediabetic State

Mesh BrowserPrediabetic State

WK 810
See also
Hyperglycemia
Predictive Genetic Testing see
Genetic Testing
Predictive Testing, Genetic see
Genetic Testing

Mesh BrowserPredictive Value of Tests
Of a specific test, with the test
Predisposition, Genetic see
Genetic Predisposition to Disease
Predni Tablinen see
Prednisone
Prednidib see
Prednisone
Predniment see
Prednisone

Mesh BrowserPrednisolone

WK 755
Prednison Acsis see
Prednisone
Prednison Galen see
Prednisone
Prednison Hexal see
Prednisone

Mesh BrowserPrednisone

WK 755
Predonine see
Prednisolone
Preeclampsia see
Pre-Eclampsia
Preeclampsia Eclampsia 1 see
Pre-Eclampsia
Preexcitation Syndrome see
Pre-Excitation Syndromes
Preferred Drug List see
Formulario
Preferred Provider Organization see
Preferred Provider Organizations

Mesh BrowserPreferred Provider Organizations

W 130
Prefin see
Buprenorphine

Mesh BrowserPrefrontal Cortex

WL 307
Prefrontal Cortex, Dorsolateral see
Prefrontal Cortex

Mesh BrowserPregnadienes

WP 530

Mesh BrowserPregnancy

WQ 200-260
General works 
WQ 200
Breast in 
WP 825
Determination 
WQ 202
Popular works 
WQ 150
See also
Maternal-Fetal Relations
See also
Obstetric Nursing
See also
Pregnant Women
See also
Prenatal Care

Mesh BrowserPregnancy, Abdominal

WQ 220
Pregnancy, Adolescent see
Pregnancy in Adolescence

Mesh BrowserPregnancy, Animal
SF 887
Pregnancy-Associated Plasma Protein D see
Placental Lactogen
Pregnancy, Cardiovascular Complications see
Pregnancy Complications, Cardiovascular

Mesh BrowserPregnancy Complications

WQ 240-260
General works 
WQ 240
Veterinary SF 887
See also
Pregnancy, Animal SF 887
See also names of specific complications
See also
Pregnancy, Prolonged

Mesh BrowserPregnancy Complications, Cardiovascular

WQ 244

Mesh BrowserPregnancy Complications, Hematologic

WQ 252
Pregnancy Complications, Hematological see
Pregnancy Complications, Hematologic

Mesh BrowserPregnancy Complications, Infectious

WQ 256
See also
Puerperal Infection 
WQ 505

Mesh BrowserPregnancy Complications, Neoplastic

WQ 240

Mesh BrowserPregnancy, Ectopic

WQ 220
Pregnancy, Extrauterine see
Pregnancy, Ectopic
Pregnancy, Hematologic Complications see
Pregnancy Complications, Hematologic

Mesh BrowserPregnancy, High-Risk
Generale
WQ 240
See also
Pregnancy Complications
Pregnancy History see
Reproductive History

Mesh BrowserPregnancy in Adolescence
Medical problems 
WQ 215-270
Psychological problems 
WS 462.5.P7
Welfare 
WA 310-352
Pregnancy in Diabetes see
Pregnancy in Diabetics

Mesh BrowserPregnancy in Diabetics

WQ 248
See also
Diabetes, Gestational 
WQ 248
Pregnancy Induced Hypertension see
Hypertension, Pregnancy-Induced
Pregnancy, Infectious Complications see
Pregnancy Complications, Infectious
Pregnancy Luteoma see
Luteoma
Pregnancy, Molar see
Hydatidiform Mole

Mesh BrowserPregnancy, Multiple

WQ 235
Pregnancy, Neoplastic Complications see
Pregnancy Complications, Neoplastic
Pregnancy Nutrition see
Prenatal Nutritional Physiological Phenomena

Mesh BrowserPregnancy Outcome

WQ 200
See also
Fetal Death
Pregnancy Outcomes see
Pregnancy Outcome

Mesh BrowserPregnancy, Ovarian

WQ 220
Pregnancy, Planned see
Family Planning Services
Pregnancy, Premarital see
Illegitimacy

Mesh BrowserPregnancy, Prolonged

WQ 240

Mesh BrowserPregnancy Proteins

WK 920

Mesh BrowserPregnancy Rate
HB 901-1108
Pregnancy Rate, Live-Birth see
Pregnancy Rate
Pregnancy Rates see
Pregnancy Rate
Pregnancy, Teenage see
Pregnancy in Adolescence
Pregnancy Test see
Pregnancy Tests

Mesh BrowserPregnancy Tests

QY 335
Pregnancy Toxemias see
Pre-Eclampsia

Mesh BrowserPregnancy, Tubal

WQ 220

Mesh BrowserPregnancy, Unplanned
Generale
WQ 200
Special topics by subject
See also
Contraceptive Effectiveness
See also
Pregnancy, Unwanted

Mesh BrowserPregnancy, Unwanted

WQ 200
See also
Pregnancy, Unplanned 
WQ 200
Pregnancy Weight Gain see
Gestational Weight Gain

Mesh BrowserPregnanediol

WP 530

Mesh BrowserPregnanediones

QV 81

Mesh BrowserPregnanes

WP 530

Mesh BrowserPregnanetriol

WP 530
Pregnant Woman see
Pregnant Women

Mesh BrowserPregnant Women
Generale
WQ 200
Popular Works 
WQ 150
Special topics, by subject
See also
Maternal-Fetal Relations 
WQ 200
See also
Pregnancy 
WQ 200-260
Pregnenedione see
Progesterone
Pregnyl see
Chorionic Gonadotropin
Prehistoric Demography see
Demography
Prehospital Emergency Care see
Emergency Medical Services

Mesh BrowserPreimplantation Diagnosis

WQ 203
See also
Genetic Testing
See also
Prenatal Diagnosis
Preimplantation Embryo Development see
Embryonic Development
Preimplantation Genetic Diagnosis see
Preimplantation Diagnosis
Preimplantation Screening see
Preimplantation Diagnosis

Mesh BrowserPrejudice
BF 575.P9
Adolescent 
WS 462.5.S6
Child 
WS 105.5.S6
In education LC 212-212.863
In employment HD 4903-4903.5
In housing HD 7288.75-7288.76
Specific prejudice, by subject
Prelestrin see
Estrogens, Conjugated (USP)
Prelingual Deaf-Blind Disorders see
Deaf-Blind Disorders
Prelingual Deafness see
Deafness
Prelingual Deafness-Blindness see
Deaf-Blind Disorders
Prelunate Gyrus see
Parietal Lobe
Premarin see
Estrogens, Conjugated (USP)

Mesh BrowserPremarital Examinations
Generale
WB 200
Femmina
WP 141
Male 
WJ 700
Premarital Pregnancy see
Illegitimacy
Premarital Sex Behavior see
Sexual Behavior
Premature Aging see
Aging, Premature
Premature Beats see
Cardiac Complexes, Premature

Mesh BrowserPremature Birth

WQ 330
See also
Infant, Premature 
WS 410
See also
Obstetric Labor, Premature
Premature Cardiac Complex see
Cardiac Complexes, Premature
Premature Cardiac Complexes see
Cardiac Complexes, Premature

Mesh BrowserPremature Ejaculation

WJ 709
See also
Ejaculation
Premature Infants see
Infant, Premature
Premature Labor see
Obstetric Labor, Premature
Premature Obstetric Labor see
Obstetric Labor, Premature
Premedical Education see
Education, Premedical
Premedical Student see
Students, Premedical
Premedical Students see
Students, Premedical

Mesh BrowserPremedication
In Surgery 
WO 179
Used for special purposes, by subject
See also
Antibiotic Prophylaxis
See also
Preanesthetic Medication 
WO 234
Premedication, Antibiotic see
Antibiotic Prophylaxis

Mesh BrowserPremenstrual Syndrome

WP 560
Premenstrual Tension see
Premenstrual Syndrome
Premolar see
Bicuspid
Premotor Area see
Motor Cortex
Premotor Cortex see
Motor Cortex

Mesh BrowserPrenatal Care

WQ 175
Prenatal Cell-Free DNA Screening see
Noninvasive Prenatal Testing
Prenatal cfDNA Screening see
Noninvasive Prenatal Testing

Mesh BrowserPrenatal Diagnosis
Generale
WQ 209
For hereditary diseases 
QZ 52
See also
Genetic Counseling
See also
Genetic Services
See also
Genetic Testing
See also
Neonatal Screening
See also
Preimplantation Diagnosis
Prenatal Diagnosis, Ultrasonic see
Ultrasonography, Prenatal

Mesh BrowserPrenatal Education
For the health professional 
WQ 175
Popular works 
WQ 150

Mesh BrowserPrenatal Exposure Delayed Effects

WQ 210
Prenatal Genetic Counseling see
Genetic Counseling

Mesh BrowserPrenatal Injuries

WQ 210
Prenatal Nutrition Physiology see
Prenatal Nutritional Physiological Phenomena

Mesh BrowserPrenatal Nutritional Physiological Phenomena

WQ 175
See also
Prenatal Care
Prenatal Nutritional Physiological Phenomenon see
Prenatal Nutritional Physiological Phenomena
Prenatal Nutritional Physiology see
Prenatal Nutritional Physiological Phenomena
Prenatal Screening see
Prenatal Diagnosis
Prenatal Structures see
Embryonic Structures
Prenatal Ultrasonic Diagnosis see
Ultrasonography, Prenatal
Prenatal Ultrasonography see
Ultrasonography, Prenatal
Preneoplastic Condition see
Precancerous Conditions
Preneoplastic Conditions see
Precancerous Conditions
Prenidation Embryo Development, Animal see
Embryonic Development

Mesh BrowserPreoperative Care
Generale
WO 179
Aged 
WO 950
Child 
WO 925
Preparation of patient for anesthesia
Generale
WO 234
Aged
WO 445
Child
WO 440
See also
Anesthesia, Obstetrical
Preoperative Procedure see
Preoperative Care
Preoperative Procedures see
Preoperative Care
Preoptico-Hypothalamic Area see
Hypothalamus
Prepaid Dental Care see
Insurance, Dental
Prepaid Group Health Organizations see
Health Maintenance Organizations
Prepaid Group Practice see
Group Practice, Prepaid
Preparation, Dental Cavity see
Dental Cavity Preparation
Preparation Technic, Cytohistologic see
Histocytological Preparation Techniques
Preparation Technic, Cytohistological see
Histocytological Preparation Techniques
Preparation Technic, Histocytologic see
Histocytological Preparation Techniques
Preparation Technic, Histocytological see
Histocytological Preparation Techniques
Preparation Technics, Cytohistologic see
Histocytological Preparation Techniques
Preparation Technics, Cytohistological see
Histocytological Preparation Techniques
Preparation Technics, Histocytologic see
Histocytological Preparation Techniques
Preparation Technics, Histocytological see
Histocytological Preparation Techniques
Preparation Technique, Cytohistologic see
Histocytological Preparation Techniques
Preparation Technique, Cytohistological see
Histocytological Preparation Techniques
Preparation Technique, Histocytologic see
Histocytological Preparation Techniques
Preparation Technique, Histocytological see
Histocytological Preparation Techniques
Preparation Techniques, Cytohistologic see
Histocytological Preparation Techniques
Preparation Techniques, Cytohistological see
Histocytological Preparation Techniques
Preparation Techniques, Histocytologic see
Histocytological Preparation Techniques
Preparation Techniques, Histocytological see
Histocytological Preparation Techniques
Preparations, Dental Cavity see
Dental Cavity Preparation
Preparations, Pharmaceutical see
Pharmaceutical Preparations
Preparations, Standard see
Reference Standards
Preparatory Manipulation, Obstetric see
Methods
Prepayment Medical Plans see
Insurance, Health
Prepro-ANP see
Atrial Natriuretic Factor
Prepro-Cardiodilatin-Atrial Natriuretic Factor see
Atrial Natriuretic Factor
Prepro-CDD-ANF see
Atrial Natriuretic Factor
Preprorenin see
Renin
Preprosthetic Oral Surgical Procedure see
Oral Surgical Procedures, Preprosthetic
Preprosthetic Oral Surgical Procedures see
Oral Surgical Procedures, Preprosthetic

Mesh BrowserPresbyopia

WW 300
Prescribing Patterns, Physician see
Practice Patterns, Physicians'
Prescription Drug Abuse see
Substance-Related Disorders

Mesh BrowserPrescription Drug Misuse
Generale
QV 58
Related to substance abuse 
WM 270-290
Particular drug, with the drug
See also
Drug-Related Side Effects and Adverse Reactions
See also
Inappropriate Prescribing
See also
Medication Errors
See also
Substance-Related Disorders

Mesh BrowserPrescription Drugs

QV 55

Mesh BrowserPrescription Fees

QV 736
Prescription Insurance see
Insurance, Pharmaceutical Services
Prescription Medicine Misuse see
Prescription Drug Misuse

Mesh BrowserPrescriptions
For specific subjects, with the subject, e.g.,
Hearing Aids 
WV 274
Prescriptions, Non-Drug see
Prescriptions
Prescriptions, Nondrug see
Prescriptions
Presenile Alzheimer Dementia see
Alzheimer Disease
Presentation, Breech see
Breech Presentation
Presentation, Fetal see
Labor Presentation
Presentation (Obstetrics) see
Labor Presentation
Preservation, Biologic see
Preservation, Biological

Mesh BrowserPreservation, Biological
Generale
QU 25
See also
Blood Preservation
See also
Organ Preservation
See also
Semen Preservation
Preservation, Food see
Food Preservation
Preservative, Pharmaceutic see
Preservatives, Pharmaceutical
Preservative, Pharmaceutical see
Preservatives, Pharmaceutical
Preservatives, Pharmaceutic see
Preservatives, Pharmaceutical

Mesh BrowserPreservatives, Pharmaceutical

QV 820
See also
Antioxidants
Presolol see
Labetalol
Presomen see
Estrogens, Conjugated (USP)
Pressimmune see
Antilymphocyte Serum

Mesh BrowserPressoreceptors

WL 102.9
Pressure, Cerebrospinal Fluid see
Cerebrospinal Fluid Pressure
Pressure Pneumothorax see
Pneumothorax
Pressure Sore see
Pressure Ulcer

Mesh BrowserPressure Ulcer

WR 598
Pressures, Cerebrospinal Fluid see
Cerebrospinal Fluid Pressure

Mesh BrowserPresumed Consent

WX 32-33
Transplantation 
WO 690
Presyncope see
Syncope
Preteen Pregnancy see
Pregnancy in Adolescence
Preterm Birth see
Premature Birth
Preterm Infants see
Infant, Premature
Preterm Labor see
Obstetric Labor, Premature
Prevalence Studies see
Cross-Sectional Studies
Preventative Care see
Preventive Medicine
Preventative Medicine see
Preventive Medicine
Prevention, Accident see
Accident Prevention
Prevention, Primary see
Primary Prevention
Prevention, Primordial see
Primary Prevention
Preventive Care see
Preventive Medicine

Mesh BrowserPreventive Dentistry

WU 113-113.7
See also
Dental Clinics
See also
Health Education, Dental
See also
Primary Prevention
Preventive Health see
Preventive Health Services
Preventive Health Care see
Preventive Health Services
Preventive Health Programs see
Preventive Health Services

Mesh BrowserPreventive Health Services

WA 108
See also
Health Promotion
See also
Immunization 
QW 800-815, etc.
See also
Preventive Dentistry
See also
Preventive Medicine
See also
Preventive Psychiatry
See also
Primary Prevention
Preventive Inoculation see
Immunization

Mesh BrowserPreventive Medicine

WA 108-245
See also
Health Promotion
See also
Preventive Health Services
See also
Public Health
Preventive Programs see
Preventive Health Services

Mesh BrowserPreventive Psychiatry

WM 31.5
See also
Preventive Health Services
Previous Abortion see
Abortion, Induced

Mesh BrowserPriapism

WJ 790
Prices see
Commerce
Prezzi see
Costs and Cost Analysis
Prickly Heat see
Miliaria
Priests see
Clergy
Prilosec see
Omeprazole
Primacin see
Primaquine
Primafen see
Cefotaxime

Mesh BrowserPrimaquine

QV 258
Primaquine Diphosphate see
Primaquine
Primaquine Phosphate see
Primaquine
Primary Adrenal Insufficiency see
Addison Disease
Primary Adrenocortical Insufficiency see
Addison Disease
Primary Antibody Deficiencies see
Primary Immunodeficiency Diseases
Primary Antibody Deficiency Disorders see
Primary Immunodeficiency Diseases
Primary Antibody Deficiency Syndromes see
Primary Immunodeficiency Diseases
Primary Auditory Cortex see
Auditory Cortex
Primary Biliary Cirrhosis see
Liver Cirrhosis, Biliary
Primary Billiary Cholangitis see
Liver Cirrhosis, Biliary
Primary Brain Neoplasms see
Brain Neoplasms
Primary Brain Stem Neoplasms see
Brain Stem Neoplasms
Primary Brainstem Neoplasms see
Brain Stem Neoplasms
Primary Bronchi see
Bronchi
Primary Bronchus see
Bronchi
Primary Cardiac Tumors, Childhood see
Heart Neoplasms
Primary Care see
Primary Health Care

Mesh BrowserPrimary Care Nursing

WY 101
Primary Care Physicians see
Physicians, Primary Care
Primary Central Nervous System Neoplasms see
Central Nervous System Neoplasms
Primary Central Nervous System Vasculitis see
Vasculitis, Central Nervous System
Primary Ciliary Dyskinesia see
Ciliary Motility Disorders
Primary CNS Vasculitis see
Vasculitis, Central Nervous System
Primary Congenital Lymphedema see
Lymphedema
Primary Cutaneous Nocardiosis see
Nocardia Infections
Primary Energy Resource see
Energy-Generating Resources
Primary Energy Resources see
Energy-Generating Resources
Primary Erythermalgia see
Erythromelalgia
Primary Erythromelalgia see
Erythromelalgia
Primary Esotropia see
Esotropia
Primary GH Resistance see
Laron Syndrome
Primary Growth Hormone Resistance see
Laron Syndrome

Mesh BrowserPrimary Health Care

W 84.6
Nursing see
Primary Care Nursing 
WY 101
Primary Healthcare see
Primary Health Care
Primary Hemochromatosis see
Hemochromatosis
Primary Hyperaldosteronism see
Hyperaldosteronism
Primary Hypersomnolence Disorders see
Disorders of Excessive Somnolence
Primary Hyperthyroidism see
Hyperthyroidism
Primary Hypertrophic Pyloric Stenosis see
Pyloric Stenosis, Hypertrophic
Primary Hyperuricemia Syndrome see
Lesch-Nyhan Syndrome
Primary Hypoadrenalism see
Addison Disease
Primary Hypothyroidism see
Hypothyroidism
Primary Immune Deficiency see
Primary Immunodeficiency Diseases
Primary Immune Deficiency Diseases see
Primary Immunodeficiency Diseases
Primary Immune Deficiency Disorders see
Primary Immunodeficiency Diseases
Primary Immune Deficiency Syndromes see
Primary Immunodeficiency Diseases

Mesh BrowserPrimary Immunodeficiency Diseases
Generale
QW 740
Child 
WS 305
See also names of specific diseases
Primary Immunodeficiency Disorders see
Primary Immunodeficiency Diseases
Primary Immunodeficiency Syndromes see
Primary Immunodeficiency Diseases
Primary Insomnia see
Sleep Initiation and Maintenance Disorders
Primary Intramedullary Spinal Cord Neoplasms see
Spinal Cord Neoplasms
Primary Lateral Sclerosis see
Motor Neuron Disease
Primary Macroglobulinemia see
Waldenstrom Macroglobulinemia
Primary Malignant Brain Neoplasms see
Brain Neoplasms
Primary Malignant Brain Tumors see
Brain Neoplasms
Primary Motor Area see
Motor Cortex
Primary Motor Cortex see
Motor Cortex

Mesh BrowserPrimary Myelofibrosis

WH 385
Primary Myocardial Diseases see
Cardiomyopathies
Primary Neoplasms, Cerebellum see
Cerebellar Neoplasms

Mesh BrowserPrimary Nursing

WY 100
Primary Nursing Care see
Primary Nursing
Primary Open Angle Glaucoma see
Glaucoma, Open-Angle
Primary Parkinsonism see
Parkinson Disease
Primary Peritonitis see
Peritonitis
Primary Polycythemia see
Polycythemia Vera

Mesh BrowserPrimary Prevention

WA 108-245
Of particular conditions, by subject
See also
Preventive Dentistry
See also
Preventive Health Services
See also
Preventive Medicine
See also
Preventive Psychiatry
Primary Schools see
Schools
Primary Senile Degenerative Dementia see
Alzheimer Disease
Primary Somatic Sensory Area see
Somatosensory Cortex
Primary Somatosensory Area see
Somatosensory Cortex
Primary Somatosensory Areas see
Somatosensory Cortex
Primary Somatosensory Cortex see
Somatosensory Cortex
Primary Spinal Cord Neoplasms, Intramedullary see
Spinal Cord Neoplasms
Primary Spontaneous Pneumothorax see
Pneumothorax
Primary Supratentorial Neoplasms see
Supratentorial Neoplasms
Primary Teeth see
Tooth, Deciduous
Primary Tooth see
Tooth, Deciduous
Primary Visual Cortex see
Visual Cortex

Mesh BrowserPrimate Diseases
SF 997.5.P7

Mesh BrowserPrimates
General QL 737.P9
As disease vectors 
QX 720
As laboratory animals 
QY 60.P7
See also
Primate Diseases
Primitive Medicine see
Medicine, Traditional
Primitive Societies see
Ethnology
Primordial Prevention see
Primary Prevention
Printed Media see
Mass Media

Mesh BrowserPrinters' Marks
Z 235-236

Mesh BrowserPrinting
Z 116-264.5
See also
Engraving and Engravings
Prinzmetal Angina see
Angina Pectoris, Variant
Prinzmetal's Angina see
Angina Pectoris, Variant
Prioderm see
Malathion
Prion-Associated Disorders see
Prion Diseases
Prion Disease see
Prion Diseases

Mesh BrowserPrion Diseases

WL 301
Prion-Induced Disorder see
Prion Diseases
Prion-Induced Disorders see
Prion Diseases
Prion Protein Diseases see
Prion Diseases

Mesh BrowserPrions

QU 55
Prioress see
Nuns
Priorities, Health see
Health Priorities
Priorix see
Measles-Mumps-Rubella Vaccine

Mesh BrowserPrisoners
Health services 
WA 300
Human experimentation
In special areas, by subject
Mental health services 
WA 305
Reform of HV 9261-9430.7
Special topics, by subject, e.g.,
Psychotherapy

Mesh BrowserPrisoners of War
Health problems 
WA 300
Mental health issues 
WA 305
Of a specific war, with the war

Mesh BrowserPrisons
HV 8301-9960
Hygiene and medical service 
WA 300
Psychiatric services 
WA 305
Sex in prisons HV 8836

Mesh Browservita privata
Medical records confidentiality 
WX 173
Psychology BF 637.P74
Special topics, by subject
See also
Civil Rights
See also
Confidentiality
See also
Personal Space
See also
Self Disclosure
Privacy Act see
vita privata
Privacy of Patient Data see
Confidentiality
Privacy of Space see
Personal Space
Private Duty Nursing see
Nursing, Private Duty
Private Hospitals see
Hospitals, Private
Private Nursing see
Nursing, Private Duty

Mesh BrowserPrivate Practice

W 89
By country 
WB 50
Legislation 
W 33
Nursing see
Nursing, Private Duty 
WY 127
Private Practice Nursing see
Nursing, Private Duty

Mesh BrowserPrivatization
In special fields, by subject, e.g.,
Mental Health Services 
WM 30, etc.
Privigen see
Immunoglobulins, Intravenous
Privileged Communication see
Confidentiality
PRL (Prolactin) see
Prolactin
PRL-Secreting Pituitary Adenoma see
Prolactinoma
Pro-ANF see
Atrial Natriuretic Factor
Pro-C3 see
Complement C3
Pro-Calcitonin see
Procalcitonin
Pro-Choice Groups see
Public Opinion
Pro-Complement 3 see
Complement C3
Pro-Drugs see
Prodrugs
Pro-Oxidants see
Reactive Oxygen Species
PRO Professional Review Organizations see
Professional Review Organizations
ProANF see
Atrial Natriuretic Factor
Proangiotensin see
Angiotensinogen
Proatrial Natriuretic Factor see
Atrial Natriuretic Factor
Probabilistic Models see
Models, Statistical

Mesh BrowserProbability
General QA 273-274.9
In public health 
WA 950

Mesh BrowserProbability Learning
LB 1060
Probability Sample see
Sampling Studies

Mesh BrowserProbability Theory
QA 273-274.8
Special topics, by subject
Probe, Molecular see
Molecular Probes
Probes, Molecular see
Molecular Probes
Probiotic see
Probiotici

Mesh BrowserProbiotici
Generale
QU 145.5
See also
Prebiotics

Mesh BrowserProblem Behavior
Generale
WS 350.6
Adulto
WM 165
See also
Attention Deficit and Disruptive Behavior Disorders
Problem Formulation see
Research Design
Problem-Oriented Medical Records see
Medical Records, Problem-Oriented

Mesh BrowserProblem Solving
General BF 449
Adolescent 
WS 462.5.D2
Infant or child 
WS 105.5.D2
See also
Decision Making

Mesh BrowserProblems and Exercises
Anesthesia 
WO 218.2
Embryology 
QS 618.2
Forensic medicine or dentistry 
W 618.2
Histology 
QS 518.2
Immunology 
QW 518.2
(Form number 18.2 in any NLM schedule where applicable)
See also
Examination Questions
Proboscidea Plant see
Lamiales

Mesh BrowserProbucol
As an anticholesteremic agent 
QU 95
Organic chemistry QD 341.P5
Procain Braun see
Procaine
Procain curasan see
Procaine
Procain Jenapharm see
Procaine
procain-loges see
Procaine
Procain Rödler see
Procaine
Procain Steigerwald see
Procaine
Procaina Serra see
Procaine

Mesh BrowserProcaine
Generale
QV 110
Procaine Hydrochloride see
Procaine

Mesh BrowserProcalcitonin

WK 202
Procambarus see
Astacoidea
Procardia see
Nifedipine
Procardia XL see
Nifedipine
Procedure, Ambulatory Surgical see
Ambulatory Surgical Procedures
Procedure, Cardiac Surgical see
Cardiac Surgical Procedures
Procedure, Cardiovascular Surgical see
Cardiovascular Surgical Procedures
Procedure, Digestive System, Endoscopic, Surgical see
Endoscopy, Digestive System
Procedure, Digestive System Surgical see
Digestive System Surgical Procedures
Procedure, Endocrine Surgical see
Endocrine Surgical Procedures
Procedure, Endoscopic, Digestive System, Surgical see
Endoscopy, Digestive System
Procedure, Endoscopic Gastrointestinal, Surgical see
Endoscopy, Gastrointestinal
Procedure, Gastrointestinal Endoscopic Surgical see
Endoscopy, Gastrointestinal
Procedure, Gastrointestinal Surgical see
Digestive System Surgical Procedures
Procedure, Gynecologic Surgical see
Gynecologic Surgical Procedures
Procedure, Heart Surgical see
Cardiac Surgical Procedures
Procedure, Laparoscopic Surgical see
Laparoscopy
Procedure, Minimal Surgical see
Minimally Invasive Surgical Procedures
Procedure, Minor Surgical see
Minor Surgical Procedures
Procedure, Obstetric Surgical see
Obstetric Surgical Procedures
Procedure, Operative Surgical see
Surgical Procedures, Operative
Procedure, Ophthalmologic Surgical see
Ophthalmologic Surgical Procedures
Procedure, Oral Surgical see
Oral Surgical Procedures
Procedure, Otologic Surgical see
Otologic Surgical Procedures
Procedure, Otorhinolaryngologic Surgical see
Otorhinolaryngologic Surgical Procedures
Procedure, Preoperative see
Preoperative Care
Procedure, Pulmonary Surgical see
Pulmonary Surgical Procedures
Procedure, Reconstructive Surgical see
Reconstructive Surgical Procedures
Procedure, Thoracic Surgical see
Thoracic Surgical Procedures
Procedure, Urogenital Surgical see
Urogenital Surgical Procedures
Procedure, Urologic Surgical see
Urologic Surgical Procedures
Procedure, Urologic Surgical, Male see
Urologic Surgical Procedures, Male
Procedure, Urological Surgical, Male see
Urologic Surgical Procedures, Male
Procedure, Vascular Surgical see
Vascular Surgical Procedures
Procedures see
Methods
Procedures, Ambulatory Surgical see
Ambulatory Surgical Procedures
Procedures, Cardiac Surgical see
Cardiac Surgical Procedures
Procedures, Cardiovascular Surgical see
Cardiovascular Surgical Procedures
Procedures, Digestive System, Endoscopic, Surgical see
Endoscopy, Digestive System
Procedures, Digestive System Surgical see
Digestive System Surgical Procedures
Procedures, Endocrine Surgical see
Endocrine Surgical Procedures
Procedures, Endoscopic, Digestive System, Surgical see
Endoscopy, Digestive System
Procedures, Endoscopic Gastrointestinal, Surgical see
Endoscopy, Gastrointestinal
Procedures, Gastrointestinal Endoscopic Surgical see
Endoscopy, Gastrointestinal
Procedures, Gastrointestinal Surgical see
Digestive System Surgical Procedures
Procedures, Gynecologic Surgical see
Gynecologic Surgical Procedures
Procedures, Heart Surgical see
Cardiac Surgical Procedures
Procedures, Laparoscopic Surgical see
Laparoscopy
Procedures, Minimal Access Surgical see
Minimally Invasive Surgical Procedures
Procedures, Minimal Surgical see
Minimally Invasive Surgical Procedures
Procedures, Minimally Invasive Surgical see
Minimally Invasive Surgical Procedures
Procedures, Minor Surgical see
Minor Surgical Procedures
Procedures, Neurosurgical see
Neurosurgical Procedures
Procedures, Obstetric Surgical see
Obstetric Surgical Procedures
Procedures, Operative Surgical see
Surgical Procedures, Operative
Procedures, Ophthalmologic Surgical see
Ophthalmologic Surgical Procedures
Procedures, Oral Surgical see
Oral Surgical Procedures
Procedures, Otologic Surgical see
Otologic Surgical Procedures
Procedures, Otorhinolaryngologic Surgical see
Otorhinolaryngologic Surgical Procedures
Procedures, Postoperative see
Postoperative Care
Procedures, Preoperative see
Preoperative Care
Procedures, Pulmonary Surgical see
Pulmonary Surgical Procedures
Procedures, Reconstructive Surgical see
Reconstructive Surgical Procedures
Procedures, Thoracic Surgical see
Thoracic Surgical Procedures
Procedures, Urogenital Surgical see
Urogenital Surgical Procedures
Procedures, Urologic Surgical see
Urologic Surgical Procedures
Procedures, Urologic Surgical, Male see
Urologic Surgical Procedures, Male
Procedures, Urological Surgical, Male see
Urologic Surgical Procedures, Male
Procedures, Vascular Surgical see
Vascular Surgical Procedures
Process, Metabolic see
Metabolism
Process, Nursing see
Nursing Process
Process, Psychiatric Therapeutic see
Psychotherapeutic Processes
Process, Psychotherapeutic see
Psychotherapeutic Processes
Process, Stochastic see
Stochastic Processes
Processes, Metabolic see
Metabolism
Processes, Neoplastic see
Neoplastic Processes
Processes, Pathologic see
Pathologic Processes
Processes, Psychiatric Therapeutic see
Psychotherapeutic Processes
Processes, Psychotherapeutic see
Psychotherapeutic Processes
Procholeragenoid see
Cholera Toxin
Proconvertin see
Factor VII
Procorum see
Gallopamil
PROCR see
Endothelial Protein C Receptor

Mesh BrowserProctitis

WI 603
Proctocolectomy see
Proctocolectomy, Restorative

Mesh BrowserProctocolectomy, Restorative

WI 650
See also
Colonic Pouches

Mesh BrowserProctocolitis

WI 522
Proctocolitis, Hemorrhagic see
Proctocolitis
Proctocolitis, Ulcerative see
Proctocolitis
Proctology see
Colorectal Surgery
Proctoscopic Surgery see
Proctoscopy
Proctoscopic Surgical Procedures see
Proctoscopy

Mesh BrowserProctoscopy

WI 620
Proctosigmoiditis see
Proctocolitis
Proctosigmoidoscopy see
Sigmoidoscopy
Procytox see
Cyclophosphamide
Prodes Brand of Aspartame see
Aspartame

Mesh BrowserProdrugs

QV 785
Product Approval see
Consumer Product Safety

Mesh BrowserProduct Labeling

WA 250
Of specific products, by subject
See also
Drug Labeling 
QV 835
Product Labeling, Drug see
Drug Labeling
Product Labeling, Food see
Food Labeling
Product Labelling see
Product Labeling
Product Surveillance, Post-Marketing see
Product Surveillance, Postmarketing

Mesh BrowserProduct Surveillance, Postmarketing
Of drugs 
QV 771
Of specific drug, with the drug
Of specific product, with the product
Production see
Economics
Productivity see
Efficiency
Products, Biological see
Biological Products
Proenzymes see
Enzyme Precursors
Proerythroblasts see
Erythroblasts
Profact see
Buserelin

Mesh BrowserProfessional Competence
Generale
W 21
(Form number 21 in any NLM schedule where applicable)
Nurses 
WY 16
As an educational measurement
Actual tests (Form number 18.2 in any NLM schedule where applicable)
Works about (Form number 18 in any NLM schedule where applicable)

Mesh BrowserProfessional Corporations

W 87
Professional Ethics see
Ethics, Professional

Mesh BrowserProfessional Impairment
Medicine 
W 21
For general impairment in other specialties, class in the number for the profession where applicable
Professional Liability see
Liability, Legal

Mesh BrowserProfessional Misconduct
(Form number 21 in any NLM schedule where applicable)
See also
Conflict of Interest
See also
Deception
See also
Ethics, Professional
See also
Fraud
See also
Malpractice
Professional Organizations see
Societies

Mesh BrowserProfessional-Patient Relations
Generale
W 62
Allied Health Personnel 
W 21.5
Hospital personnel 
WX 160
Particular specialty, with the specialty
See also specific professional-patient relationship terms
See also
Truth Disclosure
Professional Patient Relationship see
Professional-Patient Relations

Mesh BrowserProfessional Practice
Medicine as a career 
W 21
Types of professional practice 
W 87
See also names of specialties in medicine and allied fields, e.g.,
Nursing 
WY 16
(Form number 21 in any other NLM schedule where applicable)
See also
Practice Management, Dental
See also
Practice Management, Medical

Mesh BrowserProfessional Review Organizations

W 84.4
By specialty, in the number for the profession, e.g.,
Pharmacology 
QV 21

Mesh BrowserProfessional Staff Committees
In hospitals 
WX 159
In schools
(Form number 19-20 in any NLM schedule where applicable)
See also
Utilization Review 
WX 153
Professional Standards Review Organizations see
Professional Review Organizations
Professional Stress see
Occupational Stress
Professional-to-Patient Disease Transmission see
Infectious Disease Transmission, Professional-to-Patient
Professional-to-Patient Transmission see
Infectious Disease Transmission, Professional-to-Patient
Profibrinolysin see
Plasminogen
Proflavin see
Proflavine

Mesh BrowserProflavine
As a local anti-infective agent 
QV 220
Proflavine Hemisulfate see
Proflavine
Progenitor Cells see
Stem Cells
Progenitor Cells, Hematopoietic see
Hematopoietic Stem Cells
Progens see
Estrogens, Conjugated (USP)

Mesh BrowserProgeria

WS 104
See also
Werner Syndrome
Progeria, Adult see
Werner Syndrome
Progestagenic Agents see
Progestins
Progestagens see
Progestins
Progestational Agents see
Progestins
Progestational Compounds see
Progestins
Progestational Hormones see
Progestins

Mesh BrowserProgesterone

WP 530
See also
Receptors, Progesterone
Progesterone, (13 alpha,17 alpha)-(+-)-Isomer see
Progesterone
Progesterone, (17 alpha)-Isomer see
Progesterone
Progesterone, (9 beta,10 alpha)-Isomer see
Progesterone
Progesterone Receptor see
Receptors, Progesterone
Progesterone Receptors see
Receptors, Progesterone
Progestin see
Progestins
Progestin Effect see
Progestins
Progestin Effects see
Progestins
Progestin Receptors see
Receptors, Progesterone

Mesh BrowserProgestins

WP 530
Progestogen Effect see
Progestins
Progestogen Effects see
Progestins
Progestogens see
Progestins
Proglucagon (33-61) see
Glucagon
Proglycem see
Diazoxide

Mesh BrowserPrognathism

WU 440
See also
Malocclusion

Mesh BrowserPrognosis

WB 142
See also names of particular diseases
Prognostic Factors see
Prognosis
Prognostic Nutritional Index see
Nutrition Assessment
Prognostic Nutritional Index (PNI) see
Nutrition Assessment
Program Acceptability see
Patient Acceptance of Health Care
Program Accessibility see
Health Services Accessibility
Program Appropriateness see
Program Evaluation
Program Effectiveness see
Program Evaluation

Mesh BrowserProgram Evaluation
Health Services 
W 84.4
Other special topics, by subject being evaluated
Program Evaluation, Nursing see
Nursing Evaluation Research
Program, Regional Medical see
Regional Medical Programs
Program Sustainability see
Program Evaluation
Programmable Implantable Insulin Pump see
Insulin Infusion Systems
Programmable Implantable Medication Systems see
Infusion Pumps, Implantable
Programmed Cell Death, Type I see
Apoptosis
Programmed Electrostimulation see
Electrophysiologic Techniques, Cardiac
Programmed Electrostimulation, Cardiac see
Electrophysiologic Techniques, Cardiac

Mesh BrowserProgrammed Instruction
Anesthesia 
WO 218.2
Embryology 
QS 618.2
Forensic medicine and dentistry 
W 618.2
Histology 
QS 518.2
Immunology 
QW 518.2
(Form number 18.2 in any NLM schedule where applicable)
Programmed Instruction, Computerized see
Computer-Assisted Instruction

Mesh BrowserProgramming Languages
General (medical) 
W 26.55.S6
General (non-medical) QA 76.7-.73
(Form number 26.5 in any NLM schedule where applicable)
Programs, Regional Medical see
Regional Medical Programs
Progressive Bulbar Palsy of Childhood see
Bulbar Palsy, Progressive
Progressive Chorea, Chronic Hereditary (Huntington) see
Huntington Disease
Progressive Chorea, Hereditary, Chronic (Huntington) see
Huntington Disease
Progressive Intracranial Occlusive Arteropathy (Moyamoya) see
Moyamoya Disease
Progressive Lenticular Degeneration see
Hepatolenticular Degeneration
Progressive Lipodystrophy see
Lipodystrophy
Progressive Muscle Relaxation see
Autogenic Training
Progressive Muscular Atrophy see
Muscular Atrophy, Spinal
Progressive Myelopathic Muscular Atrophy see
Muscular Atrophy, Spinal
Progressive Neuronal Degeneration of Childhood with Liver Disease see
Diffuse Cerebral Sclerosis of Schilder

Mesh BrowserProgressive Patient Care

W 84.7-84.8
Of hospital patients 
WX 162-162.5
Progressive Proximal Myelopathic Muscular Atrophy see
Muscular Atrophy, Spinal
Progressive Relaxation see
Autogenic Training
Progressive Sclerosing Poliodystrophy see
Diffuse Cerebral Sclerosis of Schilder
Progressive Supranuclear Ophthalmoplegia see
Supranuclear Palsy, Progressive
Progressive Supranuclear Palsy see
Supranuclear Palsy, Progressive
Progressive Torsion Spasm see
Dystonia Musculorum Deformans
Progynon C see
Ethinyl Estradiol
Progynon-Depot see
Estradiol
Progynova see
Estradiol

Mesh BrowserProinsulin

WK 802
Proinsulin C-Peptide see
C-Peptide

Mesh BrowserProjection

WM 193.5.P7
Projections and Predictions see
Forecasting
Projective Technics see
Projective Techniques

Mesh BrowserProjective Techniques
Generale
WM 145.5.P8
Adolescent 
WS 462.5.E8
In psychology BF 698.8.S85
Infant or child 
WS 105.5.E8
See also
Psychological Tests

Mesh BrowserProkaryotic Cells

QW 51

Mesh BrowserProlactin

WK 515
See also
Hyperprolactinemia
Prolactin Hypersecretion Syndrome see
Hyperprolactinemia
Prolactin, Inappropriate Secretion see
Hyperprolactinemia
Prolactin-Producing Pituitary Adenoma see
Prolactinoma
Prolactin-Secreting Pituitary Adenoma see
Prolactinoma

Mesh BrowserProlactinoma

WK 585
See also
Hyperprolactinemia
Prolactinoma, Familial see
Prolactinoma
Prolair see
Beclomethasone
Prolapsed Disc see
Intervertebral Disc Displacement
Prolapsed Disk see
Intervertebral Disc Displacement
Prolapsed Mitral Valve see
Mitral Valve Prolapse
Prolastin see
alpha 1-Antitrypsin
Prolecofen see
Propafenone
Proliferation Therapy see
Prolotherapy
Prolixan see
Apazone
Prolixin see
Fluphenazine
Prolongation of Life see
Life Support Care
Prolonged-Action Preparations see
Delayed-Action Preparations
Prolonged Post-Traumatic Unawareness see
Persistent Vegetative State
Prolonged Pregnancy see
Pregnancy, Prolonged
Proloprim see
Trimethoprim

Mesh BrowserProlotherapy

WE 140
Promeco Brand of Alteplase see
Tissue Plasminogen Activator
Promeco Brand of Bromhexine Hydrochloride see
Bromhexine
Promeran see
Chlormerodrin
Promit see
Dextrans
PROMM (Proximal Myotonic Myopathy) see
Myotonic Dystrophy
Promoter, Genetic see
Promoter Regions, Genetic
Promoter (Genetics) see
Promoter Regions, Genetic
Promoter Regions see
Promoter Regions, Genetic

Mesh BrowserPromoter Regions, Genetic

QU 470
Promotion of Health see
Health Promotion
Promotional Items see
Health Promotion
Promotor, Genetic see
Promoter Regions, Genetic
Promotor Regions see
Promoter Regions, Genetic
Pronatalist Policy see
Family Planning Policy
Pronatriodilatin see
Atrial Natriuretic Factor
Pronisone see
Prednisone
Pronormoblasts see
Erythroblasts
Propaderm see
Beclomethasone
Propafenon AL see
Propafenone
Propafenon Hexal see
Propafenone
Propafenon Minden see
Propafenone

Mesh BrowserPropafenone

QV 152
Propafenone, (+-)-Isomer see
Propafenone
Propafenone Hydrochloride see
Propafenone
Propafenone Hydrochloride, (R)-Isomer see
Propafenone
Propafenone Hydrochloride, (S)-Isomer see
Propafenone
Propafenone, (R)-Isomer see
Propafenone
Propafenone, (S)-Isomer see
Propafenone

Mesh BrowserPropaganda
HM 1231
Propamerck see
Propafenone
Propamidine see
Antiprotozoal Agents
Propanoates see
Propionates
Propanoic Acid, 2-Hydroxy-, (2R)- see
Lactic Acid
Propanoic Acid, 2-Hydroxy-, (2S)- see
Lactic Acid
Propanoic Acid Derivatives see
Propionates
Propanoic Acids see
Propionates

Mesh BrowserPropanolamines
Organic chemistry QD 305.A4
Used for specific purposes, by subject, e.g.,
Adrenergic beta-Antagonists
Propanolol see
Propranolol

Mesh BrowserPropanols
Organic chemistry QD 305.A4
Pharmacology 
QV 82
Propaphenin see
Chlorpromazine

Mesh BrowserProperdin

QW 680
Prophage Integration see
Lysogeny
Prophylactic Immunization see
Vaccination
Prophylaxis see
Dental Prophylaxis
Prophylaxis, Dental see
Dental Prophylaxis

Mesh BrowserPropionates

QU 98

Mesh BrowserPropionibacteriaceae

QW 125.5.P7
Propionic Acid Derivatives see
Propionates
Propionic Acids see
Propionates

Mesh BrowserPropiophenones
Organic chemistry QD 341.K2
Pharmacology 
QV 150

Mesh BrowserPropolis
As an anti-infective agent 
QV 250
See also
Apitherapy

Mesh BrowserPropranolol

QV 132
Propranolol Hydrochloride see
Propranolol

Mesh BrowserProprioception

WE 104
Proprioceptive Disorders see
Somatosensory Disorders
Proprioceptive Neuromuscular Facilitation (PNF) Stretching see
Muscle Stretching Exercises
Proptosis see
Exophthalmos
Propylisopropylacetic Acid see
Valproic Acid
Prorenin see
Renin
Prosana Brand of Quinine Bisulfate see
Quinine
Proserine see
Neostigmine
Prosimians see
Strepsirhini
Prosimii see
Strepsirhini
Prospective Memory see
Memory, Episodic

Mesh BrowserProspective Payment System
Generale
W 74
Hospitals 
WX 157
Prospective Pricing see
Prospective Payment System
Prospective Reimbursement see
Prospective Payment System

Mesh BrowserProspective Studies
In epidemiology 
WA 950
Special topics, by subject
Prostacyclin see
Epoprostenol
Prostaglandin Antagonist see
Prostaglandin Antagonists

Mesh BrowserProstaglandin Antagonists

QU 91
Prostaglandin Cyclo-Oxygenase see
Prostaglandin-Endoperoxide Synthases
Prostaglandin Cyclooxygenase see
Prostaglandin-Endoperoxide Synthases
Prostaglandin E1 see
Alprostadil
Prostaglandin E1alpha see
Alprostadil
Prostaglandin-Endoperoxide Synthase see
Prostaglandin-Endoperoxide Synthases

Mesh BrowserProstaglandin-Endoperoxide Synthases

QU 140
Prostaglandin Endoperoxide Synthetase see
Prostaglandin-Endoperoxide Synthases

Mesh BrowserProstaglandin Endoperoxides

QU 91
Prostaglandin F2 see
Dinoprost
Prostaglandin F2 alpha see
Dinoprost
Prostaglandin F2alpha see
Dinoprost
Prostaglandin G-H Synthase see
Prostaglandin-Endoperoxide Synthases
Prostaglandin H Synthase see
Prostaglandin-Endoperoxide Synthases
Prostaglandin H2 Synthetase see
Prostaglandin-Endoperoxide Synthases
Prostaglandin I(2) see
Epoprostenol
Prostaglandin I2 see
Epoprostenol
Prostaglandin Inhibitor see
Prostaglandin Antagonists
Prostaglandin Inhibitors see
Prostaglandin Antagonists
Prostaglandin Receptor see
Receptors, Prostaglandin
Prostaglandin Receptors see
Receptors, Prostaglandin
Prostaglandin Synthase see
Prostaglandin-Endoperoxide Synthases
Prostaglandin Synthetase see
Prostaglandin-Endoperoxide Synthases

Mesh BrowserProstaglandins

QU 91
See also
Prostaglandin Antagonists
See also
Receptors, Prostaglandin

Mesh BrowserProstaglandins A

QU 91

Mesh BrowserProstaglandins E

QU 91

Mesh BrowserProstaglandins F

QU 91

Mesh BrowserProstanoic Acids

QU 90
Prostanoids see
Prostaglandins

Mesh BrowserProstate

WJ 750-768
See also
Prostatectomy
Prostate Cancer see
Prostatic Neoplasms
Prostate Neoplasms see
Prostatic Neoplasms
Prostate Specific Antigen see
Prostate-Specific Antigen

Mesh BrowserProstate-Specific Antigen

WJ 762
See also
Prostatic Neoplasms

Mesh BrowserProstatectomy

WJ 768
Prostatectomy, Retropubic see
Prostatectomy
Prostatectomy, Suprapubic see
Prostatectomy
Prostatectomy, Transurethral see
Transurethral Resection of Prostate
Prostatic Adenoma see
Prostatic Hyperplasia
Prostatic Cancer see
Prostatic Neoplasms

Mesh BrowserProstatic Diseases

WJ 752
General Surgery 
WJ 768
Of specific disease, with disease

Mesh BrowserProstatic Hyperplasia
Generale
WJ 752
See also
Prostatic Neoplasms 
WJ 762
Prostatic Hyperplasia, Benign see
Prostatic Hyperplasia
Prostatic Hypertrophy see
Prostatic Hyperplasia
Prostatic Hypertrophy, Benign see
Prostatic Hyperplasia

Mesh BrowserProstatic Neoplasms

WJ 762
See also
Prostate-Specific Antigen
See also
Prostatic Hyperplasia

Mesh BrowserProstatitis

WJ 752
Prostavasin see
Alprostadil
Prostheses see
Prostheses and Implants

Mesh BrowserProstheses and Implants
Generale
QT 37
See also names of specific implants or prostheses
Specific location, by site
See also
Artificial Limbs
See also
Device Removal
See also
Prosthesis Implantation
Prostheses, Dental see
Dental Prosthesis
Prostheses, Ossicular Replacement see
Ossicular Prosthesis
Prostheses, Surgical Dental see
Dental Implants
Prosthesis see
Prostheses and Implants
Prosthesis Adjustment see
Prosthesis Fitting
Prosthesis, Dental see
Dental Prosthesis
Prosthesis Dental, Implant-Supported see
Dental Prosthesis, Implant-Supported

Mesh BrowserProsthesis Design
Generale
QS 26
Biocompatible Materials 
QT 37
Localized, by site
Prosthesis Design, Dental see
Dental Prosthesis Design
Prosthesis Designs, Dental see
Dental Prosthesis Design
Prosthesis Durability see
Prosthesis Failure

Mesh BrowserProsthesis Failure
Equipment failure (General) 
W 26
Of particular prosthesis, with the prosthesis
See also
Dental Restoration Failure
Prosthesis Failure, Dental see
Dental Restoration Failure
Prosthesis Failures, Dental see
Dental Restoration Failure

Mesh BrowserProsthesis Fitting
Artificial Limbs 
WE 172
For particular prosthesis, with the prosthesis
Prosthesis, Heart Valve see
Heart Valve Prosthesis

Mesh BrowserProsthesis Implantation
See also specific implantations, e.g.,
Breast Implantation
Specific implantations by site, e.g.,
Arthroplasty, Replacement, Hip
See also
Prostheses and Implants
Prosthesis Implantation, Dental see
Dental Implantation
Prosthesis Loosening see
Prosthesis Failure
Prosthesis Migration see
Prosthesis Failure
Prosthesis, Ossicular Replacement see
Ossicular Prosthesis

Mesh BrowserProsthesis-Related Infections
Generale
WO 184
Specific infections, with the infection, e.g.,
Staphylococcal Infections
Specific prosthesis, with the prosthesis or site, e.g.,
Heart Valve Prosthesis
See also
Biofilms
Prosthesis, Surgical Dental see
Dental Implants
Prosthesis Survival see
Prosthesis Failure
Prosthetic Implants see
Prostheses and Implants

Mesh BrowserProsthodontics

WU 500
See also
Dental Prosthesis 
WU 500-530
See also
Oral Surgical Procedures, Preprosthetic
Prosthodontists see
Dentists
Prostigmin see
Neostigmine
Prostigmine see
Neostigmine
Prostin VR see
Alprostadil
Prostine VR see
Alprostadil
Prostitutes see
Sex Workers
Prostitution see
Sex Work
Protagens see
Povidone
Protagent see
Povidone
Protan Defect see
Color Vision Defects
Protandry see
Sex Determination Processes
Protease Antagonists see
Protease Inhibitors
Protease Inhibitor see
Protease Inhibitors

Mesh BrowserProtease Inhibitors

QU 143
Proteases see
Peptide Hydrolases
Protected Sex see
Safe Sex
Protection, Environmental see
Conservation of Natural Resources
Protection, Radiation see
Radiation Protection

Mesh BrowserProtective Clothing
Generale
WA 260
Occupational 
WA 485-487
See also specific types of clothing
Special topics, by topic

Mesh BrowserProtective Devices
Generale
WA 260
For the head see
Head Protective Devices
In hospitals 
WX 185
In sports 
QT 260
Specific sport, with the sport
Occupational 
WA 485-487
Aviation
WD 740
Respiratory 
WF 26
(Form number 26 in any schedule where applicable for particular parts of the body)
Protective Gloves see
Gloves, Protective

Mesh BrowserProtein Array Analysis

QU 25
Protein Array Assay see
Protein Array Analysis
Protein Arrays see
Protein Array Analysis
Protein, Bacterial see
Bacterial Proteins
Protein Band 3 see
Anion Exchange Protein 1, Erythrocyte

Mesh BrowserProtein Binding
Generale
QU 55
See also
Binding Sites
See also
Carrier Proteins 
QU 55.2
See also
Metalloproteins 
QU 55.8
See also
Thyroxine-Binding Proteins 
WK 202
Protein Biochips see
Protein Array Analysis

Mesh BrowserProtein Biosynthesis

QU 55
See also
Genetic Code
Protein Biosynthesis, Ribosomal see
Protein Biosynthesis
Protein-Bound Iodine Test see
Thyroid Function Tests

Mesh BrowserProtein C
As an anticoagulant 
QV 193
Protein C Receptor see
Endothelial Protein C Receptor
Protein-Calorie Malnutrition see
Protein-Energy Malnutrition
Protein Chips see
Protein Array Analysis

Mesh BrowserProtein Conformation

QU 55.9

Mesh BrowserProtein Deficiency

WD 105
Protein Degradation see
Proteolysis

Mesh BrowserProtein Denaturation

QU 55.9
Protein Digestion see
Proteolysis

Mesh BrowserProtein-Energy Malnutrition

WD 105
See also
Emaciation

Mesh BrowserProtein Engineering

QU 55.95
See also
Mutagenesis, Site-Directed

Mesh BrowserProtein Folding

QU 55.9
See also
Intrinsically Disordered Proteins
See also
Protein Conformation
See also
Proteostasis
Protein Folding, Globular see
Protein Folding
Protein Glycosylation see
Glycosylation
Protein Homeostasis see
Proteostasis

Mesh BrowserProtein Hydrolysates

QU 55
Protein Inducer MGI see
Colony-Stimulating Factors

Mesh BrowserProtein Interaction Mapping

QU 25
See also
Binding Sites
See also
Protein Array Analysis
See also
Protein Binding
Protein Kinase see
Protein Kinases

Mesh BrowserProtein Kinases

QU 141
Protein Localization Processes, Cellular see
Protein Transport

Mesh BrowserProtein-Losing Enteropathies

WI 418
See also
Agammaglobulinemia
See also
Lymphopenia
Protein-Losing Enteropathy see
Protein-Losing Enteropathies
Protein Methylases see
Protein Methyltransferases

Mesh BrowserProtein Methyltransferases

QU 141
Protein Microarray Analysis see
Protein Array Analysis
Protein Microarray Assay see
Protein Array Analysis
Protein Microarrays see
Protein Array Analysis
Protein Microchips see
Protein Array Analysis
Protein Modification, Post-Translational see
Protein Processing, Post-Translational
Protein NMR Spectroscopy see
Nuclear Magnetic Resonance, Biomolecular
Protein Phosphatase C see
Phosphoprotein Phosphatases
Protein Phosphatase C-I see
Phosphoprotein Phosphatases
Protein Phosphatase C-II see
Phosphoprotein Phosphatases
Protein Phosphatase H-II see
Phosphoprotein Phosphatases
Protein Phosphatases see
Phosphoprotein Phosphatases
Protein Processing, Post Translational see
Protein Processing, Post-Translational

Mesh BrowserProtein Processing, Post-Translational

QU 55
Protein Processing, Posttranslational see
Protein Processing, Post-Translational
Protein Profiling Chips see
Protein Array Analysis
Protein Profiling Microarrays see
Protein Array Analysis
Protein-Restricted Diet see
Diet, Protein-Restricted
Protein Sensitization see
Hypersensitivity
Protein Sequence Analysis see
Sequence Analysis, Protein
Protein Sequencing see
Sequence Analysis, Protein
Protein-Serine-Threonine Phosphatase see
Phosphoprotein Phosphatases
Protein Sorting see
Protein Transport

Mesh BrowserProtein Sorting Signals

QU 68
See also
Protein Transport 
QU 120
Protein Structure, Primary see
Amino Acid Sequence
Protein Synthesis, Ribosomal see
Protein Biosynthesis
Protein Targeting see
Protein Transport
Protein-Threonine Phosphatase see
Phosphoprotein Phosphatases
Protein Trafficking see
Protein Transport
Protein Translation see
Protein Biosynthesis
Protein Translocation see
Protein Transport

Mesh BrowserProtein Transport
Generale
QU 55
See also
Protein Sorting Signals 
QU 68
Proteinases see
Peptide Hydrolases
ProteinChip see
Protein Array Analysis
Proteinoses, Pulmonary Alveolar see
Pulmonary Alveolar Proteinosis
Proteinosis, Pulmonary Alveolar see
Pulmonary Alveolar Proteinosis

Mesh BrowserProteins

QU 55
See also names of specific proteins
See also
Amino Acid Sequence
See also
Blood Proteins
See also
Protein Conformation
Proteins, Acute-Phase see
Acute-Phase Proteins
Proteins, Acute Phase see
Acute-Phase Proteins
Proteins, Bacterial see
Bacterial Proteins
Proteins, Biosynthetic see
Recombinant Proteins
Proteins, Cerebrospinal Fluid see
Cerebrospinal Fluid Proteins
Proteins, Dietary see
Dietary Proteins
Proteins, Genetic Engineering see
Protein Engineering
Proteins, Mitochondrial see
Mitochondrial Proteins
Proteins, Neuronal Growth-Associated see
Nerve Growth Factors
Proteins, Recombinant DNA see
Recombinant Proteins

Mesh BrowserProteinuria

WJ 343
Proteinuria-Edema-Hypertension Gestosis see
Pre-Eclampsia

Mesh BrowserProteobacteria

QW 150
Proteoglycan see
Proteoglycans
Proteoglycan Type H see
Proteoglycans

Mesh BrowserProteoglycans

QU 55.5

Mesh BrowserProteolysis

QU 55.9
Proteolytic Enzymes see
Peptide Hydrolases

Mesh BrowserProteome

QU 460
See also
Genome
Proteomes see
Proteome

Mesh BrowserProteomics

QU 460
See also
Genomics

Mesh BrowserProteostasis

QU 460
See also
Protein Folding
Proterelin Tartrate see
Thyrotropin-Releasing Hormone
Proterelin Tartrate Hydrate see
Thyrotropin-Releasing Hormone

Mesh BrowserProteus

QW 138.5.P7
Prothesis, Heart Valve see
Heart Valve Prosthesis

Mesh BrowserProthrombin

WH 310
Clinical analysis 
QY 410
See also
Coagulants
Prothrombin Deficiency see
Hypoprothrombinemias

Mesh BrowserProthrombin Time

QY 410
See also
Blood Coagulation
Prothrombinase see
Thromboplastin
Protirelin see
Thyrotropin-Releasing Hormone
Protirelin Tartrate (1:1) see
Thyrotropin-Releasing Hormone
Proto-Oncogene see
Proto-Oncogenes
Proto-oncogene c-ErbB-1 Protein see
ErbB Receptors
Proto-Oncogene Products, Cellular see
Proto-Oncogene Proteins

Mesh BrowserProto-Oncogene Proteins

QZ 210
Proto Oncogene Proteins, Cellular see
Proto-Oncogene Proteins

Mesh BrowserProto-Oncogenes

QZ 210
Protocol, Clinical see
Clinical Protocols
Protocol, Clinical Research see
Clinical Protocols
Protocol-Directed Therapy, Computer-Assisted see
Therapy, Computer-Assisted
Protocols, Clinical see
Clinical Protocols
Protocols, Clinical Research see
Clinical Protocols
Protocols, Nursing see
Nursing Assessment
Protocols, Treatment see
Clinical Protocols
Protogyny see
Sex Determination Processes
Protoheme see
Heme
Protoheme IX see
Heme
Protohemin see
Hemin
Protohemin IX see
Hemin
Proton Beam Radiation Therapy see
Proton Therapy
Proton Beam Therapy see
Proton Therapy
Proton Induced X Ray Emission Spectrometry see
Spectrometry, X-Ray Emission
Proton-Induced X-Ray Emission Spectrometry see
Spectrometry, X-Ray Emission
Proton Spin Tomography see
Magnetic Resonance Imaging

Mesh BrowserProton Therapy
Generale
WN 250.5.P7
For treatment of neoplasms 
QZ 269
Proton-Translocating ATPase see
Proton-Translocating ATPases
Proton-Translocating ATPase Complex see
Proton-Translocating ATPases
Proton-Translocating ATPase Complexes see
Proton-Translocating ATPases
Proton-Translocating ATPase, F0 Sector see
Proton-Translocating ATPases
Proton-Translocating ATPase, F1 Sector see
Proton-Translocating ATPases

Mesh BrowserProton-Translocating ATPases

QU 136

Mesh BrowserProtons
QC 793.5.P72-793.5.P729
See also
Proton Therapy
Protoplasm see
Cytoplasm

Mesh BrowserProtoplasts
Bacteria 
QW 51
Plants QK 725
Protosteliomycetes see
Myxomycetes
Protozoa see
Eukaryota

Mesh BrowserProtozoan Infections

WC 700-770
Veterinary see
Protozoan Infections, Animal SF 780.6
See also
Antiprotozoal Agents

Mesh BrowserProtozoan Infections, Animal
SF 780.6
Protracted Pregnancy see
Pregnancy, Prolonged
Provatene see
beta Carotene
Proverbs see
Aphorisms and Proverbs
Providine see
Povidone-Iodine
Provocation Tests, Bronchial see
Bronchial Provocation Tests
Provocation Tests, Nasal see
Nasal Provocation Tests
Proxemics see
Behavioral Sciences
Proxen see
Naproxen
Proximal Hereditary Motor Neuropathy Type I see
Spinal Muscular Atrophies of Childhood
Proximal Myelopathic Muscular Atrophy, Progressive see
Muscular Atrophy, Spinal
Proximal Myotonic Myopathy see
Myotonic Dystrophy
Proximal Renal Tubular Acidosis see
Acidosis, Renal Tubular
Prozac see
Fluoxetine
Prozerin see
Neostigmine

Mesh BrowserPrurigo

WR 282
Pruritis see
Pruritus

Mesh BrowserPruritus

WR 282

Mesh BrowserPruritus Vulvae

WP 200
Pryleugan see
Imipramine
Pröcaine chlorhydrate Lavoisier see
Procaine
Psammomatous Meningioma see
Meningioma
Psammomys see
Gerbillinae
Pseudalopex see
Foxes

Mesh BrowserPseudarthrosis

WE 180
Pseudo-Ullrich-Turner Syndrome see
Noonan Syndrome
Pseudoaneurysm see
Aneurysm, False
Pseudoaphakia see
Cataract
Pseudoarthrosis see
Pseudarthrosis
Pseudobulbar Mutism see
Pseudobulbar Palsy

Mesh BrowserPseudobulbar Palsy

WL 346
Pseudobulbar Paralysis see
Pseudobulbar Palsy
Pseudobulbar Paresis see
Pseudobulbar Palsy
Pseudobulbar Syndrome see
Pseudobulbar Palsy
Pseudocoma see
Coma
Pseudodementia see
Factitious Disorders
Pseudodystonia see
Dystonic Disorders
Pseudoglobulins see
Serum Globulins
Pseudognaphalium see
Asteraceae
Pseudohermaphroditism see
Disorders of Sex Development

Mesh BrowserPseudohypoparathyroidism

WD 200.5.C2
Inborn error 
WD 205.5.M3
Pseudohypoparathyroidism, Type Ia see
Pseudohypoparathyroidism
Pseudohypoparathyroidism, Type Ib see
Pseudohypoparathyroidism
Pseudomelia see
Phantom Limb
Pseudomembranous Colitis see
Enterocolitis, Pseudomembranous
Pseudomembranous Enteritis see
Enterocolitis, Pseudomembranous
Pseudomembranous Enterocolitis see
Enterocolitis, Pseudomembranous

Mesh BrowserPseudomonadaceae

QW 131

Mesh BrowserPseudomonas

QW 131

Mesh BrowserPseudomonas aeruginosa

QW 131
Pseudomonas aeruginosa Infection see
Pseudomonas Infections

Mesh BrowserPseudomonas fluorescens

QW 131

Mesh BrowserPseudomonas Infections

WC 330
Pseudomonas pyocyanea see
Pseudomonas aeruginosa
Pseudoneurotic Schizophrenia see
Schizotypal Personality Disorder
Pseudonyms see
Anonyms and Pseudonyms
Pseudonyms and Anonyms see
Anonyms and Pseudonyms
Pseudoophthalmoplegia see
Ocular Motility Disorders
Pseudopelade see
Alopecia
Pseudopolyarthritis, Rhizomelic see
Polymyalgia Rheumatica
Pseudopromoter, Genetic see
Promoter Regions, Genetic
Pseudopromoter (Genetics) see
Promoter Regions, Genetic
Pseudopsychopathic Schizophrenia see
Schizotypal Personality Disorder
Pseudopsychosis see
Factitious Disorders

Mesh BrowserPseudorabies
SF 809.A94
Pseudorca crassidens see
Dolphins
Pseudosclerosis see
Hepatolenticular Degeneration
Pseudotuberculosis, Pasteurella see
Yersinia pseudotuberculosis Infections

Mesh BrowserPseudotumor Cerebri

WL 203

Mesh BrowserPseudoxanthoma Elasticum

WD 375
Pseudoxanthoma Elasticum, Autosomal Dominant see
Pseudoxanthoma Elasticum
Pseudoxanthoma Elasticum, Forme Fruste see
Pseudoxanthoma Elasticum
Pseudoxanthoma Elasticum, Incomplete see
Pseudoxanthoma Elasticum
Psicocen see
Sulpiride
Psicofarma Brand of Sulpiride see
Sulpiride
Psicofarma Brand of Trifluoperazine Hydrochloride see
Trifluoperazine
Psilocibin see
Psilocybin

Mesh BrowserPsilocybin
Generale
QV 77.7
Indian ritual use E 98.R3
Psilocybine see
Psilocybin

Mesh BrowserPsittacosis

WC 660
Psittacosis-Lymphogranuloma Group see
Chlamydia
Psoralen Ultraviolet A Therapy see
PUVA Therapy
Psoralens see
Furocoumarins

Mesh BrowserPsoriasis

WR 205
Psoriasis, Arthritic see
Arthritis, Psoriatic
Psoriasis Arthropathica see
Arthritis, Psoriatic
Psoriatic Arthritis see
Arthritis, Psoriatic
Psoriatic Arthritis, Juvenile see
Arthritis, Juvenile
Psoriatic Arthropathy see
Arthritis, Psoriatic
Psoriazin see
Mustard Gas
PSRO see
Professional Review Organizations
Psychedelic Agents see
Hallucinogens
Psychedelics see
Hallucinogens

Mesh BrowserPsychiatric Aides

WY 160

Mesh BrowserPsychiatric Department, Hospital

WM 27-28
In a children's hospital 
WS 27-28
Psychiatric Departments, Hospital see
Psychiatric Department, Hospital
Psychiatric Diagnosis see
Mental Disorders
Psychiatric Diagnosis, Dual see
Diagnosis, Dual (Psychiatry)
Psychiatric Dual Diagnosis see
Diagnosis, Dual (Psychiatry)
Psychiatric Emergency Services see
Emergency Services, Psychiatric
Psychiatric Hospital Orderlies see
Psychiatric Aides
Psychiatric Hospitals see
Hospitals, Psychiatric

Mesh BrowserPsychiatric Nursing

WY 160
Formazione scolastica
WY 18-18.5

Mesh BrowserPsychiatric Rehabilitation

WM 30
Psychiatric Social Service see
Social Work, Psychiatric
Psychiatric Social Work see
Social Work, Psychiatric

Mesh BrowserPsychiatric Status Rating Scales

WM 141
Psychiatric Therapeutic Process see
Psychotherapeutic Processes
Psychiatric Therapeutic Processes see
Psychotherapeutic Processes
Psychiatric Ward Attendants see
Psychiatric Aides
Psychiatric Wills see
Advance Directives
Psychiatrists see
Psychiatry

Mesh BrowserPsychiatry
Generale
WM 100
As a profession 
WM 21
Biografia
Collective
WZ 112.5.P6
Individuale
WZ 100
Counseling 
WM 55, etc.
Directories 
WM 22
Experimental 
WM 20
Techniques
WM 25
Legislation & jurisprudence 
WM 32-33
Office management 
WM 30.2
Socioenvironmental Therapy 
WM 428
Case Reports 
WM 40-49
In intellectual disability
WM 302
See also
Adolescent Psychiatry
See also
Child Psychiatry
See also
Community Psychiatry
See also
Forensic Psychiatry
See also
Geriatric Psychiatry
See also
Insurance, Psychiatric
See also
Psychiatric Nursing
Psychiatry, Biological see
Biological Psychiatry
Psychiatry, Community see
Community Psychiatry
Psychiatry, Geriatric see
Geriatric Psychiatry

Mesh BrowserPsychiatry in Literature

WM 49
Psychiatry, Military see
Military Psychiatry
Psychiatry, Preventive see
Preventive Psychiatry
Psychic Energizers see
Antidepressive Agents
Psychic Maladjustment see
Personality Disorders
Psychic Research see
Parapsychology
Psychical Research see
Parapsychology

Mesh BrowserPsycho-Oncology

QZ 21
Psychoacoustical Disorders see
Auditory Perceptual Disorders

Mesh BrowserPsychoacoustics

WV 270
Psychoactive Agents see
Psychotropic Drugs
Psychoactive Drugs see
Psychotropic Drugs

Mesh BrowserPsychoanalysis

WM 460-460.5
Adolescent 
WS 463
Aged 
WT 150
Child 
WS 350
See also
Psychoanalytic Therapy

Mesh BrowserPsychoanalytic Interpretation
Generale
WM 460.7
Adolescent 
WS 463
Aged 
WT 150
Child 
WS 350
Of art and literature 
WM 49
Of famous people from their works 
WZ 313

Mesh BrowserPsychoanalytic Theory
Generale
WM 460.2
Special topics, by subject

Mesh BrowserPsychoanalytic Therapy
Generale
WM 460.6
Adolescent 
WS 466
Child 
WS 350.5
Psychoanalytic Therapy, Balint see
Psychoanalytic Therapy
Psychoanalytical Interpretation see
Psychoanalytic Interpretation
Psychoanalytical Theory see
Psychoanalytic Theory
Psychoanalytical Therapy see
Psychoanalytic Therapy

Mesh BrowserPsychodrama
Generale
WM 430.5.P8
Adolescent 
WS 467
Child 
WS 350.55
See also
Acting Out
Psychodynamic Analysis see
Psychoanalysis
Psychodynamic Assessment see
Projective Techniques
Psychogenetics see
Genetics, Behavioral
Psychogenic Inversion of Circadian Rhythm see
Chronobiology Disorders
Psychogeriatrics see
Geriatric Psychiatry
Psychoimmunology see
Psychoneuroimmunology

Mesh BrowserPsycholinguistics
General BF 455-463
Adolescent 
WS 462.5.C8
Infant or child 
WS 105.5.C8
See also
Language Development
Psychologic Desensitization see
Desensitization, Psychologic
Psychologic Technics see
Psychological Techniques
Psychologic Techniques see
Psychological Techniques
Psychologic Tests see
Psychological Tests
Psychologic Theory see
Psychological Theory
Psychologic Warfare see
Psychological Warfare
Psychological Adaptation see
Adaptation, Psychological
Psychological Bonding see
Object Attachment
Psychological Co-Dependence see
Codependency, Psychological
Psychological Co-Dependency see
Codependency, Psychological
Psychological Codependence see
Codependency, Psychological
Psychological Codependency see
Codependency, Psychological
Psychological Conditioning see
Conditioning, Psychological
Psychological Conflict see
Conflict, Psychological
Psychological Denial see
Denial, Psychological
Psychological Dependence see
Dependency, Psychological
Psychological Dependency see
Dependency, Psychological
Psychological Desensitization see
Desensitization, Psychologic
Psychological Displacement see
Displacement, Psychological

Mesh BrowserPsychological Distress

WM 172.4
Psychological Extinction see
Extinction, Psychological
Psychological Factors see
Psychology
Psychological Feedback see
Feedback, Psychological
Psychological Inhibition see
Inhibition, Psychological
Psychological Interview see
Interview, Psychological
Psychological Interviews see
Interview, Psychological
Psychological Manipulation see
Machiavellianism
Psychological Models see
Models, Psychological
Psychological Orientation see
Orientamento
Psychological Regression see
Regression, Psychology
Psychological Reinforcement see
Reinforcement, Psychology
Psychological Retention see
Retention, Psychology
Psychological Set see
Set, Psychology
Psychological Side Effects see
Psychology
Psychological Stress see
Stress, Psychological
Psychological Technic see
Psychological Techniques
Psychological Technics see
Psychological Techniques
Psychological Technique see
Psychological Techniques

Mesh BrowserPsychological Techniques

WM 141
Psychological Test see
Psychological Tests

Mesh BrowserPsychological Tests
General BF 176
Adolescent 
WS 462.5.E8
In psychiatry 
WM 145
Infant or child 
WS 105.5.E8
See also names of specific tests
See also
Intelligence Tests
See also
Personality Tests
See also
Projective Techniques
Psychological Theories see
Psychological Theory

Mesh BrowserPsychological Theory
BF 38-64
Psychological Transference see
Transference, Psychology

Mesh BrowserPsychological Trauma

WM 172.5
See also
Stress Disorders, Post-Traumatic
Psychological Unconscious see
Unconscious, Psychology

Mesh BrowserPsychological Warfare
UB 275-277
See also
Persuasive Communication
See also
Propaganda
Psychologists see
Psychology

Mesh BrowserPsychology
As a profession BF 75-76
Biografia
Collective
WZ 112.5.P7
Individuale
WZ 100
Counseling 
WM 55
Directories BF 30
Evolutionary BF 698.95
Geriatric 
WT 145
Nursing 
WY 87
Phenomenological BF 204.5
Psychological Warfare UB 275-277
See also
Behavior
See also
Mental Processes
See also
Psychology, Adolescent
See also
Psychology, Child
See also
Psychology, Military
See also
Psychopathology

Mesh BrowserPsychology, Adolescent

WS 462
See also
Psychology, Developmental
Psychology and Religion see
Religion and Psychology

Mesh BrowserPsychology, Applied
BF 636-637

Mesh BrowserPsychology, Child

WS 105
See also
Child Development
See also
Psychology, Developmental

Mesh BrowserPsychology, Clinical
Generale
WM 105
Adolescent 
WS 463
Infant or child 
WS 350

Mesh BrowserPsychology, Comparative
Animals (primarily) QL 785-785.27
Human BF 660-685
Psychology, Criminal see
Criminal Psychology

Mesh BrowserPsychology, Developmental
As a specialty BF 713
See also
Human Development
See also
Psychology, Adolescent
See also
Psychology, Child

Mesh BrowserPsychology, Educational
LB 1051-1091
Psychology, Engineering see
Ergonomics
Psychology, Existential see
Existentialism

Mesh BrowserPsychology, Experimental
BF 181-198.7
Adolescent 
WS 462
Infant or child 
WS 105
Laboratory manuals BF 79
Works about research BF 76.5
Psychology, Forensic see
Forensic Psychology
Psychology, Health see
Behavioral Medicine

Mesh BrowserPsychology, Industrial
General HF 5548.7-.985
Mental health of working people 
WA 495
See also
Ergonomics
Psychology, Infant see
Psychology, Child

Mesh BrowserPsychology, Medical

WB 104
Special topics, by subject

Mesh BrowserPsychology, Military
U 22.3
Psychology, Pastoral see
Pastoral Care
Psychology, Pediatric see
Psychology, Child
Psychology, Perceptual see
Psychology, Social
Psychology, Physiologic see
Psychophysiology
Psychology, Physiological see
Psychophysiology

Mesh BrowserPsychology, Positive
BF 204.6
Psychology, Religion see
Religion and Psychology
Psychology, Schizophrenic see
Schizophrenic Psychology
Psychology, Self see
Self Psychology

Mesh BrowserPsychology, Social
General HM 1001-1281
Adolescent 
WS 462.5.S6
Infant or child 
WS 105.5.S6
See also
Race Relations

Mesh BrowserPsychometrics
BF 39

Mesh BrowserPsychomotor Agitation

WM 197

Mesh BrowserPsychomotor Disorders
Generale
WM 197
Neurological aspects 
WL 390
Of the intellectually disabled child 
WS 107.5.P7
See also names of specific disorders
See also
Movement Disorders
Psychomotor Disorders, Developmental see
Psychomotor Disorders
Psychomotor Hyperactivity see
Psychomotor Agitation
Psychomotor Impairment see
Psychomotor Disorders

Mesh BrowserPsychomotor Performance

WE 104
See also
Athletic Performance
Psychomotor Restlessness see
Psychomotor Agitation

Mesh BrowserPsychoneuroimmunology

WL 103.7
See also
Neuroimmunomodulation
Psychoneuroses see
Neurotic Disorders
Psychooncology see
Psycho-Oncology
Psychopathic Personality see
Antisocial Personality Disorder

Mesh BrowserPsychopathology
Adolescent 
WS 463
As a profession 
WM 21
Infant or child 
WS 350
Psychopharmaceuticals see
Psychotropic Drugs

Mesh BrowserPsychopharmacology

QV 77
Drug therapy of mental disorders 
WM 402
See also
Psychotropic Drugs

Mesh BrowserPsychophysics

WL 702

Mesh BrowserPsychophysiologic Disorders

WM 90
Infant or child 
WM 90
Sex disorders 
WM 611
Psychophysiologic Feedback see
Biofeedback, Psychology
Psychophysiologic Habituation see
Habituation, Psychophysiologic
Psychophysiological Disorders see
Psychophysiologic Disorders
Psychophysiological Habituation see
Habituation, Psychophysiologic
Psychophysiological Insomnia see
Sleep Initiation and Maintenance Disorders

Mesh BrowserPsychophysiology

WL 103
See also
Psychosomatic Medicine
Psychoses see
Psychotic Disorders
Psychoses, Affective see
Affective Disorders, Psychotic

Mesh BrowserPsychoses, Alcoholic

WM 274
See also
Substance-Related Disorders
Psychoses, Drug see
Psychoses, Substance-Induced
Psychoses, Manic-Depressive see
Bipolar Disorder
Psychoses, Paranoid see
Paranoid Disorders

Mesh BrowserPsychoses, Substance-Induced

WM 270
Psychoses, Toxic see
Psychoses, Substance-Induced
Psychoses, Traumatic see
Neurocognitive Disorders

Mesh BrowserPsychosexual Development
Generale
WM 620
Adolescent 
WS 462.5.S4
Infant or child 
WS 105.5.S4
Psychosexual Disorders see
Sexual Dysfunctions, Psychological
Psychosexual Dysfunctions see
Sexual Dysfunctions, Psychological
Psychosis see
Psychotic Disorders
Psychosis, Brief Reactive see
Psychotic Disorders
Psychosis, Involutional see
Depressive Disorder, Major
Psychosis, Manic-Depressive see
Bipolar Disorder

Mesh BrowserPsychosocial Deprivation
General BF 575.D35
Adolescents 
WS 462.5.D3
Infant or child
Psychological aspects
WS 105.5.D3
Welfare
WA 320
Psychosocial Factors see
Psychology
Psychosocial Nursing see
Psychiatric Nursing
Psychosocial Oncology see
Psycho-Oncology
Psychosocial Rehabilitation see
Psychiatric Rehabilitation
Psychosomatic Assessment see
Projective Techniques
Psychosomatic Disorders see
Psychophysiologic Disorders

Mesh BrowserPsychosomatic Medicine

WM 90
Diseases see
Psychophysiologic Disorders 
WM 90, etc.
See also
Psychophysiologic Disorders
See also
Psychophysiology

Mesh BrowserPsychosurgery

WL 370
Psychotherapeutic Imagery see
Imagery, Psychotherapy

Mesh BrowserPsychotherapeutic Processes
Generale
WM 420
Adolescent 
WS 466
Infant or child 
WS 350.2
Psychotherapists see
Psychotherapy

Mesh BrowserPsychotherapy
Generale
WM 420
Adolescent 
WS 466
Aged 
WT 152
Infant or child 
WS 350.2
See also
Psychology, Clinical

Mesh BrowserPsychotherapy, Brief

WM 420.5.P5
Psychotherapy, Cognitive see
Cognitive Behavioral Therapy

Mesh BrowserPsychotherapy, Group

WM 430-430.5
Adolescent 
WS 467
Child 
WS 350.55
See also names of specific types of group therapy, e.g.,
Sensitivity Training Groups
Psychotherapy Imagery see
Imagery, Psychotherapy

Mesh BrowserPsychotherapy, Multiple

WM 420.5.P7

Mesh BrowserPsychotherapy, Psychodynamic

WM 420.5.P75
Psychotherapy, Rational see
Psychotherapy, Rational-Emotive

Mesh BrowserPsychotherapy, Rational-Emotive

WM 420.5.P8
Psychotherapy, Short-Term see
Psychotherapy, Brief
Psychotic Affective Disorders see
Affective Disorders, Psychotic

Mesh BrowserPsychotic Disorders

WM 200
Psychotic Mood Disorders see
Affective Disorders, Psychotic
Psychotomimetic Agents see
Hallucinogens
Psychotomimetic Drugs see
Hallucinogens

Mesh BrowserPsychotropic Drugs

QV 77.2-77.9
Psyllids see
Hemiptera
Psylloidea see
Hemiptera
PT-NANBH see
Hepatitis C
PTCA see
Angioplasty, Balloon, Coronary
PtcO2 see
Blood Gas Monitoring, Transcutaneous
PtdIns see
Phosphatidylinositols

Mesh BrowserPteridines
In folic acid 
QU 188
Organic chemistry QD 401
Pteridinones see
Pteridines

Mesh BrowserPterins

QU 110
Pteropodidae see
Chiroptera
Pteropus see
Chiroptera
Pteroylglutamic Acid see
Folic Acid

Mesh BrowserPterygium

WW 212
Pterygopalatine Ganglia see
Ganglia, Parasympathetic
PTH(1-34) see
Parathyroid Hormone
PTH (1-84) see
Parathyroid Hormone
Ptosis, Eyelid see
Blepharoptosis
PTSD see
Stress Disorders, Post-Traumatic
Pubertas Praecox see
Puberty, Precocious

Mesh BrowserPuberty
Generale
WS 450
See also
Menarche 
WP 540

Mesh BrowserPuberty, Delayed

WS 450

Mesh BrowserPuberty, Precocious

WS 450

Mesh BrowserPubic Bone

WE 750
Surgery to facilitate delivery 
WQ 430

Mesh BrowserPubic Symphysis
Generale
WE 760
Surgery to facilitate delivery 
WQ 430
See also
Symphysiotomy
Pubis see
Pubic Bone
Public Access to Information see
Access to Information
Public Advocacy see
Consumer Advocacy

Mesh BrowserPublic Assistance
HV 687-4630
For maternal and child welfare (public health aspects) 
WA 310-320
See also more specific headings, e.g.,
Medicaid
See also
Old Age Assistance
See also
Social Welfare
Public Baths see
Baths

Mesh BrowserPublic Health
Generale
WA 100
Impact of environment on public health see
Environmental Health
In developing countries 
WA 395
In specific countries or regions 
WA 300
Statistics 
WA 900
See also
Morbidity
See also
Statistiche vitali
As a profession 
WA 21
See also
Allied Health Personnel
See also
Preventive Medicine
See also
Social Medicine
See also
Zoonoses

Mesh BrowserPublic Health Administration

WA 525-590
See also
Community Health Services

Mesh BrowserPublic Health Dentistry

WU 113
See also
Health Education, Dental
Public Health Education for Professionals see
Education, Public Health Professional

Mesh BrowserPublic Health Informatics
Generale
WA 26.5
Used for special purpose, by subject
See also
Public Health
Public Health Nurses see
Nurses, Public Health

Mesh BrowserPublic Health Nursing

WY 108
Formazione scolastica
WY 18-18.5
Government (General) 
WY 130
Indian services 
WY 130
See also
Military Nursing 
WY 130

Mesh BrowserPublic Health Practice

WA 100
Public Health Schools see
Schools, Public Health

Mesh BrowserPublic Health Surveillance

WA 950
Public Hospitals see
Hospitals, Public

Mesh BrowserPublic Housing
General HD 7288.77-7288.78
Sanitary control 
WA 795
Public Law 93-579 see
vita privata
Public Law 93-641 see
Health Planning

Mesh BrowserPublic Opinion
HM 1236
Specific topics, by subject
See also
Attitude to Health
Public Opinion Polls see
Public Opinion
Public Participation see
Community Participation

Mesh BrowserPublic Policy
Abortion HQ 767
Other areas, by subject
See also
Social Control, Formal

Mesh BrowserPublic Relations
HM 1221
In dentistry 
WU 61
In hospital administration 
WX 160
Specific relations by subject, professions, or named group of persons involved
Public Reporting of Health Care Data see
Public Reporting of Healthcare Data

Mesh BrowserPublic Reporting of Healthcare Data

WX 153
Public Reporting of Quality Data see
Public Reporting of Healthcare Data
Public Speaking see
Speech

Mesh BrowserPublishing
Z 278-544
Medico
WZ 345
See also
Book Industry
See also
Periodicals as Topic
Publishing, Electronic see
Publishing
Puericulture see
Assistenza all'infanzia

Mesh BrowserPuerperal Disorders
Generale
WQ 500-505
Specific disorder with the disorder

Mesh BrowserPuerperal Infection

WQ 505
Puerperium see
Postpartum Period
Puerto Ricans see
Hispanic Americans
Pulex see
Siphonaptera
Pulmin see
Aprotinin
Pulmonary Abscess see
Lung Abscess
Pulmonary Abscesses see
Lung Abscess
Pulmonary Alveolar Proteinoses see
Pulmonary Alveolar Proteinosis

Mesh BrowserPulmonary Alveolar Proteinosis

WF 600

Mesh BrowserPulmonary Alveoli

WF 600
Pulmonary Alveolus see
Pulmonary Alveoli

Mesh BrowserPulmonary Arterial Hypertension

WG 343
Pulmonary Arteries see
Pulmonary Artery

Mesh BrowserPulmonary Artery

WG 595.P8
See also
Pulmonary Circulation

Mesh BrowserPulmonary Atelectasis

WF 645
Pulmonary Cancer see
Lung Neoplasms

Mesh BrowserPulmonary Circulation

WF 600
See also
Ventilation-Perfusion Ratio 
WF 141
Pulmonary Coin Lesion see
Solitary Pulmonary Nodule
Pulmonary Coin Lesions see
Solitary Pulmonary Nodule
Pulmonary Consumption see
Tuberculosis, Pulmonary
Pulmonary Cystic Fibrosis see
Cystic Fibrosis

Mesh BrowserPulmonary Diffusing Capacity

WF 141
Pulmonary Disease see
Lung Diseases

Mesh BrowserPulmonary Disease, Chronic Obstructive

WF 600
Pulmonary Diseases see
Lung Diseases
Pulmonary Echinococcoses see
Echinococcosis, Pulmonary
Pulmonary Echinococcosis see
Echinococcosis, Pulmonary

Mesh BrowserPulmonary Edema

WF 600
Pulmonary Edemas see
Pulmonary Edema

Mesh BrowserPulmonary Embolism

WG 420
Pulmonary Embolisms see
Pulmonary Embolism

Mesh BrowserPulmonary Emphysema

WF 648
Pulmonary Emphysemas see
Pulmonary Emphysema
Pulmonary Fibroses see
Pulmonary Fibrosis

Mesh BrowserPulmonary Fibrosis

WF 600
Pulmonary Fibrosis – from Asbestos Exposure see
Asbestosis
Pulmonary Function Test see
Respiratory Function Tests
Pulmonary Function Tests see
Respiratory Function Tests
Pulmonary Fungal Diseases see
Lung Diseases, Fungal
Pulmonary Fungal Infections see
Lung Diseases, Fungal

Mesh BrowserPulmonary Gas Exchange

WF 102
Used for diagnostic aspects 
WF 141

Mesh BrowserPulmonary Heart Disease

WG 420
Pulmonary Heart Diseases see
Pulmonary Heart Disease
Pulmonary Histiocytosis X see
Histiocytosis, Langerhans-Cell
Pulmonary Hydatid Cyst see
Echinococcosis, Pulmonary
Pulmonary Hydatid Cysts see
Echinococcosis, Pulmonary
Pulmonary Hydatidoses see
Echinococcosis, Pulmonary
Pulmonary Hydatidosis see
Echinococcosis, Pulmonary
Pulmonary Hypertension see
Hypertension, Pulmonary
Pulmonary Hypertension, Familial Persistent, of the Newborn see
Persistent Fetal Circulation Syndrome
Pulmonary Incompetence see
Pulmonary Valve Insufficiency
Pulmonary Inflammation see
Pneumonia
Pulmonary Injury see
Lung Injury
Pulmonary Langerhans Cell Granulomatosis see
Histiocytosis, Langerhans-Cell
Pulmonary Lavage Fluid see
Bronchoalveolar Lavage Fluid

Mesh BrowserPulmonary Medicine

WF 21
See also
Lung Diseases
See also
Pulmonologists
Pulmonary Neoplasms see
Lung Neoplasms
Pulmonary Nocardiosis see
Nocardia Infections
Pulmonary Nodule, Solitary see
Solitary Pulmonary Nodule
Pulmonary Nodules, Solitary see
Solitary Pulmonary Nodule
Pulmonary Parasitic Infections see
Lung Diseases, Parasitic
Pulmonary Phthisis see
Tuberculosis, Pulmonary
Pulmonary Physiological Phenomena see
Respiratory Physiological Phenomena
Pulmonary Physiological Phenomenon see
Respiratory Physiological Phenomena
Pulmonary Physiological Process see
Respiratory Physiological Phenomena
Pulmonary Physiological Processes see
Respiratory Physiological Phenomena
Pulmonary Regurgitation see
Pulmonary Valve Insufficiency
Pulmonary Surfactant see
Pulmonary Surfactants

Mesh BrowserPulmonary Surfactants

WF 600
Pulmonary Surgical Procedure see
Pulmonary Surgical Procedures

Mesh BrowserPulmonary Surgical Procedures

WF 668
Pulmonary Thromboembolism see
Pulmonary Embolism
Pulmonary Thromboembolisms see
Pulmonary Embolism
Pulmonary Tuberculoses see
Tuberculosis, Pulmonary
Pulmonary Tuberculosis see
Tuberculosis, Pulmonary

Mesh BrowserPulmonary Valve

WG 269
Pulmonary Valve Incompetence see
Pulmonary Valve Insufficiency

Mesh BrowserPulmonary Valve Insufficiency

WG 269
Pulmonary Valve Regurgitation see
Pulmonary Valve Insufficiency
Pulmonary Valves see
Pulmonary Valve
Pulmonary Vascular Resistance see
Vascular Resistance
Pulmonary Vein see
Pulmonary Veins

Mesh BrowserPulmonary Veins

WG 625.P8
See also
Pulmonary Circulation

Mesh BrowserPulmonary Ventilation

WF 102
Pulmonary Ventilator see
Ventilators, Mechanical
Pulmonary Ventilators see
Ventilators, Mechanical
Pulmonic Plague see
Plague

Mesh BrowserPulmonologists

WF 21
Pulmonology see
Pulmonary Medicine
Pulp see
Dental Pulp
Pulp Calcification, Dental see
Dental Pulp Calcification
Pulp Canal see
Dental Pulp Cavity
Pulp Capping see
Dental Pulp Capping
Pulp Capping, Dental see
Dental Pulp Capping
Pulp Cavities, Dental see
Dental Pulp Cavity
Pulp Cavity, Dental see
Dental Pulp Cavity
Pulp Chamber see
Dental Pulp Cavity
Pulp, Dental see
Dental Pulp
Pulp Devitalization, Dental see
Dental Pulp Devitalization
Pulp Disease, Dental see
Dental Pulp Diseases
Pulp Diseases, Dental see
Dental Pulp Diseases
Pulp Stone, Dental see
Dental Pulp Calcification
Pulp Stones see
Dental Pulp Calcification
Pulp Stones, Dental see
Dental Pulp Calcification
Pulpal Dysplasia see
Dental Pulp Calcification

Mesh BrowserPulpitis

WU 230

Mesh BrowserPulpotomy

WU 230
Pulps, Dental see
Dental Pulp

Mesh BrowserPulsatile Flow

WG 106
See also
Blood Circulation
Pulsatile Tinnitus see
Tinnitus

Mesh BrowserPulse
General diagnosis 
WB 282
Hemodynamics 
WG 106
See also
Heart Rate
See also
Traditional Pulse Diagnosis
Pulse Drug Therapy see
Pulse Therapy, Drug
Pulse Oximetry see
Oximetry
Pulse Polarography see
Polarography
Pulse Pressure see
Blood Pressure

Mesh BrowserPulse Radiolysis
QD 643.P84
Pulse Rate see
Heart Rate
Pulse Rate Determination see
Heart Rate Determination

Mesh BrowserPulse Therapy, Drug

WB 340
Pulsed Laser Tissue Ablation see
Laser Therapy
Pulsed Lasers see
Lasers
Pulseless Disease see
Takayasu Arteritis
Pulsus Alternans see
Arrhythmias, Cardiac
Pummelo Tree see
Citrus
Pump, Biologic see
Membrane Transport Proteins
Pump, Biological see
Membrane Transport Proteins
Pump, Metabolic see
Membrane Transport Proteins
Pump, Programmable Implantable Insulin see
Insulin Infusion Systems
Pumping, Intra-Aortic Balloon see
Intra-Aortic Balloon Pumping
Pumps, Biological see
Membrane Transport Proteins
Pumps, Heart-Assist see
Heart-Assist Devices
Pumps, Infusion see
Infusion Pumps
Pumps, Metabolic see
Membrane Transport Proteins

Mesh BrowserPunched-Card Systems
Z 695.92
Special topics, by subject
Puncto E see
Tocopherols
Puncture and Aspiration see
Paracentesis
Puncture and Drainage see
Paracentesis
Puncture Biopsy see
Biopsy, Needle

Mesh BrowserPunctures

WB 373-377
Cisternal 
WB 377
Sternal 
WH 380
Ventricular 
WB 377
See also
Amniocentesis 
WQ 209
See also
Biopsy, Needle 
WB 379, etc.
See also
Paracentesis 
WB 373-377
See also
Spinal Puncture 
WB 377, etc.

Mesh BrowserPunishment
Adolescent 
WS 462-463
Conditioned response BF 319.5.P8
Infant or child 
WS 105.5.C3
School management LB 3025
Theory of (Penology) K 5103

Mesh BrowserPupil

WW 240
Dilatation 
WW 240
Dilatation, Pathologic see
Mydriasis
WW 240
Dilators see
Mydriatics 
QV 134
See also
Mydriatics
See also
Reflex, Pupillary

Mesh BrowserPupil Disorders

WW 240
Pupil Malformations see
Pupil Disorders
Pupil Nurses see
Students, Nursing
Pupil Reaction Absent see
Pupil Disorders
Pupillary Anomaly see
Pupil Disorders
Pupillary Disorders see
Pupil Disorders
Pupillary Functions, Abnormal see
Pupil Disorders
Pupillary Occlusion see
Pupil Disorders
Pupillary Paralysis see
Pupil Disorders
Pupillary Reflex see
Reflex, Pupillary
Pupillary Sector Paralysis see
Pupil Disorders
Pupillary Sphincter Rupture see
Pupil Disorders
Puppets see
Play and Playthings

Mesh BrowserPurchasing, Hospital

WX 157
See also
Equipment and Supplies, Hospital
Purchasing, Hospital, Group see
Group Purchasing
Purchasing, Hospital, Joint see
Group Purchasing
Purchasing, Hospital, Shared see
Group Purchasing
Purchasings, Hospital see
Purchasing, Hospital
Pure Agraphia see
Agraphia
Pure Red-Cell Aplasia see
Red-Cell Aplasia, Pure
Purgatives see
Cathartics
Purified Protein Derivative of Tuberculin see
Tuberculin

Mesh BrowserPurine Nucleosides

QU 57
Purine Pyrimidine Metabolism, Inborn Errors see
Purine-Pyrimidine Metabolism, Inborn Errors

Mesh BrowserPurine-Pyrimidine Metabolism, Inborn Errors

WD 205.5.P8
See also
Gout 
WE 350
Purine Receptor see
Receptors, Purinergic
Purine Receptors see
Receptors, Purinergic
Purinergic P1 Receptors see
Receptors, Purinergic P1
Purinergic P2 Receptors see
Receptors, Purinergic P2
Purinergic Receptors see
Receptors, Purinergic

Mesh BrowserPurines
Constituents of nucleic acids 
QU 58
Organic chemistry QD 401
Stimulants 
QV 107
Purinoceptor see
Receptors, Purinergic
Purinoceptors see
Receptors, Purinergic
Purkinje Cell see
Purkinje Cells

Mesh BrowserPurkinje Cells

WL 320
Purkinje Neuron see
Purkinje Cells
Purkyne Cell see
Purkinje Cells
Purple Bacteria see
Proteobacteria

Mesh BrowserPurpura

WH 314-320
Purpura Fulminans (Waterhouse-Friderichsen Syndrome) see
Waterhouse-Friderichsen Syndrome

Mesh BrowserPurpura, Hyperglobulinemic

WH 320

Mesh BrowserPurpura, Thrombocytopenic

WH 315
Purpura, Thrombopenic see
Purpura, Thrombocytopenic
Pursuit, Saccadic see
Saccades
Purtilo Syndrome see
Lymphoproliferative Disorders
Pus see
Suppuration
Pustulants see
Irritants
Pustular Dermatosis, Subcorneal see
Skin Diseases, Vesiculobullous
Pustular Psoriasis of Palms and Soles see
Psoriasis
Pustulosis of Palms and Soles see
Psoriasis
Pustulosis Palmaris et Plantaris see
Psoriasis

Mesh BrowserPUVA Therapy

WB 480
Puvalen see
Methoxsalen
PVP 40 see
Povidone
PVP-I see
Povidone-Iodine
PVP-Iodine see
Povidone-Iodine
PVS (Persistent Vegetative State) see
Persistent Vegetative State
Pyaemia see
Sepsis

Mesh BrowserPyelitis

WJ 351
Pyelogram see
Urography
Pyelography see
Urography

Mesh BrowserPyelonephritis
Generale
WJ 351
See also
Kidney Failure, Chronic
Pyelonephritis, Acute Necrotizing see
Pyelonephritis
Pyelostomy see
Nephrotomy
Pyelotomy see
Nephrotomy
Pyemia see
Sepsis
Pygmy Chimpanzee see
Pan paniscus
Pygmy Killer Whale see
Dolphins
Pygmy Right Whale see
Whales
Pygmy Sperm Whale see
Whales
Pykno-Epilepsy see
Epilepsy, Absence
Pyknolepsy see
Epilepsy, Absence

Mesh BrowserPyloric Antrum

WI 387
Pyloric Glands see
Gastric Mucosa
Pyloric Sphincter see
Pylorus

Mesh BrowserPyloric Stenosis

WI 387

Mesh BrowserPyloric Stenosis, Hypertrophic

WI 387

Mesh BrowserPyloromyotomy

WI 387
Pylorospasm see
Spasm

Mesh BrowserPylorus

WI 387
See also
Gastric Emptying
Pyoctanium aureum see
Benzophenoneidum

Mesh BrowserPyoderma

WR 220
Pyohemia see
Sepsis
Pyopneumothorax see
Pneumothorax
Pyorrhea Alveolaris see
Periodontal Diseases
Pyothorax see
Empyema, Pleural
Pyquiton see
Praziquantel
Pyralgin see
Dipyrone

Mesh BrowserPyramidal Tracts

WL 400
Pyramidalis Muscle see
Abdominal Muscles
Pyrazinopyrimidines see
Pteridines

Mesh BrowserPyrazoles
Organic chemistry QD 401
Pharmacology 
QV 95
Pyrenzepine see
Pirenzepine
Pyrethrum see
Chrysanthemum cinerariifolium
Pyrethum Daisy see
Chrysanthemum cinerariifolium
Pyretotherapy see
Hyperthermia, Induced
Pyrexia see
Fever
Pyrexial Convulsion see
Seizures, Febrile
Pyrexial Seizure see
Seizures, Febrile

Mesh BrowserPyridines
Enzyme inhibitors 
QU 143
Organic chemistry QD 401
Pyridinones see
Pyridones
Pyrido(4,3-b)Indoles see
Carbolines

Mesh BrowserPyridones
Organic chemistry QD 401

Mesh BrowserPyridoxal

QU 195
Pyridoxin see
Pyridoxine

Mesh BrowserPyridoxine

QU 195
Pyridoxine Deficiency see
Vitamin B 6 Deficiency
Pyridoxine Hydrochloride see
Pyridoxine
Pyridoxol see
Pyridoxine
Pyridoxol Hydrochloride see
Pyridoxine

Mesh BrowserPyrimethamine

QV 256

Mesh BrowserPyrimidines
Constituents of nucleic acids 
QU 58
Organic chemistry QD 401
Pyrocatechols see
Catechols

Mesh BrowserPyrogens
As substances causing fever 
WB 152
Special topics, by subject
See also
Endotoxins

Mesh BrowserPyrolysis
TP 156.P9
Pyromania see
Firesetting Behavior

Mesh BrowserPyrophosphatases

QU 136
Pyrophosphate Analogs see
Diphosphates
Pyrophosphates see
Diphosphates
Pyrophosphoric Acids see
Phosphoric Acids
Pyrosis see
Heartburn

Mesh BrowserPyrroles
As anti-rheumatic agents 
QV 247
In heme and porphyrin chemistry 
WH 190
Organic chemistry QD 401

Mesh BrowserPyrrolidines
As antineoplastic agents 
QV 269
Organic chemistry QD 401

Mesh BrowserPyruvates

QU 98
Organic chemistry
Aliphatic compounds QD 305.A2

Mesh BrowserPyuria
In urine analysis 
QY 185
Urinary tract infections 
WJ 151


Psorilax:Risparmi |travocort crema anche per psoriasi

0

Psorilax: prezzo, funziona, recensioni, opinioni, composizione

diagnosi

Nella maggior parte dei casi, la diagnosi di psoriasi è abbastanza semplice.

  • Esame fisico e anamnesi. Il medico di solito può diagnosticare la psoriasi con la tua storia medica ed esaminando la tua pelle, cuoio capelluto e unghie.
  • Biopsia cutanea In rare occasioni, il medico può prelevare un piccolo campione di pelle (biopsia). Probabilmente ti verrà somministrata prima l'anestesia locale. Il campione viene esaminato al microscopio per determinare il tipo esatto di psoriasi e per escludere altri disturbi.

trattamento

I trattamenti per la psoriasi riducono l'infiammazione e alleggeriscono la pelle. I trattamenti possono essere suddivisi in tre tipi principali: trattamenti topici, fototerapia e farmaci sistemici.

Trattamenti topici

Se usati da soli, creme e unguenti applicati sulla pelle sono efficaci nel trattamento della psoriasi da lieve a moderata. Quando la malattia è più estesa, è probabile che le creme siano combinate con farmaci per via orale o fototerapia. I trattamenti topici per la psoriasi includono:

  • Corticosteroidi topici. Questi farmaci sono i più frequentemente prescritti per il trattamento della psoriasi da lieve a moderata. Riducono l'infiammazione e alleviano il prurito e possono essere utilizzati con altri trattamenti.

    Gli unguenti corticosteroidi lievi sono generalmente raccomandati per le aree sensibili, come il viso o le pieghe della pelle, e per trattare le imperfezioni estese della pelle danneggiata.

    Il medico può prescrivere un unguento corticosteroideo più potente per aree piccole, meno sensibili o più difficili da trattare.

    L'uso prolungato o eccessivo di potenti corticosteroidi può causare l'assottigliamento della pelle. Nel tempo, i corticosteroidi topici possono smettere di funzionare. In generale, è meglio usare corticosteroidi topici come trattamento a breve termine durante le esacerbazioni.

  • Analoghi della vitamina D. Queste forme sintetiche di vitamina D rallentano la crescita delle cellule della pelle. Il calcipotriolo (Dovonex) è una crema o una soluzione di prescrizione che contiene un analogo della vitamina D ed è usato per trattare la psoriasi da lieve a moderata insieme ad altri trattamenti. Il calcipotriolo può irritare la pelle. Il calcitriolo (Vectical) è costoso, ma può essere altrettanto efficace e forse meno irritante del calcipotriolo.
  • Anthralin. Questo medicinale aiuta a rallentare la crescita delle cellule della pelle. Anthralin (Dritho-Scalp) può anche rimuovere le squame e ammorbidire la pelle. Tuttavia, l'antralina può irritare la pelle e macchia quasi tutto ciò con cui viene a contatto. Generalmente, viene applicato per un breve periodo e quindi rimosso con acqua.
  • Retinoidi topici. Questi sono derivati ​​della vitamina A che possono ridurre l'infiammazione. L'effetto collaterale più frequente è l'irritazione della pelle. Questi farmaci possono anche aumentare la sensibilità alla luce solare, motivo per cui è necessario applicare la protezione solare prima di uscire all'aperto durante l'utilizzo del farmaco.

    Il rischio di difetti alla nascita è molto più basso per i retinoidi topici che per i retinoidi orali. Tuttavia, il tazarotene (Tazorac, Avage) non è raccomandato in caso di gravidanza o in allattamento o se si intende rimanere incinta.

  • Inibitori della calcineurina. Gli inibitori della calcineurina, il tacrolimus (Prograf) e il pimecrolimus (Elidel), riducono l'infiammazione e l'accumulo di placca.

    Gli inibitori della calcineurina non sono raccomandati per un uso prolungato o continuo, a causa di un potenziale aumento del rischio di cancro della pelle e linfoma. Possono essere particolarmente utili nelle regioni della pelle sottile, come intorno agli occhi, dove le creme steroidee o retinoidi sono troppo irritanti o possono causare effetti dannosi.

  • Acido salicilico. Disponibile in modalità over-the-counter (over-the-counter), l'acido salicilico promuove lo spargimento di cellule morte della pelle e riduce la formazione di calcare. A volte è combinato con altri farmaci, come corticosteroidi topici o catrame di carbone, per aumentarne l'efficacia. Per trattare la psoriasi del cuoio capelluto, l'acido salicilico è disponibile in shampoo medicinali e soluzioni di cuoio capelluto.
  • Catrame di carbone. Derivato dal carbone, il catrame di carbone riduce la formazione di calcare, il prurito e l'infiammazione. Il catrame di carbone può irritare la pelle. Inoltre è sporco, macchia i vestiti e la biancheria da letto e ha un forte odore.

    Il catrame di carbone è disponibile in shampoo, creme e oli da banco. Può anche essere acquistato in concentrazioni più elevate con una prescrizione. Questo trattamento non è raccomandato per le donne in gravidanza o in allattamento.

  • Creme idratanti Le creme idratanti non curano la psoriasi da sole, ma possono ridurre il prurito, la formazione di calcare e la secchezza. Le creme idratanti a base di unguento sono generalmente più efficaci delle creme e lozioni più leggere. Dovrebbero essere applicati immediatamente dopo il bagno o la doccia per trattenere l'umidità.

Terapia della luce (fototerapia)

Questo trattamento utilizza luce ultravioletta naturale o artificiale. La forma più semplice e più semplice di fototerapia è esporre la pelle a quantità controllate di luce solare naturale.

Altre forme di fototerapia includono l'uso della luce artificiale ultravioletta A o ultravioletta B, da sola o in combinazione con farmaci.

  • Luce del sole. L'esposizione ai raggi ultravioletti della luce solare o artificiale rallenta il turnover delle cellule della pelle e riduce l'infiammazione e la formazione di calcare. Brevi esposizioni quotidiane a piccole quantità di luce solare possono migliorare la psoriasi, ma un'intensa esposizione al sole può peggiorare i sintomi e causare danni alla pelle. Prima di iniziare un regime di luce solare, chiedi al tuo medico il modo più sicuro di utilizzare la luce solare naturale per il trattamento della psoriasi.
  • Fototerapia a luce ultravioletta B. Dosi controllate di luce ultravioletta B da una fonte di luce artificiale possono migliorare i sintomi della psoriasi a diffusione lieve o moderata. La fototerapia a luce ultravioletta B, chiamata anche “fototerapia a luce ultravioletta a banda larga B”, può essere utilizzata per il trattamento di punti isolati, psoriasi diffusa e psoriasi resistenti ai trattamenti topici. Gli effetti collaterali a breve termine possono includere arrossamento, prurito e pelle secca. L'uso di una crema idratante può aiutare a ridurre questi effetti collaterali.
  • Fototerapia a luce ultravioletta B a banda stretta. La fototerapia a luce ultravioletta a banda stretta B è un nuovo tipo di trattamento della psoriasi che può essere più efficace della terapia a luce ultravioletta a banda larga B. Di solito viene somministrato 2 o 3 volte a settimana fino a quando la pelle non migliora e quindi la manutenzione può richiedere solo sessioni settimanali. Tuttavia, la fototerapia a luce ultravioletta B a banda stretta può causare ustioni più gravi e durature.
  • Terapia di Goeckerman. Alcuni medici combinano il trattamento con la luce ultravioletta B e il trattamento con catrame di carbone, che è noto come “trattamento Goeckerman”. Le due terapie combinate sono più efficaci di entrambe separatamente, poiché il catrame di carbone aumenta la ricettività della pelle alla luce UV B.
  • Psoralen plus ultraviolet light A. Questa forma di fotochemioterapia prevede l'assunzione di un farmaco sensibilizzante alla luce (psoralene) prima dell'esposizione alla luce UV La luce UV A penetra nella pelle più in profondità della luce UV B e psoralene migliora la risposta di la pelle all'esposizione alla luce ultravioletta A.

    Questo trattamento più aggressivo migliora la pelle in modo uniforme ed è spesso usato nei casi più gravi di psoriasi. Gli effetti collaterali a breve termine includono nausea, mal di testa, bruciore e prurito. Gli effetti collaterali a lungo termine includono pelle secca e rugosa, lentiggini, elevata sensibilità al sole e un aumentato rischio di cancro della pelle, come il melanoma.

  • Laser ad eccimeri. Questa forma di fototerapia, utilizzata nella psoriasi da lieve a moderata, tratta solo la pelle colpita senza danneggiare la pelle sana. Un raggio controllato di luce UV B colpisce le placche di psoriasi per controllare desquamazione e infiammazione. La terapia laser con eccimeri richiede meno sessioni rispetto alla fototerapia tradizionale poiché viene utilizzata una luce UV B più potente. Gli effetti collaterali includono arrossamento e vesciche.

Farmaci orali o iniettabili

Se hai una psoriasi estesa o resistente ad altri tipi di trattamento, il medico può prescrivere farmaci per via orale o iniettabili. Questo è noto come “trattamento sistemico”. A causa di gravi effetti collaterali, alcuni di questi farmaci vengono utilizzati solo per brevi periodi e possono essere alternati con altre forme di trattamento.

  • I retinoidi. Se hai una psoriasi grave che non risponde ad altre terapie, questo gruppo di farmaci correlati alla vitamina A può essere utile. Gli effetti collaterali possono includere gonfiore delle labbra e perdita di capelli. E poiché i retinoidi, come l'acitretina (Soriatane), possono causare gravi difetti alla nascita, le donne dovrebbero evitare la gravidanza per almeno tre anni dopo l'assunzione del farmaco.
  • Methotrexate. Il metotrexato (Rheumatrex) viene somministrato per via orale e aiuta la psoriasi diminuendo la produzione di cellule della pelle e riducendo l'infiammazione. In alcune persone, può anche rallentare la progressione dell'artrite psoriasica. Il metotrexato è generalmente ben tollerato a basse dosi, sebbene possa causare mal di stomaco, perdita di appetito e affaticamento. Se usato per lunghi periodi, può causare una serie di gravi effetti collaterali, tra cui gravi danni al fegato e riduzione della produzione di piastrine e globuli rossi e bianchi.
  • Ciclosporina. La ciclosporina (Gengraf, Neoral) sopprime il sistema immunitario e la sua efficacia è simile a quella del metotrexato, ma può essere assunta solo per un breve periodo. Come altri farmaci immunosoppressori, la ciclosporina aumenta il rischio di infezione e altri problemi di salute, incluso il cancro. La ciclosporina ti rende anche più sensibile ai problemi renali e alla pressione alta; il rischio aumenta con dosi più elevate e terapia a lungo termine.
  • Farmaci che alterano il sistema immunitario (biosimilari). Molti di questi farmaci sono stati approvati per il trattamento della psoriasi da moderata a grave. Questi includono etanercept (Enbrel), infliximab (Remicade), adalimumab (Humira), ustekinumab (Stelara), golimumab (Simponi), apremilast (Otezla), secukinumab (Cosentyx) e ixekizumab (Taltz). La maggior parte di questi farmaci sono iniettabili (l'apremilast viene somministrato per via orale) e sono generalmente utilizzati in persone che non hanno risposto alla terapia tradizionale o che hanno associato l'artrite psoriasica. I farmaci biologici devono essere usati con cautela, poiché hanno gravi effetti sul sistema immunitario e possono causare infezioni potenzialmente letali. In particolare, le persone che seguono questi trattamenti dovrebbero sottoporsi a un test di screening della tubercolosi.
  • Altri farmaci. La tioguanina (tabloide) e l'idrossiurea (Droxia, Hydrea) sono farmaci che possono essere utilizzati quando altri non possono essere somministrati.

Considerazioni sul trattamento

Sebbene i medici scelgano i trattamenti in base al tipo e all'estensione della psoriasi e alle regioni cutanee colpite, l'approccio tradizionale è quello di iniziare con i trattamenti più lievi – creme topiche e fototerapia a luce ultravioletta – in pazienti con lesioni del pelle tipica (piastre) e poi passare al più potente, solo se necessario. In generale, i pazienti con psoriasi eritrodermica, pustolosa o associata ad artrite hanno bisogno di un trattamento sistemico sin dall'inizio. L'obiettivo è trovare il modo più efficace per rallentare il ricambio cellulare con il minor numero di effetti collaterali possibili.

Possibili trattamenti futuri

Ci sono una serie di nuovi farmaci che sono attualmente in fase di studio e che possono migliorare il trattamento della psoriasi. I trattamenti mirano a diverse proteine ​​che funzionano con il sistema immunitario.

Medicina alternativa

Esistono diversi trattamenti alternativi che sostengono di alleviare i sintomi della psoriasi, come diete speciali, creme, integratori alimentari ed erbe. L'efficacia di nessuno di questi trattamenti non è dimostrata. Ma alcuni trattamenti alternativi sono generalmente considerati sicuri e possono essere utili ad alcune persone riducendo segni e sintomi, come prurito e desquamazione. Questi trattamenti sarebbero più adatti per le persone con la più lieve malattia della placca, ma non per quelle con pustole, eritroderma o artrite.

  • Aloe Vera. La crema con estratto di aloe, prelevata dalla pianta di aloe vera, può ridurre arrossamenti, desquamazione, prurito e infiammazione. Potrebbe essere necessario utilizzare la crema più volte al giorno per un mese o più per notare miglioramenti nella pelle.
  • Olio di pesce Gli acidi grassi omega-3 negli integratori di olio di pesce possono ridurre l'infiammazione causata dalla psoriasi, sebbene i risultati degli studi non siano conclusivi. L'assunzione di 3 grammi o meno di olio di pesce al giorno è generalmente considerata sicura e può essere utile.
  • Uva dell'Oregon. L'uva dell'Oregon, chiamata anche “crespino”, ha applicazioni topiche che possono ridurre l'infiammazione e alleviare i sintomi della psoriasi.

Se stai pensando di utilizzare integratori alimentari o altri trattamenti alternativi per alleviare i sintomi della psoriasi, consulta il medico. Può aiutarti ad analizzare i vantaggi e gli svantaggi di trattamenti alternativi specifici.

Studi clinici

Esplora gli studi della Mayo Clinic che valutano nuovi trattamenti, interventi e test come un modo per prevenire, rilevare, trattare o controllare questa malattia.

Stile di vita e rimedi casalinghi

Sebbene le misure di auto-cura non curino la psoriasi, possono aiutare a migliorare l'aspetto e la sensazione della pelle danneggiata. Queste misure possono essere utili:

  • Fare il bagno ogni giorno. Facendo il bagno ogni giorno, rimuovi le squame e lenisci la pelle infiammata. Aggiungi olio da bagno, avena colloidale, solfato di magnesio naturale o sali del Mar Morto all'acqua e immergiti. Evitare acqua calda e saponi abrasivi, che possono peggiorare i sintomi; usare acqua calda e saponi delicati con oli e grassi aggiunti. Immergiti per circa 10 minuti e poi asciuga la pelle.
  • Usa una crema idratante. Dopo il bagno, applica una crema idratante a base di unguento mentre la pelle è ancora bagnata. Per la pelle molto secca, sono preferibili oli, poiché tendono a rimanere più a lungo di creme o lozioni e sono più efficaci nel prevenire l'evaporazione dell'acqua dalla pelle. Nei climi freddi e asciutti, dovrai applicare una crema idratante più volte al giorno.
  • Esporre la pelle a piccole quantità di luce solare. Una quantità controllata di luce solare può migliorare la psoriasi, ma troppo sole può innescare o peggiorare i razzi e aumentare il rischio di cancro della pelle. Prima di tutto chiedi al tuo medico il modo migliore per usare la luce solare naturale per curare la tua pelle. Registra il tempo che passi al sole e usa la protezione solare sulle aree della pelle che non sono interessate dalla psoriasi.
  • Se possibile, evitare i fattori scatenanti per la psoriasi. Scopri cosa innesca o peggiora la psoriasi nel tuo caso e prendi provvedimenti per prevenire o evitare questi fattori scatenanti. Infezioni, lesioni cutanee, stress, fumo e intensa esposizione al sole possono peggiorare la psoriasi.
  • Evita di consumare alcolici. Bere alcolici può ridurre l'efficacia di alcuni trattamenti per la psoriasi. Se hai la psoriasi, evita di bere alcolici. Se bevi, fallo in modo moderato.

Strategie di supporto e supporto

Far fronte alla psoriasi può essere una vera sfida, specialmente se la malattia colpisce vaste aree del corpo o appare in luoghi facilmente visibili da altri, come il viso o le mani. La natura continua e persistente della malattia e le difficoltà del suo trattamento non fanno che aumentare il problema.

Ecco alcuni modi per aiutarti ad affrontarlo e avere la sensazione di poterlo controllare:

  • Scoprilo Trova quante più informazioni possibili sulla malattia e sulle opzioni di trattamento della ricerca. Comprendi quali sono i possibili fattori scatenanti di questa malattia per prevenire le esacerbazioni. Informa chi ti circonda (compresi familiari e amici) in modo che possano identificare, riconoscere e supportare i tuoi sforzi per affrontare questa malattia.
  • Segui le raccomandazioni del medico. Se il medico raccomanda determinati trattamenti e cambiamenti nello stile di vita, assicurati di seguirli. Chiedi se qualcosa non ti sembra chiaro.
  • Trova un gruppo di supporto. Prendi in considerazione l'idea di unirti a un gruppo di supporto con altri che hanno la malattia e sanno cosa stai passando. Può essere confortante condividere la tua esperienza e la tua lotta e incontrare persone che affrontano sfide simili. Chiedi al tuo medico informazioni sui gruppi di supporto della psoriasi in cui vivi o sei virtuale.
  • Indossa abiti che ti coprano quando ritieni che sia necessario. In quei giorni in cui ti senti particolarmente imbarazzato, copri la tua psoriasi con abiti o prodotti cosmetici speciali come il trucco per il corpo o il correttore. Questi prodotti possono nascondere placche e arrossamenti psoriasici. Tuttavia, possono irritare la pelle e non devono essere utilizzati su piaghe, tagli o lesioni che non sono ancora guarite.

Preparazione per la consultazione

Probabilmente vedrai prima il tuo medico di famiglia o il medico di famiglia. In alcuni casi, possono indirizzarti direttamente a uno specialista in malattie della pelle (dermatologo).

Qui hai informazioni che ti aiuteranno a prepararti per la consultazione e a sapere cosa aspettarti dal medico.

Cosa puoi fare

Fai un elenco di quanto segue:

  • I sintomi che hai, anche quelli che sembrano non correlati al motivo per cui hai programmato l'appuntamento
  • Tutti i farmaci, le vitamine e le erbe che prendi e le loro dosi
  • Domande da porre al medico

Per la psoriasi, le domande di base che potresti porre al medico sono:

  • Cosa può causare i miei segni e sintomi?
  • Ho bisogno di test diagnostici?
  • Quali trattamenti sono disponibili e quali mi consigliate?
  • Quali tipi di effetti collaterali posso aspettarmi?
  • Il trattamento raccomandato causerà la remissione dei miei sintomi?
  • Quanto tempo posso aspettare risultati?
  • Quali sono le alternative all'approccio principale che suggerisci?
  • Ho altri problemi di salute. Come posso controllarli insieme?
  • Quali prodotti di routine e per la cura della pelle sono raccomandati per migliorare i miei sintomi?

Cosa aspettarsi dal medico

Il medico probabilmente ti farà diverse domande, come le seguenti:

  • Quando hai iniziato ad avere sintomi?
  • Quanto spesso hai questi sintomi?
  • I sintomi sono stati continui o occasionali?
  • C'è qualcosa che sembra migliorare i sintomi?
  • C'è qualcosa che sembra peggiorare i sintomi?
Scritto dallo staff della Mayo Clinic

Psorilax:A basso prezzo |creme per la psoriasi ultimi ritrovati

0

Psorilax: prezzo, funziona, recensioni, opinioni, ingredienti

Psoriasis is a long-lasting autoimmune disease characterized by patches of abnormal skin.(6) These skin patches are typically red, or purple on some people with darker skin,(9) dry, itchy, and scaly.(3) Psoriasis varies in severity from small, localized patches to complete body coverage.(3) Injury to the skin can trigger psoriatic skin changes at that spot, which is known as the Koebner phenomenon.(10)

There are five main types of psoriasis: plaque, guttate, inverse, pustular, and erythrodermic.(6) Plaque psoriasis, also known as psoriasis vulgaris, makes up about 90 percent of cases.(4) It typically presents as red patches with white scales on top.(4) Areas of the body most commonly affected are the back of the forearms, shins, navel area, and scalp.(4) Guttate psoriasis has drop-shaped lesions.(6) Pustular psoriasis presents as small non-infectious pus-filled blisters.(11) Inverse psoriasis forms red patches in skin folds.(6) Erythrodermic psoriasis occurs when the rash becomes very widespread, and can develop from any of the other types.(4) Fingernails and toenails are affected in most people with psoriasis at some point in time.(4) This may include pits in the nails or changes in nail color.(4)

Psoriasis is generally thought to be a genetic disease that is triggered by environmental factors.(3) If one twin has psoriasis, the other twin is three times more likely to be affected if the twins are identical than if they are non-identical.(4) This suggests that genetic factors predispose to psoriasis.(4) Symptoms often worsen during winter and with certain medications, such as beta blockers or NSAIDs.(4) Infections and psychological stress can also play a role.(3)(6) Psoriasis is not contagious.(4) The underlying mechanism involves the immune system reacting to skin cells.(4) Diagnosis is typically based on the signs and symptoms.(4)

There is no cure for psoriasis; however, various treatments can help control the symptoms.(4) These treatments include steroid creams, vitamin D3 cream, ultraviolet light and immune system suppressing medications, such as methotrexate.(6) About 75 percent of skin involvement improves with creams alone.(4) The disease affects two to four percent of the population.(8) Men and women are affected with equal frequency.(6) The disease may begin at any age, but typically starts in adulthood.(5) Psoriasis is associated with an increased risk of psoriatic arthritis, lymphomas, cardiovascular disease, Crohn disease, and depression.(4) Psoriatic arthritis affects up to 30 percent of individuals with psoriasis.(11)

Signs and symptoms(edit)

Plaque psoriasis(edit)

Psoriatic plaque, showing a silvery center surrounded by a reddened border.

Psoriasis vulgaris (also known as chronic stationary psoriasis or plaque-like psoriasis) is the most common form and affects 85%–90% of people with psoriasis.(12) Plaque psoriasis typically appears as raised areas of inflamed skin covered with silvery-white scaly skin. These areas are called plaques and are most commonly found on the elbows, knees, scalp, and back.(12)(13)

Other forms(edit)

Additional types of psoriasis comprise approximately 10% of cases. They include pustular, inverse, napkin, guttate, oral, and seborrheic-like forms.(14)

Pustular psoriasis(edit)

Pustular psoriasis appears as raised bumps filled with noninfectious pus (pustules).(15) The skin under and surrounding the pustules is red and tender.(16) Pustular psoriasis can either be localized or more widespread throughout the body. Two types of localized pustular psoriasis include psoriasis pustulosa palmoplantaris (PPP) and acrodermatitis continua of Hallopeau, both forms are localized to the hands and feet.(17)

Inverse psoriasis(edit)

Inverse psoriasis (also known as flexural psoriasis) appears as smooth, inflamed patches of skin. The patches frequently affect skin folds, particularly around the genitals (between the thigh and groin), the armpits, in the skin folds of an overweight abdomen (known as panniculus), between the buttocks in the intergluteal cleft, and under the breasts in the inframammary fold. Heat, trauma, and infection are thought to play a role in the development of this atypical form of psoriasis.(18)

Napkin psoriasis(edit)

Napkin psoriasis is a subtype of psoriasis common in infants characterized by red papules with silver scale in the diaper area that may extend to the torso or limbs.(19) Napkin psoriasis is often misdiagnosed as napkin dermatitis (diaper rash).(20)

Guttate psoriasis(edit)

Guttate psoriasis is characterized by numerous small, scaly, red or pink, droplet-like lesions (papules). These numerous spots of psoriasis appear over large areas of the body, primarily the trunk, but also the limbs and scalp. Guttate psoriasis is often triggered by a streptococcal infection, typically streptococcal pharyngitis.(18)

Erythrodermic psoriasis(edit)

Psoriatic erythroderma (erythrodermic psoriasis) involves widespread inflammation and exfoliation of the skin over most of the body surface, often involving greater than 90% of the body surface area.(17) It may be accompanied by severe dryness, itching, swelling, and pain. It can develop from any type of psoriasis.(17) It is often the result of an exacerbation of unstable plaque psoriasis, particularly following the abrupt withdrawal of systemic glucocorticoids.(21) This form of psoriasis can be fatal as the extreme inflammation and exfoliation disrupt the body’s ability to regulate temperature and perform barrier functions.(22)

Mouth(edit)

Psoriasis in the mouth is very rare,(23) in contrast to lichen planus, another common papulosquamous disorder that commonly involves both the skin and mouth. When psoriasis involves the oral mucosa (the lining of the mouth), it may be asymptomatic,(23) but it may appear as white or grey-yellow plaques.(23) Fissured tongue is the most common finding in those with oral psoriasis and has been reported to occur in 6.5–20% of people with psoriasis affecting the skin. The microscopic appearance of oral mucosa affected by geographic tongue (migratory stomatitis) is very similar to the appearance of psoriasis.(24) However, modern studies have failed to demonstrate any link between the two conditions.(25)

Seborrheic-like psoriasis(edit)

Seborrheic-like psoriasis is a common form of psoriasis with clinical aspects of psoriasis and seborrheic dermatitis, and it may be difficult to distinguish from the latter. This form of psoriasis typically manifests as red plaques with greasy scales in areas of higher sebum production such as the scalp, forehead, skin folds next to the nose, skin surrounding the mouth, skin on the chest above the sternum, and in skin folds.(19)

Psoriatic arthritis(edit)

Psoriatic arthritis is a form of chronic inflammatory arthritis that has a highly variable clinical presentation and frequently occurs in association with skin and nail psoriasis.(26)(27) It typically involves painful inflammation of the joints and surrounding connective tissue and can occur in any joint, but most commonly affects the joints of the fingers and toes. This can result in a sausage-shaped swelling of the fingers and toes known as dactylitis.(26) Psoriatic arthritis can also affect the hips, knees, spine (spondylitis), and sacroiliac joint (sacroiliitis).(28) About 30% of individuals with psoriasis will develop psoriatic arthritis.(12) Skin manifestations of psoriasis tend to occur before arthritic manifestations in about 75% of cases.(27)

Nail changes(edit)

Psoriasis of a fingernail, with visible pitting.

A photograph showing the effects of psoriasis on the toenails.

Psoriasis can affect the nails and produces a variety of changes in the appearance of finger and toe nails. Nail psoriasis occurs in 40–45% of people with psoriasis affecting the skin and has a lifetime incidence of 80–90% in those with psoriatic arthritis.(29) These changes include pitting of the nails (pinhead-sized depressions in the nail is seen in 70% with nail psoriasis), whitening of the nail, small areas of bleeding from capillaries under the nail, yellow-reddish discoloration of the nails known as the oil drop or salmon spot, dryness, thickening of the skin under the nail (subungual hyperkeratosis), loosening and separation of the nail (onycholysis), and crumbling of the nail.(29)

Medical signs(edit)

In addition to the appearance and distribution of the rash, specific medical signs may be used by medical practitioners to assist with diagnosis. These may include Auspitz’s sign (pinpoint bleeding when scale is removed), Koebner phenomenon (psoriatic skin lesions induced by trauma to the skin),(19) and itching and pain localized to papules and plaques.(18)(19)

The cause of psoriasis is not fully understood, but a number of theories exist.

Genetics(edit)

Around one-third of people with psoriasis report a family history of the disease, and researchers have identified genetic loci associated with the condition. Identical twin studies suggest a 70% chance of a twin developing psoriasis if the other twin has the disorder. The risk is around 20% for nonidentical twins. These findings suggest both a genetic susceptibility and an environmental response in developing psoriasis.(30)

Psoriasis has a strong hereditary component, and many genes are associated with it, but it is unclear how those genes work together. Most of the identified genes relate to the immune system, particularly the major histocompatibility complex (MHC) and T cells. Genetic studies are valuable due to their ability to identify molecular mechanisms and pathways for further study and potential medication targets.(31)

Classic genome-wide linkage analysis has identified nine loci on different chromosomes associated with psoriasis. They are called psoriasis susceptibility 1 through 9 (PSORS1 through PSORS9). Within those loci are genes on pathways that lead to inflammation. Certain variations (mutations) of those genes are commonly found in psoriasis.(31) Genome-wide association scans have identified other genes that are altered to characteristic variants in psoriasis. Some of these genes express inflammatory signal proteins, which affect cells in the immune system that are also involved in psoriasis. Some of these genes are also involved in other autoimmune diseases.(31)

The major determinant is PSORS1, which probably accounts for 35%–50% of psoriasis heritability.(32) It controls genes that affect the immune system or encode skin proteins that are overabundant with psoriasis. PSORS1 is located on chromosome 6 in the major histocompatibility complex (MHC), which controls important immune functions. Three genes in the PSORS1 locus have a strong association with psoriasis vulgaris: HLA-C variant HLA-Cw6,(33) which encodes a MHC class I protein; CCHCR1, variant WWC, which encodes a coiled coil protein that is overexpressed in psoriatic epidermis; and CDSN, variant allele 5, which encodes corneodesmosin, a protein which is expressed in the granular and cornified layers of the epidermis and upregulated in psoriasis.(31)

Two major immune system genes under investigation are interleukin-12 subunit beta (IL12B) on chromosome 5q, which expresses interleukin-12B; and IL23R on chromosome 1p, which expresses the interleukin-23 receptor, and is involved in T cell differentiation. Interleukin-23 receptor and IL12B have both been strongly linked with psoriasis.(33) T cells are involved in the inflammatory process that leads to psoriasis.(31) These genes are on the pathway that upregulate tumor necrosis factor-α and nuclear factor κB, two genes involved in inflammation.(31) The first gene directly linked to psoriasis was identified as the CARD14 gene located in the PSORS2 locus. A rare mutation in the gene encoding for the CARD14 protein plus an environmental trigger was enough to cause plaque psoriasis (the most common form of psoriasis).(34)(35)

Lifestyle(edit)

Conditions reported as worsening the disease include chronic infections, stress, and changes in season and climate.(33) Others that might worsen the condition include hot water, scratching psoriasis skin lesions, skin dryness, excessive alcohol consumption, cigarette smoking, and obesity.(33)(36)(37)(38) The effects of stopping cigarette smoking or alcohol misuse have yet to be studied as of 2019.(38)

HIV(edit)

The rate of psoriasis in HIV-positive individuals is comparable to that of HIV-negative individuals; however, psoriasis tends to be more severe in people infected with human immunodeficiency virus (HIV).(39) A much higher rate of psoriatic arthritis occurs in HIV-positive individuals with psoriasis than in those without the infection.(39) The immune response in those infected with HIV is typically characterized by cellular signals from Th2 subset of CD4+ helper T cells,(40) whereas the immune response in psoriasis vulgaris is characterized by a pattern of cellular signals typical of Th1 subset of CD4+ helper T cells and Th17 helper T cells.(41)(42) It is hypothesized that the diminished CD4+-T cell presence causes an overactivation of CD8+-T cells, which are responsible for the exacerbation of psoriasis in HIV-positive people. Psoriasis in those with HIV/AIDS is often severe and may be untreatable with conventional therapy.(43) In those with long-term, well-controlled psoriasis, new HIV infection can trigger a severe flare of psoriasis and/or psoriatic arthritis.(medical citation needed)

Microbes(edit)

Psoriasis has been described as occurring after strep throat, and may be worsened by skin or gut colonization with Staphylococcus aureus, Malassezia, and Candida albicans.(44) Guttate psoriasis often affects children and adolescents and can be triggered by a recent Group A streptococcal infection (tonsillitis or pharyngitis).(17)

Medications(edit)

Drug-induced psoriasis may occur with beta blockers,(11) lithium,(11) antimalarial medications,(11) non-steroidal anti-inflammatory drugs,(11) terbinafine, calcium channel blockers, captopril, glyburide, granulocyte colony-stimulating factor,(11) interleukins, interferons,(11) lipid-lowering medications,(14):197 and paradoxically TNF inhibitors such as infliximab or adalimumab.(45) Withdrawal of corticosteroids (topical steroid cream) can aggravate psoriasis due to the rebound effect.(46)

Mechanism(edit)

Psoriasis is characterized by an abnormally excessive and rapid growth of the epidermal layer of the skin.(47) Abnormal production of skin cells (especially during wound repair) and an overabundance of skin cells result from the sequence of pathological events in psoriasis.(16) The sequence of pathological events in psoriasis is thought to start with an initiation phase in which an event (skin trauma, infection or drugs) leads to activation of the immune system and then the maintenance phase consisting of chronic progression of the disease.(31)(17) Skin cells are replaced every 3–5 days in psoriasis rather than the usual 28–30 days.(48) These changes are believed to stem from the premature maturation of keratinocytes induced by an inflammatory cascade in the dermis involving dendritic cells, macrophages, and T cells (three subtypes of white blood cells).(12)(39) These immune cells move from the dermis to the epidermis and secrete inflammatory chemical signals (cytokines) such as interleukin-36γ, tumor necrosis factor-α, interleukin-1β, interleukin-6, and interleukin-22.(31)(49) These secreted inflammatory signals are believed to stimulate keratinocytes to proliferate.(31) One hypothesis is that psoriasis involves a defect in regulatory T cells, and in the regulatory cytokine interleukin-10.(31) The inflammatory cytokines found in psoriatic nails and joints (in the case of psoriatic arthritis) are similar to those of psoriatic skin lesions, suggesting a common inflammatory mechanism.(17)

Gene mutations of proteins involved in the skin’s ability to function as a barrier have been identified as markers of susceptibility for the development of psoriasis.(50)(51)

Deoxyribonucleic acid (DNA) released from dying cells acts as an inflammatory stimulus in psoriasis(52) and stimulates the receptors on certain dendritic cells, which in turn produce the cytokine interferon-α.(52) In response to these chemical messages from dendritic cells and T cells, keratinocytes also secrete cytokines such as interleukin-1, interleukin-6, and tumor necrosis factor-α, which signal downstream inflammatory cells to arrive and stimulate additional inflammation.(31)

Dendritic cells bridge the innate immune system and adaptive immune system. They are increased in psoriatic lesions(47) and induce the proliferation of T cells and type 1 helper T cells (Th1). Targeted immunotherapy as well as psoralen and ultraviolet A (PUVA) therapy can reduce the number of dendritic cells and favors a Th2 cell cytokine secretion pattern over a Th1/Th17 cell cytokine profile.(31)(41) Psoriatic T cells move from the dermis into the epidermis and secrete interferon-γ and interleukin-17.(53) Interleukin-23 is known to induce the production of interleukin-17 and interleukin-22.(47)(53) Interleukin-22 works in combination with interleukin-17 to induce keratinocytes to secrete neutrophil-attracting cytokines.(53)

Diagnosis(edit)

Micrograph of psoriasis vulgaris. Confluent parakeratosis, psoriasiform epidermal hyperplasia ((A), EH), hypogranulosis, and influx of numerous neutrophils in the corneal layer ((A), arrow). (B) Transepidermal migration of neutrophils from the dermis to the corneal layer (arrows).(54)

A diagnosis of psoriasis is usually based on the appearance of the skin. Skin characteristics typical for psoriasis are scaly, erythematous plaques, papules, or patches of skin that may be painful and itch.(18) No special blood tests or diagnostic procedures are usually required to make the diagnosis.(16)(55)

The differential diagnosis of psoriasis includes dermatological conditions similar in appearance such as discoid eczema, seborrheic eczema, pityriasis rosea (may be confused with guttate psoriasis), nail fungus (may be confused with nail psoriasis) or cutaneous T cell lymphoma (50% of individuals with this cancer are initially misdiagnosed with psoriasis).(46) Dermatologic manifestations of systemic illnesses such as the rash of secondary syphilis may also be confused with psoriasis.(46)

If the clinical diagnosis is uncertain, a skin biopsy or scraping may be performed to rule out other disorders and to confirm the diagnosis. Skin from a biopsy will show clubbed epidermal projections that interdigitate with dermis on microscopy. Epidermal thickening is another characteristic histologic finding of psoriasis lesions.(16)(56) The stratum granulosum layer of the epidermis is often missing or significantly decreased in psoriatic lesions; the skin cells from the most superficial layer of skin are also abnormal as they never fully mature. Unlike their mature counterparts, these superficial cells keep their nucleus.(16) Inflammatory infiltrates can typically be visualized on microscopy when examining skin tissue or joint tissue affected by psoriasis. Epidermal skin tissue affected by psoriatic inflammation often has many CD8+ T cells while a predominance of CD4+ T cells makes up the inflammatory infiltrates of the dermal layer of skin and the joints.(16)

Classification(edit)

Morphological(edit)

Psoriasis is classified as a papulosquamous disorder and is most commonly subdivided into different categories based on histological characteristics.(3)(11) Variants include plaque, pustular, guttate, and flexural psoriasis. Each form has a dedicated ICD-10 code.(57) Psoriasis can also be classified into nonpustular and pustular types.(58)

Pathogenetic(edit)

Another classification scheme considers genetic and demographic factors. Type 1 has a positive family history, starts before the age of 40, and is associated with the human leukocyte antigen, HLA-Cw6. Conversely, type 2 does not show a family history, presents after age 40, and is not associated with HLA-Cw6.(59) Type 1 accounts for about 75% of persons with psoriasis.(60)

The classification of psoriasis as an autoimmune disease has sparked considerable debate. Researchers have proposed differing descriptions of psoriasis and psoriatic arthritis; some authors have classified them as autoimmune diseases(16)(33)(61) while others have classified them as distinct from autoimmune diseases and referred to them as immune-mediated inflammatory diseases.(31)(62)(63)

Severity(edit)

There is no consensus about how to classify the severity of psoriasis. Mild psoriasis has been defined as a percentage of body surface area (BSA)≤10, a Psoriasis Area Severity Index (PASI) score ≤10, and a Dermatology Life Quality Index (DLQI) score ≤10.(64) Moderate to severe psoriasis was defined by the same group as BSA >10 or PASI score >10 and a DLQI score >10.(64)

The DLQI is a 10 question tool used to measure the impact of several dermatologic diseases on daily functioning. The DLQI score ranges from 0 (minimal impairment) to 30 (maximal impairment) and is calculated with each answer being assigned 0–3 points with higher scores indicating greater social or occupational impairment.(65)

The psoriasis area severity index (PASI) is the most widely used measurement tool for psoriasis. PASI assesses the severity of lesions and the area affected and combines these two factors into a single score from 0 (no disease) to 72 (maximal disease).(66) Nevertheless, the PASI can be too unwieldy to use outside of research settings, which has led to attempts to simplify the index for clinical use.(67)

Management(edit)

Schematic of psoriasis treatment ladder

While no cure is available for psoriasis,(46) many treatment options exist. Topical agents are typically used for mild disease, phototherapy for moderate disease, and systemic agents for severe disease.(68)

Topical agents(edit)

Topical corticosteroid preparations are the most effective agents when used continuously for 8 weeks; retinoids and coal tar were found to be of limited benefit and may be no better than placebo.(69) Greater benefit has been observed with very potent corticosteroids when compared to potent corticosteroids.

Vitamin D analogues such as paricalcitol were found to be superior to placebo. Combination therapy with vitamin D and a corticosteroid was superior to either treatment alone and vitamin D was found to be superior to coal tar for chronic plaque psoriasis.(70)

For psoriasis of the scalp, a 2016 review found dual therapy (vitamin D analogues and topical corticosteroids) or corticosteroid monotherapy to be more effective and safer than topical vitamin D analogues alone.(71) Due to their similar safety profiles and minimal benefit of dual therapy over monotherapy, corticosteroid monotherapy appears to be an acceptable treatment for short-term treatment.(71)

Moisturizers and emollients such as mineral oil, petroleum jelly, calcipotriol, and decubal (an oil-in-water emollient) were found to increase the clearance of psoriatic plaques. Some emollients have been shown to be even more effective at clearing psoriatic plaques when combined with phototherapy.(72) However, certain emollients have no impact on psoriasis plaque clearance or may even decrease the clearance achieved with phototherapy, e.g. the emollient salicylic acid is structurally similar to para-aminobenzoic acid (PABA), commonly found in sunscreen, and is known to interfere with phototherapy in psoriasis. Coconut oil, when used as an emollient in psoriasis, has been found to decrease plaque clearance with phototherapy.(72) Medicated creams and ointments applied directly to psoriatic plaques can help reduce inflammation, remove built-up scale, reduce skin turnover, and clear affected skin of plaques. Ointment and creams containing coal tar, dithranol, corticosteroids (i.e. desoximetasone), fluocinonide, vitamin D3 analogues (for example, calcipotriol), and retinoids are routinely used. (The use of the finger tip unit may be helpful in guiding how much topical treatment to use.)(36)(73)

Vitamin D analogues may be useful with steroids; however, alone have a higher rate of side effects.(70) They may allow less steroids to be used.(74)

Another topical therapy used to treat psoriasis is a form of balneotherapy, which involves daily baths in the Dead Sea. This is usually done for four weeks with the benefit attributed to sun exposure and specifically UVB light. This is cost-effective and it has been propagated as an effective way to treat psoriasis without medication.(75) Decreases of PASI scores greater than 75% and remission for several months have commonly been observed.(75) Side-effects may be mild such as itchiness, folliculitis, sunburn, poikiloderma, and a theoretical risk of nonmelanoma skin cancer or melanoma has been suggested.(75) Recent(when?) studies have determined that there does not appear to be increased risk of melanoma in the long-term.(76) Data are inconclusive with respect to non-melanoma skin cancer risk, but support the idea that the therapy is associated with an increased risk of benign forms of sun-induced skin damage such as, but not limited to, actinic elastosis or liver spots.(76) Dead Sea balneotherapy is also effective for psoriatic arthritis.(76)

UV phototherapy(edit)

Phototherapy in the form of sunlight has long been used for psoriasis.(68) UVB Wavelengths of 311–313 nanometers are most effective, and special lamps have been developed for this application.(68) The exposure time should be controlled to avoid over exposure and burning of the skin. The UVB lamps should have a timer that will turn off the lamp when the time ends. The amount of light used is determined by a person’s skin type.(68) Increased rates of cancer from treatment appear to be small.(68) Narrow band UVB light (NBUVB) phototherapy has been demonstrated to have similar efficacy to Psoralen and ultraviolet A phototherapy (PUVA).(77) A 2013 meta-analysis found no difference in efficacy between NB-UVB and PUVA in the treatment of psoriasis, but NB-UVB is usually more convenient.(78)

One of the problems with clinical phototherapy is the difficulty many people have gaining access to a facility. Indoor tanning resources are almost ubiquitous today and could be considered as a means for people to get UV exposure when dermatologist provided phototherapy is not available. Indoor tanning is already used by many people as a treatment for psoriasis; one indoor facility reported that 50% of its clients were using the center for psoriasis treatment; another reported 36% were doing the same thing. However, a concern with the use of commercial tanning is that tanning beds that primarily emit UVA might not effectively treat psoriasis. One study found that plaque psoriasis is responsive to erythemogenic doses of either UVA or UVB, as exposure to either can cause dissipation of psoriatic plaques. It does require more energy to reach erythemogenic dosing with UVA.(79)

UV light therapies all have risks; tanning beds are no exception, being listed by the World Health Organization as carcinogens.(80) Exposure to UV light is known to increase the risks of melanoma, squamous cell and basal cell carcinomas; younger people with psoriasis, particularly those under age 35, are at increased risk from melanoma from UV light treatment. A review of studies recommends that people who are susceptible to skin cancers exercise caution when using UV light therapy as a treatment.(79)

A major mechanism of NBUVB is the induction of DNA damage in the form of pyrimidine dimers. This type of phototherapy is useful in the treatment of psoriasis because the formation of these dimers interferes with the cell cycle and stops it. The interruption of the cell cycle induced by NBUVB opposes the characteristic rapid division of skin cells seen in psoriasis.(77) The activity of many types of immune cells found in the skin is also effectively suppressed by NBUVB phototherapy treatments. The most common short-term side effect of this form of phototherapy is redness of the skin; less common side effects of NBUVB phototherapy are itching and blistering of the treated skin, irritation of the eyes in the form of conjunctival inflammation or inflammation of the cornea, or cold sores due to reactivation of the herpes simplex virus in the skin surrounding the lips. Eye protection is usually given during phototherapy treatments.(77)

PUVA combines the oral or topical administration of psoralen with exposure to ultraviolet A (UVA) light. The mechanism of action of PUVA is unknown, but probably involves activation of psoralen by UVA light, which inhibits the abnormally rapid production of the cells in psoriatic skin. There are multiple mechanisms of action associated with PUVA, including effects on the skin’s immune system. PUVA is associated with nausea, headache, fatigue, burning, and itching. Long-term treatment is associated with squamous cell carcinoma (but not with melanoma).(37)(81) A combination therapy for moderate to severe psoriasis using PUVA plus acitretin resulted in benefit, but acitretin use has been associated with birth defects and liver damage.(82)

Systemic agents(edit)

Psoriasis resistant to topical treatment and phototherapy may be treated with systemic therapies including medications by mouth or injectable treatments.(83) People undergoing systemic treatment must have regular blood and liver function tests to check for medication toxicities.(83) Pregnancy must be avoided for most of these treatments. The majority of people experience a recurrence of psoriasis after systemic treatment is discontinued.

Non-biologic systemic treatments frequently used for psoriasis include methotrexate, ciclosporin, hydroxycarbamide, fumarates such as dimethyl fumarate, and retinoids.(84) Methotrexate and ciclosporin are medications that suppress the immune system; retinoids are synthetic forms of vitamin A. These agents are also regarded as first-line treatments for psoriatic erythroderma.(21) Oral corticosteroids should not be used, for they can severely flare psoriasis upon their discontinuation.(85)

Biologics are manufactured proteins that interrupt the immune process involved in psoriasis. Unlike generalized immunosuppressive medical therapies such as methotrexate, biologics target specific aspects of the immune system contributing to psoriasis.(84) These medications are generally well tolerated, and limited long-term outcome data have demonstrated biologics to be safe for long-term use in moderate to severe plaque psoriasis.(84)(86) However, due to their immunosuppressive actions, biologics have been associated with a small increase in the risk for infection.(84)

Guidelines regard biologics as third-line treatment for plaque psoriasis following inadequate response to topical treatment, phototherapy, and non-biologic systemic treatments.(86) The safety of biologics during pregnancy has not been assessed. European guidelines recommend avoiding biologics if a pregnancy is planned; anti-TNF therapies such as infliximab are not recommended for use in chronic carriers of the hepatitis B virus or individuals infected with HIV.(84)

Several monoclonal antibodies target cytokines, the molecules that cells use to send inflammatory signals to each other. TNF-α is one of the main executor inflammatory cytokines. Four monoclonal antibodies (MAbs) (infliximab, adalimumab, golimumab, and certolizumab pegol) and one recombinant TNF-α decoy receptor, etanercept, have been developed to inhibit TNF-α signaling. Additional monoclonal antibodies, such as ixekizumab,(87) have been developed against pro-inflammatory cytokines(88) and inhibit the inflammatory pathway at a different point than the anti-TNF-α antibodies.(31) IL-12 and IL-23 share a common domain, p40, which is the target of the FDA-approved ustekinumab.(33) In 2017 the US FDA approved guselkumab for plaque psoriasis.(89) There have been few studies of the efficacy of anti-TNF medications for psoriasis in children. One randomized control study suggested that 12 weeks of etanercept treatment reduced the extent of psoriasis in children with no lasting adverse effects.(90)

Two medications that target T cells are efalizumab and alefacept. Efalizumab is a monoclonal antibody that specifically targets the CD11a subunit of LFA-1.(84) It also blocks the adhesion molecules on the endothelial cells that line blood vessels, which attract T cells. Efalizumab was voluntarily withdrawn from the European market in February 2009, and from the U.S. market in June 2009, by the manufacturer due to the medication’s association with cases of progressive multifocal leukoencephalopathy.(84) Alefacept also blocks the molecules that dendritic cells use to communicate with T cells and even causes natural killer cells to kill T cells as a way of controlling inflammation.(31) Apremilast may also be used.(12)

Individuals with psoriasis may develop neutralizing antibodies against monoclonal antibodies. Neutralization occurs when an antidrug antibody prevents a monoclonal antibody such as infliximab from binding antigen in a laboratory test. Specifically, neutralization occurs when the antidrug antibody binds to infliximab’s antigen binding site instead of TNF-α. When infliximab no longer binds tumor necrosis factor alpha, it no longer decreases inflammation, and psoriasis may worsen. Neutralizing antibodies have not been reported against etanercept, a biologic medication that is a fusion protein composed of two TNF-α receptors. The lack of neutralizing antibodies against etanercept is probably secondary to the innate presence of the TNF-α receptor, and the development of immune tolerance.(91)

A 2020 meta-analysis found that ixekizumab, secukinumab, brodalumab, guselkumab, certolizumab, and ustekinumab were the most effective biologics for treating psoriasis.(92)(93) In general, anti-IL17, anti-IL12/23, anti-IL23, and anti-TNF alpha biologics were found to be more effective than traditional systemic treatments.(92) The immunologic pathways of psoriasis involve Th9, Th17, Th1 lymphocytes, and IL-22. The aforementioned biologic agents hinder different aspects of these pathways.(citation needed)

Another treatment for moderate to severe psoriasis is fumaric acid esters (FAE) which may be similar in effectiveness to methotrexate.(94)

It has been theorized that antistreptococcal medications may improve guttate and chronic plaque psoriasis; however the limited studies do not show that antibiotics are effective.(95)

Surgery(edit)

Limited evidence suggests removal of the tonsils may benefit people with chronic plaque psoriasis, guttate psoriasis, and palmoplantar pustulosis.(96)(97)

Diet(edit)

Uncontrolled studies have suggested that individuals with psoriasis or psoriatic arthritis may benefit from a diet supplemented with fish oil rich in eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).(98) A low-calorie diet appears to improve the severity of psoriasis.(38) Diet recommendations include consumption of cold water fish (preferably wild fish, not farmed) such as salmon, herring, and mackerel; extra virgin olive oil; legumes; vegetables; fruits; and whole grains; and avoid consumption of alcohol, red meat, and dairy products (due to their saturated fat). The effect of consumption of caffeine (including coffee, black tea, mate, and dark chocolate) remains to be determined.(99)

There is a higher rate of celiac disease among people with psoriasis.(99)(100) When adopting a gluten-free diet, disease severity generally decreases in people with celiac disease and those with anti-gliadin antibodies.(98)(101)(102)

Prognosis(edit)

Most people with psoriasis experience nothing more than mild skin lesions that can be treated effectively with topical therapies.(69)

Psoriasis is known to have a negative impact on the quality of life of both the affected person and the individual’s family members.(33) Depending on the severity and location of outbreaks, individuals may experience significant physical discomfort and some disability. Itching and pain can interfere with basic functions, such as self-care and sleep.(48) Participation in sporting activities, certain occupations, and caring for family members can become difficult activities for those with plaques located on their hands and feet.(48) Plaques on the scalp can be particularly embarrassing, as flaky plaque in the hair can be mistaken for dandruff.(103)

Individuals with psoriasis may feel self-conscious about their appearance and have a poor self-image that stems from fear of public rejection and psychosexual concerns. Psoriasis has been associated with low self-esteem and depression is more common among those with the condition.(3) People with psoriasis often feel prejudiced against due to the commonly held incorrect belief that psoriasis is contagious.(48) Psychological distress can lead to significant depression and social isolation; a high rate of thoughts about suicide has been associated with psoriasis.(20) Many tools exist to measure the quality of life of people with psoriasis and other dermatological disorders. Clinical research has indicated individuals often experience a diminished quality of life.(104) Children with psoriasis may encounter bullying.(105)

Several conditions are associated with psoriasis. These occur more frequently in older people. Nearly half of individuals with psoriasis over the age of 65 have at least three comorbidities (concurrent conditions), and two-thirds have at least two comorbidities.(106)

Cardiovascular disease(edit)

Psoriasis has been associated with obesity(3) and several other cardiovascular and metabolic disturbances. The number of new cases per year of diabetes is 27% higher in people affected by psoriasis than in those without the condition.(107) Severe psoriasis may be even more strongly associated with the development of diabetes than mild psoriasis.(107) Younger people with psoriasis may also be at increased risk for developing diabetes.(106)(108) Individuals with psoriasis or psoriatic arthritis have a slightly higher risk of heart disease and heart attacks when compared to the general population. Cardiovascular disease risk appeared to be correlated with the severity of psoriasis and its duration. There is no strong evidence to suggest that psoriasis is associated with an increased risk of death from cardiovascular events. Methotrexate may provide a degree of protection for the heart.(37)(106)

The odds of having hypertension are 1.58 times higher in people with psoriasis than those without the condition; these odds are even higher with severe cases of psoriasis. A similar association was noted in people who have psoriatic arthritis—the odds of having hypertension were found to be 2.07 times greater when compared to odds of the general population. The link between psoriasis and hypertension is not currently(when?) understood. Mechanisms hypothesized to be involved in this relationship include the following: dysregulation of the renin–angiotensin system, elevated levels of endothelin 1 in the blood, and increased oxidative stress.(108)(109) The number of new cases of the heart rhythm abnormality atrial fibrillation is 1.31 times higher in people with mild psoriasis and 1.63 times higher in people with severe psoriasis.(110) There may be a slightly increased risk of stroke associated with psoriasis, especially in severe cases.(37)(111) Treating high levels of cholesterol with statins has been associated with decreased psoriasis severity, as measured by PASI score, and has also been associated with improvements in other cardiovascular disease risk factors such as markers of inflammation.(112) These cardioprotective effects are attributed to ability of statins to improve blood lipid profile and because of their anti-inflammatory effects. Statin use in those with psoriasis and hyperlipidemia was associated with decreased levels of high-sensitivity C-reactive protein and TNFα as well as decreased activity of the immune protein LFA-1.(112) Compared to individuals without psoriasis, those affected by psoriasis are more likely to satisfy the criteria for metabolic syndrome.(16)(110)

Other diseases(edit)

The rates of Crohn disease and ulcerative colitis are increased when compared with the general population, by a factor of 3.8 and 7.5 respectively.(3) People with psoriasis also have a higher risk of celiac disease.(99)(102) Few studies have evaluated the association of multiple sclerosis with psoriasis, and the relationship has been questioned.(3)(113) Psoriasis has been associated with a 16% increase in overall relative risk for non-skin cancer.(37) People with psoriasis have a 52% increased risk cancers of the lung and bronchus, a 205% increase in the risk of developing cancers of the upper gastrointestinal tract, a 31% increase in the risk of developing cancers of the urinary tract, a 90% increase in the risk of developing liver cancer, and a 46% increase in the risk of developing pancreatic cancer.(37) The risk for development of non-melanoma skin cancers is also increased. Psoriasis increases the risk of developing squamous cell carcinoma of the skin by 431% and increases the risk of basal cell carcinoma by 100%.(37) There is no increased risk of melanoma associated with psoriasis.(37) People with psoriasis have a higher risk of developing cancer.(114)

Epidemiology(edit)

Psoriasis is estimated to affect 2–4% of the population of the western world.(8) The rate of psoriasis varies according to age, region and ethnicity; a combination of environmental and genetic factors is thought to be responsible for these differences.(8) It can occur at any age, although it most commonly appears for the first time between the ages of 15 and 25 years. Approximately one third of people with psoriasis report being diagnosed before age 20.(115) Psoriasis affects both sexes equally.(59)

Psoriasis affects about 6.7 million Americans and occurs more frequently in adults.(5)

Psoriasis is about five times more common in people of European descent than in people of Asian descent. (116)

People with inflammatory bowel disease such as Crohn disease or ulcerative colitis are at an increased risk of developing psoriasis.(45) Psoriasis is more common in countries farther from the equator.(45) Persons of white European ancestry are more likely to have psoriasis and the condition is relatively uncommon in African Americans and extremely uncommon in Native Americans.(46)

History(edit)

Scholars believe psoriasis to have been included among the various skin conditions called tzaraath (translated as leprosy) in the Hebrew Bible, a condition imposed as a punishment for slander. The person was deemed “impure” (see tumah and taharah) during their afflicted phase and is ultimately treated by the kohen.(117) However, it is more likely that this confusion arose from the use of the same Greek term for both conditions. The Greeks used the term lepra (λεπρα) for scaly skin conditions. They used the term psora to describe itchy skin conditions.(117) It became known as Willan’s lepra in the late 18th century when English dermatologists Robert Willan and Thomas Bateman differentiated it from other skin diseases. Leprosy, they said, is distinguished by the regular, circular form of patches, while psoriasis is always irregular. Willan identified two categories: leprosa graecorum and psora leprosa.(118)

Psoriasis is thought to have first been described in Ancient Rome by Cornelius Celsus.(119) The British dermatologist Thomas Bateman described a possible link between psoriasis and arthritic symptoms in 1813.(119)

The history of psoriasis is littered with treatments of dubious effectiveness and high toxicity. In the 18th and 19th centuries, Fowler’s solution, which contains a poisonous and carcinogenic arsenic compound, was used by dermatologists as a treatment for psoriasis.(117) Mercury was also used for psoriasis treatment during this time period.(117) Sulfur, iodine, and phenol were also commonly used treatments for psoriasis during this era when it was incorrectly believed that psoriasis was an infectious disease.(117) Coal tars were widely used with ultraviolet light irradiation as a topical treatment approach in the early 1900s.(117)(120) During the same time period, psoriatic arthritis cases were treated with intravenously administered gold preparations in the same manner as rheumatoid arthritis.(120)

Etymology(edit)

The word psoriasis is from Greek ψωρίασις, meaning “itching condition” or “being itchy”(121) from psora, “itch” and -iasis, “action, condition”.

Society and culture(edit)

The International Federation of Psoriasis Associations (IFPA) is the global umbrella organization for national and regional psoriasis associations and also gathers the leading experts in psoriasis and psoriatic arthritis research for scientific conferences every three years.(122) The Psoriasis International Network, a program of the Fondation René Touraine, gathers dermatologists, rheumatologists and other caregivers involved in the management of psoriasis.
Non-profit organizations the National Psoriasis Foundation in the United States, the Psoriasis Association in the United Kingdom and Psoriasis Australia offer advocacy and education about psoriasis in their respective countries.

Cost(edit)

The annual cost for treating psoriasis in the United States is estimated as high as $32.5 billion, including $12.2 billion in direct costs. Pharmacy costs are the main source of direct expense, with biologic therapy the most prevalent. These costs increase significantly when co-morbid conditions such as heart disease, hypertension, diabetes, lung disease and psychiatric disorders are factored in. Expenses linked to co-morbidities are estimated at an additional $23,000 per person per year.(123)

Research(edit)

The role of insulin resistance in the pathogenesis of psoriasis is under investigation. Preliminary research has suggested that antioxidants such as polyphenols may have beneficial effects on the inflammation characteristic of psoriasis.(124)

Many novel medications being researched(when?) target the Th17/IL-23 axis,(124) particularly IL-23p19 inhibitors, as IL-23p19 is present in increased concentrations in psoriasis skin lesions while contributing less to protection against opportunistic infections.(125) Other cytokines such as IL-17 and IL-22 also have been targets for inhibition as they play important roles in the pathogenesis of psoriasis.(125) Another avenue of research has focused on the use of vascular endothelial growth factor inhibitors to treat psoriasis.(61) Oral agents being investigated(when?) as alternatives to medications administered by injection include Janus kinase inhibitors, protein kinase C inhibitors, mitogen-activated protein kinase inhibitors, and phosphodiesterase 4 inhibitors, all of which have proven effective in various phase 2 and 3 clinical trials.(124)(125) These agents have potentially severe side-effects due to their immunosuppressive mechanisms.(125)

References(edit)

  1. ^ Jones D (2003) (1917). Peter Roach, James Hartmann, Jane Setter (eds.). English Pronouncing Dictionary. Cambridge: Cambridge University Press. ISBN 978-3-12-539683-8.
  2. ^ “Psoriasis”. Merriam-Webster Dictionary.
  3. ^ a b c d e f g h i j k Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, et al. (May 2008). “Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics”. Journal of the American Academy of Dermatology. 58 (5): 826–50. doi:10.1016/j.jaad.2008.02.039. PMID 18423260.
  4. ^ a b c d e f g h i j k l m n o p q r Boehncke WH, Schön MP (September 2015). “Psoriasis”. Lancet. 386 (9997): 983–94. doi:10.1016/S0140-6736(14)61909-7. PMID 26025581.
  5. ^ a b c “Questions and Answers About Psoriasis”. www.niams.nih.gov. 12 April 2017. Archived from the original on 22 April 2017. Retrieved 22 April 2017.
  6. ^ a b c d e f g h “Questions and Answers about Psoriasis”. National Institute of Arthritis and Musculoskeletal and Skin Diseases. October 2013. Archived from the original on 8 July 2015. Retrieved 1 July 2015.
  7. ^ GBD 2015 Disease and Injury Incidence and Prevalence Collaborators (October 2016). “Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015”. Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.
  8. ^ a b c d Parisi R, Symmons DP, Griffiths CE, Ashcroft DM (February 2013). Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. “Global epidemiology of psoriasis: a systematic review of incidence and prevalence”. The Journal of Investigative Dermatology. 133 (2): 377–85. doi:10.1038/jid.2012.339. PMID 23014338.
  9. ^ LeMone P, Burke K, Dwyer T, Levett-Jones T, Moxham L, Reid-Searl K (2015). Medical-Surgical Nursing. Pearson Higher Education AU. p. 454. ISBN 9781486014408.
  10. ^ Ely JW, Seabury Stone M (March 2010). “The generalized rash: part II. Diagnostic approach”. American Family Physician. 81 (6): 735–9. PMID 20229972. Archived from the original on 2 February 2014.
  11. ^ a b c d e f g h i Jain S (2012). Dermatology : illustrated study guide and comprehensive board review. Springer. pp. 83–87. ISBN 978-1-4419-0524-6. Archived from the original on 8 September 2017.
  12. ^ a b c d e Palfreeman AC, McNamee KE, McCann FE (March 2013). “New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast”. Drug Design, Development and Therapy. 7: 201–10. doi:10.2147/DDDT.S32713. PMC 3615921. PMID 23569359.
  13. ^ Colledge, N.R., Walker, B.R., Ralston, S.H., eds. (2010). Davidson’s principles and practice of medicine (21st ed.). Edinburgh: Churchill Livingstone/Elsevier. pp. 1260–1. ISBN 978-0-7020-3084-0.
  14. ^ a b James, William, Berger, Timothy, Elston, Dirk (2005). Andrews’ Diseases of the Skin: Clinical Dermatology (10th ed.). Saunders. pp. 191–7. ISBN 978-0-7216-2921-6.
  15. ^ Robinson A, Van Voorhees AS, Hsu S, Korman NJ, Lebwohl MG, Bebo BF, Kalb RE (August 2012). “Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis Foundation”. Journal of the American Academy of Dermatology. 67 (2): 279–88. doi:10.1016/j.jaad.2011.01.032. PMID 22609220.
  16. ^ a b c d e f g h Raychaudhuri SK, Maverakis E, Raychaudhuri SP (January 2014). “Diagnosis and classification of psoriasis”. Autoimmunity Reviews. 13 (4–5): 490–5. doi:10.1016/j.autrev.2014.01.008. PMID 24434359.
  17. ^ a b c d e f Rendon A, Schäkel K (March 2019). “Psoriasis Pathogenesis and Treatment”. International Journal of Molecular Sciences. 20 (6): 1475. doi:10.3390/ijms20061475. PMID 30909615.
  18. ^ a b c d Weigle N, McBane S (May 2013). “Psoriasis”. American Family Physician. 87 (9): 626–33. PMID 23668525.
  19. ^ a b c d Gudjonsson JE, Elder JT, Goldsmith LA, et al. (2012). “18: Psoriasis”. Fitzpatrick’s Dermatology in General Medicine (8th ed.). McGraw-Hill. ISBN 978-0-07-166904-7.
  20. ^ a b Gelmetti C (January 2009). “Therapeutic moisturizers as adjuvant therapy for psoriasis patients”. American Journal of Clinical Dermatology. 10 Suppl 1 (Suppl 1): 7–12. doi:10.2165/0128071-200910001-00002. PMID 19209948.
  21. ^ a b Zattra E, Belloni Fortina A, Peserico A, Alaibac M (May 2012). “Erythroderma in the era of biological therapies”. European Journal of Dermatology. 22 (2): 167–71. doi:10.1684/ejd.2011.1569. PMID 22321651.
  22. ^ Stanway A. “Erythrodermic psoriasis”. DermNet NZ. Archived from the original on 2 February 2014. Retrieved 16 March 2014.
  23. ^ a b c Yesudian PD, Chalmers RJ, Warren RB, Griffiths CE (January 2012). “In search of oral psoriasis”. Archives of Dermatological Research. 304 (1): 1–5. doi:10.1007/s00403-011-1175-3. PMID 21927905.
  24. ^ Greenberg MS, Glick M, Ship JA, eds. (2008). Burket’s oral medicine (11th ed.). Hamilton, Ont: BC Decker. pp. 103–4. ISBN 978-1-55009-345-2.
  25. ^ Reamy BV, Derby R, Bunt CW (March 2010). “Common tongue conditions in primary care”. American Family Physician. 81 (5): 627–34. PMID 20187599.
  26. ^ a b Chimenti MS, Saraceno R, Chiricozzi A, Giunta A, Chimenti S, Perricone R (April 2013). “Profile of certolizumab and its potential in the treatment of psoriatic arthritis”. Drug Design, Development and Therapy. 7: 339–48. doi:10.2147/DDDT.S31658. PMC 3633576. PMID 23620660.
  27. ^ a b Goldenstein-Schainberg C, Favarato MH, Ranza R (January–February 2012). “Current and relevant concepts in psoriatic arthritis” (PDF). Revista Brasileira De Reumatologia. 52 (1): 98–106. doi:10.1590/s0482-50042012000100010. PMID 22286649. Archived (PDF) from the original on 13 April 2014.
  28. ^ Krawczyk-Wasielewska A, Skorupska E, Samborski W (April 2013). “Sacroiliac joint pain as an important element of psoriatic arthritis diagnosis”. Postepy Dermatologii I Alergologii. 30 (2): 108–12. doi:10.5114/pdia.2013.34161. PMC 3834688. PMID 24278057.
  29. ^ a b Tan ES, Chong WS, Tey HL (December 2012). “Nail psoriasis: a review”. American Journal of Clinical Dermatology. 13 (6): 375–88. doi:10.2165/11597000-000000000-00000. PMID 22784035.
  30. ^ Krueger G, Ellis CN (July 2005). “Psoriasis–recent advances in understanding its pathogenesis and treatment”. Journal of the American Academy of Dermatology. 53 (1 Suppl 1): S94-100. doi:10.1016/j.jaad.2005.04.035. PMID 15968269.
  31. ^ a b c d e f g h i j k l m n o Nestle FO, Kaplan DH, Barker J (July 2009). “Psoriasis”. The New England Journal of Medicine. 361 (5): 496–509. doi:10.1056/NEJMra0804595. PMID 19641206.
  32. ^ Smith CH, Barker JN (August 2006). “Psoriasis and its management”. Bmj. 333 (7564): 380–4. doi:10.1136/bmj.333.7564.380. PMC 1550454. PMID 16916825. Archived from the original on 9 August 2016.
  33. ^ a b c d e f g Prieto-Pérez R, Cabaleiro T, Daudén E, Ochoa D, Roman M, Abad-Santos F (August 2013). “Genetics of psoriasis and pharmacogenetics of biological drugs”. Autoimmune Diseases. 2013 (613086): 613086. doi:10.1155/2013/613086. PMC 3771250. PMID 24069534.
  34. ^ Jordan CT, Cao L, Roberson ED, Duan S, Helms CA, Nair RP, et al. (May 2012). “Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis”. American Journal of Human Genetics. 90 (5): 796–808. doi:10.1016/j.ajhg.2012.03.013. PMC 3376540. PMID 22521419.
  35. ^ Jordan CT, Cao L, Roberson ED, Pierson KC, Yang CF, Joyce CE, et al. (May 2012). “PSORS2 is due to mutations in CARD14”. American Journal of Human Genetics. 90 (5): 784–95. doi:10.1016/j.ajhg.2012.03.012. PMC 3376640. PMID 22521418.
  36. ^ a b Clarke P (July 2011). “Psoriasis” (PDF). Australian Family Physician. 40 (7): 468–73. PMID 21743850.
  37. ^ a b c d e f g h Richard MA, Barnetche T, Horreau C, Brenaut E, Pouplard C, Aractingi S, et al. (August 2013). “Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion”. Journal of the European Academy of Dermatology and Venereology. 27 Suppl 3 (Supplement 3): 2–11. doi:10.1111/jdv.12162. PMID 23845148.
  38. ^ a b c Ko SH, Chi CC, Yeh ML, Wang SH, Tsai YS, Hsu MY (July 2019). “Lifestyle changes for treating psoriasis”. The Cochrane Database of Systematic Reviews. 7: CD011972. doi:10.1002/14651858.CD011972.pub2. PMC 6629583. PMID 31309536. CD011972.
  39. ^ a b c Cedeno-Laurent F, Gómez-Flores M, Mendez N, Ancer-Rodríguez J, Bryant JL, Gaspari AA, Trujillo JR (January 2011). “New insights into HIV-1-primary skin disorders”. Journal of the International AIDS Society. 14 (5): 5. doi:10.1186/1758-2652-14-5. PMC 3037296. PMID 21261982.
  40. ^ Fife DJ, Waller JM, Jeffes EW, Koo JY (May 2007). “Unraveling the paradoxes of HIV-associated psoriasis: a review of T-cell subsets and cytokine profiles”. Dermatology Online Journal. 13 (2): 4. PMID 17498423. Archived from the original on 21 April 2008.
  41. ^ a b Wong T, Hsu L, Liao W (January–February 2013). “Phototherapy in psoriasis: a review of mechanisms of action”. Journal of Cutaneous Medicine and Surgery. 17 (1): 6–12. doi:10.2310/7750.2012.11124. PMC 3736829. PMID 23364144.
  42. ^ Martin DA, Towne JE, Kricorian G, Klekotka P, Gudjonsson JE, Krueger JG, Russell CB (January 2013). “The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings”. The Journal of Investigative Dermatology. 133 (1): 17–26. doi:10.1038/jid.2012.194. PMC 3568997. PMID 22673731.
  43. ^ “Images of Memorable Cases: Case 34”. Connexions. Rice University. This AIDS patient presented with a pruritic eruption over most of his body
  44. ^ Fry L, Baker BS (2007). “Triggering psoriasis: the role of infections and medications”. Clinics in Dermatology. 25 (6): 606–15. doi:10.1016/j.clindermatol.2007.08.015. PMID 18021899.
  45. ^ a b c Guerra I, Gisbert JP (January 2013). “Onset of psoriasis in patients with inflammatory bowel disease treated with anti-TNF agents”. Expert Review of Gastroenterology & Hepatology. 7 (1): 41–8. doi:10.1586/egh.12.64. PMID 23265148.
  46. ^ a b c d e Weller R, John AA Hunter, John Savin, Mark Dahl (2008). Clinical dermatology (4th ed.). Malden, MA: Blackwell. pp. 54–70. ISBN 978-1-4443-0009-3.
  47. ^ a b c Ouyang W (December 2010). “Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease”. Cytokine & Growth Factor Reviews. 21 (6): 435–41. doi:10.1016/j.cytogfr.2010.10.007. PMID 21106435.
  48. ^ a b c d Parrish L (November 2012). “Psoriasis: symptoms, treatments and its impact on quality of life”. British Journal of Community Nursing. 17 (11): 524, 526, 528. doi:10.12968/bjcn.2012.17.11.524. PMID 23124421.
  49. ^ Baliwag J, Barnes DH, Johnston A (June 2015). “Cytokines in psoriasis”. Cytokine. Skin Disease, Immune Response and Cytokines. 73 (2): 342–50. doi:10.1016/j.cyto.2014.12.014. PMC 4437803. PMID 25585875.
  50. ^ Roberson ED, Bowcock AM (September 2010). “Psoriasis genetics: breaking the barrier”. Trends in Genetics. 26 (9): 415–23. doi:10.1016/j.tig.2010.06.006. PMC 2957827. PMID 20692714.
  51. ^ Ramos-e-Silva M, Jacques C (May–June 2012). “Epidermal barrier function and systemic diseases”. Clinics in Dermatology. 30 (3): 277–9. doi:10.1016/j.clindermatol.2011.08.025. PMID 22507041.
  52. ^ a b Dombrowski Y, Schauber J (May 2012). “Cathelicidin LL-37: a defense molecule with a potential role in psoriasis pathogenesis”. Experimental Dermatology. 21 (5): 327–30. doi:10.1111/j.1600-0625.2012.01459.x. PMID 22509827.
  53. ^ a b c Mudigonda P, Mudigonda T, Feneran AN, Alamdari HS, Sandoval L, Feldman SR (October 2012). “Interleukin-23 and interleukin-17: importance in pathogenesis and therapy of psoriasis”. Dermatology Online Journal. 18 (10): 1. PMID 23122008. Archived from the original on 31 March 2016.
  54. ^ Giang J, Seelen MA, van Doorn MB, Rissmann R, Prens EP, Damman J (2018). “Complement Activation in Inflammatory Skin Diseases”. Frontiers in Immunology. 9: 639. doi:10.3389/fimmu.2018.00639. PMC 5911619. PMID 29713318.
  55. ^ Johnson MA, Armstrong AW (April 2013). “Clinical and histologic diagnostic guidelines for psoriasis: a critical review”. Clinical Reviews in Allergy & Immunology. 44 (2): 166–72. doi:10.1007/s12016-012-8305-3. PMID 22278173.
  56. ^ Kunz M, Ibrahim SM (2009). “Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity”. Mediators of Inflammation. 2009: 979258. doi:10.1155/2009/979258. PMC 2768824. PMID 19884985.
  57. ^ “Application to Dermatology of International Classification of Disease (ICD-10)”. The International League of Dermatological Societies. Archived from the original on 9 July 2006.
  58. ^ Freedberg, Irwin M., Fitzpatrick, Thomas B. (2003). Fitzpatrick’s dermatology in general medicine (6th ed.). McGraw-Hill. p. 414. ISBN 978-0-07-138076-8.
  59. ^ a b Kupetsky EA, Keller M (November–December 2013). “Psoriasis vulgaris: an evidence-based guide for primary care”. Journal of the American Board of Family Medicine. 26 (6): 787–801. doi:10.3122/jabfm.2013.06.130055. PMID 24204077.